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New Routes to Planar Chiral Ligands and their Use in Asymmetric Catalysis 
Abstract 
This thesis contains 8 chapters detailing 3 optimised methods to synthesise 
[2.2]paracyclophane derivatives and our studies in the C-H activation field, namely selective 
remote β-C-H activation of cyclic amines, and enantioselective γ-C(sp3)-H functionalisation of 
cyclic amines, as well as a future direction. 
As the main focus of this thesis is on the development of novel planar chiral 
[2.2]paracyclophane derivatives, Chapter 1 starts with a brief description of 
[2.2]paracyclophane chemistry. A short introduction about the synthesis of key 
enantioenriched [2.2]paracyclophane derivatives is given. Finally, a short introduction of the 
recent applications of [2.2]paracyclophane-based ligands in asymmetric catalysis is also 
mentioned. 
Chapter 2 describes the synthesis of (RSp,SRP)-4-tert-butyl[2.2]paracyclophane phosphine 
oxide (SPO) and attempts to synthesise its asymmetric variant. Further, its synthetic utility is 
investigated, mainly in Suzuki-Miyaura cross-coupling, Buchwald-Hartwig amination, and 
Au(I)-catalysed cyclisation reactions. Additionally, a general route to the P-stereogenic 
[2.2]paracyclophane-derived phosphines via the reduction of tertiary phosphine oxides is 
reported. 
Chapter 3 mainly outlines attempts for β-C(sp3)-H activation of cyclic amine to target the 
shortest route of epibatidine moiety. A stepwise approach is mentioned. Firstly, a range of 
heteroatom-substituted secondary phosphine oxides (HASPOs) is evaluated to access (chiral) 
indolines via intramolecular C(sp3)-H activation. Next, an intramolecular C(sp3)-H activation 
of 7-azanorbornane, a core skeleton of epibatidine, is investigated. The third approach is mainly 
targeted for the directing-group-assisted intermolecular C(sp3)-H activation of 7-
azanorbornane. Lastly, enantioselective γ-C(sp3)-H activation of N-cyclohexylpicolinamide 
using various chiral Brønsted acids, again targeting the epibatidine moiety by the late-stage 
cyclisation, is described.  
In a search for suitable planar chiral Brønsted acid, an optimised single-step protocol for the 
synthesis of [2.2]paracyclophanes carboxylic acid derivatives is reported in Chapter 4. This 
XI 
 
protocol proceeds via C(sp2)-H activation of chiral oxazolines and their coupling with 
bromo[2.2]paracyclophanes.  
Chapters 5 & 6 are related to pyridine sulfinates. Chapter 5 describes an attempted 
regioselective C-H functionalisation of aromatic acids via desulfitative coupling with pyridine-
2-sulfinate. A detailed study with catalytic Pd(OAc)2 and pre-formed palladacycle is 
mentioned. The effect of catalytic Pd(OAc)2 on homo-coupling of pyridine-2-sulfinates is also 
investigated.  
The potential of sulfinates as nucleophilic coupling partners is investigated in Chapter 6. A 
novel methodology to synthesise pyridyl[2.2]paracyclophanes is described. The method 
involves desulfitative cross-coupling reactions between pyridine sulfinates and 
bromo[2.2]paracyclophanes. One of the interesting results of the desulfitative coupling with 
the unreactive (±)-4-bromo-5-amino[2.2]paracyclophane is also mentioned. 
Chapter 7 explains the future scope of the research work mentioned in this thesis. 
Finally, Chapter 8 describes the experimental procedures and characterisation of the 





Chapter 1   




1.0.  Introduction  
At the heart of organic chemistry is the ability to synthesise new molecules with specific 
properties, be they pharmaceuticals, agrochemicals, or new materials for energy conversion 
and storage. These novel molecules are crucial to the functioning of modern society. Gone are 
the days when a chemist’s goal was to simply make a compound. Now, the goal is to prepare 
these molecules in an efficient manner on a large enough scale to feed progress and to perform 
this without undue impact on the environment. The key to achieving these goals lies in catalysis 
or the synthesis of replenishable reagents. Catalysts would aim to increase the rate of some 
reactions and control the selectivity in others. Ultimately, they permit new molecules to be 
formed with less wasted material or energy. 
 
Chirality or handedness is a prerequisite for life. Without this uniformity in biological 
molecules, life would not exist. A chiral enantioenriched catalyst can alter the selectivity of a 
reaction in order to bias a reaction towards the synthesis of a single-handed product. In fact, 
nature has selected enantioselective catalysis as its means of creating chirality.1 Despite the 
significant progress that has been achieved by chemists, asymmetric catalysis remains a 
fledgling field.2 Most catalytic reactions lack generality, working for specific examples only. 
Chemists are also missing key information about many of the processes involved in asymmetric 
catalysis, especially how chiral information is communicated from the catalyst to the product. 
As a result, there is still considerable research that needs to be undertaken in the area of 
asymmetric catalysis.  
1.1.  Asymmetric catalysis 
 
The careful selection of a suitable chiral backbone has become a crucial step in the synthesis 
of any modern chiral ligand for asymmetric catalysis.3 Several natural building blocks have 
been widely exploited in the development of chiral ligands, although this can lead to limitations 
if only one enantiomer is naturally available.4  
Asymmetric catalysts do not solely depend on ‘centres’ of chirality.5 Axial and planar chirality 
were introduced in the middle of the last century and are found in an increasing number of 
chiral compounds devoid of a tetrahedral stereocentre.6 Some of the commonly used ligands 
possessing  non-traditional chirality are axially chiral binaphthalene derivatives,7 planar chiral 
ferrocene derivatives,8,9 and planar chiral arene transition metal complexes.10,11 Recently, 
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planar chiral cyclophanes have also attracted considerable interest due to their unusual 
structural and electronic properties.12,13 Cyclophanes offer a well-defined, three-dimensional 
structure suited for chiral induction and these characteristics are being harnessed in the 
formation of planar chiral functional materials.14,15  
 
This thesis covers the chemistry we have developed for the synthesis of planar chiral secondary 
phosphine oxides (SPO), planar chiral oxazolines, and pyridine derivatives as well as our 
studies in the field of C-H activation. Each topic is introduced at the beginning of the 
appropriate chapter. As the whole thesis centres on the planar chiral [2.2]paracyclophane 
scaffold, the key objective of this general introduction is to provide a brief literature overview 
on [2.2]paracyclophane chemistry. The following discussion is divided into different sections 
dealing with the single-crystal structure of [2.2]paracyclophane with fundamental properties 
(Section 1.2) and the synthesis of key enantioenriched [2.2]paracyclophane derivatives 
(Section 1.3). Though planar chiral [2.2]paracyclophanes have been largely exploited in 
catalysis, the biomedical field,16,17 and materials science,18 the applications discussed here are 
mainly limited to asymmetric catalysis (Section 1.4). 
1.2. [2.2]Paracyclophane  
 
[2.2]Paracyclophane19-27 comprises of two eclipsing aryl rings or decks held rigidly in place at 
the para positions by two ethylene groups (Figure 1.1, Structure 1.1). The discovery of this 
molecule is considered rather serendipitous. In 1947, Micheal Szwarc of the University of 
Manchester was conducting pyrolysis-type experiments on p-xylene. During this experiment, 
he observed a di-p-xylene impurity in a vapour decomposition product poly(para-xylene).28 
This impurity is now known as [2.2]paracyclophane. Two years later, the X-ray crystal 






Figure 1.1. Single crystal structure of [2.2]paracyclophane (left) and same at bond lengths and angles 





According to the X-ray crystal structure of [2.2]paracyclophane, the two aromatic rings are 
distorted out of the plane.29 A strong repulsion between the two decks leads to distortion giving 
a shallow boat-like conformation. The close proximity of these rings leads to transannular π-π 
strain in the aromatic rings. The separation of these rings is less than the sum of the van der 
Waals radii for carbon (3.40 Å) and ranges from 2.78 Å for the bridgehead for carbon (C3-
C14) to a maximum of 3.09 Å between C4-C13. This rigid structure results in the bridgehead 
σ bonds (C1-C2 and C9-C10) being held almost perpendicular to the aryl rings allowing a 
strong σbridge-π interaction as observed by the lengthening of the C-C bond (1.63 Å cf.- 1.54 Å 
in ethane). The bond angle of C-Cbridge to aromatic bond (inner) is 113.7°, which is greater than 
the normal tetrahedral bond angle of 109.5°. The bond strain energy of [2.2]paracyclophane is 
129.8 kJ/mol.  
The unusual electronic and distortion of [2.2]paracyclophane rings increase the nucleophilicity 
of the aromatic ring and it undergoes electrophilic substitution more rapidly than analogous 
aryl systems. It also has the ability to form π-complexes. [2.2]Paracyclophane derivatives are 
generally robust, crystalline, stable towards light, mild acids, bases, and thermally stable up to 
160-180 °C. The [2.2]paracyclophane framework acts as a bulky shield and planar chirality 
can be introduced by the addition of single substituents. With the appropriate steric bulk, the 
chiral environment can be properly modulated on the [2.2]paracyclophane framework for 
catalysis.26,30,31 
1.2.1. π-complexes and transannular effect 
A study by Cram and Singer revealed that the transannular effect plays a role in the formation 
of π-complexes with [2.2]paracyclophane.32 According to the studies, the complexes formed 
between [2.2]paracyclophane and tetracyanoethylene (TCNE) are more stable than the 
analogous aryl complexes (Figure 1.2). The substituents on  the [2.2]paracyclophane greatly 
affect the stability of these complexes. Derivatives with electron-donating substituents are 
found to be more stable than those with electron-withdrawing groups. This is thought to be due 
to complexes with electron-donating groups on the substituted ring being able to participate in 
the π-π interaction with TCNE, while in [2.2]paracyclophanes containing an electron-
withdrawing group, the unsubstituted ring is more likely to be directly associated with TCNE. 
Due to the π-cloud system present in [2.2]paracyclophane, reactions taking place on one 
aromatic ring can be influenced by electronic effects exerted by the substituents on the second 




Figure 1.2:  π-π Complexes between TCNE and [2.2]paracyclophane with electron-donating group 
(EDG) X and electron withdrawing group (EWD) Y. 
 
1.2.2. Configuration of [2.2]paracyclophane 
The assignment of Rp and Sp for [2.2]paracyclophane is designated by choosing a plane that 
contains as many of the atoms of the molecule as is possible.33 As depicted in Figure 1.3, the more 
substituted benzene ring is considered as the chiral plane. To determine the descriptor, the 
chiral plane is viewed from the out-of-plane atom closest to the plane. If there are two or more 
candidates, the one closest to the atom of higher priority is chosen according to the Cahn–
Ingold–Prelog (CIP) system34,35 of the stereochemical assignment. This pilot atom is assigned 
as carbon atom number one for cyclophane nomenclature. When viewed from the pilot atom, 
if atoms a, b, and c are in a clockwise array, the descriptor is Rp and if the array is 
counterclockwise, the descriptor is Sp, where subscript P ( p ) denotes planar chirality. For 
example, the carboxy[2.2]paracyclophane shown in figure 1.3 is Sp. 
 




1.3. Enantioenriched [2.2]paracyclophanes  
For the synthesis of enantiopure compounds, two common methods have been used. The first 
is the resolution of racemates while the second is the synthesis of a single enantiomer using an 
asymmetric catalyst. Even though the latter method allows the synthesis of one enantiomer 
preferentially, thus avoiding the undesired enantiomer, the reports based on this concept are 
sparse.36 Most of the methodologies that rely on the concept of classical resolution are tedious 
and costly. The section below summarises some of the methods to resolve commonly employed 
enantiomerically enriched [2.2]paracyclophane derivatives (Figure 1.4). 
 
Figure 1.4: Monosubstituted [2.2]paracyclophane derivatives. 
Qunici et al. developed a method for the resolution of (±)-4-formyl[2.2]paracyclophane 1.6.37 
(R)-(+)-α-Methylbenzylamine was reacted with (±)-1.6 to form diastereoisomeric imines 
(Scheme 1.1). A single crystallisation of the crude product resulted in the crystals being 
enriched in the (R,Sp) diastereoisomer 1.8. The pure (R,Sp) diastereoisomer was obtained by 
the second crystallisation in ≥98% de (diastereomeric excess). Hydrolysis on silica gel during 
column chromatography gave (Sp)-(+)-1.6 in ≥98% ee (enantiomeric excess) and 20% isolated 
yield. However, the enantiomer (Rp)-(–)-4-formyl[2.2]paracyclophane 1.6 was not isolated 
during this procedure. To obtain the Rp enantiomer [(Rp)-(–)-1.6], an alternative method was 
employed. In this method, (±)-4-formyl[2.2]paracyclophane 1.6 was reacted with (S)-(+)-1-
phenyl-2-(p-tolyl)ethylamine and repeated crystallisation of the diastereomeric imine followed 




Scheme 1.1: Resolution of (±)-4-formyl[2.2]paracyclophane 1.6. i) (R)-(+)-α-Methylbenzylamine, ii) 
hydrolysis on silica, iii) (S)-(+)-1-phenyl-2-(p-tolyl)ethylamine, iv) Hydrolysis. 
 
The most efficient way to date for the synthesis of an enantiopure carboxylic acid was 
established by Rozenberg et al. (Scheme 1.2).38 This involves the resolution of (±)-1.5 by 
diastereomeric salt formation with (S)-(–)-α-(p-nitrophenyl)ethylamine. The less soluble (S,Sp) 
salt 1.10 crystallises from chloroform at -5 °C and subsequently by neutralising with 
hydrochloric acid,  gives (Sp)-(+)-4-carboxy[2.2]paracyclophane 1.5 in 32% yield. 
Concentrating the mother liquor provides (S,Rp) diasteroisomeric salt 1.10 and once 
hydrolysed, gives (Rp)-(–)-4-carboxy[2.2]paracyclophane 1.5 in 84% ee and 24% yield. 
 
Scheme 1.2: Resolution of (±)-4-carboxy[2.2]paracyclophane 1.5  i) (S)-(–)-α-(p-
nitrophenyl)ethylamine, ii) HCl(aq.). 
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The resolution of (±)-4-hydroxy[2.2]paracyclophane 1.7 was achieved via an ester formation 
with (1S,4R)-(–)-camphanoyl chloride (Scheme 1.3).39 The first recrystallisation from ethyl 
acetate produced (1S,4R,Rp) diastereoisomer 1.11 with a de >95%. The (1S,4R,Sp) 
diastereoisomer 1.11 can be obtained after a series of crystallisations from the mother liquor in  
≥99% de. The diastereomeric esters can then be reduced separately with lithium aluminium 
hydride, to afford enantiopure (Rp)-(+)-1.7 and (Sp)-(–)-1.7 (11% isolated yield, >99% ee). 
 
Scheme 1.3: Resolution of (±)-4-hydroxy[2.2]paracyclophane 1.7  i) (1S,4R)-(–)-camphanoyl 
chloride, ii) LiAlH4. 
 
Disubstituted [2.2]paracyclophane ligands carrying substituents on the same aromatic ring are 
better ligands than the analogous monodentate ligands. The majority of such bidentate ligands 
that have two substituents on the same aromatic ring are derived from (Sp)- or (Rp)-5-formyl-
4-hydroxy[2.2]paracyclophane (FHPC) 1.12. This aldehyde (±)-1.12 can be resolved by 
complexation with Cu(ClO4)2 and the dipeptide, H2N-Val-Val-OH in presence of sodium 
isopropoxide to give 1.13a and 1.13b (Scheme 1.4).40 (Rp)-(+)-FHPC 1.12 can be isolated in 
86% ee and 17% yield after the complex crystallises at a low temperature followed by 
hydrolysis. Purification of the second diastereomeric complex required flash column 




Scheme 1.4: Resolution of (±)-FHPC 1.12 i) Cu(ClO4)2, H2N-Val-Val-OH, sodium isopropoxide. 
1.4.  Recent applications of [2.2]paracyclophane in asymmetric catalysis 
This section explains different substituents on [2.2]paracyclophane and how they are exploited 
as chiral ligands in asymmetric catalysis. [2.2]Paracyclophane derivatives are intrinsically 
planar chiral, and they have been utilised as chiral auxiliaries, reagents and ligands in 
enantioselective synthesis as outlined in reviews by Gibson,33 Rozenberg,12 Rowlands,26 
Paradies41, and Bräse.18  
The majority of [2.2]paracyclophane ligands reported so far are based on one of the four 
different substitution patterns (mono 1.14, ortho 1.15, pseudo-ortho 1.16, pseudo-geminal 




Figure 1.5. [2.2]Paracyclophane substitution patterns. 
 
The pseudo-ortho position 1.16 is commonly exploited in asymmetric catalysis due to its 
characteristic chiral pocket. Ortho-[2.2]paracyclophane derivatives 1.15 are also widely 
explored since they can be easily prepared from the monosubstituted derivatives. The pseudo-
gem-[2.2]paracyclophane derivatives 1.17 can also be easily synthesised as the transannular 
effect facilitates regioselective bromination on the monosubstituted derivatives containing O-
basic substituents such as nitro, carboxy, and acetyl groups. The oxygen atom of these 
functionalities acts as an intramolecular base to accept the proton from the pseudo-gem position 
in the σ-complex to facilitate electrophilic aromatic bromination (Scheme 1.5). The first step 
of dearomatisation-aromatisation is a fast, reversible process. Of note, the mechanism differs 
from the electrophilic aromatic bromination of benzene, in which the first step involving attack 
of brominium cation is the rate-determining step. This pseudo-gem bromo functionality can be 
further transformed into a variety of other functional groups.  
 





1.4.1. Planar chiral [2.2]paracyclophane-derived phosphine ligands  
 
The planar chirality of [2.2]paracyclophane 1.1 has been known since 1955, yet it was not until 
the 1990s that this chirality was exploited in the field of asymmetric catalysis. The first 
application was reported by Pye and Rossen in 1997 for [2.2]paracyclophane-based 
bisphosphine ligand. Amongst the various ligands, (Sp)-phanephos 1.23 is the most successful 
[2.2]paracyclophane-based ligand to date.42 It is similar to the axially chiral bisphosphine 
ligand BINAP 1.24,43 which has also been extensively employed in asymmetry synthesis as a 
ligand for many enantioselective transformations (Figure 1.6).  
 
Figure 1.6. (Sp)-Phanephos 1.23 and (R)-BINAP 1.24. 
 
(Sp)-Phanephos 1.23  was first applied in the enantioselective hydrogenation of dehydroamino 
acid methyl ester 1.25 by forming the triflate salt with rhodium(I) (Rp)-1.27 under extremely 
mild conditions and the product was isolated in 99.6% ee (Scheme 1.6).42 This planar chiral 
catalyst has proven efficient under milder conditions compared to many other chiral 
bisphosphine catalysts. It is worth mentioning that the previous benchmark catalysts require 
more harsh conditions e.g. (R)-BINAP 1.24 required 70 atm. 40 °C for 24 hrs to give the 
reduction product in 56% ee. Dow Chemical Ltd. now uses (Sp)-Phanephos 1.23 on an 
industrial scale for the hydrogenation of ketones, using a catalyst loading as low as 0.001% on 
a scale of hundreds of kilogrammes.44  
 
Scheme 1.6: Enantioselective hydrogenation of dehydroamino acid methyl ester 1.25. 
12 
 
Below are the some examples of recently developed [2.2]paracyclophane-based ligands and 
their applications in asymmetric catalysis. 
 
A range of planar chiral pseudo-ortho-substituted-[2.2]paracyclophane-phosphine-phenol 
catalysts were synthesised and studied in the aza-Morita-Baylis-Hillman (MBH) reaction of 
aldimines 1.29 with vinyl ketones 1.28 by Takenaga et al (Scheme 1.7a).45 Of these catalysts, 
the one with the phosphino group in the meta-position of the aryl spacer group and hydroxyl 
functionality at the pseudo-ortho position 1.31 was found to be the most efficient. Here, the 
synergistic interaction of functional groups in the catalyst controls the proton transfer step and 
hence the enantioselectivity (Scheme 1.7b). The key characteristic of this catalyst is to produce 
the aza-MBH adducts 1.30 with an unprecedented short reaction time (5-30 min.-) and good 
enantioselectivity (93% ee). 
 
 
Scheme 1.7a: Aza-MBH reaction catalysed by [2.2]paracyclophane-based phosphine-phenol.  
 
 




Inspired by the success of axially chiral BINOL ligand and central chiral TADDOL 
phosphoramidate in asymmetric catalysis, Jiang et al. demonstrated the synthesis of a planar 
chiral [2.2]paracyclophane phosphoramidite.46 In their initial attempt, the PHANOL 
framework 1.34 (pseudo-ortho dihydroxy derivatives) was too rigid to synthesise planar chiral 
phosphoramidite. Later, the additional phenyl spacer was introduced to impart flexibility and 
the desired ligands were synthesised. All of the newly synthesised ligands were screened in the 
copper-catalysed asymmetric conjugate addition of diethylzinc to chalcones 1.41 with a low 
catalyst loading of 1.0 mol% and the products 1.42 were obtained with high enantioselectivity 




Scheme 1.8: Preparation of chiral phosphoramidite ligands and their application to copper-




1.4.2. Planar chiral [2.2]paracyclophane-derived N-heterocyclic carbene ligands  
Bolm et al. reported the first carbene precursors derived from the [2.2]paracyclophane 
framework.47 Since then many other examples have been reported.   
Recently, Wang et al. synthesised new [2.2]paracyclophane oxazoline-NHC ligands 1.43-1.45 
derived from L-valinol with planar and central chirality (Scheme 1.9).48 The main purpose of 
this study was to evaluate the effect of various substituents on the catalytic outcome of the 
different complexes. The oxazoline-carbene copper complex generated in-situ by the reaction 
of the oxazoline-substituted imidazolium (S,Sp)-1.43 and CuO demonstrated an exceptionally 
high catalytic activity in the asymmetric 1,2-silylation of N-tosylaldimines 1.46, affording 
chiral α-amino silanes 1.48 with excellent yields and enantioselectivities. The presence of an 
oxazoline ring had a major influence on the enantioselectivity of the products. Without it, the 
unsubstituted [2.2]paracyclophane-carbene ligand (Sp)-1.45 catalysed the reaction but failed to 
induce high selectivity. The authors reasoned that the inhibition of free rotation around the C-
N bond led to conformational stability of the copper complex with oxazoline-carbene bidentate 
ligand (S,Sp)-1.43 over the monodentate carbene ligand 1.45.  
 
 
Scheme 1.9: Evaluation of [2.2]paracyclophane oxazoline-carbene ligands in the asymmetric 1,2-
silylation of N-tosylaldimines. 
 
Fluorine-substituted [2.2]paracyclophane-based carbene precursor (R,Rp)-1.51 was reported by 
Wang et al. (Scheme 1.10).49 The main aim of this study was to investigate the effect of a 
fluorinated [2.2]paracyclophane backbone and the corresponding stereoelectronic effect on 
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catalytic activity. The copper-catalysed asymmetric β-boration of α,β-unsaturated ketones 1.49 
to form chiral β-boryl ketones 1.50 was selected as a model reaction. It was observed that 
fluorination of the planar chiral carbene has a significant effect on the catalytic performance of 
the NHC-copper complex. A high conversion rate and good enantioselectivity (up to 99% ee) 
were achieved with the planar chiral imidazolium salts.  
 
 
Scheme 1.10: Effect of fluorine-substituted [2.2]paracyclophane-based NHC in the asymmetric β-
boration of α,β-unsaturated ketones. 
 
Sankararaman and co-workers explored the reactivity of [2.2]paracyclophane-based chiral 
mesoionic carbene (MIC) metal complex in catalytic asymmetric hydrogenation (Scheme 
1.11).50 [2.2]Paracyclophane-based 1,2,3-triazole-5-ylidene-Pd complex 1.54 possessing labile 
acetonitrile (CH3CN) ligand was synthesised and characterised. This complex 1.54 showed 
good enantioselectivity in the hydrogenation of prochiral alkene 1.52 at ambient conditions and 
1.0 atmosphere of H2. 
 
Scheme 1.11: Application of planar chiral NHC complex in catalytic asymmetric hydrogenation. 
1.4.3. Planar chiral [2.2]paracyclophane-derived N,O-chelating ligands  
 
Bräse and Schafer et al. have recently shown the potential of [2.2]paracyclophane-containing 
mono- and tethered bis(amide) ligands (Sp)-1.55 and (Sp)-1.56 in translating their planar 
chirality into central chirality of a hydroamination product (Scheme 1.12).51 These amides act 
as potent chelating ligands for titanium- and zirconium-catalysed hydroamination of 
aminoalkenes. The substrate 1.57 produced the hydroamination product 1.58 with 
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hydroaminoalkylation by-product 1.59 (from C-H activation). The ligand (Sp)-1.56 with 
Ti(NMe2)4 proved superior forenantioselectivity (68% ee) and chemoselectivity (1.58 vs. 1.59: 
36% vs. 6%) albeit in moderate yield and long reaction time. The reactivity of monoamide 
ligand (Sp)-1.55 was excellent (95%) but failed to induce any enantiocontrol. The authors 
speculated the lack of enantiocontrol was due to free rotation of [2.2]paracyclophane 
framework, even though the 1,3-N,O-ligand is chelated to the metal center.    
 
Scheme 1.12: Amido[2.2]paracyclophane-catalysed hydroamination reaction.  
The general introduction above provides a brief overview of [2.2]paracyclophane derivatives 
and their potential in the stereoselective synthesis. Despite the recent advancements in 
[2.2]paracyclophane chemistry, the main limitation is the lack of elegant methods to sythesise 
the enantiomerically pure planar chiral derivatives. There are still many opportunities to 
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2.0. Secondary phosphine oxides: strategy and objectives 
The first objective of this project was to synthesise new planar chiral secondary phosphine 
oxides (SPOs) based on the [2.2]paracyclophane framework (Scheme 2.1). These SPO ligands 
will be used to create new palladium and gold catalysts. Further, these new compounds will be 
screened for a range of key reactions as ligands in transition-metal catalysis. 
 
Scheme 2.1: Synthesis of new planar chiral secondary phosphine oxides and phosphines with 
[2.2]paracyclophane backbone.  
 
The second objective was the development of new methodologies that would permit 
enantiospecific synthesis of SPOs and their subsequent conversion into chiral phosphines. The 
latter will be achieved by derivatisation of both the [2.2]paracyclophane framework and the 
secondary phosphine functionality. This manipulation of the core structure should allow the 
modular synthesis of a range of ligands in which the properties of the molecule have been tuned 
to match a particular reaction (Scheme 2.2). The new SPOs and phosphines will be screened 




Scheme 2.2: Modular synthesis of a range of ligands. 
Realising both of these objectives will permit the creation of a modular family of ligands in 
which the steric and electronic characteristics can be systematically varied. This stereochemical 
information is crucial to the rational design of new catalysts. Before discussing our attempts to 
achieve these two objectives, it is worth discussing about chiral phosphorus ligands, 
specifically, SPOs and phosphines. 
 
2.1.  Chiral phosphorus ligands 
Phosphorus is an abundant element that forms many useful compounds. Organophosphorus 
molecules normally exist in one of two oxidation states, P(III) and P(V), and these have been 
used in a diverse range of applications including geochemistry,1 pharmaceuticals,2-4 catalysis,5 
materials,6-8 extracting agents for hydrometallurgy,9 and chemical reagents.10 P-Chirogenic 
compounds have been exploited in the synthesis of  ligands for asymmetric catalysis.11  
Phosphorus-based ligands and their chiral versions are most commonly employed due to their 
inherent ability to strongly coordinate to transition metals. Moreover, they are configurationally 
stable due to the restricted pyramidal inversion at phosphorus. The phosphorus lone pair has 
greater s-character than p-character, and inversion must pass through a planar intermediate in 
which the lone pair is in a p-orbital. Interconversion between s and p orbital is difficult.   
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2.1.1. Secondary phosphine oxides  
 
Phosphines are the most important type of ligands in transition-metal-catalysed reactions.12 
The number of known transition-metal complexes containing phosphine ligands is truly 
immense and include monodentate, bidentate, tridentate, and higher chelating phosphines, as 
well as a great variety of diverse substituents on phosphorus.13-15 However, many phosphines 
are sensitive to aerial oxidation and moisture, which makes them difficult to handle.16 
Secondary phosphine oxides (SPOs) are seen as a potential solution to these issues.17 They are 
widely used in homogeneous metal catalysis due to their strong donor properties. They can also 
be precursors to chiral phosphines via cross-coupling,18 nucleophilic substitution,19 or 
alkylation20-22 reactions. Organometallic complexes can also be synthesised using SPOs as 
ligands.23 
SPOs are air-stable pentavalent phosphorus species 2.11 that exist in equilibrium with the 
trivalent phosphinous acid 2.12 (Scheme 2.3). The equilibrium strongly favours the P(V) 
species until a transition metal is added, the equilibrium is then shifted towards the formation 
of P(III) monodentate ligand 2.14. SPOs can form bimetallic species 2.15 & 2.16 by 
coordinating late-transition metals through the ‘soft’ phosphorus atom and early-transition 
metals through the ‘hard’ oxygen atoms or they can ‘self-assemble’ into a bidentate ligand 2.13 
through a hydrogen-bonding or as a bimetallic bidentate complex 2.15.  These complexes have 
been shown to exhibit interesting reactivity in which the strongly electron-donating OH group 




Scheme 2.3: Tautomeric equilibrium and SPO complexes. 
Achiral SPOs have been used as ligands in various transformations such as iridium-catalysed 
hydrogenation,29  hydrolysis of nitriles,30 amidation of nitriles31 and in palladium-catalysed 
coupling reactions and C-H activation.32 However, the synthetic accessibility of enantiopure 
SPOs is a fundamental challenge. Only a few examples of asymmetric transformations with 
enantioenriched SPO have been reported.14,33 
Fiaud et al. employed secondary phosphine oxide 2.20 in a Rh-catalysed asymmetric 
hydrogenation of (Z)-methyl-acetamido-cinnamate 2.17 (Scheme 2.4).34 Interestingly, in this 
study, the solvent used had a profound impact on the stereochemical outcome of hydrogenation. 
In methanol, a polar protic solvent, full conversion to the S-enantiomer 2.18 was observed in 
83% ee. The same catalyst in dichloromethane gave the opposite R-enantiomer 2.19 in 24% ee. 
Though the exact reason is not known, the authors suggested a different equilibrium between 




Scheme 2.4: Rh-catalysed hydrogenation reaction with (R,R)-2.20 and Rh(COD)2BF4. 
 
Recently, heteroatom-substituted secondary phosphine oxides, (HASPOs) have emerged as 
useful ligands. Ackermann demonstrated that some N–P–N-type HASPOs 2.22 behave as 
excellent ligands in various reactions (Figure 2.1).35,36  
 
Figure 2.1: Heteroatom-substituted secondary phosphine oxides, (HASPOs). 
Cramer and co-workers reported the use of HASPO 2.25 in the hydrocarbamoylation of alkenes 
2.23 to synthesise chiral γ-lactams 2.24 (Scheme 2.5).37 In this reaction, the HASPO supports 
two metals, which work in concert to promote the reaction. The key to achieving high 
enantioselectivity is the chiral N–P–N-type SPO 2.25 possessing large 1-naphthyl and t-butyl 
substituents in a pseudo C2-symmetric fashion. The authors postulated that AlMe3 coordinates 
the oxygen of the phosphinous acid form of the ligand 2.25 and releasing methane gas while 
retaining its Lewis acidic character. Subsequently, AlMe3 activates the carbonyl of substrate 
2.23 and hence activates the formamide C-H bond. [Ni(COD)2] can now oxidatively insert into 
the activated C-H bond to form a six membered bimetallic heterocycle 2.26. The resulting 








Phosphines are extensively employed as ligands,38 reagents,39 and in catalysis38 for preparing 
various pharmaceuticals, functional materials, and fine chemicals. Trivalent phosphines are 
used in various classic organic transformations, such as the Mitsunobu reaction,40 and the 
Appel reaction.41 Such phosphines are also of special interest as ligands for diverse transition-
metal catalysed reactions.42  
Chiral phosphines are classified into two categories, P-chiral phosphines and backbone chiral 
ligands. P-Chiral phosphines possess the stereogenic centre on the phosphorus atom (Figure 
2.2).42 They have limited use due to a lack of efficient synthetic methods to form enantiopure 
P-chiral phosphines.  
 
Figure 2.2: Representative examples of P-chiral phosphine ligands. 
The majority of phosphines employed in asymmetric transformations have chiral 
frameworks.43 This chiral backbone possesses either point, planar or axial chirality. In this type 
of molecules, two substituents on the phosphorus atoms are diastereotopic and are capable of 
26 
 
inducing an asymmetric environment around the reaction centre. Selected examples of ligands 
with a chiral backbone which have been applied in homogeneous catalysis are shown in Figure 
2.3. 
 
Figure 2.3: Selected phosphine ligands for industrial homogeneous catalysis. 
Currently, four major methods are used for the synthesis of phosphines: (1) substitution 
reactions of P-Cl derivatives with nucleophiles; (2) substitution of electrophiles with alkali 
metal phosphides; (3) phosphination of alkenes, alkynes, or aromatic halides; and (4) reduction 
of phosphine oxides.  
The first approach is mostly limited to the reactions of chlorophosphines 2.36 with Grignard 
or organolithium reagents (Scheme 2.6).44 
 
Scheme 2.6: Substitution reactions of P-Cl derivatives with nucleophiles. 
The second approach uses the reaction of an alkali metal with diaryl-, diarylhalo-, or 
triarylphosphines 2.39 (Scheme 2.7).45 This strategy has the advantage that many 
triarylphosphines are commercially available. Others are readily made following the first 
approach. The reductive cleavage of triarylphosphines is the commonly used methodology but 
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is especially difficult to scale up since it requires sodium dispersions in oil. Classic metal 
ammonia reduction also introduces problems of handling, over-reduction, and operational 
safety.  
 
Scheme 2.7: Substitution of electrophiles with alkali metal phosphides. 
The third approach involves C-P cross-coupling of alkenes, alkynes, or aromatic halides with 
phosphine 2.42 or a phosphine-borane (Scheme 2.8).46  
 
Scheme 2.8: C-P cross-coupling. 
Synthesis of phosphines by the fourth approach - reduction of phosphine oxides is limited by 
the use of an excess of sensitive and/or highly expensive reducing agents, e.g. LiAlH4, DIBAL-
H or HSiCl3/Et3N, and HSiCl3/PhSiH3 (Scheme 2.9).
47 Due to harsh reaction conditions, only 
poor functional group tolerance is achieved.  
 
Scheme 2.9: Reduction of phosphine oxides. 
All of the above methods require multistage procedures, sensitive organometallic reagents, 
anhydrous conditions, and an inert atmosphere. Therefore, the development of metal-free and 
step-economic routes toward bulky phosphines remains a challenging task in 
organophosphorus and green chemistry.  
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Inspired by the success of chiral phosphorus-based ligands in asymmetric transformations,48-50 
our first objective of this project was to synthesise new planar chiral secondary phosphine 























2.2. Results and Discussion 
2.2.1. Synthesis of monodentate SPO-based on [2.2]paracyclophane backbone 
Our study began with the synthesis of (RSp,SRP)
a-4-tert-butyl[2.2]paracyclophane phosphine 
oxide 2.47 to get an electron rich SPO (Scheme 2.10). The synthesis involved generating a 
highly nucleophilic organolithium species, 4-litho[2.2]paracyclophane, from 4-
bromo[2.2]paracyclophane 2.46 and reacting this with tert-butyldichlorophosphine under an 
inert argon atmosphere. The resulting chlorophosphine was hydrolysed in one-pot to furnish 
secondary (RSp,SRP)-2.47 in 55% yield with a diastereomeric ratio of 94:6.  
 
Scheme 2.10: Synthesis of (RSp,SRP)-4-tert-butyl[2.2]paracyclophane phosphine oxide 2.47. 
Several other reaction conditions were attempted in order to improve the reaction conversion 
such as heating the reaction mixture to reflux (Table 2.1, entry 1) or changing the solvent to 
dry diethyl ether (entry 2). However, both reactions provided even lower chemical conversions. 
Further, the formation of organomagnesium intermediate proved ineffective (entry 3). 
                             Table 2.1: Deviation from the reaction conditions of scheme 2.10 
Entry Deviation from scheme 2.10 YieldIsolated 
1 -78 °C to rt to reflux  30% 
2 Et2O 18% 




a For compounds possessing both a stereogenic plane and a stereogenic centre the following nomenclature is used. 
Sp (lowercase P) refers to the planar chirality as defined from the C1 pilot atom and SP (uppercase P) refers to 
phosphorus stereochemistry. For racemates (RS, SR = R*,S*) according to Cahn-Ingold-Prelog rules. 
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The fact that 2.47 formed with a high diastereomeric ratio (94:6, determined from the 1H NMR 
spectrum of the crude product)b indicated that this reaction proceeded with high 
stereoselectivity and that the unlike (RSp,SRP) diastereomer was favoured. Moreover, H-2 
proton was observed downfield (3.94 ppm) in 1H NMR spectrum, indicating the anisotropic 
influence of the proximal oxygen of the SPO (Scheme 2.10). The relative configuration of 2.47 
was unambiguously determined as (RSp,SRP) by the single crystal X-ray diffraction technique 
(Figure 2.4). 
 
Figure 2.4. Crystal structure of (RSp,SRP)-4-tert-butyl[2.2]paracyclophane phosphine oxide 2.47.  
(Ellipsoids are drawn at a 50% probability level.) 
The origin of the diastereoselectivity is not clear. We believe that (RSp,SRP)-2.47 is the more 
sterically encumbered diastereomer as the oxygen is forced into close proximity to the ethylene 
bridge. A possible explanation as to its formation might involve addition to the tBuPCl2 forming 
a single diastereomer of chlorophosphine 2.48 with the chlorine atom oriented towards the 
ortho position, in the least sterically demanding position. Hydrolysis then occurs with the 
inversion of the stereochemistry to give the congested phosphine oxide (Scheme 2.11).  
 
Scheme 2.11: Plausible intermediate to form a favourable diastereomer (RSp,SRP)-2.47. 
 
b The diastereomeric ratio of the compound 2.47 was determining from the integration of tBu peaks at 1.02 δ and 
1.17 δ.  
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We also attempted to synthesise 4-phenyl[2.2]paracyclophane phosphine oxide 2.49 following 
the same approach (Scheme 2.12). However, the reaction did not proceed and only 
[2.2]paracyclophane 2.1 was recovered. This result suggests that the initial metal-halogen 
exchange is occurring efficiently, but the formation of the corresponding chlorophosphine is a 
problematic step. Based on 100% recovery of [2.2]paracyclophane, we speculated that the 
phenyl group of PhPCl2 might be acting as a proton source via benzyne mechanism (Scheme 
2.13). 
 
Scheme 2.12: Attempted synthesis of (±)-4-phenyl[2.2]paracyclophane phosphine oxide 2.49. 
 
Scheme 2.13: Plausible mechanism for formation of 2.1 in scheme 2.12 
Alternative approaches like, transmetallation (Table 2.2, Li-Mg, entry 1) and the use of PCl3 
(entry 2), were not successful either.  
                         Table 2.2: Deviation from the reaction conditions of scheme 2.12 
Entry Deviation from scheme 2.12 Yield 
1 MgBr2.OEt (1.05 eq.), PhPCl2 (1.05 eq.) - 






2.2.2. Synthesis of racemic bidentate-SPO based on [2.2]paracyclophane backbone 
To synthesise a bidentate SPO, the pseudo-ortho-substituted pattern was selected as it is 
possible to construct a more efficient chiral pocket than the pseudo-geminal- or ortho-
substituted paracyclophanes. First, the bromination was performed with [2.2]paracyclophane 
2.1 to obtain pseudo-para-dibromo[2.2]paracyclophane 2.55, which was later isomerised to the 
pseudo-ortho-dibromo[2.2]paracyclophane 2.56 (Scheme 2.14). The aromatic protons were 
observed downfield in 1H NMR spectrum of 2.56 cf., giving indication of complete 
isomerization. 
 
Scheme 2.14:  Bromination and isomerisation of pseudo-para-dibromo[2.2]paracyclophane 2.55 to 
pseudo-ortho-dibromo[2.2]paracyclophane 2.56. 
 
The preparation of (±)-2.57 commenced with rac-4,12-dibromo[2.2]paracyclophane (±)-2.56, 
which after the halogen-metal exchange with tBuLi was reacted with tBuPCl2 at -78 °C under 
an inert argon atmosphere (Scheme 2.15). Unfortunately, only 5% of the desired SPO (±)-2.57 
was isolated. The major by-product was [2.2]paracyclophane 2.1 formed by 
protodebromination of (±)-2.56.  
 
 
Scheme 2.15: Attempted synthesis of bidentate pseudo-ortho SPO (±)-2.57. 
We next planned to resolve the chirality and separate the enantiomers of the major diastereomer 





2.2.3. Attempted synthesis of enantioenriched SPO 
The synthetic accessibility of enantiopure P-chiral compounds is a fundamental challenge 
which mainly lies in attaining individual enantiomers with high yields, and through 
straightforward procedures.51 Enantiomerically pure SPOs are normally obtained through 
chemical resolution or chromatographic separation but rarely by asymmetric synthesis.52,53 
Early asymmetric routes were based on the use of chiral auxiliaries, with a menthol phosphinate 
being the most common.54-56 For example, Berger et al. synthesised cinnamyl-H-phosphonate 
(S)-2.60 from cinnamyl-H-phosphinic acid 2.58 in high yield and diastereoselectivity.56 First, 
2.58 was esterified and hydroxymethylated in one-pot to give (R)-2.59 (>99% de). Next, the 
Corey-Kim oxidation provided (S)-2.60 in >99% de (Scheme 2.16). 
 
Scheme 2.16: Synthesis of P-stereogenic cinnamyl derivative using a menthol phosphinate. 
We wanted to establish a new methodology that would allow efficient and general access to a 
range of enantioenriched SPOs. Our first approach was based on the norephedrine auxiliary 
(Scheme 2.17). 
First, (1R,2S)-(–)-phenylpropanolamine 2.61 underwent alkylation to form (1R,2S)-2-
(isopropylamino)-1-phenylpropan-1-ol 2.62. Further reaction with tBuPCl2 and BH3.THF 
complex provided the borane oxazaphospholidine (BOP) as a 74:26 mixture of diastereomers 
2.63a & 2.63b in 72% yield. After separation of diastereomers, the geometry of each 
diastereomer was determined using NOESY and COSY techniques. The configuration of major 
diastereomer 2.63a was assigned to (2S,4S,5R) while minor 2.63b to (2R,4S,5R) according to 
the Cahn–Ingold–Prelog (CIP) sequence rules.57 Several attempts were performed on major 
diastereomer 2.63a to test the ring-opening with (±)-4-litho[2.2]paracyclophane 2.50 and 
Grignard reagent (PhMgCl), but to no avail. We reasoned the failure of this reaction to the 
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steric hindrance of the tert-butyl substituent that prevented nucleophilic attack at the 
phosphorus centre. 
 
Scheme 2.17: Norephedrine-based approach to chiral SPO. 
As the norephedrine-based approach was not looking promising, we decided to investigate a 
less hindered chiral auxiliary in the hope that addition would occur.  
(–)-Menthol has been successfully used for the multigramme-scale preparation of 
diastereomerically pure phosphinates.55,56 These diastereomerically enriched menthyl 
phosphinates are useful precursors in the synthesis of chiral secondary and tertiary phosphines. 
The starting materials for this synthesis, the unsymmetrically substituted menthyl phosphinates 
(1R,2S,5R)-2.66 & (1R,2S,5R)-2.67, were obtained by the reaction of the corresponding 
tBuPCl2 or PhPCl2 with (–)-menthol in the presence of pyridine (Scheme 2.18). 
Recrystallisation of the menthyl esters (1R,2S,5R)-2.66 & (1R,2S,5R)-2.67 from pentane or 
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hexane failed to resolve the diastereomers. Further, the reaction of menthyl phosphinates with 
4-litho[2.2]paracyclophane 2.50 did not proceed.  
 
Scheme 2.18: (–)-Menthol-based approach for chiral SPO. 
We planned to synthesise aza-SPO so that we could substitute the P-N bond and make our 
desired SPO. (Scheme 2.19 & 2.20). First, benzyl aniline 2.70 was prepared by reacting benzyl 
bromide 2.68 with aniline hydrochloride 2.69 in anhydrous DMF using Cs2CO3 as a base at 90 
°C. Subsequently, lithium N-benzylanilide was prepared and reacted with tBuPCl2 at -78 °C in 
dry THF followed by the addition of H2O to give 2.71. Unfortunately, the further reaction of 
2.71 with 4-litho-[2.2]paracyclophane 2.50 failed to produce the desired product (Scheme 
2.19). 
 




At this stage, the strategy was modified to use the sulfonamide precursor because of its 
electron-withdrawing nature would make it a better leaving group aiding transfer to 4-
litho[2.2]paracyclophane 2.50. Benzyl amine 2.72 was converted to sulfonamide under 
microwave conditions at 110 °C in H2O as solvent. Attempted synthesis of amino-SPO 
serendipitously gave an aminophosphine chloride 2.75. We confirmed the compound 2.75 with 
different spectroscopy techniques. The HRMS spectra also showed a parent ion peak at 
406.0762 m/z with the chlorine isotope pattern. While we anticipated that 2.75 would be a 
better transfer reagent as the phosphorus would be more electrophilic and chloride a good 
potential leaving group, the compound remained unreactive and no addition was observed 
either with aryl lithium or with aryl magnesium chloride (Scheme 2.20).  
 
Scheme 2.20: Tosylbenzylamine as an auxiliary-based approach for achiral SPO. 
However, after several attempts, we were not successful in synthesising the enantioenriched 
SPO. We then decided to move forward to prepare monodentate and bidentate metal complexes 







2.2.4. Attempted synthesis of phosphinous acid-coordinated mono- and binuclear 
palladium (II) & gold(I) complexes 
 
The coordination chemistry of symmetrical (R1 = R2) and nonsymmetrical (R1 ≠ R2 = alkyl, 
aryl) phosphinous acids R1R2POH with transition-metal salts is of great interest due to their 
applications in homogeneous catalysis and asymmetric catalysis using SPOs.58-62. They do 
exist as monodentate ligands, but more frequently form bidentate ligands with the oxygen 
functionality acting as a bridge. Generally, bidentate ligands self-assemble through hydrogen 
bonds. 
A number of simple palladium complexes containing phosphinous acid ligands have been 
studied in the past decade. These complexes are highly efficient catalysts in various cross-
coupling reactions e.g. Suzuki, Heck, Kumada, Negishi, and Stille,63,64 hydroformylation 
reactions,65 and asymmetric allylic substitution.66 Recently, Li reported that Combiphos 
complexes are efficient catalysts in C-C, C-N, and C-S  bond-forming reactions (Figure 2.5).63  
  
Figure 2.5: Li’s Combiphos catalysts. 
Considering the impressive success of metal complexes in various organic transformations, we 
sought to prepare palladium complexes with SPO (RSp,SRP)-2.47 (Scheme 2.21, Table 2.3). 
Initial attempts with different palladium sources ([PdCl2(CH3CN)2] and [Pd(COD)Cl2]) and 
changing solvents (dioxane and CH2Cl2) did not help to form the desired complex, and only 
starting material was observed. The failure of forming Pd(II)-SPO-2.47 complex(es) was 
reasoned to the presence of a mixture of diastereomers along with potential geometrical 
isomers. In further attempts, the reaction of (RSp,SRP)-2.47 with 0.5 eq. of Pd(OAc)2 led to its 
decomposition resulting in the scission of the P-C bond, elimination of the phosphorous-




Scheme 2.21: Attempted mono and binuclear palladium complex formation with (RSp,SRP)-2.47.  
         Table 2.3: Reaction conditions for palladium complex formation with SPO (RSp,SRP)-2.47 
Entry Reaction conditions Observation 
1 [PdCl2(CH3CN)2] (1.0 eq.) / Pd(COD)Cl2 (1.0 eq.) 
Toluene / Dioxane / CH2Cl2, rt / reflux 
 (RSp,SRP)-2.47 
recovered 
2 Pd(OAc)2 (1.0 eq.), PhMe, 50 °C, 2 hrs P-C cleavage 2.1 
3 Pd(OAc)2 (1.0 eq.), CH2Cl2, rt P-C cleavage 2.1 
 
4 NaOAc (1.0 eq.), CDCl3, rt (RSp,SRP)-2.47 recovered 
 
Interested in why C-P cleavage was observed only upon treatment with Pd(OAc)2, we 
performed two control experiments. The first (entry 4) used NaOAc. Conversely, such C-P 
bond cleavage was not observed with the different acetate source. The second looked at another 
electron-rich SPO. We carried out reaction between tert-butyl(2-
(dimethylamino)phenyl)phosphine oxide 2.79 and a stoichiometric quantity of Pd(OAc)2. 
However, the C-P bond remained intact in 2.79 (Scheme 2.22). These results suggest that the 
combination of the tert-butyl SPO and [2.2]paracyclophane activates the C-P bond. 
 





Generally, Pd-mediated cleavage of C-P bonds is unusual. There have been reports of 
triarylphosphine (PAr3) acting as a source of the aryl moiety in cross-coupling reactions when 
Pd(OAc)2 was employed in sub-stoichiometric quantity.
67-70 For example, Xu and co-workers 
reported that the aryl group of PAr3 could be transferred through C-P bond cleavage in the 
presence of a palladium catalyst (Scheme 2.23).71 
 
Scheme 2.23: Palladium-catalysed arylation of olefins by PAr3. 
The formation of palladium complex with SPO-2.47 was not promising, but we could see if 
they can be formed in-situ. We decided to evaluate the role of SPO-2.47 as a potential ligand 
with an external source of palladium catalyst. 
2.2.4.1. Investigation of the role of SPO-2.47 ligand in palladium-catalysed coupling 
reactions 
First, we choose to perform the Suzuki-Miyaura cross-coupling reaction of electronically 
deactivated coupling partners 2-bromotoluene 2.82 and 2-methoxyboronic acid 2.83 to 
evaluate the reactivity of SPO-2.47 by using different palladium sources: Pd(OAc)2, PdCl2, 
Pd2(dba)3, bases and solvents (Scheme 2.24, Table 2.4). 
 








             Table 2.4: Screening conditions for Suzuki-Miyaura Cross Coupling  
Entry Solvent Base Yielda 
1             Toluene Cs2CO3 PdCl2             10% 
Pd2(dba)3    12% 







PdCl2         19% 
Pd2(dba)3      9% 







PdCl2          13% 
Pd2(dba)3     11% 
Pd(OAc)2    24% 
 
4 EtOH CsF Pd(OAc)2     5% 
5                H2O   K3PO4                  - 
                       aIsolated Yield 
 
In the initial reactions conditions by varying different palladium catalysts while keeping 
Cs2CO3 and toluene constant, the reaction with Pd(OAc)2 gave the best conversion among three 
(entry 1). The product formation was slightly increased with polar solvent ethanol (entry 2) as 
well as with NaOtBu (entry 3). However, the reaction with CsF and K3PO4/H2O did not show 
much promise (entry 3 & 4). Based on the optimal conversion in Pd(OAc)2 and ethanol 
conditions, the next screening was carried out using different bases (Scheme 2.25, Table 2.5). 
 
Scheme 2.25: SPO-2.47-catalysed Suzuki-Miyaura cross-coupling. 
                             Table 2.5: Screening conditions for Suzuki-Miyaura Cross Coupling 
 
                                              aGC yield is determined using p-nitrotoluene as an internal standard. 
Entry Base         % Yielda 
1 CsF 24 
2 KOtBu 11 
3 NaOH 24 
4 K2CO3 20 
5 K3PO4 45 
6 KOH 45 
7 KF 46 
8 Cs2CO3 35 
9 NaOtBu 64 
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The reaction conversion was observed in the same range (~20%) as previous conditions with 
CSF, NaOH, and K2CO3 (entry 1, 2, & 3). Surprisingly, the product formation was nearly 
doubled with K3PO4, KOH and KF (entry 5, 6, & 7). Among all of the bases screened, the 
optimal conversion was obtained with NaOtBu (entry 9). These results suggest that SPO-2.47 
is a competent ligand to catalyse the Suzuki reaction between unactivated coupling partners at 
1 mol% scale. 
We next moved to evaluate the catalytic potential of SPO-2.47 in Buchwald-Hartwig amination 
reactions (Scheme 2.26). The results were more promising. Both electron-rich and electron-
poor aryl bromides can be coupled to various anilines including sterically demanding 
substrates.   
 
Scheme 2.26: Buchwald-Hartwig coupling of aryl bromides (unless otherwise noted) and anilines. 
After evaluating the potential of SPO-2.47 in palladium-catalysed cross-coupling reactions, we 
decided to attempt the complex formation with another metal and chose gold. To the best of 
our knowledge, there has been only a single report of an Au(I)-SPO complex being used in 




2.2.4.2. Synthesis of SPO-67-Au(I) complex and investigation of its catalytic potential 
Homogeneous gold catalysis has emerged as a highly versatile synthetic tool for the 
construction of carbon-carbon or carbon-heteroatom bonds.73-75 Echavarren,76 Fürstner,77 and 
Toste78 developed enyne cycloisomerisations in the presence of cationic gold(I) complexes. 
The nature of the ligand coordinated to the gold centre plays a major role in the reactivity and 
selectivity of gold-catalysed reactions.  
The synthesis of the SPO-Au(I) complex 2.95 was readily achieved by following Schmidbaur’s 
procedure (Scheme 2.27).72 The complex 2.95 was air-sensitive and had to be stored under an 
inert atmosphere. Despite this, the formation of the complex 2.95 was confirmed by 1H and 31P 
NMR spectroscopy. The 31P NMR peak was shifted to125.63 ppm (P(III) in 2.95) from the 57.81 
ppm P(V) observed in SPO-2.47.  
 
Scheme 2.27: Au(I)-complex formation with SPO-2.95. 
 
Having successfully synthesised the desired Au(I)-SPO-2.95 complex, we proceeded to 
evaluate its catalytic potential in cycloisomerisation reactions. 
2.2.4.2.1. Enyne cycloisomerisation 
To evaluate the activity of complex 2.95, we investigated two cycloisomerisation reactions and 
an addition process. One isomerisation and the addition could be performed on enyne 2.100 
(Scheme 2.28). This was readily prepared by consecutive alkylations of dimethyl malonate 
2.96. Each step occurred in high yield. The cycloisomerisation was performed in CH2Cl2 at 
room temperature. Mixing the Au(I)-SPO-2.95 complex with AgSbF6 leads to a cationic 




Scheme 2.28: Cycloisomerisation of enyne 2.100. 
The mechanism for this reaction is complex (Scheme 2.29). After activation of the alkyne, the 
alkene attacks the triple bond to give a vinyl gold species and relatively stable tertiary 
carbocation 2.103. This undergoes intramolecular cyclopropanation. 
 
Scheme 2.29: Plausible mechanism of cycloisomerisations enyne 2.100. 
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If the reaction is performed in a protic solvent like methanol then the initial intermediate 2.103 
can be trapped and methoxycyclisation occurs to give the ether 2.106 (Scheme 2.30). This latter 
reaction is interesting as the product controls a stereogenic centre and it could be formed in 
enantiomerically enriched form if the correct ligand was used. 
 
Scheme 2.30: Methoxycyclisation of enyne 2.100. 
 
This reaction was repeated with a second substrate 2.110 to give pyrrolidine 2.111 (Scheme 2.31). 
 
 
Scheme 2.31: Methoxycyclisation of enyne 2.110. 
The catalytic reactions of Au(I)-SPO-2.95 complex were promising and results are similar to 
those reported for the only other known example of a Au(I)-SPO.72 We suggest that if SPO-
2.95 can be synthesised in an enantiomerically pure form, it would be a good catalyst for 
asymmetric intramolecular cyclisation reactions. 
After the initial investigation, we concluded that the synthesis of planar chiral SPO based on a 
[2.2]paracyclophane framework is limited to the tert-butyl substituent. A comprehensive array 
of reactions had been performed to resolve the planar chirality but all to no avail. Fortunately, 




Next, we attempted to synthesise planar chiral phosphines. For this, we chose the reduction of 
the tertiary phosphine oxide (TPO) route. The section below describes the synthetic route, we 
have developed to access various planar chiral TPOs from the SPO-2.47. 
 
2.2.5. P-Arylation of secondary phosphine oxide (SPO) 
The role of P-arylation in the formation of tertiary phosphines is significant.22 A direct route 
to tertiary phosphines involves functionalisation of secondary phosphines. However, secondary 
phosphines are unstable towards oxidation and require rigorous oxygen-free conditions in their 
synthesis. An alternative approach that minimises the handling of oxygen-sensitive 
intermediates, involves the functionalisation of secondary phosphine oxides (SPOs) to form 
tertiary phosphine oxides (TPOs), which can be reduced to give the desired phosphines.79-81 
The arylation of SPO-2.47 would provide a general route to P-stereogenic 
[2.2]paracyclophane-phosphine. This is an unstudied area of [2.2]paracyclophane chemistry 
with only a single example reported in a patent.82 We have optimised an efficient method for 
P-arylation of SPO-2.47 in the formation of TPOs (Scheme 2.32, Table 2.6). 
 
Scheme 2.32: P-Arylation of SPO-2.47. 
The initial conditions trialed were those of Bloomfield (entry 1),22 but these did not give 
satisfactory yields so we performed a quick optimisation. Changing the ligand to dppf (entry 
2), solvent to toluene (entry 3), and metal to NiCl2.5H2O (entry 4) and CuI (entry 5) failed to 
produce the desired product. Surprisingly, in the latter case, the iodide-adduct 2.115 was 
formed in 55% yield. It became clear that aryl bromides were not sufficiently reactive so we 
started coupling aryl iodides. 
At this point, the most successful coupling was observed with Pd(OAc)2, dppf, DIPEA, in 
dioxane with DCE as a co-solvent (4.5:0.5) (entry 6). In an attempt to improve the reaction 
conversion, a range of coupling conditions were screened by altering ligands dippf (entry 7), 
xanthphos (entry 8), solvent dioxane to toluene (entry 9), and palladium source from Pd(OAc)2 
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to Pd2(dba)3 (entry 10). Unfortunately, product formation was reduced to below 5% in every 
case. Gratifyingly, changing the base from DIPEA to Cs2CO3 increased the reaction yield 
substantially up to 87% (entry 11). To investigate the scope of this P-arylation protocol, we 
applied the optimised conditions to a variety of substituted aryl iodides. Neutral (entry 12), 
electron-rich (entry 13), electron-deficient (entry 14) aryl iodides, and a heteroaromatic iodide 
(entry 15) were all well-tolerated for the P-arylation with SPO (RSp,SRP)-2.47 to smoothly 
produce the corresponding tertiary phosphine oxides (TPOs) in 55-85% yields. 
        Table 2.6: Optimisation conditions for P-arylation of SPO-2.47 

















2 2.112 Pd(OAc)2, Dppf, 
DIPEA, 
DME, 85 °C, 24 h 
-        - 
3 2.112 Pd(OAc)2, Xanthphos, 
DIPEA, 
Toluene, 110 °C, 24 h 
-        - 
4 2.112 NiCl2.5H2O, Zn, 2,2’-
bipyridine 









CuI, (S)-α-phenyl ethyl 
amine, 
K2CO3, Toluene, 110 



















7 2.114 Pd(OAc)2, dippf, 
DIPEA, dioxane:DCE 






8 2.114 Pd(OAc)2, Xanthphos, 
DIPEA, dioxane:DCE 




9 2.114 Pd(OAc)2, dppf, 
DIPEA, toluene:DCE 




10 2.114 Pd2(dba)3, dppf, 
DIPEA,  dioxane:DCE 




11 2.114 Pd(OAc)2, dppf, 
Cs2CO3, dioxane:DCE 









Cs2CO3,  dioxane:DCE 









































         *[Pd], [Ni], or [Cu] 2 mol%, ligand 2.2 mol%, base 1.3 eq.                 
             aIsolated yield   
              bNMR yield is determined by using p-xylene as an internal standard.  
               
It should be noted that this protocol requires a higher temperature compared to Bloomfield’s 
original couplings, suggesting that the sterically demanding nature of the SPO-2.47 impedes 
the reaction. In each case, the new TPO was formed as a single diastereomer as confirmed by 
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1H NMR spectroscopy. As we anticipated, the 1H NMR spectrum indicates the close proximity 
of one of the H-2 protons (4.48 ppm) to P=O, which suggests the unlike diastereomer is 
favoured. In the case of 2-pyridyl TPO, the like diastereomer is formed due to the change in 
priorities according to the Cahn-Ingold-Prelog guidelines.57 This was later confirmed when the 
structure of the TPO 2.116 was determined by X-ray analysis (Figure 2.6).  
 
Figure 2.6: X-ray structure of tertiary phosphine oxide (RSp,SRP)-2.116. 
(Ellipsoids are drawn at a 50% probability level.) 
After synthesising the various TPOs based on [2.2]paracyclophane, our next goal was to reduce 
them to the corresponding phosphines. 
2.2.6. Synthesis of monodentate P-ligands 
Bulky tertiary phosphines are of special interest as ligands for diverse transition-metal 
catalysed reactions.83-85 One of the routes to synthesise phosphines is through the reduction of 
TPO.47,86,87 This is always a challenging reaction, but there are several reported reductions of 
[2.2]paracyclophane phosphine oxides by trichlorosilane (HSiCl3).
88-92 For example, during the 
synthesis of planar chiral pseudo-ortho aryl[2.2]paracyclophanyl-phosphine 2.125, Kitagaki et 
al. used HSiCl3 to reduce a TPO 2.124 to a phosphine 2.125 (Scheme 2.33).
91 However, the 
reduction conditions often require an excess of HSiCl3 with unusually long reaction times. 




Scheme 2.33: Reduction of TPO 2.124 to phosphine 2.125 with HSiCl3. 
In an attempt to avoid the use of silanes, we initially performed the reduction of TPO-112 by 
employing conventional hydride reagents (Scheme 2.34, Table 2.7).  
 
Scheme 2.34:  Reduction of tertiary phosphine oxide (RSp,RSP)-2.116. 
                       Table 2.7: Optimisation conditions for reduction of (RSp,SRP)-2.116 
Entry Reaction conditions %Yielda,b 
193 MeI, DME, rt, 2 hrs, 
LAH, 0 °C to reflux 
- 
294 Meerwein’s salt, NaBH4, CH2Cl2 - 
394 (COCl)2, LAH, toluene,  
0 °C to reflux 
 
- 
494 (COCl)2, NaBH4 in diglyme, 
 toluene, 0 °C to reflux 
 
- 
595 CeCl3, NaBH4, LAH,  
THF, 0 °C to reflux 
 
- 
696 DIBAL, c-hex3P=O, CH2Cl2, 45 °C 
BH3.THF, 23 °C 
- 





886 HSiCl3 (35 eq.), p-xylene, 140 °C, 48 hrs 71%c 
dr = 60:40 
986 HSiCl3 (28 eq.), p-xylene, 
 140 °C, 15 hrs 
75%c 
dr = 60:40 
1086 HSiCl3 (28 eq.), p-xylene, 
 110 °C, 15 hrs 
68%c 
dr = 60:40 
                                   a Crude yield 
                                   b dr = diastereomeric ratio (determined from crude product by 1H NMR spectroscopy) 
                      c reaction was performed in the pressure tube. 
With the hydride reducing agents, strong alkylating agents were first used to form the 
phosphonium species, which was then reduced by the hydride source. Initial attempts to 
alkylate TPO-2.116 with MeI and Meerwein’s salt [(C2H5)3O(BF4)] followed by reduction with 
LiAlH4 and NaBH4 (entry 1 & 2) were not promising. Further reactions to form 
chlorophosphonium ion of TPO-2.116 by the treatment with oxalyl chloride (COCl)2 followed 
by reducing agents LiAlH4 (entry 3) and NaBH4 (entry 4) were also not effective. Likewise, 
other strategies such as activation of phosphine oxide by coordination with trivalent cerium 
(CeCl3, entry 5) and employing an ancillary substrate tricyclohexylphosphine oxide (c-
hex3P=O, entry 6) also failed.  
As the regular reducing agents did not reduce the TPO-2.116, we decided to attempt reduction 
with silane reagents (Table 2.7). The P=O bond in a phosphine oxide can be activated by 
forming in-situ the P-O-Si bond. Heating TPO-2.116 in toluene (110 °C) with an excess of 
HSiCl3 did not produce the desired reduction product (entry 7). Gratifyingly, changing solvent 
to p-xylene and reaction conditions to the pressure tube (140 °C) furnished the desired 
phosphine 2.126 but with epimerisation (entry 8 & 9). Epimerisation was confirmed by 1H 
NMR as a single diastereomer of 2.116 produced two diastereomers of 2.126 (Scheme 2.34).  
This reaction left us with a question, whether epimerisation occurred at the phosphorus 
stereocentre or at the paracyclophane? The paracyclophane ethylene bridge tends to cleave at 
>150 °C but bulky substituents can lower this. We believed that lowering the temperature 
would rule out this possibility. The reaction was performed under the same conditions but at 
lower temperature 110 °C. We observed nearly the same reaction conversion in the same 
diastereomeric ratio (entry 10). This result ruled out the possibility of epimerisation of planar 
chirality since it is highly unlikely to cause homolytic scission of the [2.2]paracyclophane 
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ethylene bridge at this temperature. This evidence suggested that the epimerisation occurred at 
the phosphorus stereogenic centre (Scheme 2.34). 
The optimised reaction conditions of HSiCl3 in p-xylene at 140 °C were used to reduce the rest 
of the TPOs-2.113, 2.119, 2.121, and 2.123. However, in all cases, the reduction of single 
diastereomer of TPO gave two new compounds as indicated by 1H NMR spectroscopy of the 
crude reaction mixture (Scheme 2.35). Moreover, all phosphines appeared to be air-sensitive 
and it became necessary to protect the putative phosphines. Initially, we attempted to protect 
them as the borane complex, but this was unsuccessful. It was later found that these phosphines 
could be protected as the phosphinium salt by reaction with tetrafluoroboric acid or by 
complexation with chloro(tetrahydrothiophene)gold(I) or chloro(dimethyl sulfide)gold(I) to 
give, in each case, inseparable diastereomeric compounds (Scheme 2.35). It should be noted 
that all phosphines were reduced, protected and isolated by these strategies as judged by 
spectroscopy, however isolation of 2.127, 2.128, and 2.129 in pure form was difficult.  
 
Scheme 2.35: Reduction of tertiary phosphine oxides.  
(a) HSiCl3 (28 eq.), xylene, 145 °C, 24 hrs or neat PhSiH3, 140 °C, 3-5 days 
(b) HBF4 (15 eq.), H2O, CH2Cl2 or Au(dms)Cl (1.0 eq.) CH2Cl2 or Au(tht)Cl (1.2 eq.), CH3CN 
  *Overlapping peaks in the 1H NMR spectrum prevented the diastereomers ratio of 2.127/2.129 being 
determined 
  ** 2.127, 2.128, 2.129 could be reduced and complexes formed but it proved impossible to remove all 
impurities 
 
Interestingly, the reduction of pyridine TPO-2.123 proceeded to give a single diastereomer. 
Inspection of its gold complex suggests that reduction occurred stereoselectively with the 
retention of stereochemistry at phosphorus. There were downfield signals that can be assigned 
to the ethylene bridge by 1H NMR spectroscopy. This was later confirmed by X-ray 




Figure 2.7: X-ray structure of gold complex of phosphine 2.137.AuCl. 
(Ellipsoids are drawn at a 50% probability level.) 
It is unclear why pyridine alters the stereochemical course of the reduction. There is speculation 
that a pyridine-silane adduct 2.138 delivers the hydride in an intramolecular fashion causing 
the stereoselective reduction (Scheme 2.36). 
 
Scheme 2.36: Plausible mechanism of stereoselective reduction of 2.123.  
2.3. Conclusions 
Overall, this project aimed to synthesise planar chiral secondary phosphine oxides based on 
[2.2]paracyclophane. The tert-butyl planar chiral secondary phosphine oxide – SPO-2.47 
proved to be a competent ligand, notably in transition metal-catalysed cross-coupling 
reactions. The Buchwald-Hartwig aminations were performed with the catalyst derived from 
SPO-2.47 in good to excellent yields with both electron-rich and electron-deficient aryl 
bromide/chlorides as well as sterically hindered anilines. However, this ligand was only 
moderately efficient in Suzuki-Miyaura cross-coupling reactions. Even more promising was 
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the complexation of SPO-2.47 with gold [Au(I)] which facilitated cycloisomerisations and 
methoxycyclisations. In order to investigate a general route to P-stereogenic 
[2.2]paracyclophane-derived phosphines, P-arylation of the SPO-2.47 was first optimised 
with a variety of substituted aryl iodides. Interestingly, in each case, tert-phosphine oxides 
were obtained as a single diastereomer. After employing an array of reducing agents, these 
tert-phosphine oxides were finally reduced under harsh conditions that caused epimerisation 
at the phosphorus centre generating two diastereomeric phosphines. Due to the instability of 
these putative phosphines, they were either protected as the phosphonium salt with 
tetrafluoroboronic acid or directly complexed with chloro(dimethylsulfide)gold(I) or 
chloro(tetrahydrothiophene)gold(I) to give useful gold complexes. Based on our study, we 
suggest that if [2.2]paracyclophane SPOs could be synthesised in enantiomerically pure 
forms, they will have a great potential in asymmetric catalysis. 
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Chapter 3   
Selective Remote β-C(sp3)-H Activation of Cyclic 
Amines and Enantioselective γ-C(sp3)-H 




3.0. Introduction to C-H activation 
It is a possible cliché that organic chemistry is at the heart of modern life. The synthesis of 
organic molecules supports the global economy through industries such as agriculture, 
pharmaceuticals, and electronics. It is no exaggeration to say that chemists can synthesise any 
organic molecule, regardless of its size and complexity. A traditional synthesis undoubtedly 
requires a multistep sequence that exploits the reactivity of the functional groups embedded in 
the intermediate compounds. Many of these sequences involve repetitive functional group 
interconversion into active moieties that facilitate the elaboration of the core structure. Even 
though this type of chemistry is highly predictable, it demands substantial skill and resources 
to prepare even a small quantity of any substance. Nonetheless, it generates a vast quantity of 
waste and is often categorised as inefficient and non-sustainable.   
In the late 20th century, transition metal-catalysed cross-coupling reactions have transformed 
the field of organic chemistry.1,2 These classical cross-coupling reactions like Mizoroki-Heck, 
Suzuki-Miyaura, Stille, and Negishi have enabled convergent synthetic methodologies by pre-
functionalisation of the starting materials. Over the past several decades, the development of 
new families of ligands and metal complexes for these reactions has paved the way for the 
synthesis of a myriad molecules.3 However, many of the organometallic reactants are highly 
toxic, air, and moisture sensitive. 
In this century, the field of chemistry has been transitioning to a more sustainable approach.4-6 
With the direct functionalisation of ‘inert’ C-H bonds, it is offering a direct, atom-economical 
tool-box. As most organic molecules are built on a hydrocarbon backbone, C-H bonds are 
ubiquitous, and direct activation of these C-H bonds convert a broader range of simple 




Figure 3.1: Traditional synthetic route vs C-H activation. 
3.1.  C-H functionalisation  
C-H activation is a revolutionising method as it circumvents many of the shortcomings of 
traditional synthetic methods.8 It renders multiple functional group interconversions redundant 
and directly transforms starting materials into complex molecules. Fundamentally, this 
technique uses ‘non-activated’ and ‘unarmed’ C-H bonds to couple molecules. C-H 
functionalisation reactions are mainly based on the noble metals (Pd, Rh, Ru, Ir),9,10 while only 
a few are based on the earth-abundant metals (Fe, Cu, Zn, Ni).11 For this reason, transition-
metal catalysed C-H activation is often defined as a ‘Holy Grail’ in organometallic chemistry. 
Theoretically, the method ‘C-H activation’ looks straightforward, however, it is not easy, and 
only a specific C-H bond within a molecule must be reacted. In the section below, I will present 
the principal challenges associated with this field.  
 
3.2. General problems associated with C-H activation 
In the C-H activation chemistry, regioselectivity and enantioselectivity are still unsolved 
problems due to the robust nature of C-H bonds. 
C-H bonds are generally unreactive. This is due to their high bond dissociation energies 
(between 355 and 439 kJ/mol) and similar electronegativities of carbon (2.5) and hydrogen 
(2.2), leading to a non-polar bond.12,13 Although the strength of the bonds follows the increasing 
trend of sp3 < sp2 < sp (bond dissociation enthalpy at 298 K: C(sp3)-H 406.2, C(sp2)-H 443.5 
and C(sp)-H 548.5, kJ/mol), the activation barrier decreases in the same trend. Studies suggest 
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that the difference in energy of σ*C-H LUMO antibonding and σC-H HOMO bonding orbital and 
steric hindrance of C-H bonds decide the ease of activation.14  
The second problem is to control the site-selectivity so that only the desired C-H bond can be 
functionalised in the presence of many C-H bonds with similar reactivity (regioselectivity).15 
An even more challenging problem is distinguishing two prochiral C-H bonds, breaking the 
symmetry of the molecule, and permitting the synthesis of chiral molecules 
(enantioselectivity).9 
The section below will describe the general strategies to address these challenges in C-H 
functionalisation reactions. 
3.3. Overview of metal-mediated C-H activation mechanism  
The metal-mediated C-H activation can be via either an ‘outer-sphere’ mechanism, which does 
not involve the direct interaction between the C-H bond and the metal reagents, or an ‘inner-
sphere’ mechanism, where the metal reagent is intimately involved in breaking the C-H bond. 
3.3.1. Outer-sphere mechanism 
The key feature of this type of mechanism is that the substrate does not interact directly with 
the transition metal but instead reacts with the metal ligand. The mechanism proceeds by two 
steps, (i) formation of a high oxidation state metal complex containing an activated species 
such as metal oxo-, imido- or carbene species followed by, (ii) reaction of the activated species 
with a C-H bond.16,17 The latter step proceeds by either direct insertion or H-atom 
abstraction/radical rebound (Figure 3.2). The selectivity of the reaction is determined either 
through the intrinsic selectivity of the substrate or through the spatial arrangement of the ligand 




Figure 3.2: Outer-sphere mechanism. 
 
3.3.2. Inner-sphere mechanism 
In this mechanism, the substrate directly coordinates to the transition metal that leads to C-H 
bond cleavage via formation of a discrete organometallic intermediate (Figure 3.3). Most inner-
sphere reactions utilise a Lewis basic functionality known as a directing group within the 
substrate to direct the metal to a specific C-H bond.18,19  
 
Figure 3.3: Inner-sphere mechanism. 
In a large number of C-H activation reactions, insertion into a C-H bond is achieved by the 
‘concerted metalation deprotonation’ (CMD) pathway, also named as ambiphilic metal-ligand 
activation (AMLA) or internal electrophilic substitution (IES). The section below will focus 
on the palladium-induced CMD. 
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3.3.4. Concerted metallation deprotonation pathway 
In palladium-mediated C-H activation reactions, the first step is a redox neutral insertion of the 
metal into the C-H bond to give a C-Pd bond, which can be further functionalised. Palladium 
acetate [Pd(OAc)2] is generally the best choice for the catalyst since the acetate ligand is 
believed to play multiple roles in cyclometallation reactions,20 namely; 
• It promotes the solvolysis of the reaction intermediates due to its larger effective 
volume.  
• It enhances the electrophilicity of the Pd(II) centre due to the dual ability of acetate to 
act as a monodentate or bidentate ligand. 
• It also plays the role of an intramolecular base for deprotonation.  
Palladium insertion is believed to proceed through concerted metallation deprotonation 
(CMD). It normally involves a concerted six-membered transition state in which a bound 
carboxylate, or appropriate conjugate base, transfers the proton while concurrently facilitating 
the formation of the palladacycle (Figure 3.4). The corresponding palladacycle undergoes a 
variety of different transformations depending on the reaction partner. Normally, the five-
membered palladacycle is kinetically favoured over six- and seven-membered palladacycles, 
and this preference can be used to control the regioselectivity of the reaction.21   
 
Figure 3.4: Concerted metallation deprotonation.7 
For most reactions involving the CMD step, the conjugate base removes the hydrogen atom as 
the carbon-metal bond forms in a concerted process. The base coordinates to the metal giving 
rise to the cyclic or concerted mechanism. The base can be either external or internal. An 
internal base could be the part of the ligand and participate in a more organised cyclic 




Figure 3.5: Type of base in CMD process. 
To give more insight on CMD pathway, Davies et al. performed computational studies on 
Pd(OAc)2-promoted cyclometallation of N,N-dimethylbenzylamine 3.1. Studies show the 
favourable route via a palladium and C-H bond interaction followed by an acetate assisted six-
membered transition state 3.2 (Figure 3.6).22 In this, the hydrogen bonding between the acetate 
oxygen and C-H proton orients the base and increases the polarity of the C-H bond. The 
resulting interaction enhances the acidity of the ortho-proton, which can then be readily 
deprotonated by the acetate base. All the above effects lower the energy barrier to the formation 
of thermodynamically stable five-membered palladacycle 3.3. The study further demonstrated 
that Pd(OAc)2 was not only the metal that promoted the cyclometallation and other catalysts 
such as [RuCl2(p-cymeme)]2, [RhCl2Cp*]2 and [IrCl2Cp*]2, in the presence of acetate reacted 
similarly with N,N-dimethylbenzylamine 3.1 to form the cyclometallated product by the same 
mechanism. 
 
Figure 3.6: Acetate-assisted six-membered transition state & palladacycle. 
The discussion below will present the general catalytic cycle for C-H activation reaction and 




3.4. A general catalytic cycle for C-H activation  
A typical C-H activation reaction comprises four steps (Figure 3.7).  
a. The metal insertion process into the C-H bond (C-H activation) 
b. Functionalisation of the corresponding organometallic intermediate 
c. Elimination of the functionalised product 
d. Regeneration of the active catalyst (if required) 
 
 
Figure 3.7: General catalytic cycle for C-H functionalisation reactions. 
 
3.5. Role of directing group in C-H Functionalisation  
The directing group has a crucial role in controlling the electronics at the metal centre and 
facilitating the regioselectivity by placing the metal in a close proximity to a single C-H bond 
in the substrate. In a directing group assisted C-H activation reaction, the directing group first 
coordinates to the metal which forms a discrete complex (Figure 3.8). In terms of kinetics, this 
increases the local effective concentration of the metal, accelerating the rate of C-H insertion. 
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This coordination helps the thermodynamics of the reaction as it stabilises the resulting 
metallacycle. The stable metallacycle has an important role in facilitating C-H activation. The 
conformation of the substrate will dictate which C-H bonds are proximal to the metal centre 
while the size of the metallacycle will determine which complex should be favoured. 
Ultimately, the structural and electronic requirements of this intermediate control the regio- 
and stereoselectivity of C-H functionalisation.   
 
Figure 3.8: Role of directing group in C-H activation.7 
One of the first examples was in 1993 when a ketone coordinated with the ruthenium catalyst 
and directed reaction to the ortho C-H position (Scheme 3.1).23 This result showed, for the first 
time, that the direct C-H activation could be a valuable tool to access the range of small 
molecule entities. 
 




Since this ground-breaking work, an array of directing groups has been reported for various 
catalytic C-H transformations. The earliest examples utilised strongly σ-donating or π-
accepting directing groups i.e. aldehyde, amide, anilide, imine, carboxylic acid, ester, ketone, 
and hydroxyl groups.24 With the progress in this field, oxazoline, pyridine, and π-chelation-
based directing groups have been developed.25 Moreover, directing groups, such as alkene, 
alkyne, and carbanion have also shown potential applications.26 Recent reviews published in 
this area cover the whole range of directing groups and their recent advances in different C-H 
activation reactions with the future scope of expansion.27-30 
Broadly, the directing groups can be categorised into three types. 
i. Auxiliary directing groups 
ii. Transient directing groups  
iii. Traceless directing groups  
 
3.5.1. Auxiliary-based directing groups 
An auxiliary directing group is not an intrinsic part of the substrate. It is appended to the 
substrate prior to the reaction and removed or converted to the final desired functional group 
after the reaction. They can be further divided into either monodentate or bidentate.  
 
3.5.1.1. Monodentate directing groups 
Monodentate directing groups show more potential, as they can be used to tune the electronics 
of the metal to exert the reactivity and selectivity. As a monodentate directing group can 
coordinate to only one valence site on the metal catalyst, an external ligand can influence to 
the metal, and hence exert better control over reactivity and stereoselectivity compared to 
bidentate directing group. 
Monodentate directing groups are mainly based on nitrogen-containing functionalities such as 
the Yu-Wasa auxiliary.31-34 For example, the selective arylation of the methylene β-C-H bond 
was achieved by employing a monodentate Yu-Wasa auxiliary (Scheme 3.2).35 The 
combination of a weak directing auxiliary and acetyl protected aminoethyl quinoline (APAQ) 
ligand proved to impart high enantioselectivity. The authors proposed that the oxygen of an 
amide of the APAQ ligand 3.11 acts as an intramolecular base to deprotonate the methylene C-
H and promote Pd-C bond formation. The transition state (TS) TS_R postulated by DFT 
calculations was observed to be more favoured than the TS_S by 1.2 kcal/mol. In both transition 
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states, the six-membered ring and bulky tert-butyl substituent orient the amide directing group 
in a way that the β-C-H bond is activated. The orientation of the terminal methyl group of the 
substrate controls the R or S transition state. In the favoured transition state, it is trans to the 
bulky-tert-aryl group and the peri-hydrogen of the quinoline.  
 
Scheme 3.2: Monodentate Yu-Wasa auxiliary directed enantioselective β-C-H activation. 
Monodentate directing groups allow functionalisation of only some primary unactivated 
C(sp3)-H bonds. There are only limited examples of activating five- and six-membered rings, 
and without the addition of the external ligand they struggle to react. Due to this drawback, the 
reaction generally demands high catalyst loading and harsh reaction conditions to operate 
which could be detrimental to other sensitive functional groups. 
 
3.5.1.2. Bidentate directing groups 
As explained above, most of the directed functionalisation of C(sp3)-H bonds are not 
compatible with monodentate ligands and this remains highly challenging. One potential 
solution would be to install two donating atoms in the directing group to stabilise the resulting 
metallacycle. For example, Daugulis and coworkers reported the use of 8-aminoquinoline as a 
bidentate directing group to facilitate the β-C(sp3)-H and C(sp2)-H functionalisation of various 




Scheme 3.3: Bidentate directing group assisted Pd(II)-catalysed arylation. 
Bidentate directing groups are mainly known to functionalise primary and secondary 
unactivated C-H bonds with only a few examples of tertiary C(sp3)-H bonds.27,37,38 Yan et al. 
utilised a combination of bidentate 8-aminoquinoline and chiral phosphoramide 3.20 to achieve 
the enantioselective methylene β-C(sp3)-H arylation (Scheme 3.4).39 A Pd(II)/Pd(IV) catalytic 
cycle was proposed, based on several kinetic isotope experiments (KIEs). The C-H activation 
step was thought to be a rate limiting step, resulting in the formation of intermediate 3.17 after 
deprotonation and complexation of an amide 3.15 with Pd(II) species. Further, the chiral amide 
3.20 promotes the selective cleavage of one of the C-H bonds at the β-position to generate an 
enantioenriched intermediate 3.18. The oxidative addition of aryl iodide to Pd(II) produces 
electron-deficient Pd(IV) intermediate 3.19. Finally, the reductive elimination from the 3.19 
delivers the respective product 3.16 and regenerates the Pd(II) catalyst after ligand exchange 
with the substrate 3.15. 
 
Scheme 3.4:  Bidentate 8-aminoquinoline directed benzylic C(sp3)-H arylation.  
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3.5.2. Transient directing group 
Transient directing groups are attractive as they can be used in sub-stoichiometric quantity. 
They can potentially minimise the requirement of structure modification and allow the reaction 
to proceed under mild reaction conditions. They reversibly react with the existing functionality 
of the substrate, direct the C-H functionalisation, and undergo cleavage in a one-pot reaction. 
Jun and co-workers used the transient existence of an imine to temporarily install a 
monodentate pyridine directing group for Rh-catalysed hydroacylation of an alkene 3.22 
(Scheme 3.5).40 The successful transformation used a substoichiometric quantity of 2-amino-
3-methyl pyridine 3.24 to temporarily form an imine 3.25 that directed C-H activation to 
deliver anti-Markovnikov hydroacylated products 3.23.  
 
Scheme 3.5: Hydroacylation of aldehyde with terminal alkenes by imine transient directing group. 
After this seminal report, the C-H activation field has experienced rapid growth in terms of 
design and utilisation of transient directing groups in myriad C-H functionalisation reactions. 
A number of reviews cover the use of transient directing groups in C-H transformations.41-43 
The catalytic cycle for C-H activation with a transient directing group is slightly different to 
the standard cycle. (Figure 3.9). Transient directing group will link to an existing functional 
group on the substrate in a reversible manner (step 1). Further, it will interact selectively with 
the transition metal catalyst, acting as either a monodentate or bidentate coordination group 
(step 2). The resulting metallacycle reacts with a coupling partner to form an intermediate III 
(step 3). After selective functionalisation, the intermediate III converts into the intermediate 
IV in a way that delivers the desired product, with the regeneration of both the transient 




Figure 3.9: Transient directing group mediated C-H functionalisation. 
Yu’s group achieved a highly enantioselective arylation of 2-alkyl benzaldehyde 3.26 using L-
tert-leucine 3.28 as the transient directing group.44 It was proposed that the geometrical 
arrangement, resulting from the steric repulsion between the bulky tBu group and the R2 group 
of the substrate 3.26 is the deciding factor for enantiocontrol (Scheme 3.6). The trans-
conformation in the transition state 3.30 is favoured and gives the major product 3.31. The cis 
transition state 3.32, which leads to the minor product 3.33, is disfavoured due to steric 




Scheme 3.6: Transient directing group directed enantioselective benzylic C-H activation of 2-alkyl 
benzaldehyde.         
 
3.5.3. Traceless directing group 
The concept of a traceless directing group involves both C-H functionalisation and removal of 
directing group in a one-pot reaction (Scheme 3.7). Sometimes, installation of a directing group 
similar to transient functionality is also possible in one-pot. A review published by Zhang et 
al. covers a range of examples based on the traceless directing group strategy.45 
 
Scheme 3.7: Concept of traceless directing group. 
Among different types of functionalities, carboxylic acids are attractive directing groups as 
they can be tracelessly removed by protodecarboxylation. Both ortho- and para-substituted 
moieties can be achieved by a carboxylic ortho directing group. Qin et al. utilised carboxylic 
acids as a traceless directing group to achieve Rh(III)-catalysed decarboxylative ortho-
heteroarylation of aromatic carboxylic acids 3.37 (Scheme 3.8). The authors proposed that the 
decarboxylative step is catalysed by Ag2CO3 rather than the Rh-catalyst. The coordination of 
carboxylic acid functionality to the Rh-catalyst directs the ortho C-H activation to form a five-
membered rhodacycle 3.40. Further reaction with heteroarenes forms heteroarene rhodacycle 
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intermediate 3.41. Lastly, reductive elimination and protodecarboxylation provide the ortho-
heteroarylated products 3.39.  
 
Scheme 3.8: Rh(III)-catalysed decarboxylative ortho-heteroarylation of aromatic carboxylic acids. 
 
3.6. Role of ligand in C-H Functionalisation 
The incorporation of the ligand has several beneficial effects in C-H functionalisation reactions. 
Ligands can stimulate the activity of the metal catalyst to increase the reaction rate, the turn 
over number (TON: moles of products per mole of the catalyst), the turn over frequency (TOF: 
moles of products per mole of catalyst per unit time), and yield of the reactions. Ligands can 
also enhance the selectivity of the reaction (i.e. chemo-, regio-, enantioselectivity).46,47  
The choice of ligand is mainly dependent on the type of reactions. Generally, phosphines and 
monoprotected amino acids (MPAA) are used.  
3.6.1. Phosphorus-based ligands 
Phosphorus-based ligands and their chiral versions are commonly employed in a variety of 
different C-H functionalisation reactions.48 Among this category, chiral phosphoric acids have 
been extensively studied. They can be employed as a co-catalyst or a ligand in asymmetric 
transformations due to their ability as strong Brønsted acids (pKa 2-4). A recent review 
published by Engle et al. details the role of chiral phosphoric acids in asymmetric palladium 
catalysis.49 Different mechanisms have been illustrated in the literature for the synergistic co-
catalysis performed by the chiral phosphoric acids/amides with palladium transition metal 




Figure 3.10: Different roles of chiral phosphoric acids with palladium catalysis. 
Baudoin and co-workers achieved the Pd(0)-catalysed enantioselective C(sp3)-H activation 
with BINOL-derived phosphoric acid (BPA) 3.45 (Scheme 3.9).50 The authors postulated a к2-
intermediate 3.46 derived from the 3,3’-disubstituted BPA, which would undergo C-H 
activation via a phosphate induced CMD mechanism. It was observed that tuning of the 3,3’-
aryl substituents of chiral phosphoric acids could play a crucial role in controlling the 
enantioselectivity, allowing the synthesis of a variety of indolines 3.44 up to 96% ee.  
 
Scheme 3.9: Pd(0)-catalysed  enantioselective C(sp3)-H activation. 
 
3.6.2. Mono-N-protected Amino Acid  
Mono-N-protected amino acids (MPAAs) have been thoroughly investigated in Pd(II)-
catalysed enantioselective C-H activation.51 Recently, Yu and coworkers demonstrated the 
potential of MPAA ligand in Pd(II)-catalysed enantioselective C(sp2)-H activation of the 2-
benzhydryl pyridine 3.47 (Scheme 3.10).52 The prochiral α,α-gem diphenyl substituents 
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underwent C(sp2)-H/R-B(OH)2 cross-coupling in the presence of Pd(II)
 and (–)-menthyl 
substituted amino acid ligand 3.49.  
 
Scheme 3.10: Enantioselective C(sp2)-H activation catalysed by MPAA ligand. 
The discovery of the MPPA ligand in the enantioselective C-H activation is intriguing. Initially, 
the reaction of 2-benzhydryl pyridine 3.47 with stoichiometric Pd(OAc)2 led to formation of 
the racemic cyclometallated dimer. This can be converted to a chiral cyclometallated dimer by 
replacing the bridging acetate of Pd(OAc)2 with an amino acid ligand. Unprotected amino acids 
and both N-protected amino acids failed to introduce the desired stereoselectivity. Later, 
MPAA had shown an average enantiocontrol. Further optimisation led to identify the (–)-
menthol derivative of leucine 3.49 as an effective MPAA ligand. The proposed transition state 
is based on the coordination of palladium to both ligand and directing group (Scheme 3.11). 
The disfavoured transition state 3.52 involves an interaction between the MPAA ligand and the 




Scheme 3.11: Stereochemical models for MPAA chiral induction.  
Initial studies suggested that MPAA reactivity depends on the bidentate coordination ability of 
both the carboxylate and mono-protected amine to the metal centre. Recently, Musaev and 
coworkers performed detailed computational studies to gain more insight on the mechanism 
governed by MPAA.53 The study suggests that a single MPAA-bridged dipalladium complex 
3.54 [Pd2MPAA] – an active catalyst comprised of two Pd centres bridged by a single MPAA 
ligand, is responsible for stereoinduction (Figure 3.11).54  
 




3.7. Role of solvent in C-H functionalisation 
The nature of the reaction medium (polar or non-polar, acidic, or basic) has a significant 
influence on the outcome of the C-H activation reactions. A wide selection of polar solvents 
has been employed including polar protic, polar aprotic, acidic, halogenated solvents, and 
recently biomass-derived green solvents.  
One of the more interesting choices is the polyfluorinated alcohol such as 1,1,1,3,3,3-
hexafluoroisopropanol (HFIP) and 1,1,1-trifluoroethanol (TFE).55-57 HFIP, which is now 
considered as a ‘magic’ solvent due to its unique properties. HFIP is a highly polar, protic 
solvent yet is non-nucleophilic. The inductive effects of six fluorine atoms make it a weakly 
acidic media with a pKa of 9.4 (at 25 °C in water). Due to its high dielectric constant, it can be 
employed as a co-solvent, generally with water, to stabilise the cationic species. All these 
characteristics allow HFIP to modulate the energy differences between different transition 
states.  
Wencel-Delord and Colobert demonstrated the superior influence of HFIP in chiral sulfoxide-
assisted atropo-diastereoselective oxidative olefination (Scheme 3.12).58 The reaction was slow 
in common solvents like DCE, i-PrOH, AcOH, and CHCl3, and gave only moderate 
stereoselectivity. The authors postulated that hydrogen bonding between the sulfoxide 
directing group and HFIP has two major implications. Firstly, H-bonding modifies the 
coordination ability of the directing group, which in turn influences the rate of C-H activation. 
Secondly, H-bonding modulates the geometry of the key palladacycle in a favourable way of 
stereoinduction.  
 
Scheme 3.12: Chiral sulfoxide-directed atropo-diastereoselective oxidative olefination in HFIP. 
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C-H functionalisation reactions accomplished so far are mainly based on the platinum group 
metals such as palladium, rhodium, ruthenium, and iridium.8,9  Recently, a new trend of 
employing the earth-abundant 3d-transition metals has also been observed towards the more 
sustainable C-H activation.11 Among all, palladium is the most employed transition metal. The 
following discussion will focus on palladium-catalysed C-H activation reactions.  
 
3.8. Nature of active catalyst in Pd-catalysed transformations  
Palladium can form complexes at different oxidation states at (0), (I), (II), (III), and (IV). There 
are different mechanistic cycles in the catalytic activity of palladium involving (a) mononuclear 
Pd(0)/Pd(II) species, or (b) Pd(II)/Pd(IV) species. Recently, Pd(III)59 and Pd(VI)60 oxidation 
states have also been proposed based on spectroscopic evidence, but not yet isolated. 
Considering the enormous success of palladium in C-H functionalisation reactions, the 
following discussion will focus on general mechanism of Pd(0)/Pd(II), Pd(II)/Pd(0), and 
Pd(II)/Pd(IV) catalytic pathways with examples of asymmetric variants.  
 
3.8.1. Pd(0)/Pd(II) catalytic cycle  
The Pd(0)/Pd(II) catalytic cycle is normally advanced for the intramolecular cyclisation of aryl 
halides (Figure 3.12). This strategy involves an initial oxidative addition to carbon-halide or 
equivalents prior to insertion into C-H bond. The oxidative addition can be accelerated by an 
electron-rich phosphine. This step requires ta monoligated Pd(II) species. The chiral 
ligand/base has an important role in controlling enantioselectivity. The regeneration of the 
carboxylate co-catalyst will occur via irreversible deprotonation. Finally, the reductive 




Figure 3.12: General catalytic cycle for Pd(0)-catalysed C-H activation.  
 
For intramolecular C-H activation reactions, enantioselectivity can be achieved in two different 
ways. First, by employing a chiral auxiliary ligand in combination with an achiral base and 
second by utilising a combination of an achiral ligand with a chiral base. These strategies have 
been successfully employed to synthesise tri- and tetrasubstituted stereocentres in high 
enantiopurity.  
Cramer et al. demonstrated an intramolecular direct arylation of vinyl triflates 3.59 at room 
temperature to give enantiopure indanes 3.60 bearing an all-carbon quaternary stereocentre 
(Scheme 3.13).61 The key to achieving the high enantioselectivity was the tailored TADDOL-
based phosphoramide ligand 3.61 in combination with the highly polar DMA solvent. The 
authors proposed a mechanistic model in which, sodium carbonate acts as a conjugate base to 




Scheme 3.13: Enantioselective Pd(0)/Pd(II) C(sp2)-H activation: synthesis of chiral indanes. 
 
The role of TADDOL-derived phosphoramidites as a chiral ligand was extended for an 
intramolecular Pd(0)-mediated C(sp3)-H activation of chloroacetamide 3.65 for the synthesis 
of highly functionalised β-lactams 3.69 (Scheme 3.14).37 Under standard conditions, this 
cyclisation was plagued by unwanted substitution of the chloride with either acid or 
phosphoramidites. The side products 3.71 & 3.72 were obtained from the undesired 
nucleophilic substitution at the α-chloro group. This side reaction could be minimised by the 
collaborative catalyst effect of precisely designed bulky TADDOL ligand 3.70 and 1-




Scheme 3.14: Enantioselective Pd(0)-catalysed C(sp3)-H activation approach to β-lactams 3.69. 
Holstein et al. demonstrated diastereoselective and enantioselective intramolecular arylation of 
primary and secondary C(sp3)-H bonds of aryl bromides 3.73 & 3.75 to synthesise up to three 
stereocentres containing fused cyclopentanes 3.74 & 3.76 (Scheme 3.15). Ferrocenylbinepine 
ligand 3.77 proved to be competent to impart high stereoselectivity. Based on computational 
studies, the authors proposed that the monoligated palladium complex 3.79 is essential for the 
enantiodetermining step. The selective formation of the (R,R)-enantiomer was reasoned to the 
weak interactions between phosphine ligand, base, and substrate in the favoured transition state 







Scheme 3.15: Enantioselective Pd(0)-catalysed C(sp3)-H activation approach to fused cyclopentanes 
3.74 & 3.76. 
 
 
3.8.3. Pd(II)/Pd(0) catalytic cycle  
Most of the reported palladium-catalysed C-H activation reactions take place at the Pd(II) 
centre. The Pd(II)/Pd(0) catalytic cycle is illustrated in Figure 3.13. First, the Pd(II) complex 
initiates the C-H activation event. This is followed by transmetallation and then reductive 
elimination to furnish the desired product. The resultant Pd(0) species must be oxidised into 
Pd(II) with an external oxidant before the completion of the cycle.62 
 
 




Cui and coworkers performed a Pd(II)-mediated desymmetrisation of a ferrocene derivative 
3.80 to give the planar chiral product 3.82.63 In this example the N,N-dimethylaminomethyl 
group was the directing group and the enantioselectivity was achieved by an MPAA ligand, – 
Boc-L-Phe-OH. Further, the experimental studies suggested that both air, and the ferrocene 
moiety are crucial. It was proposed that a ferrocenium 3.81 was formed in situ by air and this 
served as a terminal oxidant to regenerate a Pd(II) species from the reduced Pd(0) in the 
catalytic cycle.  
 
Scheme 3.16: Pd(II)-mediated desymmetrisation of a ferrocene derivative 3.80. 
 
3.8.4. Pd(II)/Pd(IV) catalytic cycle  
The C-H transformation by the Pd(IV) catalytic cycle is an emerging topic, and reactions 
proceeding through this cycle are generally operationally simple with good functional group 
compatibility. Moreover, both C-C and C-heteroatom bonds can be constructed. The strong 
oxidant that converts Pd(II) to Pd(IV) is normally based on electrophilic “F+” reagents, 
hypervalent iodine reagents, or inorganic peroxides. C-H activation reactions that follow the 
Pd(II)/Pd(IV) catalytic cycle are believed to proceed with the generation of a Pd(II)-C bond 
prior to the oxidation event.  
The general Pd(II)/Pd(IV) catalytic cycle is believed to proceed following the four steps as 
depicted in Figure 3.14. The first step is similar to the Pd(II)/Pd(0) cycle, C-H activation at 
Pd(II) centre (step 1). The second step differs, here a stoichiometric external oxidant converts 
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Pd(II) into an electron deficient Pd(IV) by the loss of two electrons (step 2). In the next step, 
the organopalladium intermediate II can interact with the substrate (R’-H) to form the Pd(IV) 
complex III (step 3). Finally, the reductive elimination closes the catalytic cycle by delivering 
the desired C-H activation product (step 4).  
 
Figure 3.14: General catalytic cycle for Pd(IV)-catalysed C-H activation. 
The first report of the Pd(IV) catalytic cycle was disclosed by the Sanford group.64 They 
achieved the intermolecular oxidative coupling of 2-aryl pyridines 3.84 in the presence of 
oxone as a terminal oxidant (Scheme 3.17). A series of mechanistic investigations proved that 
the reaction involved two sequential C-H activation steps. The first C-H activation was 




Scheme 3.17: Pd(IV)-catalysed dimerization of 2-aryl pyridines 3.84. 
The first enantioselective reaction to proceed through a Pd(II)/Pd(IV) catalytic cycle was 
reported by Yu and co-workers.65 The direct synthesis of α,α-disubstituted chiral benzofuran-
2-ones 3.90 was achieved by C-H activation/C-O bond formation from diphenyl acetic acids 
3.89, employing the MPAA ligand, Boc-L-Ile-OH 3.91, and the oxidant – 
diacetoxyiodobenzene (Scheme 3.18).  
 
Scheme 3.18: Enantioselective C-H lactonisation of diphenyl acetic acids 3.89. 
 
3.9. C-H functionalisation of saturated-N-heterocycles 
Due to the abundance of saturated-N-heterocycles in natural products and their prominent 
biological activities, the efficient synthesis of these scaffolds has always been of great interest 
to organic chemists.66 Among various methods available, C-H functionalisation offers shorter 
and easier route to access the library of analogues.67  
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For a piperidine system, the proximal position i.e. α-position to the nitrogen centre is the easiest 
to functionalise.68,69 However, the research on C(sp3)-H functionalisation of the remote sites 
i.e. β-position and γ-position is still limited (Figure 3.15).  
 
Figure 3.15: C(sp3)-H functionalisation of saturated cyclic aza-heterocycles.  
The C(sp3)-H functionalisation of saturated aza-heterocycle has been achieved in numerous 
ways.68 Among all, the most common method is deprotonation with strong base. For example, 
Campos and co-workers reported Pd(II)-catalysed enantioselective α-arylation of N-Boc-
pyrrolidine 3.93.69 The strategy includes the butyllithium/(–)-sparteine-mediated asymmetric 
deprotonation from the α-position followed by transmetallation with ZnCl2, and subsequently 
palladium-catalysed Negishi coupling with aryl bromides (Scheme 3.19). 
 
Scheme 3.19: Enantioselective α-arylation of N-Boc-pyrrolidine 3.93. 
Reports on the remote β-C(sp3)-H functionalisation are sparse. Only two methods have been 
reported to the best of our knowledge.70,71 Both of these approaches utilise existing ring 
substituents to control the regioselectivity. In Maes’s approach, a bidentate directing group 
permits the site-selective arylation of the piperdine ring 3.95.70 The addition of a carboxylic 
acid additive was crucial to success, suggesting that CMD is an important step. The authors 




Scheme 3.20: Maes’s approach for β-C(sp3)-H functionalisation. 
Bull and co-workers adopted a similar strategy with a carboxylic acid functionality at C3 
permitting formation of a bidentate directing group (Scheme 3.21).71 However, this protocol 
gave the mixture of both isomers, cis- and trans-3,4-disubstituted products 3.99 & 3.100. The 
authors suggested the formation of trans-palladacycle for the minor trans-piperidine isomer 
3.100. In both these methods for β-C(sp3)-H functionalisation, the necessity for an existing 
functional group on the ring limit the substrate generality. 
 
Scheme 3.21: Bull’s approach for β-C(sp3)-H functionalisation. 
Sandford et al. achieved the transannular γ-C(sp3)-H arylation of cyclic amines with the well-
designed fluoroamide directing group.72 The authors postulated that the directing group 
prearranges the cyclic amine system in the presence of the palladium catalyst from the stable 
chair conformation to the thermodynamically disfavoured boat conformation. However, with 
the piperidine substrate 3.101, the desired product 3.102 was obtained only in moderate yield, 
giving the aminal by-products 3.103 & 3.104, both from the starting material 3.101 and the 




Scheme 3.22: Sandford’s approach for γ-C(sp3)-H functionalisation. 
Over the past two decades, the C-H activation field has experienced enormous progress in 
achieving both chemo- and regioselectivity. Among the different types of C-H activation 
described in the introductory section, the selective functionalisation of C(sp3)-H remains the 
most challenging. The poor reactivity of C(sp3)-H bond is attributed to its high bond energy 
(376-416 kJ/mol) and low acidity (~ pKa = 50). Compared to the C(sp
2)-H system, the C(sp3)-
H holds an added degree of conformational freedom so that metal cannot directly coordinate 
to the selective C-H bond via a π-orbital interaction. Moreover, the methylene C(sp3)-H 
functionalisation is more restricted than its methyl counterpart because of more steric hindrance 
in the key palladacycle formation. Further, the differentiation of enantiotopic methylene C-H 










3.10. Results and discussion 
The main aim of this project was to develop the chemistry that would allow the shortest route 
to synthesise the alkaloid epibatidine 3.109, a potent analgesic isolated from Ecuadoran poison 
dart frog in enantiomerically pure form.73 There have been multiple procedures reported in the 
literature for the total synthesis of epibatidine.74 However, the reported multi-steps synthetic 
procedures restrict the diversity of analogues. We aimed to develop the chemistry by the late-
stage β-C(sp3)-arylation of the 7-azanorbornene (7-azabicyclo[2.2.1]heptane) 3.106, which is 
the core skeleton of epibatidine (Scheme 3.23). In this way, a number of analogues can be 
synthesised simply by altering the aromatic ring. Moreover, this approach would allow us to 
investigate one of the current limitations in the C-H activation field, namely the β-C(sp3)-H 
functionalisation of cyclic amines. The C-H functionalisation of the α-position of cyclic aza-
heterocycles is well researched68 and the γ-position to some extent,72,75 but the chemistry for 
the β-C(sp3)-H functionalisation is limited. Here, we aimed to develop the chemistry with a 
suitable directing group that can lead to form the metallacycle at the β-position. 
 
Scheme 3.23: Synthetic plan for the β-C(sp3)-arylation of the 7-azabicyclo[2.2.1]heptane 3.106 
system and the structure of epibatidine 3.109. 
 
For the asymmetric synthesis of epibatidine, we chose the intermolecular desymmetrisation76 
of enantiotopic β-C(sp3)-H bonds. This would a be challenging target. The main problem in 
this type of C-H activation is that the oxidative insertion into the C-X (X = halide) bond 
precedes the coordination of the directing group to control regio- and chemoselectivity. This 
prohibits the coordination of a chiral ligand, making the task of imparting enantioselectivity 
difficult. It would be nearly unprecedented to achieve the C-H activation without the prior 
coordination of the substrate.  
Achieving above goal will be a stepwise process; it is unlikely that we will be able to study this 
objective straight away. One starting point would be to investigate the intramolecular 
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functionalisation of the 7-azanorbornene system 3.110 (Scheme 3.24). Intramolecular 
cyclisation reaction does not require the prior coordination as the coupling partners are in the 
same molecule, enforcing the proximity into the reacting sites. Additionally, this system would 
avoid the need for a directing group, so that the main focus will remain the optimisation of the 
catalytic system while studying the effect of different reaction additives.   
 
Scheme 3.24: Intramolecular β-C(sp3)-arylation of 7-azanorbornene system 3.110. (3.110 structure 
nitrogen in amide looks like Sp3- hybridised) 
There is always an element of risk in attempting new chemistry. We wanted to minimise this 
risk by developing a fallback position that would enable us to undertake the challenging task 
while building upon the past precedent. For this, we planned to achieve the γ-C(sp3)-H 
activation on the 1,4-disubstituted cyclohexylamine system 3.112 (Scheme 3.25). The main 
aim would remain the same. The only difference is formation of azabicyclo[2.2.1]heptane 
system would be achieved by the late-stage cyclisation. Moreover, the nitrogen would not be a 
part of the ring system, which will simplify the directing group-assisted C-H activation.  
 
Scheme 3.25: Intramolecular γ-C(sp3)-arylation of 1,4-disubstituted cyclohexylamine system 3.112. 
It is worth mentioning that the above objective involves the intermolecular desymmetrisation 
of enantiotopic methylene C-H substituents. Before we study this objective, we first planned 
to study an intramolecular C(sp3)-H activation at the enantiotopic carbon. We selected a model 
reaction based on the construction of (fused) indoline system 3.116 (Scheme 3.26). We wanted 
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to learn C-H activation chemistry by employing SPO-based ligands. We also planned to 
synthesise other heteroatom-substituted secondary phosphine oxide (HASPO) ligands and to 
check if they could be useful ligands. This will help in studying the influence of the chiral 
ligand and its stereoelectronics on the metal centre. The knowledge gained from this process 
would be transferred to the former challenging objective. 
 
Scheme 3.26: Model reaction to study intramolecular C(sp3)-H activation at the enantiotopic carbon. 
The overall aim of this project was to increase the generality of C-H activation reactions while 
improving the enantioselectivity. The key to this project would not be exotic ligands but readily 
available and useful chiral ligands. We wanted to develop efficient chiral catalysts that could 
be versatile in terms of different substrates. Our focus was also to develop step and atom-
economical catalytic processes which could minimise the requirement for specific directing 
groups.  
 
3.11. Intramolecular C(sp3)-H activation at enantiotopic carbon - a chiral indoline     
system 
 
Our study began with accessing chiral indolines by the palladium-mediated functionalisation 
of unactivated C(sp3)-H alkyl groups. During the last decade, the research groups of Kundig,77 
Kagan,78 Cramer,79,80 and Baudoin,50 have all generated indolines by a desymmetrisation 
strategy. Each group achieved this objective by an intramolecular cyclisation following the 
Pd(0)/Pd(II) cycle. Notably, the initial step of C-H activation proceeds through proton 
abstraction by the coordinated base, usually either carbonate or in situ generated carboxylate 
(CMD mechanism).81 The CMD step is crucial for achieving high enantioselectivity. The 
method of achieving the CMD step varies based on the type of (chiral) ligand and (chiral) acid 
in each strategy. 
In Kundig’s pioneering work, chiral indolines were synthesised by an intramolecular 
desymmetrisation (Scheme 3.27).82  Here, a chiral NHC ligand aided oxidative insertion and 




Scheme 3.27: Synthesis of indolines 3.118 & 3.119 via enantioselective C(sp3)-H activation. 
Subsequently, a combination of other chiral ligands with an achiral conjugated basec were 
reported for the same  transformation, namely the Sagephos ligand with 9H-xanthene-9-
carboxylic acid by Saget et al.,79 and (R,R)-Me-DuPho with pivalic acid by Anas et al. 78 In all 
the cases, the bulky substituents on the ligand and resulting interaction with the achiral 
carboxylic acid were believed to favour the CMD step. Baudoin and co-workers achieved the 
same transformation with a cooperative effect of an achiral phosphine ligand and BINOL-
derived phosphoric acid (BPA) chiral base (Section 3.6.1, Scheme 3.9).50  
Overall, it was observed that the chiral conjugate base has dominance over ligand in governing 
the asymmetric induction during C-H functionalisation. For example, Cramer and co-workers 
observed an 85.5% ee with a chiral tetraline carboxylic acid 3.124 and an achiral NHC ligand 
(Scheme 3.28, Table 3.1, entry 1),79 while Kagan and co-workers obtained 82.5% ee in the 
presence of 50 mol% Boc-valine 3.125 in the absence of any ligand (entry 2).78  
 
 




Scheme 3.28: Intramolecular desymmetrisation of aryl(pseudo)halide to the synthesis of chiral 
indolines 
            Table 3.1: Influence of the chiral Brønsted acid on the intramolecular desymmetrisation of 
                           aryl(pseudo)halide   














From the above studies, it is clear that the cooperative effect of a chiral ligand and chiral 
conjugate base plays a pivotal role in the formation of enantioenriched indolines. We planned 
to design a bifunctional ligand by combining both functionalities into one molecule (Figure 
3.16). In the Pd(0)/(II) mechanism, the C-H insertion occurs through a CMD step with a 
conjugate base removing the proton. This base can be external or incorporated into the ligand. 
We prefer the latter approach. Our strategy involves a single molecule that acts as both the 
chiral ligand and chiral conjugate base. By incorporating both functionalities in a single 
molecule, we hope the transition state would be more rigid and hence greater control over the 
environment in which reaction proceeds. Moreover, it will leave the palladium coordinate site 
free to facilitate the C-H activation step effectively.  
Inspired by our previous planar chiral SPO study (Chapter 2), we planned to elaborate on a 
diverse range of SPOs, such as P,N-type SPOs. We surmised that a heteroatom-substituted 
secondary phosphine oxide (HASPO) ligand could fulfil two roles (Figure 3.16). 
i. The soft phosphorus centre can coordinate to palladium to stabilise the metal catalyst.  
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ii. The hard oxygen functionality could act as an internal conjugate base to facilitate the 
CMD step.20 
 
Figure 3.16: Design of bifunctional – HASPO ligands. 
HASPO ligands are implemented in the palladium-catalysed coupling of unactivated aryl 
halides.85-87 The role of HASPO ligands as an internal base is also revealed in the C(sp2)-H 
activation of aromatic rings with palladium87,88 or ruthenium.89 For example, Ackermann et al. 
utilised an air-stable sterically hindered adamantyl-substituted phosphine oxide [(1-
Ad)2P(O)H] for the arylation of α-C-H acidic compounds. Various substituted (aza)oxindoles 
3.127 were synthesised by intramolecular α-arylation of amides with aryl chlorides 3.126 
(Scheme 3.29). 
 
Scheme 3.29: Palladium-catalysed (aza)oxindoles 3.127 synthesis. 
The electronic and steric properties of HASPO ligands can be easily modulated by varying 
both nitrogen substituents and the functional groups on the nitrogen backbone. Several moieties 
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would be suitable such as amino acids, chiral amines, or chiral diamines. Ideally, this unit 
should be readily available in an enantiomerically pure form and should be easily modified to 
synthesise a variety of ligands quickly. This would allow us to acquire more empirical data and 
help to optimise the ligand design. Ultimately, the main objective is to design modular 
bifunctional ligands to control the stereoselectivity while improving the versatility of the C-H 
activation reactions. 
We planned to design an electron-rich and bulky HASPO ligand. Based on the ligand design, 
the organometallic intermediate 3.128 was predicted (Scheme 3.30). We surmise that the 
HAPSO ligand promotes C-H activation via a phosphine oxide – induced CMD mechanism. 
The model shows the CMD step via a five-membered palladacycle, which is usually the 
kinetically favoured in most of the reported C-H functionalisation reactions.90  
 
Scheme 3.30: Structural basis for design of HASPO catalyst.  
 
3.11.1.  Design and synthesis of HASPO ligands and substrates 
Initially, we decided to screen a number of readily available achiral SPO and HASPO ligands.  
The knowledge obtained from this would be later transferred to study the effect of chiral ligands 
(Scheme 3.31). As a starting point, we investigated electron-rich HASPO and SPO as Pd(0)-
catalysed C-H activation often benefits from the electron-rich phosphine ligands.91 The first 
targets were tert-butyl (HASPO-I) 3.131, mesitylene (HASPO-II) 3.132, and 2,6-diisopropyl 
phenyl (HASPO-III) 3.133, and which were synthesised by the reported procedures (Scheme 
3.32).92 The analogue, SPO-IV, 3.134, was prepared to compare the activity of an SPO with 
the HASPO. SPO-IV 3.134 was synthesised from commercially available di-tert-





Scheme 3.31: HASPO and SPO ligands for test reaction.d 
 
Scheme 3.32: Synthesis of SPO-IV 3.134. 
At this stage, we have synthesised only one chiral HAPSO (HASPO-VI) 3.136 to investigate 
the chiral effect. HASPO-VI 3.136 was readily achieved in three steps from the (R)-(–)1-
phenylethylamine 3.138 and glyoxal 3.137 as reported by Cramer and co-workers (Scheme 
3.33).94  
 
d  HASPO-I, HASPO-II and HASPO-VI were synthesised by the author of this thesis, while HASPO-II and HASPO-III were synthesised by interns 





Scheme 3.33: Synthesis of HASPO-VI 3.136.  
The test precursor, ethyl (2-bromophenyl)(isopropyl)carbamate 3.115 was selected based on 
the two geminal enantiotopic methyl groups. In Kundig’s study, the repulsive interaction 
between the aryl ring and an ester group was a key factor for determining the enantioselectivity. 
We also believed that an electron-withdrawing group is required to allow greater rotation of 
the C(aryl)-N bond permitting the substrate to adopt the correct conformation.
77,78  
 
Figure 3.17: Precursor ethyl (2-bromophenyl)(isopropyl)carbamate 3.115.  
Once the initial ligands and substrate were prepared, the screening process commenced. This 
focused first on HASPO-I and substrate 3.115.   
 
3.11.2.   Optimisation study 
A preliminary study was performed with HASPO-I 3.131 ligand to identify a suitable 
palladium catalyst. As explained different mechanisms in the introductory section, it is clear 
that the oxidation state of palladium is in Pd(II) state and an acetate ion has an important role 
in coordinating one of the four sites on Pd(II). We decided to analyse the commercially 
available Pd(0) and Pd(II) catalysts (Scheme 3.34, Table 3.2). The reaction proceeded with 
Pd(OAc)2, giving the product in 22% compared to the starting material (entry 1). However, 
only minute conversion of the starting material was observed with Pd2(dba)3 (entry 2), whereas 
bis[cinnamyl palladium(II) chloride] and PdCl2(CH3CN)2 failed to give any detectable product 




Scheme 3.34: Effect of different palladium catalysts. 
Table 3.2: Effect of different palladium catalysts 
Entry [Pd] Yielda 
1 Pd(OAc)2 22% 
2 Pd2(dba)3 2% 
3 Bis[cinnamyl palladium(II) chloride] - 
4 PdCl2(CH3CN)2 - 
a NMR yield with internal standard: - 1,3,5-trimethoxybenzene    
- Reaction did not proceed 
 
Next, we screened different HASPO ligands with Pd(OAc)2 as the catalyst. Sterically 
encumbered HASPOs gave unsatisfactory results (Scheme 3.35, Table 3.3). It was observed 
that the pivalic acid additive had a major influence to promote the reaction (entry 2 & 4). The 
product formation was observed in an average of 20% yield range except for the case of 
HASPO-III 3.133 (entry 5). These results were quite contrary to our hypothesis that hard 
oxygen of HASPO can act as an internal base. These results suggest that pivalic acid promotes 
the CMD step. However, even a small quantity of product 3.116 formation supported our idea 
that HASPO may have some potential to catalyse the reaction.   
 







                         Table 3.3: Optimisation study with different HASPO ligands 
Entry HASPO  Brønsted acid Yielda 
1 HASPO-I 3.131 w/o 3% 
2 HASPO-I 3.131 Pivalic acid 22% 
3 HASPO-II 3.132 w/o 4% 
4 HASPO-II 3.132 Pivalic acid 12% 
5 HASPO-III 3.133 Pivalic acid - 
                            a NMR yield with internal standard: - 1,3,5-trimethoxybenzene  
                            w/o without 
                            - Reaction did not proceed 
The optimisation was extended to evaluate the influence of base and solvent (Scheme 3.36, 
Table 3.4). The literature suggests that caesium bases are superior to other metal salts,53 but to 
confirm this we screened bases such as K2CO3, NaO
tBu, and KOtBu (entry 1, 2 & 3). The 
reaction conditions involving these bases failed even to initiate the reaction. The enhanced 
reactivity of caesium may be reasoned to the so-called ‘caesium effect’, better solubility, 
generation of highly naked anions, the large size of caesium, and its facile polarisability. 
Changing the solvent from xylene also affected the yield. Compared to xylene, 16% yield was 
observed when the reaction was conducted in NMP (entry 4), while reactions did not proceed 
at all in 1,4-dioxane and DCE (entry 5 & 6).   
 
Scheme 3.36: Effect of different bases and solvents.  
                                Table 3.4: Effect of different bases and solvents 
Entry Deviation from scheme 3.36 Yielda 
1 K2CO3 - 
2 NaOtBu - 
3 KOtBu - 
4 NMP 16% 
5 1,4-dioxane - 
6 DCE - 
    - Reaction did not proceed 
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One common observation in all of the above reactions was that they rapidly turned black, which 
suggested decomposition of the active palladium species. We decided to increase the amount 
of ligand and base (Scheme 3.37, Table 3.5). This proved successful with HASPO-I 3.131 but 
not with HASPO-II 3.132. Increasing the reaction time led to the highest yield of 38% (entry 
6).  
 
Scheme 3.37: Effect of different HASPO ligands.  
                                      Table 3.5: Optimisation study with HASPO ligands 
Entry (HA)SPO  Yielda 
1 HASPO-I 3.131 27% 
2 HASPO-II 3.132 6% 
3 HASPO-VI 3.136 - 
4 SPO-V 3.135 4% 
5 SPO-IV 3.134 1% 
6* HASPO-I 3.131 38%b 
             a NMR yield with internal standard 1,3,5-trimethoxybenzene  
             - Reaction did not proceed 
            * 24 hours, b isolated yield 
 
It is clear that our designed HASPO ligands were incapable of the desired proton abstraction 
to initiate the C-H insertion step. The reactions only proceeded when pivalic acid was 
incorporated, suggesting it was involved in CMD. It was decided to investigate chiral acid 
additive. The test reactions were separately performed with N-acetyl-L-valine 3.141 and 
[2.2]paracyclophane acid derivatives 3.142 & 3.143 (Scheme 3.38). In all reactions, only the 
starting material was returned. We reasoned the failure of these reactions was due to the steric 




Scheme 3.38: Effect of acid additives. 
Based on the screening of the reagents for an intramolecular C(sp3)-H activation of ethyl (2-
bromophenyl)(isopropyl)carbamate 3.115, it can be concluded that HASPO is capable of 
stabilising the palladium catalyst through the soft phosphorus centre but does not act as an 
internal base. It became apparent that reaction progress was observed only when the external 
acid additive was present. That suggests, the CMD process could be attributed to the external 
acid additive but not to the HAPSOs.  
As per our research objectives, we moved forward from a fused cyclic system to the bridged 
bicyclic system to study the desymmetrisation of enantiotopic methylene C-H substituents. 
Here, our focus was to differentiate the enantiotopic protons of the cyclic amine in a remote C-








3.12.  Intramolecular C(sp3)-H activation of enantiotopic and diastereotopic protons - a 
7-azanorbornane system 
Many C-H activation reactions share a common feature with formation of a kinetically 
favoured five-membered palladacycle. However, other sized metallacycles are possible 
although they are rarer (Figure 3.18).90,7,95 
Figure 3.18: Influence of chelate ring on regioselectivity of C-H activation.7 
Here, we aimed to develop the chemistry with a suitable directing group that can form the 
metallacycle at the β-position of a saturated cyclic aza-heterocycle. We selected the azabicyclic 
system - 7-azabicyclo[2.2.1]heptane (7-azanorbornane) system as a test moiety for our study. 
As shown in Figure 3.19, the six-membered ring in 7-azanorbornane is held by a one-nitrogen 
bridge to the two bridgehead carbons (C-1 & C-4).    
 
Figure 3.19: Norbornane 3.144 and 7-azanorbornane skeleton 3.106. 
Initially, we planned to study the palladium-catalysed intramolecular β-C(sp3)-H activation of 
7-azabicyclo[2.2.1]heptane scaffold 3.110 to form a C(sp3)-C(sp2) bond (Scheme 3.39). This 
cyclisation does not require the prior coordination since the coupling partners are in the same 
molecule, enforcing the reacting sites in a closed proximity. The knowledge from this study 
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would allow us to gain information required for our next goal of developing an intermolecular 
variant.  
For an intramolecular β-C(sp3)-H functionalisation, we proposed a seven-membered 
palladacycle 3.145 based on a pivalate-assisted CMD (Scheme 3.39). As C-H activation 
through a seven-membered palladacycle is sparse in the literature,96,97 we already anticipated 
the challenges associated with this precursor. If we succeed in an achiral intramolecular 
cyclisation, the enantioselective version of the reaction will be attempted either by using a 
chiral ligand or a chiral conjugate base. 
 
Scheme 3.39: Synthetic plan for an intramolecular C-H activation on 7-azabicyclo[2.2.1]heptane. 
To begin our study, we first synthesised the stable hydrochloride salt of 7-
azabicyclo[2.2.1]heptane 3.106 from trans-4-aminocyclohexanol 3.146 by following the 
reported procedure.98 Under amide formation conditions, the test precursor 3.110 was formed 
in 68% by reacting the 3.106.HCl with 2-bromobenzoyl chloride 3.147 (Scheme 3.40). 
 
Scheme 3.40: Synthesis of 7-(2-bromobenzoyl)-7-azabicyclo[2.2.1]heptane 3.110. 
We assumed that the reaction would proceed through the Pd(0)/Pd(II) cycle with the palladium 
inserting into the C-Br bond first before C-H activation. As the earlier mechanistic discussion 
indicates (Figure 3.12, page no. 79), if the reaction proceeds by a CMD mechanism, a conjugate 
base is required. Therefore, our initial reaction screening varied monodentate phosphines, 
bases, and Pd sources (Scheme 3.41). We screened different phosphine ligands (PCy3, 
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P(tBu)3.HBF4, JohnPhos) in the presence of Pd(OAc)2. However, in all reactions, only the 
starting material was recovered, indicating the failure to form the seven-membered 
palladacycle.  
 
Scheme 3.41: Initial attempts for intramolecular methylene C-H activation. 
A possible explanation for the failure could be the amide bond enforcing an unfavourable 
conformation 3.148 of the molecule. Delocalisation of the nitrogen lone pair results in a 
trigonal planar nitrogen in the amide. This would place the aromatic ring perpendicular to the 
ring (Figure 3.20). We wanted to have a desired conformation, in which the amide bond 
arranges the β-H in the close proximity of the palladium centre. The palladium insertion into 
the axial β-C-H can only be possible in a favourable conformation 3.149 or 3.150 of the 
molecule.  
 
Figure 3.20: Proposed conformation 3.148 and desired conformation 3.149 or 3.150. 
 
We decided to modify the precursor so that the unfavourable conformational bias was 
minimised. To allow more freedom in the linker, we removed the carbonyl group. We also the 
selected aryl iodide instead of aryl bromide to rule out the possibility of a slow oxidative 
insertion. The precursor 3.152 was synthesised by N-alkylation of 7-azabicyclo[2.2.1]heptane 




Scheme 3.42: Synthesis of 7-(2-iodobenzyl)-7-azabicyclo[2.2.1]heptane 3.152. 
When the reaction was carried out with the precursor 3.152, an undesired coupling with the 
solvent xylene was observed and by-product 3.153 was isolated (Scheme 3.43). The formation 
of by-product 3.153 was reasoned to the dominance of C(sp2)-C(sp2) bond formation over 
C(sp2)-C(sp3) bond. It became necessary to change the aromatic solvent to an aliphatic solvent. 
Hence, a polar aprotic solvent, NMP was employed instead of xylene (Scheme 3.44). The 
substrate 3.152 instead proceeded for a protodeiodination to generate another by-product 3.154. 
This result indicates that the palladium inserts into the C-I bond but that C-H activation does 
not occur.   
 
Scheme 3.43: Initial attempts for an intramolecular methylene C-H activation. 
 
 
Scheme 3.44: Initial attempts for an intramolecular methylene C-H activation. 
It appeared that formation of the atypical seven-membered palladacycle was challenging. 
Either the size of the ring was disfavoured or the molecule could not adopt the correct 
conformation to place the palladium close to the C-H bond. Thus, we decided to move to the 
next goal: an intermolecular desymmetrisation of enantiotopic methylene C-H protons of 7-
106 
 
azabicyclo[2.2.1]heptane. This protocol can be designed to follow the more usual five- or six-
membered palladacycle.  
 
3.13.   Intermolecular C(sp3)-H activation of enantiotopic and diastereotopic methylene 
protons - a 7-azanorbornane system 
 
For this objective, one starting point will be to design an appropriate directing group that can 
coordinate to the palladium, forcing the metal and C-H bond into close proximity to form a 
stable metallacycle. At this stage, the insertion of a metal catalyst into the C-H bond would be 
the key activation step. With the palladium catalyst, we surmise that the catalytic cycle would 
proceed through either the Pd(II)/Pd(0) or Pd(II)/Pd(IV) pathway (Figure 3.20). Depending on 
the coupling partner, if a boronic acid was used as the coupling partner, the reaction will most 
likely follow the Pd(II)/Pd(0) pathway. If an aryl bromide was used the mechanism would be 
the Pd(II)/Pd(IV) pathway.  
Figure 3.20: Proposed catalytic pathways for intermolecular cyclisation of 7-azanorbornane system. 
Sanford et al. revealed the palladium-catalysed transannular C-H arylation of an array of cyclic 
amines (Scheme 3.45).72 The remote C-H functionalisation was achieved through coordination 
of the amine nitrogen to a tethered directing group and 2-quinaldic acid 3.158 as a bidentate 
ligand.75 They claimed that ligand 3.158 plays a crucial role in recovering the active catalyst 




Scheme 3.45: Sanford’s approach for remote C-H functionalisation of cyclic amine. 
MacMillan et al. reported a dual catalyst approach that merged hydrogen atom transfer (HAT) 
catalysis with transition-metal catalysis under photoredox conditions (Scheme 3.46).99 A wide 
range of saturated aliphatic and cyclic scaffolds were functionalised in these site-selective C-
H arylation reactions. In this protocol, photoexcited tetrabutylammonium decatungstate 
(TBADT) abstracts a hydrogen atom from an alkyl/cyclic nucleophile to generate a carbon-
centred radical, which is captured by a nickel(0) complex. This nickel(0) complex is generated 
by HAT and two single-electron reductions from the pre-catalyst, Ni(dtbbpy)Br2. After 
oxidative addition of the aryl halide, reductive elimination furnishes the cross-coupled product. 
With this concept, the synthesis of (±)-N-Boc-epibatidine 3.161 was accomplished from 7-
azabicyclo[2.2.1]heptane in two steps (28% yield).   
 




Our primary approach was similar to Sanford’s approach72 i.e. to design an appropriate 
catalytic system based on a directing group. A range of different directing groups was planned 
that could potentially form a five-, six- or seven-membered metallacycle (Figure 3.21). The 
design of directing group will have a major influence on directing the transition-metal catalyst 
to activate the distal β-C-H bond. 
 
Figure 3.21: List of directing groups to study β-C(sp3)-H functionalisation of 7-azabicyclo-
[2.2.1]heptane 
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The strong coordinating nitrogen-containing directing groups such as pyridine, quinoline, 
pyrimidine, and oxazoline have been successfully employed for various C-H transformations.25 
They are mainly σ-donating in nature, hence they can bind to the metal reversibly to induce the 
site-selective C-H functionalisation. Although, the use of strong-coordinating directing groups 
is not without its limitations (section 3.5.1.),100 we thought they were more likely to realise the 
109 
 
desired C-H activation. Once we had proved the reaction was possible, we could optimise the 
directing group. 
As shown in Figure 3.22, amide and urea-based directing groups were designed based on the 
commonly employed auxiliaries.101 At the outset of this research, Sanford’s chemistry72 had 
not been reported and we were unsure if the bridge nitrogen would be involved in metallacycle 
formation.  
 
Figure 3.22: Design of amide and urea based directing groups. 
The study began with the pyridine-based auxiliary. The synthesis of the precursor (±)-7-
(picolinoyl)-7-azabicyclo[2.2.1]heptane 3.162 was achieved by reacting (±)-7-
azabicyclo[2.2.1]heptane 3.106.HCl with picolinoyl chloride 3.166 in a moderate yield 
(Scheme 3.47).  
 
Scheme 3.47: Synthesis of (±)-7-(picolinoyl)-7-azabicyclo[2.2.1]heptane 3.162 . 
Initially, for the β-arylation of the precursor 3.162, we decided to follow the procedures 
reported by Daugulis et al. 36,102 In these reports, the β-arylation and β-alkylation of (sp3)- and 
(sp2)-C-H bonds of carboxylic acid derivatives were accomplished with pyridine and 8-
aminoquinoline-based auxiliaries. However, these conditions proved conformation issues 
again (Scheme 3.48). With the pyridine auxiliary, β-C-H functionalisation of 7-
azabicyclo[2.2.1]heptane would only be possible via a 7-membered palladacycle 3.169 unless 
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the bridgehead nitrogen participated. If this was involved, it would result in a strained 4,5-
membered palladacycle 3.170. 
 
Scheme 3.48: Screening of pyridine auxiliary for intermolecular C-H activation with (±)-7-(picolinoyl)-
7-azabicyclo[2.2.1]heptane 3.162 and tentative palladacycles.   
 
Considering the widespread applicability of 8-aminoquinoline103 and the Yu-Wasa auxiliary104 
in C-H functionalisation reactions (section 3.5.1), we decided to install these auxiliaries on the 
7-azabicyclo[2.2.1]heptane 3.106 skeleton. We envisaged that these auxiliaries would form 
fused 6,5-membered 3.171 and 6-membered 3.172 palladacycles respectively (Figure 3.23). 
While the C-H activation with the 6,5-membered metallacycle is unusual, there are several 






Figure 3.23: Proposed palladacycles with 8-aminoquinoline and Yu-Wasa auxiliaries. 
 
Both 8-aminoquinoline and Yu-Wasa auxiliaries can be installed on the 7-
azabicyclo[2.2.1]heptane skeleton 3.106.HCl from their respective amine moieties by forming 
urea derivatives. Synthesis of the urea derivative is facile in theory by attack of a nucleophilic 
amine to an electrophilic isocyanate moiety (ArNCO). Both auxiliaries were converted into 
their corresponding isocyanate moieties by reacting either with triphosgene or N,N’-
disuccinimidyl carbonate (Scheme 3.49). Further reactions were carried out in one-pot with the 
hydrochloride salt of 7-azabicyclo[2.2.1]heptane 3.106 under reflux, in an appropriate solvent 
system. However, after several attempts, only minute quantities of the corresponding products 
were isolated. Due to the difficulties associated with the synthesis of the desired urea 





Scheme 3.49: Attempted synthesis of urea precursors with 7-azabicyclo[2.2.1]heptane 3.106 based on 
8-aminoquinoline and Yu-Wasa auxiliaries.  
 
As the synthesis of precursor, 7-azabicyclo[2.2.1]heptane 3.106.HCl, was itself challenging, a 
more readily available precursor was proposed, (±)-7-azabenzobicyclo[2.2.1]heptane 3.181. 
This precursor contains an aromatic ring that makes the precursor less volatile and easier to 
work with. It can be synthesised in just three steps from the anthranilic acid 3.177 and Boc-N-
pyrrole 3.178 following the method reported by Ohwada et al. (Scheme 3.50).106 
 
Scheme 3.50: Synthesis of (±)-7-benzoazabicyclo[2.2.1]heptane 3.181. 
We postulated the failure of pyridine auxiliary was due to the unfavourable conformation of 
the amide as discussed in Section 3.12 (Figure 3.20). We decided to modify the pyridine 
auxiliary in such a way that it allows greater rotation around the C-N bond. For this, we 
proposed an auxiliary 3.185 as shown in Scheme 3.51. For the synthesis of the desired 
precursor, (±)-7-[N-(pyridin-2-yl)isobutyramide]-7-benzoazabicyclo[2.2.1]heptane 3.186, first 
the alkylating reagent 2-bromo-2-methyl-N-phenylpropanamide 3.185 was prepared from 2-
bromo-2-methylpropanoic acid 3.182 and 2-aminopyridine 3.184. Next, the N-alkylation of 7-
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benzoazabicyclo[2.2.1]heptane 3.181 was performed with 3.185 in the presence of K2CO3 to 
furnish the title precursor 3.186, albeit in a low yield.  
 
Scheme 3.51: Precursor synthesis, (±)-7-[N-(pyridin-2-yl)isobutyramide]-7-
benzoazabicyclo[2.2.1]heptane 3.186 and tentative palladacycle 3.187. 
 
With the modified pyridine-based precursor 3.186 in hand, two trial conditions were carried 
out based on [Pd] and [Rh] catalysts (Scheme 3.52). The former reaction is believed to proceed 
via a Pd(II)/Pd(IV) pathway with the assistance of pivalic acid as a Brønsted acid, whereas the 
latter reaction is based on Wilkinson’s catalyst for a Rh(I)/Rh(III) pathway. Unfortunately, only 
the starting material was recovered from both reactions, indicating the unfavourable 5,4-




Scheme 3.52: Screening of modified pyridine auxiliary for intermolecular C-H activation with (±)-7-
[N-(pyridin-2-yl)isobutyr amide]-7-benzoazabicyclo[2.2.1]heptane 3.186. 
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The trend of utilising sulfur-containing directing groups has been rapidly growing in lieu of 
carbonyl based directing groups (amide, carboxylic acid).107 Different sulfur-containing 
directing groups such as thioether, thioamide, sulfoxides, and alkoxythiocarbonyl groups have 
been employed in a variety of C-H functionalisation reactions.  
Considering the influence of sulfur-containing directing groups in successful C-H activation 
reactions, two electron-rich sulfinamide directing groups 3.189 & 3.190 were planned (Figure 
3.24). It was predicted that these directing groups will form either a five-membered (through S 
atom) or a six-membered (through O atom) palladacycle. Both palladacycles should facilitate 
the desired product formation. However, one drawback of sulfur-based directing groups is their 




Figure 3.24: Proposed palladacycles 3.191 & 3.192 with sulfur-containing directing groups, 3.189 & 
3.190. 
 
First, we added the sulfinyl directing group to the bicyclic system by reacting (±)-7-
azabicyclo[2.2.1]heptane 3.181 with tert-butylsulfinyl chloride 3.193 with an acceptable yield 
(Scheme 3.53). 
 
Scheme 3.53: Precursor synthesis, (±)-7-(tert-butylsulfinyl)-7-benzoazabicyclo[2.2.1]heptane 3.189 
 
Our biggest concern was the stability of the N-S bond under acidic conditions. We selected 
reaction parameters accordingly and screened a wide range of reaction conditions (Scheme 
3.54, Table 3.6). The Brønsted acid chosen was either organic or inorganic, depending on the 
compatibility with other additives. In some cases, it was a part of a bidentate ligand such as 
picolinic acid or MPAA. Mostly, a monodentate ligand was employed. The choice of the base 
was similar to the cross-coupling reactions such as carbonates/metal tert-butoxides. The 
preference was given to polar solvents, considering their influence in lowering the energy 
barrier of the transition states of the reactants. All reactions were performed near to the boiling 








Table 3.6: Screening of reaction parameters for intermolecular C-H activation with (±)-7-(tert-   
butylsulfinyl)-7-benzoazabicyclo[2.2.1]heptane 3.189 
Entry Reaction conditions Observation 
1 Pd(OAc)2 (10 mol%), Cs2CO3 (3 eq.), PivOH (3 eq.), t-BuOH, 
130 °C 
3.189 
2 Pd(OAc)2 (10 mol%), K2HPO4 (3 eq.), Ag2CO3 (1.5 eq.), NaOAc 
(2 eq.), t-BuOH, 130 °C 
3.189 + 3.195 
(1:0.5)a 
3 Pd(OAc)2 (10 mol%), PCy3 (15 mol%), Ag2CO3 (2 eq.), HFIP,  
85 °C 
3.189 + 3.181 
4 Pd(OAc)2 (10 mol%), KOAc (2 eq.), DMA, 130 °C 3.195 
5 Pd(OAc)2 (10 mol%), AgOAc (2.2 eq.), Tol/HFIP (4:1), 110 °C 3.195 
6 Pd(OAc)2 (10 mol%), KOAc (2 eq.), t-BuOH, 90 °C 3.189 
7 Pd(OAc)2 (10 mol%), KOAc (2 eq.), DMA, 130 °C 3.195 
8 Pd(OAc)2 (10 mol%), PhCOOK (2 eq.), DMA, 130 °C 3.195 
9 Pd(OAc)2 (10 mol%), picolinic acid (2 eq.), Cs2CO3 (2 eq.), 
DMA, 130 °C 
3.195+ 3.196a 
10 Pd(OAc)2 (10 mol%), picolinic acid (2 eq.), K2HPO4 (2 eq.),  
1,4-dioxane, 150 °C 
3.196a 
11 Pd(OAc)2 (10 mol%), Ag2O, 1,4-dioxane, 100 °C 3.189 
12 Pd(OAc)2 (10 mol%), K2CO3 (2 eq.), PivOH (1 eq.), toluene,  
100 °C 
3.189 
13b Pd(OAc)2 (10 mol%), PivOH (2 eq.), neat, 100 °C 3.189 
14 [RhCl(PPh3)3] (5 mol%), PCy3, NaO
tBu (2 eq.), 1,4-dioxane,  
120 °C 
3.189 
15 [RhCl(PPh3)3] (5 mol%), PCy3, LiO





16c Pd(OAc)2 (10 mol%), KHCO3 (3 eq.), BQ (1.2 eq.), 
tBuOH, 
 130 °C 
3.189 
17d Pd(OAc)2 (10 mol%), N-Ac-Leu-OH (20 mol %), BQ (1.5 eq.), 
NaHCO3 (3 eq.), 
tBuOH [0.2 M], 100 °C 
3.189 
        a = Based on crude 1H NMR 
      b = 4-Iodotoluene (30 eq.) 
      c = Phenyl boronic acid (1.5 eq.) was used instead of 4-iodotoluene. 
      d = Potassium phenyltrifluoroborate (1.5 eq.) was used instead of 4-iodotoluene. 
No product arising from the targeted C-H activation was observed in any reaction. In most of 
the reactions, the starting material 3.189 was recovered. Moreover, the influence of the polar 
solvent and/or high temperature were proven to be detrimental in some cases. Cleavage of the 
weak N-S bond led to the formation of amine 3.181 (N-S clv) (entry 3); which formed an 
undesired byproduct N-Ac-bp 3.195 (entry 2, 4, 5, 7, & 8).e In all but two reactions we believe 
that the solvent, DMA, acted as the source of the acetyl group. In the others, the source is less 
obvious. The same effect was observed when picolinic acid was employed as a bidentate 
ligand, resulting in an N-PCN-bp by-product 3.196 (entry 9 & 10). Surprisingly, the same type 
of impurity was not found in the presence of pivalic acid (entry 12 &13) and N-Ac-Leu-OH 
additives (entry 17), presumably due to interference of sterics from the bulky tert-butyl or 
isobutyl. Changing the catalyst source to Wilkinson’s catalyst (entry 14 & 15) as well as the 
coupling partner to boronates (entry 16 & 17) did not show any positive effect for C-H 
functionalisation.  
At this stage, we decided to replace the large tert-butyl group with the smaller p-tolyl group. 
The synthesis of sulfinamide was achieved albeit in low yield due to the instability of p-tolyl 
sulfinyl chloride 3.191 (Scheme 3.55). We also tried to synthesise this precursor (S)-3.191 by 
employing (1R,2S,5R)-(–)-menthyl-(S)-p-tolylsulfinate (Andersen’s reagent) 3.192, via 
lithiation of 7-benzoazabicyclo[2.2.1]heptane 3.190. However, all attempts were unsuccessful.  
 
e The protons in the 1H NMR spectrum are quite distinguishable in both impurities, N-Ac-bp 3.195 and N-PCN-





Scheme 3.55:  Synthesis of (±)-7-(p-tolylsulfinyl)-7-benzoazabicyclo[2.2.1]heptane 3.192. 
Sulfinamide 3.192 was screened in two reactions. One used palladium and the other, rhodium. 
Both reactions failed to produce a product arising from the desired C-H functionalisation 
(Scheme 3.56). 
 
Scheme 3.56: Attempted for intermolecular C-H activation of (±)-7-(p-tolylsulfinyl)-7-
benzoazabicyclo[2.2.1]heptane 3.192. 
 
The inactivity of both the tBu- and p-tolyl sulfinyl directing groups suggests that steric 
hindrance was not an issue. At this stage, we were curious to see if the sulfinyl directing group 
would coordinate palladium, and attempted to form a palladium complex with a stoichiometric 








3.13.3. Thioamide directing group    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
Next, we looked at a thioamide. The reduced electronegativity of sulfur compared to oxygen 
and its larger size means thioamides are better directing groups than amides. The C=S bond 
length (~1.6 Å) is considerably longer than C=O. Moreover, the C=S π-orbital is higher in 
energy than the C=O π-orbital. The lone pairs of S can also coordinate to the metal.107 
Considering these properties, the electron-rich tert-butyl thioamide directing group was 
investigated. By reacting 2,2-dimethyl-1-(7-benzoazabicyclo[2.2.1]heptane)-1-propanone 
3.197 with Lawesson’s reagent, the thioamide precursor 2,2-dimethyl-1-(7-
benzoazabicyclo[2.2.1]heptane)-1-propanethione 3.198 was prepared in good yield (Scheme 
3.58). 
 
Scheme 3.58: Precursor synthesis, 2,2-dimethyl-1-(7-benzoazabicyclo[2.2.1]heptane)-1-
propanethione 3.198 and putative palladacycle 3.199. 
Both Yu and Glorius have used thioamides as directing groups for the α-C(sp3)-H arylation of 
saturated azaheterocycles via a five-membered metallacycle.68,108 We employed their reaction 
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conditions with our azabicyclic system. Unfortunately, only the starting material was recovered 
(Scheme 3.59). We believe that the failure of the desired C-H functionalisation may be due to 
the inability of the thioamide directing group to form a six-membered metallacycle. We 
speculated that similar to the amide, the larger rotational barrier of the thioamide may arrange 
the 7-benzoazabicyclo[2.2.1]heptane skeleton in an unfavourable conformation for C-H 
activation. 
 
Scheme 3.59: Screening of thioamide directing group for intermolecular C-H activation with (±)- 2,2-
dimethyl-1-(7-benzoazabicyclo[2.2.1]heptane)-1-propanethione 3.198. 
 
3.13.4.  Phosphine oxide/sulfide directing groups     
We examined phosphine oxide/sulfides directing groups, which had a single coordination site. 
Recently, diphenyl phosphine oxide [Ph2(O)P] directing group has been shown to be competent 
in various C-H activation reactions.109-111  
Addition of Ph2P(O)Cl to the 7-benzoazabicyclo[2.2.1]heptane 3.190 took a surprisingly long 
reaction time (Scheme 3.60). The resulting phosphinamide 3.202 could be converted to a 
phosphine sulfide 3.203 by reacting with Lawesson’s reagent (Scheme 3.60). We thought that 
either the Ph2(O)P/Ph2(S)P would allow us to form the six-membered metallacycles 3.204 & 




Scheme 3.60: Synthesis of (±)-7-(diphenylphosphine oxide)-7-benzoazabicyclo[2.2.1]heptane 3.202 
and (±)-7-(diphenylphosphine sulfide)-7-benzoazabicyclo[2.2.1]heptane 3.203, and proposed 
palladacycles 3.204 & 3.205. 
 
As before, a number of different reaction conditions were screened (Scheme 3.61). We believed 
that the reactions may proceed via the Pd(II)/Pd(0) or Pd(II)/Pd(IV) pathway based on the 
coupling partner. The MPAA was selected as a ligand and pivalic acid was selected as a 
Brønsted acid in different reactions to promote a CMD. Frustratingly, the starting material was 
recovered unchanged in all reactions. The only exception was when trifluoroethanol was 
employed as the solvent. Oddly, the by-product N-Ac-bp 3.195 was observed. We speculated 
that the more acidic character of the solvent led to cleavage of the P-N bond, and the resulting 
amine 3.198 reacted with the ligand Ac-Leu-OH (yield <20%). 
 





In all the above studies, monodentate directing groups were used. They would all possibly form 
a 6-membered metallacycle, except for tert-butyl sulfinyl directing group. The latter group 
could form either a 5- or a 6-membered metallacycle. As stated earlier, monodentate directing 
groups have shown less success with the activation of methylene positions than have bidentate 
directing groups. We therefore wanted to investigate a bidentate directing group but we were 
aware that we could not use the bridge nitrogen as this would lead to a four-membered ring. 
We needed a donor atom attached directly to the nitrogen. We wondered if hydrazine might 
work. 
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We envisioned that installing a donor atom next to the ring nitrogen would enable us to form a 
stable 5-membered metallacycle (Figure 3.24). It was thought that converting the 7-
benzoazabicyclo[2.2.1]heptane 3.181 into a hydrazine would allow the formation of hydrazone 
and hydrazide-based directing groups. Generally, bidentate directing groups are known to 
facilitate C-H functionalisation through their strong chelation. In a bidentate directing group, 
it is easier to tune both the steric and electronic environment. This would also, allow us to 
perfectly position a nitrogen donor to selectively target the β-position via the 5,5-chelation 
system. Moreover, the N-N bond would allow simple removal of the directing group at the end 




Figure 3.24: Hydrazone- and hydrazide-based directing groups. 
Synthesis of the precursor started with the conversion of 3.198 to N-nitroso 3.215 by reacting 
it with tert-butyl nitrile in 67% yield (Scheme 3.62). Next, we needed to reduce the N=O bond 
without cleaving the weak N-N bond. A number of reductants were screened including LAH, 
DIBAL, and single-electron reducing agents such as Zn/AcOH (Table 3.7). With the former 
reagents, either the starting material was returned or an uncharacterised side-product was 
formed. Single-electron reduction conditions showed more promise. It was observed that the 
reaction time had a major influence on the outcome of the reaction. Longer reaction times led 
to N-N bond cleavage, returning the amine 3.198. It is still unclear whether this cleavage is 
occurring only in the starting material, N-nitroso moiety 3.215, in the expected hydrazine 
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derivative 3.216, or in both moieties. By reducing the reaction time (4 hrs), the expected 
hydrazine product 3.216 was obtained as an inseparable mixture with 3.198. It was, therefore, 
decided to perform the acetylation on a mixture of 3.216 and 3.198. Reaction with picolinoyl 
chloride 3.166, gave expected hydrazine derivative albeit in 16% yield, with an amide by-
product (10%) (Scheme 3.63). 
 
Scheme 3.62: Synthesise of 7-(N-nitroso)-7-benzoazabicyclo[2.2.1]heptane 3.215 followed by 
attempted reduction. 
 
     Table 3.7: Attempted reduction conditions of 7-(N-nitroso)-benzoazabicyclo[2.2.1]heptane 3.215 
Entry Reduction conditions Observations 
1 LAH (1.5 eq.), THF, 0 °C to rt to reflux Starting material 3.125 returned 
2 DIBAL (1 M, 2 eq.), CH2Cl2, -78 °C to rt Uncharacterised by-product 
3 Zn (3 eq.), NH4Cl (3 eq.), THF : H2O, 0 °C to rt Starting material 3.125 returned 
4 Zn (4 eq.), AcOH : EtOH : H2O, 0 °C to rt, o/n N-N cleavage observed 
5 Zn (4 eq.), AcOH : H2O (1:1), 0 °C, 4 hrs Mixture of 3.216 and 3.198 
 
 
Scheme 3.63: Precursor synthesis, 7-(picolinoylhydrazine)-7-benzoazabicyclo[2.2.1]heptane 3.211.  
Considering the difficulties associated with formation of the hydrazine derivative 3.211, an 
alternative strategy was investigated (Scheme 3.64). This involved adding the hydrazine moiety 
3.222 before forming the bicyclic molecule. The synthetic scheme proceeded smoothly until 
the penultimate stage. However, deacetylation of 3.224 did not work. If we would have able to 
form the 3.225, we had anticipated the challenges associated with the cyclisation of 
cyclohexanol intermediate 3.225. We expected only the trans isomer of 3.225 to cyclise to the 
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desired bicyclic amine scaffold 3.211 and made the separation feasible from the cis isomer of 
3.225.  
 
Scheme 3.64: Attempted precursor synthesis, 7-(picolinoylhydrazine)-7-azabicyclo[2.2.1]heptane 
3.211.  
 
After comprehensive screening of a range of directing groups, β-C(sp3)-H arylation of 7-
(benzo)azabicyclo[2.2.1]heptane failed. We believed that all of the directing groups led to an 
unfavourable conformation of the directing group in the 7-azanorbornane, so that the metal 
catalyst could access the β-C(sp3)-H bonds to form a metallacycle. We suggest that it would be 
advantageous to design an appropriate directing group that could form a thermodynamically 
more favoured metallacycle such as a 5- or 5,5-membered metallacycle. This suggestion is in 
agreement of Sanford’s γ-C(sp3)-H arylation of cyclic systems, which was published75 when 
we were evaluating our last designed directing groups. In their study, they proposed the 
formation of a thermodynamically favoured fused 5,5-membered palladacycle with the 
tethered directing group, considering the involvement of ring nitrogen. 
The β-C(sp3)-H functionalisation of saturated azaheterocycles would definitely open a new 
avenue to access substituted azaheterocycles in the shortest way. Considering the timeline of 
Ph.D., we decided to move to our fallback plan, γ-C(sp3)-H arylation of 1-cyclohexylamine 
where the methods to achieve the desired C-H activation have already been reported but its 
asymmetric version still needs to be addressed.   
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3.14.  Enantioselective γ-C(sp3)-H of a cyclohexylamine system 
As explained in the objective section of this chapter, we sought to investigate C(sp3)-H 
activation on the 1,4-disubstituted cyclohexylamine system 3.112. We could still achieve the 
goal of epibatidine synthesis by a late-stage cyclisation approach. With this system, the 
directing group can be designed based on the external amine functionality. 
 
Scheme 3.65: Intramolecular γ-C(sp3)-arylation of 1,4-disubstituted cyclohexylamine system 3.112. 
The main goal of this project was to achieve the enantioselective γ-C(sp3)-H functionalisation 
of the cyclohexylamine system. The catalytic system leveraging an amide directing group such 
as picolinamide directing group has been exploited for C(sp3)-H activation on a wide range of 
aliphatic and cyclic amine substrates.95   
Before C(sp3)-H activation of the 1,4-disubstituted cyclohexylamine system, we thought that 
the simple 1-aminocyclohexane would be a good test system. The achiral γ-C(sp3)-H arylation 
on this system using a picolinamide directing group has been reported (Scheme 3.66a).36,112  
Seki et al. also achieved C-H activation of unsubstituted cycloalkylamine derivatives using the 
same conditions (Scheme 3.66b).113  Very recently, a similar study was published by Sheppard 
and co-workers with an improved reaction efficiency and diverse substrate scope. Under these 
silver-free reaction conditions, caesium carboxylate salt and CuBr additive were shown to 




Scheme 3.66: Different reaction conditions reported for picolinamide-directed γ-C(sp3)-H arylation of 
cycloalkylamine derivatives.  
As per the proposed mechanism, the picolinamide directing group coordinates with Pd(OAc)2 
to form a palladium complex I (Figure 3.25). The next step would enable the activation of γ-
C(sp3)-H bond. The bidentate coordination of both the amide and pyridine leads to a 
thermodynamically favoured 5,5-fused palladacycle II. Subsequently, the oxidative addition 
of aryl iodide generates Pd(IV) intermediate III, which would lead to product formation upon 




Figure 3.25:  Proposed Pd(II)/Pd(IV) pathway for a γ-C(sp3)-H arylation of N-cyclohexylpicolinamide 
3.234. 
We sought to achieve an asymmetric version of γ-C(sp3)-H activation of the N-
cyclohexylpicolinamide 3.234. It is noteworthy to mention here that the initial proton 
abstraction step is enabled by an acetate from the catalyst Pd(OAc)2. By replacing it with a 
chiral conjugate base, it may be possible to achieve the enantioselective C-H functionalisation. 
We envisaged that chirality could be introduced in two possible ways (Figure 3.26). 
i. By introducing a chiral Brønsted acid (chiral conjugate base) (Enantioselective) 






Figure 3.26:  Proposed strategies for asymmetric γ-C(sp3)-H arylation of N-cyclohexylpicolinamide 
3.234. 
 
Inducing asymmetry during C-H functionalisation might be possible if the diastereomeric 
transition states formed by using a chiral conjugate base were sufficiently different. This is 
particularly challenging in this example where we must also consider about the conformation 
of the molecule. Our study began by probing various (chiral) Brønsted acids (Scheme 3.68, 
Table 3.8). 
The first experiment was a control to establish that we could functionalise 3.234 (Scheme 
3.67).113 The C-H transformation was accomplished in 60% yield. Using HPLC, Daicel As-H 
column (normal phase), and Lux Amulose column (reverse phase), it was possible to resolve 
the two enantiomers distinctly so that the enantiomeric ratio could be accurately determined.  
 




Our screening of different (chiral) Brønsted acids began (Scheme 3.68, Table 3.8). The 
Pd(OAc)2 was replaced by PdCl2 [Pd(II)] as an active catalyst so that we could remove the 
acetate ion and hopefully avoid a non-selective background reaction. The reaction was set up 
in the absence of any Brønsted acid (entry 1). Surprisingly, product formation was observed 
(SM:P 82:18), suggesting that the strong chelating effect of the bidentate directing group was 
sufficient to initiate the reaction albeit slowly. When pivalic acid was employed as an acid 
additive, the reaction conversion increased to 88% (entry 2). This clearly shows that a Brønsted 
acid, presumably, as the carboxylate salt, mediates the concerted metalation deprotonation 
process. Next, we investigated a range of chiral acid derivatives as shown in Table 3.8.  
 
Scheme 3.68: Optimisation study to evaluate the effect of chiral acid on γ-C(sp3)-H arylation of N-
cyclohexylpicolinamide 3.234.a  
a = HPLC conditions (Normal Phase) for separation of enantiomers of 3.240:- stationary phase : Daicel As-H 
column, mobile phase: 10% iPr-OH: Hexane (1% TFA) for 45 min. Flow rate: 1.0 ml/min, Injection vol. 10 μl, 
RT:  for enantiomer 1: 18.39 min., for enantiomer 2: 22.99 min. 
  = HPLC conditions (Reverse Phase) for separation of enantiomers of 3.240:- stationary phase : Lux Amulose 
column, mobile phase: 70% CH3CN: H2O for 50 min. Flow rate: 0.5 ml/min, Injection vol. 10 μl, RT:  for 












             Table 3.8: Effect of various (chiral) Brønsted acid 
Entry (Chiral) Brønsted acid Observationa, b, c 
1 no Brønsted acid SM:P = 82:18 
2 
 
SM:P = 12:88 
339 
 
SM:P = 78:22* 
 
4 Deviation from the reaction conditions of scheme 
3.68d 




SM:P = 76:24 
er = 49.42:50.58 
6 
 




SM:P = 27:73 
er = 52.38:47.62 
8115 
 
SM:P = 35:65 





SM:P = 0:100 
















SM:P = 0:100 
 
a = The ratio of starting material and product (SM:P) was determined based on crude 1H NMR,  
     comparing the ratio of distinct C1-proton of SM and P.    
b = Enantiomeric ratio (e.r.) was determined based on optimised HPLC conditions on pure product  
*  e.r. is not determined due to low conversion.       
c= (Chiral) Brønsted acids were synthesised by following the reported procedures of  
     respective references mentioned in the entry column 
                     d = PdCl2(CH3CN)2 (10 mol%), (S)-BINOL-P(O)2H, (20 mol%), Cs2CO3 (1.5 eq.),  
                   xylene, 140 °C, 22 hrs.  
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Considering the widespread success of BINOL derivatives in asymmetric catalysis,120 we 
started with the BINOL-based chiral phosphoric acid 3.242. BINOL possesses an axis of 
chirality and the high rotational barrier of 1,1’-binaphthyl enables the high configurational 
stability of the enantiomers. When (S)-BINOL-P(O)2H 3.242 was employed, it had shown a 
very minimal effect on reaction conversion (entry 3). Product formation was nearly the same 
as the background reaction (entry 1). Chen et al. reported an enantioselective picolinamide 
directed benzylic C(sp3)-H arylation of phenylpropylamine by employing BINOL phosphate 
ligand. His team proposed that the cooperative effect of the BINOL with the caesium carbonate, 
generating caesium phosphate complex may be responsible for the good stereocontrol in the 
C-H palladation step.121 When the same reaction conditions were applied for the substrate 
3.234, it proved detrimental to the reaction progress (entry 4). An alternative C2-symmetric 
additive HASPO-VI 3.136 was also implemented, hoping to act as an internal base but with no 
success (entry 5).  
We then screened a collection of readily accessible chiral acids. With (1S)-(+)-10-
camphorsulfonic acid 3.243, the reaction did not show any promise (entry 6) while significant 
product formation was accomplished with dibenzyl-L-tartrate 3.244 (entry 7) but failed to 
induce good enantiocontrol (er = 52.38:47.62). Due to the bidentate nature of the picolinamide 
directing group, only one valence site of Pd(II) is available to interact with a chiral acid. Hence, 
we selected bis-N-protected naphthalimide-based amino acids (entry 8 & 9).115 When 
naphthalimide-L-valine 3.245 and naphthalimide-L-phenylalanine 3.246 were employed in the 
reaction, complete product formation was observed in the latter case (entry 9). Unfortunately, 
neither reaction showed any selectivity (51.63:48.37 and 47.96: 52.04). 
In light of the recent success of a novel C2-symmetric carboxylic acid, (4S,5S)-1,3-dibenzoyl-
4,5-diphenylimidazolidine-2-carboxylic acid 3.247 in the enantioselective cobalt(III) catalysed 
C-H activation,116 it was exciting to explore its potential on the current 1-aminocyclohexyl 
system (entry 10). The reaction proceeded in 75% yield and 49.42:50.58 er.  
An obvious interest of our group is planar chiral [2.2]paracyclophane derivatives. Generally, 
the resolution of planar chiral [2.2]paracyclophane carboxylic acid derivatives can be 
tedious.122 Therefore, the efficiency of racemic carboxylic acids was established first. 
Gratifyingly, all [2.2]paracyclophane carboxylic acid derivatives, including mono- and 
disubstituted derivatives 3.142, 3.248, and 3.249 showed 100% reaction conversion (entry 11, 
12 & 13).  
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With the success of racemic paracyclophane acids, we needed a quick method to resolve them. 
Initially, we attempted desymmetrisation of the diacid 3.248 by formation of a monoamide. 
The desymmetrisation of 3.248 was attempted by adding the readily available chiral amine - 
(R)-phenylethylamine 3.138 using standard amide coupling methods (Scheme 3.69).123 Here, 
our aim was to form only a mono-coupled product with the half equivalent of desired coupling 
reagents. Unfortunately, the reaction was non-selective, occurring on both carboxylic acid 
groups to give a chiral monosubstituted product 3.250 in 16% and chiral disubstituted product 
3.251 in 13%.  
 
Scheme 3.69: Attempted desymmetrisation of [2.2]paracyclophane-4,13-dicarboxylic acid 3.248. 
 
Due to the difficulty encountered in desymmetrising the disubstituted derivative, we decided 
to resolve the monosubstituted derivative (±)-[2.2]paracyclophane-4-carboxylic acid 3.142 
(Scheme 3.70). The same approach was applied but this time with L-phenyl alaninol 3.252. 
Unfortunately, the product formation 3.253 was observed in low yield and the diastereomers 
were inseparable by column chromatography.  
 
Scheme 3.70: Attempted resolution of (±)-[2.2]paracyclophane-4-carboxylic acid 3.142. 
Due to the challenges faced during the synthesis of enantiopure mono- and di-substituted 
[2.2]paracyclophane carboxylic acid derivatives, we became interested in developing an 
alternative methodology to access these useful compounds. One of the most intriguing 
strategies was through the direct synthesis of an oxazoline that would be formed as a 
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diastereomeric mixture that could be resolved. Once the pure diastereomer was in hand, it could 
be hydrolysed to obtain the enantiopure [2.2]paracyclophane carboxylic acid (Figure 3.27).  
 
Figure 3.27: Strategy to access enantiopure [2.2]paracyclophane acid derivatives. 
At this point, we decided to develop the methodology for the synthesis of [2.2]paracyclophane-
oxazoline derivatives. If we succeed to gain access to the planar chiral acid derivatives, the 
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4.0. Coupling between [2.2]paracyclophane halides and chiral oxazolines 
Similar to the success of BOX ligands in asymmetric catalysis,1-5 [2.2]paracyclophane-bis-
oxazolines could be explored as chiral ligands in various stereoselective transformations. In the 
literature, [2.2]paracyclophane-oxazoline derivatives are synthesised from the corresponding 
carboxylic acid derivatives by a traditional route involving three steps (Scheme 4.1).6-16 In the 
first step, carboxylic acid 4.1 is converted into an acyl chloride which subsequently reacts with 
an amino alcohol to form amide derivative 4.2. Finally, Appel cyclisation17 of the amide 
derivative gives oxazoline derivative 4.3.  
 
Scheme 4.1: Traditional route to synthesis [2.2]paracyclophane-oxazoline derivatives. 
It is worth mentioning that the synthesis of the [2.2]paracyclophane-carboxylic acid derivatives 
is not always straight forward. The synthesis of the monosubstituted carboxylic acid requires a 
minimum of two steps from [2.2]paracyclophane. To access disubstituted carboxylic acid 
derivatives is lengthier. Due to these challenges associated with the synthesis of 
[2.2]paracyclophane-oxazoline derivatives, there is always a need for practical methodology 
that can access these valuable compounds.  
Recently, Lu et al.18,19 and Ackermann et al.20 independently reported the direct C-H 
(hetero)arylation of oxazolines 4.5 at the 2-position (Scheme 4.2). The former group employed 
bidentate diphosphine ligands (dppe or dppp) while the latter group used a bulky SPO-based 
catalyst 4.7. These protocols are good alternatives to the traditional methods for the synthesis 









Scheme 4.2: Reported conditions for the C-H (hetero)arylation of oxazolines. 
 
4.1. Scope of bromo[2.2]paracyclophane for oxazoline coupling  
The chemistry above served as inspiration for a new synthesis of planar chiral oxazolines. 
We screened different SPO and HASPO ligands (Scheme 4.3). After a brief optimisation 
study, we found that a combination of Pd(OAc)2 and di-tert-butyl SPO 4.15 coupled (4S)-
4-benzyl-oxazoline 4.10 to (±)-4-bromo[2.2]paracyclophane 4.9 in 82% yield. We were 
unable to separate the diastereomers but it has subsequently become clear that they are 
separable.f Further hydrolysis of the coupled product 4.11 proceeded smoothly in an acidic 
medium to give (±)-[2.2]paracyclophane-4-carboxylic acid 4.12 in 100% yield. While we 
did not resolve the enantiomers here, it is clear that it can be achieved. 
 




Scheme 4.3: Synthesis of 4-(4-benzyl-oxazoline-2-yl)[2.2]paracyclophane 4.11 and its hydrolysis. 
* SM : P was determined based on the crude 1H NMR spectroscopy 
A plausible mechanism for the coupling is based on the Pd(0) /Pd(II) pathway and is shown 
in Figure 4.1. The catalytic cycle is initiated by the oxidative addition of the ligated Pd(0)  
to the [2.2]paracyclophane-halide. The oxazoline 4.5 is deprotonated by the LiOtBu to 
generate the lithium oxazoline intermediate, which subsequently undergoes transmetallation 
with the organopalladium intermediate I to give the palladium-oxazoline intermediate II. 
Finally, reductive elimination produces coupled product 4.17, and simultaneously reducing 




Figure 4.1: Proposed mechanism for [2.2]paracyclophane halide and oxazoline coupling. 
Having optimised the coupling, we decided to delineate the scope of the reaction using 
various bromo[2.2]paracyclophanes. It would be further exciting to resolve the enantiomers 
of [2.2]paracyclophane moieties by isolating diastereomers in a pure form. If we succeed, 
hydrolysis of the pure diastereomers will be carried out to derive an array of planar chiral 
[2.2]paracyclophane-carboxylic acid derivatives. 
 
4.2. Scope of dibromo[2.2]paracyclophane derivatives for oxazoline coupling 
First, we investigated whether the addition of two oxazolines was possible, then whether it was 
possible to stop the reaction halfway. The latter reaction would retain a bromide for subsequent 
functionalisation.  
To attempt mono coupling, just one equivalent of (4S)-4-benzyl-oxazoline 4.10 was employed 
with 4,16-dibromo[2.2]paracyclophane (pseudo-para) 4.18 under the optimised protocol 
(Scheme 4.4). Monocoupling was observed but unfortunately also with protodebromination, 
which resulted in oxazoline 4.11 in 52% yield. A single diastereomer of bis-coupling product 
4.19 was also isolated in 31% from the same reaction (entry 1). This result suggests that nothing 
is stopping the second coupling from occurring. Doubling the catalytic loading, while 
maintaining the same equivalent of the base was detrimental to the reaction (entry 2). The 
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reaction conversion dropped by nearly half compared to the previous conditions. It became 
imperative to double the concentration of base (5 eq.) with other additives to achieve the bis-
coupled product 4.19 in maximum yield (81%, entry 3). 
 
Scheme 4.4: Attempted mono- and bis-coupling of 4,16-dibromo[2.2]paracyclophane 4.18 with (4S)-
4-benzyl-oxazoline 4.10. 
 
The same strategy was applied to (±)-4,12-dibromo[2.2]paracyclophane (pseudo-ortho) 
substrate 4.21 (Scheme 4.5). Using one equivalent of (4S)-4-benzyl-oxazoline 4.10 led to both 
the mono- and the bis-coupled oxazoline products, 4.22 & 4.23 in 25% and 38% yield, 
respectively, with 4.11 in 31% (entry 1). It was possible to isolate the bis-oxazolines as single 
diastereomers by flash chromatography. Again, when performing the double addition, the 
quantity of base was crucial. Doubling all the reagents except the base (2.5 eq.) had a 
detrimental effect on the coupling (entry 2). Doubling all the reagents including base (5 eq.) 
gave bis-oxazolines 4.23 as the exclusive product in 70% yield (entry 3). Moreover, each pure 
diastereomer of product 4.23 was separated. With that, we achieved the shortest route to access 






Scheme 4.5: Mono- and bis-coupling of (±)-4,12-dibromo[2.2]paracyclophane 4.21 with (4S)-4-
benzyl-oxazoline 4.10. 
Dia1: Isolated yield of first diastereomer, Dia 2: Isolated yield of second diastereomer 
 
4.3. Scope of pseudo-gem-[2.2]paracyclophane derivatives for oxazoline coupling 
 
The true power of the methodology would be in forming any functionalised oxazoline so we 
set out to determine the functional group compatibility. We started with the pseudo-gem 
derivatives as we believed they would be the easiest to synthesise but the hardest to react. 
Surprisingly, the electron-donating groups (NH2 and 1-piperidine) 4.25 & 4.28 gave good 
yields (Scheme 4.6, entry 1 & entry 2). Moreover, the separation of diastereomeric products 
was possible. We were surprised with the results because the same precursor, (±)-4-bromo-13-
amino[2.2]paracyclophane 4.25 gave poor yields in the desulfitative reactions (see Section 
6.3.1.4).  
Equally surprising was the lack of success obtained with the electron-deficient nitro and ester 
derivatives 4.31 & 4.34. No reaction was obtained with the electron-withdrawing NO2 group 
(entry 3). However, the oxazoline coupling was observed in low yield with (±)-4-




Scheme 4.6: Scope of pseudo-gem-[2.2]paracyclophane derivatives for oxazoline coupling.  
Dia1*: Isolated yield of the first diastereomer, Dia mix: Isolated yield of mixed fraction of first diastereomer 
and second diastereomer, Dia 2*: Isolated yield of the second diastereomer, Yield: Total isolated yield of the 
reaction. *The exact configuration of the diastereomer is not determined yet. 
 
We decided to hydrolyse the ester 4.34 substrate to a carboxylic acid 4.37. It is also clear that 
electron-rich systems give better yields, so by making carboxylate, we obtained an electron-
rich variant. The reaction was set up with (±)-4-bromo[2.2]paracyclophane-13-carboxylic acid 
4.37. Fortunately, the product formation was nearly doubled. On the down side, the 
diastereomers of 4.38 were inseparable.  
 





4.4. Scope of pseudo-ortho-[2.2]paracyclophane derivatives for oxazoline coupling 
Normally, we expect higher yield from pseudo-ortho substrates compared to pseudo-gem 
substrates due to a reduction in steric congestion. However, when the oxazoline coupling 
reaction was performed with (±)-4-bromo-13-amino[2.2]paracyclophane 4.39, we observed the 
opposite. Only protodebromination coupling was detected (Scheme 4.8, entry 1) The same 
result was observed with (±)-4-bromo[2.2]paracyclophane-13-ethyl ester 4.41 (entry 2). This 
result suggests that oxidative insertion is occurring but transmetallation is a problematic. When 
(±)-4-bromo[2.2]paracyclophane-13-carboxylic acid 4.41 was employed under the same 
reaction conditions, the desired coupling was obtained in 61% yield. No protodebromination 
was observed (entry 3). It is still unclear why the less sterically hindered pseudo-ortho pocket 
isomer is a poor substrate for this reaction. This study suggests that a detailed mechanistic 
investigation is required to probe the reactivity of these systems. 
 
Scheme 4.8: Scope of pseudo-ortho-[2.2]paracyclophane derivatives for oxazoline coupling. 
 
4.5. Scope of ortho-[2.2]paracyclophane derivatives for oxazoline coupling 
Due to steric hindrance, the coupling of ortho-substituted bromides is often taxing. The 
substrate, (±)-4-bromo-5-amino[2.2]paracyclophane coupled 4.46 in a moderate yield under 
the optimised conditions (Scheme 4.9, entry 1). The diastereomers were separable by 
preparative TLC. The only other ortho-substituted derivative we had access to was formyl 
151 
 
derivative 4.48; however, this failed to react (entry 2). This reaction produced by-products in 
DMA solvent. By changing the reaction solvent to 1,4-dioxane, only the starting material was 
recovered (entry 3). These results suggest that further studies are required before this 
methodology proves its generality.   
 
Scheme 4.9: Scope of ortho-[2.2]paracyclophane derivatives for oxazoline coupling. 
4.6. Attempts to improve generality of the reaction and resolution of the 
[2.2]paracyclophane derivatives 
 
The preliminary investigation of the coupling of (4S)-4-benzyl-oxazoline 4.10 with various 
[2.2]paracyclophane derivatives raised several concerns. The coupling was possible and in a 
number of examples the diastereomers could be separated. But the resolution was challenging 
and a number of substituents delivered the product of protodebromination. We wondered if a 
different oxazoline might help the separation of the diastereomers and possibly give more 
information about the coupling. 
Chiral oxazolines can be easily synthesised from chiral 2-amino alcohols and carboxylic acid 
derivatives such as naturally/specifically designed amino acids and amino alcohols. The 
oxazoline ring substituents play a major role in tuning the steric property e.g. bulky groups 
and/or aromatic substituents can exert intra- and intermolecular interactions. Both C-4 and C-
5 positions of oxazolines can be modified to regulate the chiral environment.  
Another problem we encountered was the separation of the resulting diastereomers. Ideally, we 
wanted to easily separate the diastereomers by column chromatography. By altering the 
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substituents in the oxazoline ring we hoped to alter the two diastereomers sufficiently that 
separation would be more facile. 
Considering the above factors, we decided to modify the chiral oxazoline substituents at the 
C4 and C5 positions and evaluate their effects on oxazoline coupling as well as separation of 
diastereomers. 
 
4.6.1.  (4S)-4-Phenyl-oxazoline-based coupling partner 
Our first attempt brought the aromatic substituent of the oxazoline closer to the 
[2.2]paracyclophane framework and we investigated (4R)-4-phenyl-oxazoline substrate 4.49 
Unexpectedly coupling of (±)-4-bromo[2.2]paracyclophane with 4.49 gave the heteroaromatic 
compound 4.50 (Scheme 4.10). We speculated that C-4 proton abstraction by a strong base 
promotes the aromatisation of oxazoline ring to the thermodynamically favourable oxazole 
(Scheme 4.11). It should be noted that aromatisation only occurred with (4R)-4-phenyl-
oxazoline substrate 4.49 but not with (4S)-4-benzyl-oxazoline 4.10. We reasoned the 
conjugated double bonds resulting after proton abstraction leads to a stable heteroaromatic ring. 
However, it is difficult to predict whether elimination occurred before or after coupling.  
 
Scheme 4.10: Coupling of (±)-4-bromo[2.2]paracyclophane 4.9 with (4S)-4-phenyl-oxazoline 4.49. 
 
Scheme 4.11: Postulated aromatisation of oxazoline ring in presence of strong base. 
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4.6.2.  Modification of C-4 position of oxazoline  
Our next oxazoline would increase the steric bulk and add a polar functional group that might 
interact with silica to facilitate separation. It also avoids the issue of conjugation so should not 
undergo aromatisation. The synthesis involved addition of Grignard reagent to an ester to form 
a tertiary amino alcohol, that could rapidly be converted into the family of oxazolines. The 
ability of the free hydroxy group for hydrogen bonding may induce intermolecular interactions 
to ease the separation of diastereomers (Figure 4.2).  
 
Figure 4.2: Design of polar sterically encumbered oxazoline. 
The synthesis of C-4 modified oxazolines and their attempted coupling with (±)-4-
bromo[2.2]paracyclophane 4.9 is shown in Scheme 4.12. 
 
Scheme 4.12: Coupling of (±)-4-bromo[2.2]paracyclophane 4.9 with C-4 modified oxazoline. 
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As per our plan, the reactions were carried out between L-serine methyl ester hydrochloride 
4.53 and Grignard reagents, PhMgBr 4.54, NaphthMgBr 4.59, and BnMgBr 4.63 separately to 
achieve their corresponding diaryl tertiary amino alcohols (Reaction A). 
During the synthesis of diphenyl tertiary aminoalcohol 4.55 (Reaction A, Scheme 4.12a), the 
oxetane-containing by-product 4.56 was detected. We speculated that an SN1 mechanism 
accounts for this by-product (Scheme 4.13). Under the strongly acidic workup conditions, the 
tertiary alcohol 4.55 is protonated. The loss of water from 4.68 creates a tertiary carbocation 
4.69. Next, the attack of primary hydroxyl group to tertiary carbocation forms the oxetane ring.  
 
Scheme 4.13: Proposed SN1mechanism for oxetane by-product formation. 
 
We also decided to introduce bulkier naphthyl groups. However, during the synthesis of 
dinaphthyl tertiary amino alcohol, only by-products, arising from NaphthMgBr 4.59, were 
recovered (Reaction A, Scheme 4.12b). Due to difficulties encountered in the synthesis of 
dinaphthyl tertiary amino alcohol, we decided to introduce different substituents in the form of 
the benzyl group. The dibenzyl tertiary aminoalcohol 4.64 was synthesised (Reaction A), which 
underwent the oxazoline-formation conditions (Reaction B) to furnish two distinct products, 
(S)-4-(tert-hydroxyl dibenzyl)oxazoline 4.65 and (S)-4-(methan-1-ol)-5,5-dibenzyloxazoline 
4.66 (Scheme 4.12c). 
 
Next, we attempted oxazoline coupling. The coupling reaction was set up between (S)-4-(tert-
hydroxyl diphenyl)-oxazoline 4.57 (Scheme 4.12a), and (±)-4-bromo[2.2]paracyclophane 4.9 
under optimised conditions (Rection C). The reaction proceeded in low yield to produce an 
inseparable diastereomeric mixture 4.58. Due to the low conversion to the other desired amino 
alcohols, the next step of coupling was not performed.  
Since the results from the modification of C-4 position alone were not encouraging as expected, 
we then thought to modify both C-4 and C-5 positions on the oxazoline backbone. 
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4.6.3.  Modification of both C-4 and C-5 positions of oxazoline 
(1S,2S)-(+)-2-Amino-1-phenyl-1,3-propanediol 4.68 is a good starting material for the 
synthesis of 4,5-disubstituted oxazolines (Scheme 4.14). Selective protection of the primary 
alcohol permits synthesis of the desired compounds. 
 





(4S,5S)-4-(Methylalcohol)-5-phenyloxazoline 4.70 was synthesised from 4.68 in 65% yield. 
(Reaction A). Here, the crude 1H NMR spectroscopy data revealed 4.70 only product. We 
speculated that both product 4.70 and 4.70a had been formed and the kinetic product 4.70a 
may rearranged in situ to give exclusive 4.70 product. The selective 1° hydroxy group 
protection of precursor 4.68 was performed with the TBDPS group to increase the steric bulk. 
However, TBDPS protected substrate 4.69 required different conditions to form the desired 
oxazoline 4.71 albeit in lower yield (Reaction B). The coupling reaction of oxazoline 4.70 with 
(±)-4-bromo[2.2]paracyclophane 4.9 produced the desired product 4.72 only in 15% yield 
while the protodebromination by-product [2.2]paracyclophane was significant (Reaction C). 
The oxazoline-coupling reaction of TBDPS protected oxazoline 4.71 gave the same product 
4.72 in 19% after TBDPS deprotection during the reaction (Reaction C). As satisfactory results 
were not forthcoming, we considered installing a benzyl group at the primary hydroxyl group 
(C4 position). 
 
Initially, we attempted the benzylation of oxazoline 4.70 with the typical conditions of NaH 
and BnBr but the yield was disappointing and could not be reproduced (Route 1). Better results 
were achieved by the selective protection of Boc carbamate of 4.68 using Bu2SnO (Route 
2).21,22 After selective benzylation, the (4S,5S)-4-((benzyloxy)(methyl))-5-phenyloxazoline 
4.73 was synthesised in 41% from I (Reaction B). The synthetic route 2 was reproducible. With 
the desired oxazoline 4.73, the oxazoline-coupling was carried out with (±)-4-
bromo[2.2]paracyclophane 4.9 (Reaction C). The coupling was accomplished in 53% yield. 
However, the separation of the diastereomers was not possible.  
These results show that modified oxazolines can also be coupled with (±)-4-
bromo[2.2]paracyclophane 4.9, albeit in moderate yields. However, separation of the 
diastereomers was not possible. We proceeded further to evaluate the scope of both aromatic 
and non-aromatic heterocycles under the coupling conditions.      
 
4.7.  Non-aromatic heterocycle as a coupling partner 
Inspired by the oxazoline-coupling results, we wondered if the chemistry would work with 
other heterocycles. We investigated imidazolines first as this would allow the stereocentre to 
be placed closer to the paracyclophane, which might increase the ease of separation. They can 
make equally good ligands. The chiral variant of the imidazoline 4.78 was synthesised 
following the method of Kotschy et al. in good yield (Scheme 4.15).23 Unfortunately, the 
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coupling failed under our standard conditions. As we did not recover any imidazoline 4.78 after 
the reaction, we suspected that the strong LiOtBu had led to decomposition. Milder conditions 
were investigated. These were based on Bischoff’s methodology and used a copper catalyst to 
activate the imidazoline and palladium to catalyse the coupling.24 Under these new conditions, 
the imidazoline substrate 4.78 coupled with (±)-4-bromo[2.2]paracyclophane 4.9 in 32% yield. 
However, the separation of the diastereomers was not feasible for the resulting product 4.79.    
 
Scheme 4.15: Coupling of (±)-4-bromo[2.2]paracyclophane 4.9 with the imidazoline substrate 4.76. 
 
As protodebromination product 4.20 was significant, it suggests that oxidative insertion 
occurred efficiently, while the copper catalyst is only moderately efficient to activate the 
imidazoline 4.76. Optimisation with a different catalyst, base, or Brønsted acid may help to 
improve the above coupling reaction. 
 
4.8.  Aromatic heterocycles as coupling partner 
Next, we looked at the coupling of an aromatic heterocycle, 1-methyl benzimidazole 4.80. 
Again, the oxazoline coupling conditions failed but modification of the imidazoline conditions 
were more promising: using a more electron-rich ligand, PCy3, in conjunction with mild base 




Scheme 4.16: Coupling of (±)-4-bromo[2.2]paracyclophane 4.9 with 1-methyl benzimidazole 4.80. 
 
We then tried to couple (±)-4-bromo[2.2]paracyclophane 4.9 with 1-methylindole 4.82. Once 
again, the oxazoline-coupling conditions failed. The above catalytic system (Scheme 4.16) was 
slightly modified where the CuI was replaced with PivOH (Scheme 4.17). With these modified 
conditions, the coupling was observed at both C-2 and C-3 positions in the indole system. The 
C-2 position of indole moiety is most prone to metalation, the major coupling was deduced to 
occur at the C-2 position. Based on the reported literature, we confirmed that C-H 
functionalisation at C-2 position delivered the major coupled product 4.83 (61%), while the 
minor coupled product 4.84 (24%) was as a result of C3-(sp2)-H activation.25  
 
Scheme 4.17: Coupling of (±)-4-bromo[2.2]paracyclophane 4.9 with 1-methylindole 4.82. 
* Data for C2-(sp2)-H activation product is comparable to that reported in literature.25 
 
 4.9. Conclusions  
The main goal of this project was to develop a method to access planar chiral 
[2.2]paracyclophane acid derivatives. For this, we optimised a facile single-step protocol for 
the synthesis of planar chiral [2.2]paracyclophane-oxazolines, and hence carboxylic acids. Di-
tert-butyl SPO 4.15 was found to be an adequate ligand for the C(sp2)-H activation of chiral 
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oxazolines and for their coupling with bromo[2.2]paracyclophanes. In some cases, such as 
pseudo-ortho and pseudo-gem derivatives, the separation of corresponding diastereomers was 
possible and thus allowed the resolution of the enantiomers. In order to improve the separation 
of the diastereomers, the C-4 and C-5 positions of chiral oxazolines modified. With these 
oxazolines, the coupling with (±)-4-bromo[2.2]paracyclophane 4.9 was achieved in moderate 
yield only and separation of corresponding diastereomers was also not successful. Further, the 
scope of both aromatic and non-aromatic heterocycles was investigated with slightly modified 
conditions. 
Ultimately, our one-pot strategy provides easy access to [2.2]paracyclophane-oxazolines that 
have great potential as planar chiral ligands in catalysis. These oxazolines could be readily 
hydrolysed to furnish an array of planar chiral carboxylic acids that could be chiral building 
blocks. Our initial results of coupling heterocycles to bromo[2.2]paracyclophane were 
promising. This study can be further elaborated to access a diverse range of planar chiral 
heterocyclic derivatives. 
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5.0. Introduction to Sulfinates 
Aryl- or alkyl-(hetero)aryl derivatives are key building blocks for natural products, medicinal 
drugs, advanced materials, agrochemicals, and fine chemicals.1 Classical transition metal-
mediated cross-coupling reactions, like Mizoroki-Heck,2 Suzuki-Miyaura,3 Stille,4 or Negishi 
reactions,5 allow rapid and convergent syntheses of these molecules. Palladium is the most 
commonly utilised transition metal catalyst for such cross-coupling reactions,6 although other 
noble metals, and more recently, earth-abundant metals, such as nickel, copper, and zinc, have 
all been studied.7,8 New methodologies such as C-H activation9 and transition metal-free 
coupling10 have recently emerged as alternative methods that overcome issue of low efficiency 
associated with the classical reactions. Each method requires different coupling partners, 
which can limit their use. As a result, there is ongoing research to find new substrates with 
greater stability, cheaper access, clean reactions, or alternative functional group tolerances.  
Sulfinates are a promising candidate for coupling reactions.11,12 They are attractive reagents 
as they are easy to handle, bench-stable, moisture-resistant, and easily accessible from simple 
precursors. They can readily be transformed into sulfones and sulfonamides by sulfonylative 
S-C and S-N bond formation (Figure 5.1). In addition, sulfinates are also employed as 
electrophilic and nucleophilic partners with the transition metal catalysis in desulfitative cross-
coupling reactions like Mizoroki-Heck, Suzuki-Miyaura, Stille couplings, C-H 
functionalisation for C-C bond formation (Figure 5.2).13 Hence, sulfinate chemistry is 
becoming increasingly popular. 
 






Figure Error! No text of specified style in document..2: Sulfinates as versatile coupling partners (C-
S cleavage). 
Before explaining the role of sulfinates, it is important to mention the different terminologies 
used here to describe the loss of the sulfur fragment (SO2, SO3, SO3
2- or thiolates), compare 





5.1.    Terminologies for extrusion of sulfur from organosulfur compounds 
Sulfur can exist in a number of oxidation states and this gives rise to a range of organosulfur 
compounds (Figure 5.3).  
 
Figure Error! No text of specified style in document..3:  Different organosulfur compounds. 
Desulfitative means the extrusion of SO2 gas during a metal-mediated C-S bond cleavage 
reaction. It is also defined as a desulfination reaction (Scheme 5.1).14  
 
Scheme 5.1: Desulfination reaction, loss of SO2. 
On the other hand, desulfonative means the loss of SO3 gas during a metal-mediated C-S bond 
cleavage reaction. It is also called a desulfonation reaction (Scheme 5.2).15 
 
Scheme 5.2: Desulfonation reaction, loss of SO3. 
A similar terminology, desulfonylation is mainly applicable to demonstrate the loss of RSO2- 
from a sulfonyl functional group (RSO2R’). The classical example, which uses 





Scheme 5.3: Julia-Kocienski elimination reaction, loss of SO2, (a) Smiles rearrangement. 
In this thesis, both terminologies desulfitative and desulfination are used, meaning the same 
loss of SO2 gas in the cleavage of a C-S bond.  
 
5.2. The ease of desulfination: desulfination vs. decarboxylation  
It has been shown that extrusion of SO2 gas from metal complexes is easier than the extrusion 
of CO2 and SO3 from analogues complexes.
17 Sraj et al. compared the intrinsic reactivity 
orders of three heteroligands, [MeCO2CuO2SMe], [MeCO2CuO3SMe], and 
[MeSO2CuCO3SMe]  for organocuprate formation via ligand decomposition in the gas phase.
  
In each case, desulfination (-SO2) dominates over decarboxylation (-CO2), while 
desulfonylation (-SO3) is least favoured. In addition, DFT calculations were also consistent 
with an experimental order of organocuprate formation which follows SO2 loss > CO2 loss > 
SO3 loss.  
The above results show that metal-mediated desulfination reactions are relatively easier than 
metal-assisted decarboxylation reactions, and avoid the need for harsh reaction conditions. 
The relative ease of desulfination and continued supply of inexpensive organosulfur 
compounds from the oil industry are the main reasons for the growing interest in the 
applications of desulfitative reactions in various organic transformations. 
 
5.3.    Sulfinato complexes 
 
As transition metal-mediated desulfitative reactions proceed via different sulfinato metal 
complexes, it is first important to understand the types of these complexes. Initial studies of 
sulfinato metal complexes suggested that there are four possibilities for coordinating the 
RSO2
- ligands to metals (Figure 5.4). RSO2
- can form a monodentate complex either through 
lone pair of electrons either on one oxygen atom (sulfinato-O complex 5.14) or sulfur atom 
(sulfinato-S complex 5.15). The coordination of lone pair of electrons on both oxygen atoms 




ordination possibility is by electron donation, by one oxygen and one sulfur to the central 
metal to produce the intramolecular (5.18) or intermolecular sulfinato-O,S complex 5.19.  
Figure 5.4: Possible sulfinato metal complexes. 
The sulfinate ion, RSO2
- can act as an electron donor through either the soft S atom or the hard 
O atom. The co-ordination of a ligand to a metal follows the HSAB (hard and soft acids and 
bases) concept. Transition-metals in low oxidation states adopt a soft character and favour the 
formation of the sulfinato-S complex. Based on the Ahrland-Chatt classification,18 it was 
observed that 5d and 4d metals tend to form sulfinato-S-complexes, while sulfinato-O-
complexes are formed with 3d metals.  
Before describing the role of sulfinates in desulfitative reactions, I have presented a brief sight 
on general synthetic methods of sulfinate derivatives. 
 
5.4.   Synthesis of sulfinates 
 
Although, there are only a few commercially available substrates, aryl sulfinates (ArSO2
-M+) 
can easily be synthesised by the following methods. 
The most common way is by metal-mediated reduction of sulfonyl chlorides 5.20 in water 
(Scheme 5.4).19 
  
Scheme 5.4: Reduction of sulfonyl chloride to sulfinates. 
An alternative synthesis involves quenching organometallic compounds 5.22 generated from 




SO2 is problematic. Instead a solid form of SO2 i.e. in-situ SO2 release or DABSO 5.23 (1,4-
diazabicyclo[2.2.2]octane bis(sulfur dioxide) permits a well-defined quantity to be added.20 
DABSO is an air-stable, white solid, formed by condensing the SO2 gas over freshly sublimed 
DABCO (1,4-diazabicyclo[2.2.2]octane).  
 
Scheme 5.5: Schematic representation of synthesis of sulfinates from SO2 or DABSCO. 
The organometallic reagent 5.22 can be replaced by an arylhalide 5.25 and a palladium-
mediated sulfinate synthesis can be performed. In this Pd(II)-catalysed reaction, the arylhalide 
5.25 can be converted into an ammonium sulfinate salt 5.26 by employing a stoichiometric 
quantity of DABSO 5.23, and catalytic bulky di(1-adamantyl)-n-butylphosphine (PAd2Bu) 
ligand (Scheme 5.6).21 
 
Scheme 5.6: Pd(II)-catalysed synthesis of ammonium sulfinates. 
Another palladium-mediated synthesis was reported by the group of Mascitti. In this reaction, 
potassium metabisulfite was not only the sulfur source but also the buffering agent of the 
reaction medium, while sodium formate was employed as a hydrogen donor (Scheme 5.7).22  
 
Scheme 5.7: Pd(II)-catalysed synthesis of aryl/heteroaryl sulfinate. 
 
 
Recently, it was shown that alkyl sulfinates can be formed from the carboxylic acids.23 The 
advantage of this source is the structural diversity of commercially available carboxylic acids. 




which rearranges to 2-pyridinyl thioether 5.31 under the photolytic Barton-type 
decarboxylation conditions.24 After oxidation, the resulting pyridine sulfone 5.32 undergoes 
nucleophilic attack by alkoxide or thiolate to release the sulfinate 5.33 in moderate to excellent 
yield (Scheme 5.8). 
 
 
Scheme 5.8: Synthesis of alkyl sulfinates from carboxylic acids via a Barton ester.   
 
5.5.   Role of sulfinates in desulfitative reactions 
Aryl sulfinates have been extensively studied over the last decade. Their most common use is 
as a replacement for organic halides and boronic acids in arylation reactions. However, alkyl 
sulfinates (AlkSO2
-M+) and heteroarene sulfinates (HetArSO2
-M+) have not been thoroughly 
exploited as organometallic reagents. 
 
5.5.1. Sulfinates as electrophilic coupling partners 
In the last few years have, a number of desulfitative C(sp2)-C(sp2) coupling reactions have 
been reported. In these reports, the electrophilic properties of sulfinates have been exploited 
and these reagents have replaced the aryl halide coupling partners (Scheme 5.9).  
 
 




As per the bond energyg for C-I (213), C-S (272), C-Br (285), and C-Cl (327), sulfinates lie 
somewhere between aryl iodides and aryl bromides in terms of reactivity.25 Due to this 
reactivity, sulfinates can easily be extended in place of organic halides in metal-catalysed 
cross-coupling reactions. The most commonly employed aryl sulfinate derivatives for such 
organic transformations are either ArSO2Na or ArSO2NHNH2. In the last few years, an 
extensive number of desulfitative cross-coupling catalysed by Pd and Ru have been reported. 
The section below will highlight the general mechanism and key examples of Mizoroki-Heck, 
Suzuki-Miyaura, Hiyama, and Sonogashira-type cross-coupling reactions. 
 
5.5.1.1. General mechanism for palladium-catalysed desulfitative reaction: (ArSO2-M+) 
as an electrophile 
 
All the palladium-catalysed reactions described in this section react the aryl sulfinates with 
nucleophilic coupling reagents. The catalytic cycle differs to the conventional cross-coupling 
reactions as outlined below. 
• In the conventional Heck reaction, an arylpalladium(II) species is generated by the 
oxidative addition of aryl halides or pseudohalides to Pd(0). However, in the Heck-
type reaction employing sulfinates, the catalytic cycle is initiated by ligand exchange 
between Pd(II) and the sulfinate, followed by desulfitative C-S bond cleavage. 
• As the first step involves the nucleophilic attack of ArSO2- anion on the active Pd(II) 












The plausible general reaction mechanism is illustrated as shown Figure 5.5. 
 
Figure 5.5:  General catalytic cycle of aryl sulfinates as electrophile in desulfitative reactions. 
Firstly, the co-ordination of Pd(II) species, generated either from Pd(II)-complexes e.g. PdCl2, 
Pd(OAc)2 or by the oxidation of Pd(0) complexes e.g. Pd2(dba)3, with ArSO2
– forms 
ArS(O)OPd(II) O–-complex (step: 1). This is followed by the expulsion of SO2 gas to give an 
ArPd(II) species (step: 2). The next step (step 3) is transmetallation of the ArPd(II) 
intermediate with either an organoborane (Suzuki-Miyaura) or organosilane (Hiyama 
reaction). For the Mizoroki-Heck-type and Sonogashira-type reactions, this step would instead 
be the insertion of the ArPd(II) intermediate into alkene double bond or alkyne triple bond 
respectively. Finally, in the first type of the reactions, reductive elimination of the desulfitative 
coupling product leads to the formation of the reduced Pd(0) species, which is oxidised by the 
appropriate oxidant (step: 5). In the latter type of reactions, the regeneration of the active 





5.5.1.2.  Mizoroki-Heck-type reaction 
The Mizoroki-Heck-type reaction is a powerful technique for the arylation of alkenes.2,26 The 
reaction involves the coupling of an alkene with an aryl halide or equivalent, such as aryl 
triflates, aryl diazonium salts, and diaryl iodonium salts. Generally, in conventional Heck 
reactions, a base and a ligand are required for the conversion of the hydropalladium(II)-
complex to the active palladium(0)-catalyst. However, Heck type reactions employing 
sulfinates as coupling partners do not require a base and a ligand.11,13 
Raj et al. disclosed a simple and mild Pd(II)-catalysed desulfitative Heck-type arylation for 
the synthesis of highly functionalised α-benzyl-β-keto ester 5.39 from sodium arenesulfinates 
5.38 and Baylis-Hillman adducts 5.37 in good to excellent yields (Scheme 5.10).27 This 
reaction tolerates a wider range of functionalities i.e. methyl, bromo, and chloro on the sodium 
arenesulfinate, under these reaction conditions. The authors proposed a plausible catalytic 
cycle in a sequence of desulfination, oxidative insertion, and β-hydride elimination followed 
by keto-enol tautomerisation. 
 
Scheme 5.10: Desulfinative synthesis of α-benzyl-β-keto ester.  
5.5.1.3. Suzuki-Miyaura cross-coupling reaction 
The palladium-catalysed cross-coupling of an aromatic halide and organoborane is known as 
the Suzuki-Miyaura reaction.28,29 Recently, C-S bond cleavage by employing aryl sulfinate as 
the electrophilic coupling partner with organoboronic acid has been shown an attractive 
approach for Suzuki-Miyaura cross-coupling reactions.11,13   
Qi and co-workers used a combination of Pd(II) and Cu(II) to catalyse desulfitative coupling 
reactions of sodium arylsulfinates 5.40 with aryl boronic acids 5.41 under aerobic conditions 
(Scheme 5.11).30 The reaction followed the standard mechanism described in Figure 5.5, with 




The stoichiometric oxidant is oxygen. The authors found the mixed solvent system was 
essential to prevent homocoupling of 5.40 but they do not say how it activates it.  
 
Scheme 5.11: Desulfitative coupling reactions of sodium arylsulfinates with aryl boronic acids. 
 
 
5.5.1.4. Hiyama-type cross-coupling reaction 
Due to inherent drawbacks such as high cost, toxicity, low stability and poor biocompatibility 
of organotin reagents in cross-coupling reactions, organosilicon reagents have emerged as 
alternative nucleophilic partners.31,32  
Qi et al. described the cross-coupling between aryltrialkoxy silanes 5.44 with arylsulfinates 
5.43.33 In this protocol, TBAF was employed to activate the silane towards transmetallation. 
The reaction proceeded in a solution of PdCl2, TBAF in THF at 70 °C in presence of air as an 
oxidant in three hours (Scheme 5.12). 
 
Scheme 5.12: Cross-coupling of trialkoxyaryl-silanes with arylsulfinates. 
 
5.5.1.5. Sonogashira-type cross-coupling reaction 
The Sonogashira cross-coupling reaction couples aryl halides and terminal alkynes using 
palladium and copper catalysts in the presence of a base.34,35 
Jiang et al. coupled sodium sulfinates 5.46 and aryl alkynes 5.47 to give unsymmetrical 
internal alkynes 5.49 and vinyl sulfones 5.51 (Scheme 5.13).36 While evaluating the optimised 
protocol, the authors noticed that electronic effects on the aromatic ring of the phenylacetylene 
play a crucial role in the selective formation of either C-C and C-S bond. Electron-rich aryl 
alkynes (alkoxy, amine and hydroxy substituents) gave the products of C-C bond formation 




product. Two different mechanisms were postulated. In the internal alkyne formation, the first 
step involves coordination of the alkyne with PdCl2 to give an alkynyl palladium intermediate 
5.48. Formation of the sulfone starts with the oxidative addition of Pd(II) to the sulfinates to 
afford intermediate 5.50. Unlike the conventional Sonogashira reaction, this convenient 
protocol does not employ a copper co-catalyst and base.  
 
Scheme 5.13: Unsymmetrical alkyne and vinyl sulfones synthesis by coupling of sodium sulfinates 
and aryl/heteroaryl alkynes. 
 
5.5.2. Aryl/heteroaryl sulfinates as nucleophilic coupling partners 
The potential of sulfinates as nucleophilic coupling partners has only been realised recently 
by the pioneering studies of the Duan and Forgione groups.37,38 Their studies demonstrated the 
desulfitative coupling between aryl triflates or bromides and aryl sulfinates.  
Before that, there had only been one report for such a reaction in a 1992 US patent where Sato 
and Okoshi attempted the reaction of aryl sulfinates with aryl halides under palladium 
catalysis, in a polar solvent NMP, at high temperature 150 °C (Scheme 5.14).39 
 




5.5.2.1. General mechanism for palladium-catalysed desulfitative reaction: (ArSO2-M+) 
as a nucleophile 
When the aryl sulfinate acts as the nucleophilic coupling partner, the catalytic cycle changes 
(Figure 5.6). The first step is oxidative addition of a Pd(0) species into the aryl halide (step 1). 
Next, transmetallation gives the tetrahedral sulfinato-S complex (step 2). Finally, extrusion of 
SO2 gas leads to the formation of the bis-aryl Pd(II) intermediate (step 3); which then 
undergoes reductive elimination to continue the Pd(0)-Pd(II) catalytic cycle (step 4).  
 
It is important to mention here that most of the reports have employed bidentate phosphine 
ligands with a wide bite angle. The stereoelectronic property of substituents on the ligand play 
a major role in controlling the Pd(0)-Pd(II) catalytic cycle as outlined below.  
• Electron-rich substituents enhance the rate of oxidative addition. (step 1) 
• Large substituents accelerate the reductive elimination step. (step 4) 
• Bulky substituents can suppress the homocoupling of the aryl sulfinates. 
The plausible general reaction mechanism is illustrated Figure 5.6. 
 




Duan et al. have investigated the formation of biaryls 5.57 through the coupling of aryl triflates 
5.55  and aryl sulfinates 5.56 (Scheme 5.15).37 This efficient protocol employs only 2 mol% 
of Pd(OAc)2 and 4 mol% of the bidentate ligand, Xanthphos, at 120 °C in toluene without any 
additives. Both electron-donating and electron-withdrawing groups are tolerated on either 
substrate and in any position. The only exception is the nitro-substituted aryl triflate or aryl 
sulfinate.  
 
Scheme 5.15: Desulfitative cross-coupling between aryl triflates and arylsulfinates. 
Forgione et al. presented a detailed mechanistic study of the desulfitative cross-coupling 
reaction of aryl sulfinates 5.58 with aryl bromides 5.59.38 The best results were obtained with 
PdCl2 and the bidentate phosphine ligand, dppf (Scheme 5.16). It was observed that increasing 
the number of equivalents of aryl sulfinate 5.58 led to desulfitative homocoupling. If electron-
deficient aryl bromides were used, SNAr gave sulfones instead. The control experiment 
between 1-bromo-4-(trifluoromethyl)benzene 5.62 and p-tolyl sulfinate 5.61 in the presence 
or absence of catalyst ruled out the possibility of a palladium-catalysed SNAr (Scheme 5.17). 
In addition, thioether 5.65 (C-S bond formation) was also observed and this will be relevant 
to the discussion in the next chapter (Chapter 6, Section 6.3.1.1, Scheme 6.15). 
 





Scheme 5.17: Desulfitative cross-coupling between 1-bromo-4-(trifluoromethyl)benzene 5.62 and p-
tolyl sulfinate 5.61. 
 
In the same year, Chen’s group established a novel one-pot elimination-cyclisation-
desulfitative reaction to convert 2-(gem-dibromovinyl)phenols(thiophenols) 5.67 into 2-
arylbenzo-furans(thiophene) 5.69 under mild conditions.40 In this efficient catalytic protocol, 
TBAF promotes the in-situ elimination of 5.67 followed by the intramolecular nucleophilic 
addition of aryl sulfinates 5.68 while the Pd(II) system plays a role for the desulfitative 
coupling reaction. This protocol does not utilise a phosphine ligand, but it incorporates a 
stoichiometric quantity of Cu(OAc)2 to maintain the Pd(0) to Pd(II) catalytic cycle.  
 
Scheme 5.18: Tandem elimination-cyclization-desulfitative reaction. 
The Forgione and Willis groups have explored the reactivity of heteroaromatic sulfinates in 
palladium-mediated cross-couplings.41,42 The focus of the former group was on five-





Initially, Forgione employed heteroaromatic sulfinates 5.70 & 5.71 to synthesise the C2-
arylated heteroaromatics 5.74 & 5.75. Both palladium pre-catalysts, Pd(PtBu3)2 and Pd(PPh3)4 
gave nearly similar results under microwave conditions for a short reaction time of 8 min. at 
170 °C even when using wet solvents (Scheme 5.19).43,44 The presence of water was thought 
to reduce the rate of sulfinic acid disproportion. The group has further evaluated the potential 
of aryl triflates 5.73 instead of aryl bromides 5.72 as electrophilic coupling partners.45 Aryl 




Scheme 5.19: Heteroaromatic desulfitative cross-coupling with aryl bromides/triflates. 
Willis and co-workers have shown that sulfinates are good replacements for azoheteroaryl 
boronates.46 The initial investigation was focused on the reaction of pyridine sulfinates 5.76 
(2-, 3- and 4-) as nucleophilic coupling partners with aryl bromide 5.77 (Scheme 5.20). A 
variety of six-membered heterocycles e.g. pyrazines, pyrimidines, quinolines, iminopyridines, 
and pyridines 5.79 were efficiently coupled with pyridine sulfinates to provide the 





Scheme 5.20: Desulfitative coupling of pyridine sulfinates 5.76 with aryl/heteroaryl halides 
5.77/5.79. 
This methodology was later extended to couple both 5- and 6-membered heteroaryl sulfinates 
5.81 (Scheme 5.21).42 The reaction protocol used a different ligand di-tert-
butylmethylphospine [P(t-Bu)2Me] and could be performed at lower temperature (120 °C) 
with less heteroaryl sulfinate (1.5 eq.). A broad range of heteroaryl sulfinates 5.81, including 
pyrazine, pyridazine, pyrimidine, pyrazole, imidazole, and indazole sulfinates were coupled 
to deliver the bis-heteroaryl and aryl-heteroaryl derivatives 5.83 in an efficient manner.  
 
Scheme 5.21: Desulfitative coupling of heteroarene sulfinates 5.81 with heteroaryl/aryl halides 5.82 
Willis’s group has performed a detail mechanistic investigation of these cross-coupling 
reactions, which provides better understanding of how the reaction proceeds.47 Two model 
reactions were studied, the coupling of an aryl sulfinate 5.85 and a heteroaryl sulfinate 5.87. 
(Scheme 5.22). Based on NMR spectroscopic data and the crystal structure studies of the 






Scheme 5.22: Model reactions to study the mechanism of desulfitative reaction. 
 
 








5.5.3. Role of arylsulfinates in C-H activation reactions 
 
C-H activation offers an efficient method for C-C bond formation and it is no surprise that 
arene sulfinates have been used as coupling partners. Recently, the arylation or alkylation of 
(hetero)aromatics via metal-catalysed C-H bond activation has revolutionised the field of 
chemistry. The scope of desulfitative reaction in metal catalysed C-H functionalisation is 
summarised in the review published by Jean-Francois11 and Henri Doucet.12  The section 
below depicts some of the recent advances of desulfitative C-H bond functionalisation using 
arylsulfinates as coupling partners.  
 
5.5.3.1. Heteroarenes containing one heteroatom 
An unexpected and highly regioselective palladium-catalysed desulfitative arylation of 
coumarin 5.102 was achieved with commercially available arenesulfinates 5.103 by Jafarpour 
and co-workers (Scheme 5.26).48 The authors were surprised to isolate 3-aryl coumarins 5.104 
instead of the expected 4-aryl coumarins 5.105 (Heck-type products). The authors did not 
show the exact reason behind the observed regioselectivity; however, the arylsulfinato-S 
complex may have changed the course of the reaction. The copper salt was added as an oxidant 
and it also contributed in the desulfination process to form the aryl metal species. 
 
Scheme 5.26: Regioselective synthesis of 3-aryl coumarin 5.104. 
Luo and co-workers demonstrated a palladium-catalysed desulfitative arylation of N-methyl 
indoles 5.106 with sodium sulfinates 5.107 using copper(II) chloride dihydrate as the 
stoichiometric oxidant.49 This methodology permits arylation exclusively in the C-2 position 




poor substituents on N-methyl indole. All arylsulfinates reacted in good to excellent yields 
except those substituted with a nitro group, which was found to be unreactive. One limitation 
of this chemistry is that the indole had to be N-methylated. The free N-H compound failed to 
react.  
 
Scheme 5.27: Desulfitative arylation of N-Methyl indoles 5.106. 
The latter limitation was overcome by performing the reaction under acidic conditions with 
microwave heating. While this method shared the same broad substrate scope as the previous 
arylation, it was found that arylsulfinic acids with ortho-substituents gave poor yields, 
presumably due to steric hindrance. The role of H2SO4 is still not known, although the authors 
proposed that it minimises the decomposition of indole and facilitates the regioselective C-2 
arylation (Scheme 5.28).37 
 
Scheme 5.28: C-2 arylation of free indole 5.109 with arylsulfinic acid 5.110. 
 
5.5.3.2. Heteroarenes containing more than one heteroatom 
Heteroarenes containing more than one heteroatom, such as benzoxazoles, thiazoles, 
imidazoles, and purine derivatives, are important building blocks for many drug molecules 
and catalysts.50 These molecules typically react at the most acidic site, which is between the 
two heteroatoms.  
Deng’s research group reported a palladium-catalysed direct desulfitative arylation of azoles. 
The optimised methodology comprises Pd(OAc)2, Cu(OAc)2 in 1,4-dioxane/diglyme. A wide 
range of azoles, such as benzothiazole 5.112, benzoxazole 5.113, and imidazoles 5.114 with 





Scheme 5.29: Desulfitative C-H arylation of azoles. 
Yu et al. revealed the construction of aryl-heteroaryl bonds by the transition-metal catalysed 
C-H arylation of a wide range of N-heteroarenes 5.119 (Scheme 5.30).52 The study mainly 
focused on caffeine derivatives and was subsequently expanded to other xanthines including 
benzylic theobromine, benzylic theophylline, and n-butyl theophylline.  
 
Scheme 5.30: C-H arylation of caffeine with aryl sulfinates. 
In general, over the past few years, the role of aryl(heteroaryl) sulfinates as either electrophilic 
or nucleophilic coupling partners has been expanded from the synthesis of sulfones and 
sulfonamides to the desulfitative cross-coupling and C-H functionalisation reactions. Despite 
the substantial improvements in the desulfitative reaction conditions, the application of 
sulfinate reagents is limited to C(sp2)-C(sp2) bond formation. However, research in this area 
is still in its infancy. There are only a few reports of C(sp3)-C(sp2) bond formation by 
employing sulfinate derivatives. The scope of sulfinates in C-H functionalisation is also 
limited. Moreover, the potential of only a few arene/heteroarene sulfinates have been realised 
in the desired transformations. The nature of heteroarene sulfinates on reactivity and 
selectivity is yet to be explored. Here, I present our efforts to broaden the scope of sulfinates 






5.6. Results and Discussion 
The desulfitative coupling of sulfinates in the direct arylation of (hetero)arenes is becoming 
increasingly important.13 The majority of these coupling reactions are based on the 
functionalisation of the most acidic proton of a heterocycle.12 To the best of our knowledge, 
there have been no reports where heterocyclic sulfinates have been employed in the 
desulfitative C-H activation reaction. Thus, our research group has decided to answer the 
following challenge of sulfinate chemistry. 
1. Can we develop an efficient system for regioselective C-H functionalisation via 
desulfitative coupling using heteroarene sulfinates? (Scheme 5.31) 
 
Scheme 5.31:  Synthetic plan to access aryl-heteroaryl scaffolds via desulfitative coupling. 
The issue of regioselectivity can be solved by introducing an appropriate directing group for 
the selective cleavage of the proximal aromatic C-H bond.53-57 However, there are a few 
drawbacks, 
• Installation and removal of the directing group require additional steps 
• Removal of the directing group is often problematic, requiring either harsh or long 
sequences; leaving the directing group in the molecule limits product utility. 
• Directing groups can direct to both ortho positions. 
• Only a few directing groups allow further ipso functionalisation after removal. 
Over the last decade, a number of groups have shown that carboxylic acids can act as directing 
groups, allowing direct C-H activation to form C-C, C-O, C-N, C-S, C-P, and C-halogen 
bonds.58 The main advantage of carboxylic directing groups is their intrinsic weak-
coordinating ability and weak σ-donor tendency. They are attractive directing groups in 
numerous transformations due to their prevalence. These functionalities can be readily 
synthesised by means of various well-established methods. Furthermore, most of them are air 




The majority of the reactions utilise the aromatic acids for the regioselective ortho-
decarboxylative C-H activation reactions.  Recently, the meta- and para-substituted moieties 
can also be achieved by a traceless carboxylic ortho directing group. In this approach, the 
products with meta- and para- substituents can be directly accessed which otherwise require 
conversion of directing group at ortho position into another functional group (Scheme 5.31a). 
Decarboxylative C-H functionalisation reactions generally follow either of the two 
mechanistic pathways.  
a. The redox-neutral decarboxylation to form a nucleophilic organometallic intermediate 
in which the oxidation state of the metal ion does not change 
b. Oxidative decarboxylation to form radical intermediates in which the oxidation state 
of the metal changes as the catalytic cycle progresses.  
 
Scheme 5.31a: Traceless/deciduous directing groups. 
With such a great potential of carboxylic acid derivatives for an ortho C-H functionalisation, 
we sought to develop a carboxylic acid-directed desulfination to access for aryl-heteroaryl 
scaffolds in a selective and efficient way (Scheme 5.31). Our main target was to choose an 
ortho-substituted aromatic acid to avoid double functionalisation and use the acid 
functionality as a directing group to introduce a heteroarene at the ortho position in the 
desulfitative reaction.  
 
5.6.1.  Initial optimisation for desulfitative coupling 
Based on our plan, we selected the potassium salt of 2-methoxybenzoic acid 5.122 and 
pyridine-2-sulfinate 5.123 as our test substrates (Scheme 5.32).  
 




We postulated the mechanism of this reaction as illustrated in Figure 5.8. The first step would 
be the carboxylic acid-directed Pd(II) insertion into the ortho C-H bond to form the dimeric 
palladacycle I as described by Yu et al. (step 1).59 The palladacycle usually adopts dimeric or 
trinuclear forms in the absence of any external ligand.59 For an efficient desulfitative coupling, 
it is imperative at this stage for the catalytic cycle to proceed through an efficient 
transmetallation step to give a trans-monomeric intermediate II. The expulsion of SO2 gas in 
the next step will result in the palladium intermediate III, which would subsequently deliver 
the desulfitative coupling product 5.124.  
 








Our initial reaction conditions are shown in Table 5.1. 
 
Scheme 5.33: Initial investigation for desulfitative coupling. 
 
          Table 5.1: Test conditions for desulfitative coupling between potassium 
   2-methoxybenzoate and pyridine-2-sulfinate 
Entry [Pd] 
source 










 (1.5 eq.) 
1,4-dioxane  






Ag2O (1 eq.), 
BQ (0.5 eq.) 
THF [0.1M],  
60 °C 
SM 




Ag2O (1.5 eq.), 
BQ (0.5 eq.) 
DMF:THF 
(1:1), 100 °C 
SM 




Ag2O (1.5 eq.), 












         SM = Starting material 2-methoxybenzoic acid recovered 
 
The initial reaction used the conditions described by Willis for the cross-coupling of 2-pyridyl 
sulfinate 5.123 and aryl bromides but these conditions failed to deliver any product (entry 1).47 
Unlike Willis’s reactions, directed C-H activation does not involve oxidative insertion into a 
C-Br bond and is more likely to follow a Pd(II) to Pd(0) pathway. This requires an oxidant to 
complete the catalytic cycle (Figure 5.8, step 4). We, therefore, decided to check the effects 
of oxidants like Ag2O, Ag2CO3 and BQ. The reactions were performed with different oxidants 
in different (co)solvents, THF (entry 2), DMF (entry 3), and tert-butyl alcohol (entry 4), but 
to no avail. In all reactions, the starting material 2-methoxybenzoic acid was recovered 
without any sign of product formation. We also attempted the established procedure (entry 5) 
of desulfitative direct arylation of indoles with substituted aryl sulfinates in the presence of 
CuCl2.2H2O, which follows the Pd(II) to Pd(0) cycle.
49 However, the result of this reaction 




At this stage, substantial changes were introduced to the reaction parameters. Firstly, the 
starting material was replaced by the potassium salt of ortho-toluic acid 5.125, as we were 
concerned that the lone pair of electrons on the ether substituent adversely affected the five-
membered palladacycle formation. The next trials were performed in the absence of any 
ligand. Lastly, we decided to reduce the reaction temperature to 100 °C (Scheme 5.34, Table 
5.2).  
 
Scheme 5.34:  Screening of different oxidants and their effects on desulfitative coupling. 
Table 5.2: Effect of different oxidants/additives in desulfitative coupling  
                        between potassium ortho-toluic acid 5.125 and sodium pyridine-2-sulfinate 5.123 
Entry Oxidant/additive Observation 
1 Cu(OAc)2.H2O SM 
2 CuCl2 SM 
3 Ag2CO3 SM 
4 K2S2O8 SM 
5 CuCl2 + Pivalic acid SM 
                           SM = Starting material ortho toluic acid recovered 
The next set of trial reactions kept the palladium source, the base, and the solvent constant and 
varied different oxidants (Scheme 5.34). Employing an excess quantity of carbonate would 
help to sequester liberated SO2 gas and thus expedite the transmetallation step. However, only 
the starting material, o-toluic acid was recovered. 
After observing no product formation in the above trials, we ruled out the influence of the 
oxidant. Though 1,4-dioxane has been shown to be an efficient solvent for a desulfitative 
coupling,46 the poor solubility of the potassium salt of the ortho toluic acid 5.125 was a 
concern. Maintaining the same reaction temperature 100 °C, the effect of polar solvents (THF, 
DME, t-amyl-OH, DMF, HFIP) was evaluated in the absence of the oxidant (Scheme 5.35). 
Surprisingly, in all cases (Table 5.3), a significant proportion of homocoupling by-product 





Scheme 5.35:  Screening of different solvents and their effect on desulfitative coupling. 
          Table 5.3: Effect of different solvents in desulfitative coupling between  
                           potassium ortho-toluic acid and sodium pyridine-2-sulfinate 
Entry Solvent/oxidant Observation* 
1 THF SM + 5.127 
2 DME SM + 5.127 
3 t-amyl-OH SM + 5.127 
4 DMF SM + 5.127 
5 HFIP SM + 5.127 
6 1,4-dioxane SM + 5.127 
7 1,4-dioxane + Ag2CO3 SM 
                        SM = Starting material ortho toluic acid recovered 
                       * 2,2ʹ-bipyridine 5.127 was detected on the average <30% 
The homocoupling of two arylsulfinates using a stoichiometric quantity of Pd(II) was reported 
by Garves.61 The author observed the evaluation of SO2 gas during the addition of a palladium 
salt to aromatic sulfinates 5.128 in a heated solution (Scheme 5.36). The aryl groups coupled 
to form biaryls 5.129 and Pd(II) was reduced to metallic palladium. The author proposed an 
electrophilic aromatic substitution process for this reaction.  
 





Based on this report, we speculated a similar palladium-mediated homocoupling with pyridyl-
2-sulfinates 5.123. We believed that the strong chelation of the Pd(II) catalyst in a κ2 N,O-mode 
of 2-pyridyl sulfinate leads to a five-membered palladacycle 5.130, which ultimately forms 
the homocoupled by-product 5.127 (Scheme 5.37). However, the same homocoupling was not 
observed in the presence of oxidant Ag2CO3. We surmise that silver replaces the palladium in 
the complex 5.130.  
 
Scheme 5.37:  Plausible pathway of homocoupling of 2-pyridine sulfinate. 
 
5.6.2. Investigation of the effect of catalytic Pd(OAc)2 on the desulfitative homocoupling 
We were curious to know whether the above homocoupling by stoichiometric Pd(OAc)2 
(Scheme 5.36) could be converted into a catalytic process. Initially, we screened the standard 
parameters such as solvent, base, temperature, and time under microwave irradiation as 
depicted in Table 5.4 (Scheme 5.38).  
 










            Table 5.4: Effect of catalytic palladium on the desulfitative homocoupling 
Entry Deviation from standard conditions Yielda 
1 No deviation 0% 
2 Without K2CO3 0% 
3 NMP 25% 
4 DMF 45% 
5 DMF, t = 12 hrs 43% 
6 DMF, without K2CO3, t = 12 hrs 46% 
7 K-Me-palladacycle (10 mol%)  0% 
8 K-Me-palladacycle (10 mol%), DMF, t = 12 hrs 42% 
                a: % YieldHPLC, HPLC condition:- stationary phase: reverse phase C18 column, mobile phase:  
                5% H2O: CH3CN for 5 min., 100% CH3CN for 25 min. RT for SM: 0.899 min., P: 2.790 min. 
No self-coupling of pyridine-2-sulfinate 5.123 was observed with the sub-stoichiometric 
quantity of Pd(OAc)2  (entry 1) or without K2CO3 in 1,4-dioxane at 110 °C (entry 2). It was 
reasoned that the poor solubility of pyridine-2-sulfinate 5.123 could be the problem, and hence 
more polar solvents i.e. DMF and NMP were investigated. The desulfitative self-coupled 
product 5.127 was observed in 25% (NMP, entry 3) and 45% (DMF, entry 4) yield. Proceeding 
further with the DMF solvent system, the experiment was set up for a long time 12 hrs, under 
the same reaction conditions. However, no significant change was seen in homocoupling 
product formation compared to the previous reaction (entry 5 & 6). 
We also trialled a different palladium catalyst – pre-formed palladacycle of substrate 5.125. 
The K-Me-palladacycle (K-Me-Palla.) 5.131 was easily synthesised by reacting equimolar 
amounts of potassium o-toluic acid 5.125 and Pd(OAc)2 in dry 1,4-dioxane at 100 °C 
overnight (Scheme 5.39).59,62   
 






We thought that the metal metathesis (K/Na) between both substrates may alleviate the 
solubility problem. However, homocoupling was not observed with the catalytic palladacycle 
5.131 (entry 7). When the reaction was performed with a pre-formed palladacycle 5.131 (10 
mol%, 20 mol% Pd) in DMF (entry 8), the homocoupled product formed in the same range as 
in entry 4 & 5. This result suggests that increasing catalyst loading (10 mol% to 20 mol%) 
does not have any influence on homocoupling. 
Based on this study, it became apparent that strong chelation of the palladium in a κ2N,O-mode 
of pyridine-2-sulfinate 5.123 and resulting homocoupling by-product 5.127 hindered the 
desired cross-coupling. Even catalytic palladium can initiate the homocoupling between 
sulfinates in nearly 45% yield. It became necessary to prevent such chelation so that the 
palladium catalyst can actively participate in the desired desulfitative reaction. For this 
purpose, we decided to introduce an alternative ligand that would coordinate the palladium in 
the reaction parameters. 
 
5.6.3. Investigation of effect of nitrogen-containing ligands 
We postulated that the ligand may coordinate to the palladium catalyst and restrict the self-
coupling of pyridine-2-sulfinates 5.123. Particularly, nitrogen-based bidentate ligands 
possessing κ2N,O-mode were selected which resembled pyridine-2-sulfinate 5.123 (Scheme 
5.40).  
 




N-Boc-Gly-OH 5.132 and pyridine-based ligands, namely 2-picolinic acid 5.133, 2-
hydrodxypyridine 5.134, 2,2ʹ-bipyridine 5.127 were screened in desulfitative reaction. To our 
surprise, only the starting material o-toluic acid was recovered. We were correct, the ligands 
prevent homocoupling. Unfortunately, they did not promote the desired coupling either.  
We decided to change the order of addition of reactants. We thought if pyridine-2-sulfinate 
5.123 is introduced at a later stage, in the reaction mixture, once the stable palladacycle had 
formed between o-toluic acid and Pd(OAc)2, this time period may avoid any interference of 
chelate formation between Pd(OAc)2 and 2-pyridinesulfinic acid. Unfortunately, the results 
were still not promising and only starting material was returned (Scheme 5.41). 
 
Scheme 5.41:  Reaction of changing the order of addition of pyridine-2-sulfinate 5.97. 
Next we also decided to reduce the number of equivalents of pyridine-2-substrate 5.123, as 
well as the catalytic loading, while maintaining the 1:2 ratio of Pd(II) and Ac-Leu-OH 5.135 
(MPAA) ligand. Reactions were set up separately in three different solvents, 1,4-dioxane, 
DMF, and NMP in microwave irradiation conditions (T = 170 °C, P = 300 Bar) with nearly 
half the concentration of solvent [0.5 M to 0.2 M] (Scheme 5.35). Gratifyingly, the 
desulfitative coupled product 5.136 was observed for the first time in 1,4-dioxane reaction 
conditions. We did not expect decarboxylation but the high reaction temperature caused it. 
The ratio of product 5.136 : 2,2ʹ-bipyridine 5.127 was only 1:6 based on crude 1H NMR 





Scheme 5.42:  Pd(II)-catalysed desulfitative coupling under microwave irradiation. 
We thought that it made sense to study the reaction using a stoichiometric amount of palladium 
as this may allow to isolate intermediates and remove the need to regenerate the catalyst. If 
we succeed, then, this knowledge could be applied to developing a catalytic version.  
 
5.6.4. Study with stoichiometric quantity of Pd(OAc)2 
The next experiment was set up to minimise the formation of complex 5.130 (Figure 5.9) so 
that the palladium catalyst could participate in C-H activation. 
 
Figure 5.9: Putative complex of pyridine-2-sulfinate 5.123 with Pd(OAc)2. 
The reaction was set up by taking the same equivalent of Pd(OAc)2 as the starting material, 
the potassium salt of o-toluic acid 5.125, but reducing the amount (0.5 equivalent) of pyridine-
2-sulfinate 5.123 (Scheme 5.43). To our surprise, neither homocoupling nor desulfitative 
coupling was observed and only the starting material returned. The conclusion made from this 
reaction was that reducing the equivalent of pyridine substrate helps to repress both 





Scheme 5.43:  Attempted desulfitative coupling with 0.5 eq. of 2-pyridine sulfinate. 
In order to simplify the reaction still further, we decided to attempt the reaction with K-Me-
palladacycle 5.131. This would mean directed C-H activation had already occurred and that 
all we would study was whether this could react with sulfinate. If this one step was impossible, 
we felt the entire methodology would be impossible. 
As mentioned before, the K-Me-palladacycle 5.131 was easily synthesised by reacting 
equimolar quantities of potassium o-toluic acid and Pd(OAc)2 in dry 1,4-dioxane at 100 °C 
overnight.59,62 The resulting dimeric palladacycle 5.131 was subsequently utilised for an 
optimisation study (Scheme 5.44, Table 5.5). Based on the previous study, the first reaction 
used a stoichiometric quantity of pyridine-2-sulfinate 5.123 compared to the palladacycle 
5.131 with two equivalents of base, K2CO3 in 1,4-dioxane at 150 °C in a Schlenk tube. 
Pleasingly, the desulfitative coupling was observed and the product 5.136 was isolated in 27% 
isolated yield. Here also decarboxylation was observed. The homocoupling by-product 5.127 
and the starting material 5.125a were observed but could not be recovered from the reaction. 
Three repetitions were performed to prove the consistency and in all of them, the desired 









             Table 5.5: Optimisation study: deviation from the standard conditions  
Entry Deviation from the standard conditions Yielda 
  5.136        5.127          5.125a 
1 Standard conditions (three repetitions) 27% n.d. n.d. 
2 Oxidant: Benzoquinone B.Q. (2 eq.) 32% n.d. n.d. 
3 Without base (K2CO3)  33% n.d. n.d. 
4 Pyridine-2-sulfinate 5.123 (4 eq.) 




5 Low temperature (100 °C) 20% n.d. n.d. 
6 Solvent: NMP, at 165 °C 37% 33% n.d. 
7 Solvent: tBuOH, at 165 °C n.d. 42% n.d. 
8 Solvent: DMF, at 165 °C n.d. 46% 33% 
9 MW: DMF, T = 170 °C, 
P = 300 bar, t = 4 hrs 
17% n.d. n.d. 
 a Isolated yield 
n.d. = not detected 
 
Encouraged by the initial result, we attempted to optimise the reaction conditions (Table 5.5). 
The inclusion of an oxidant, B.Q. was seen to improve product formation with a slightly higher 
yield (32%, entry 2). Removing the base also gave the product in nearly the same yield (33%, 
entry 3). We decided to double the loading of pyridine substrate 5.123 (2 eq.) and increase 
temperature to 166 °C, the reaction proceeded, albeit in lower yield (26%) with 34% o-toluic 
acid recovery (entry 4), once again showing an excess of pyridine-2-sulfinate 5.123 was 
detrimental to the reaction. 
In a further optimisation attempt, the reaction was performed at 100 °C (entry 5), however, 
the yield dropped to 20%. The effect of different solvents was also evaluated. Using a more 
polar solvent was beneficial only for NMP. In this case, the conversion was seen in 37% with 
the recovery of 33% homocoupled by-product 5.127 (entry 6). On the contrary, the reaction 
in both tBuOH and DMF failed to produce desulfitative coupling, giving either the by-product 
5.127 or the starting material 5.125a only (entry 7 & 8). Further, the effect of microwave 
irradiation was also studied in order to reduce reaction time. The reaction conversion was 
affected and the product was isolated only in 17% yield.  
Results from the attempted desulfitative coupling of pre-formed palladacycle 5.131 with 
pyridine-2-sulfinate 5.123 showed that the maximum yield could be achieved in a range of 




We thought that the transmetallation might be the problematic step, which hindered the 
reaction progress. In order to gain more insight into the reaction mechanism, we planned to 
isolate products or intermediates at different time intervals.  
 
5.6.5. Time-based study with a stoichiometric quantity of Pd(OAc)2 
In this study, a total six reactions were set up with the same reaction conditions for 1 h, 2 hrs, 
4 hrs, 8 hrs, 12 hrs, and 24 hrs to check the reaction progress (Scheme 5.45, Table 5.6). All 
reactions were purposefully carried out at 100 °C to allow isolation of the all-possible stable 
intermediates and subsequently their characterisation. 
 
Scheme 5.45:  Time-based study for desulfitative coupling with dimeric K-Me-palladacycle. 
                                        Table 5.6: Time-based study 
Entry Time hr(s) Observation 
1 1 hr 5.137 + 5.138 
2 2 hrs 5.137 + 5.138 
3 4 hrs 5.137 + 5.138 
4 8 hrs 5.126 
5 12 hrs 5.126 
6 24 hrs 5.136 
After 1 hour, the data implies that complex 5.137 was formed although we did not isolate it. 
The 1H NMR spectroscopy was showing a shift of the resonance for the proton adjacent to the 
pyridine nitrogen at 9.1 ppm which was at 8.6 in pyridine-2-sulfinate 5.123. The isotope 
pattern in mass spectrometry (m/z = 381) and fragmentation peak at m/z = 318 also indicated 
the formation of plausible complex 5.137 and intermediate 5.138 after SO2 extrusion (entry 




attempted crystallisation also failed to give a single crystal for X-ray crystallography. The 
reaction gave the same results after 2 hours (entry 2). Based on these results, we speculated 
that the tendency of pyridine-2-sulfinate 5.123 towards the strong co-ordination to the 
palladium via κ2 N,O- is a driving force for the transmetallation step. Once the intermediate 
5.137 is formed, it might possess lower energy, making the expulsion of SO2 slower as seen 
from the outcome of the reaction after 4 hrs.  
The reaction data after 8 hrs indicated the formation of the coupled product 5.126 (with an 
acid functionality). The analysis of the reaction after 12 hrs produced similar characterisation 
data. These results suggest a chelated Pd(II)-sulfinate intermediate 5.138 formed post-
transmetallation is the resting-state intermediate, while the extrusion of the SO2 is the 
turnover-limiting step. This suggestion is in agreement with Willis’s study published later in 
2020.47 The loss of CO2 is most likely to be a slower rate, delivering the decarboxylative 
product 5.136 in between 12 hrs to 24 hrs. 
In an extension of our study, we thought to check the desulfitative reaction on palladacycle 
5.140. The N-methylbenzamide 5.139 was reacted with a stoichiometric quantity of Pd(OAc)2 
in AcOH at 120 °C as reported by Masilamani et al. (Scheme 5.46).63 The reaction was carried 
out with the resultant palladacycle 5.140 and pyridine-2-sulfinate 5.123 in dry CH3CN at 150 
°C. The reaction proceeded to furnish the desulfitative coupled product 5.126 without 
corresponding decarboxylation as suggested by the crude 1H NMR spectroscopy and mass 
spectrometry techniques.  
 
Scheme 5.46:  Study of desulfitative coupling with palladacycle 5.140. 
Due to the problem of coupling of pyridine-2- sulfinate 5.123, we sought to simplify the 
experiment. Lao and co-workers have shown that aryl sulfinates can be coupled to N-methyl 
indole 5.141 in good yield.49 We attempted to replicate this experiment but replacing the aryl 
sulfinate with the pyridine-2-sulfinate 5.123 (Scheme 5.47). A large number of conditions 




a κ2N,O-mode of pyridine-2-sulfinate 5.123 by the Pd(II)-catalyst and resulting five-membered 
palladacycle 5.130 is impeding the desulfitative coupling.  
 
Scheme 5.47:  Attempted desulfitative coupling of N-methyl indole with pyridine-2-sulfinate. 
5.7. Conclusions 
This project was aimed at the site-selective carboxylic acid-directed C-H functionalisation via 
desulfitative coupling with pyridine-2-sulfinate 5.123. Initial optimisation with a Pd(OAc)2  
catalyst failed to deliver any desired product. Moreover, significant homocoupling between 
the 2-pyridyl substrate was observed to form 2,2ʹ-bipyridine 5.127. Hence, we evaluated the 
efficiency of catalytic Pd(OAc)2 to probe such homocoupling. Surprisingly, it can initiate this 
side-reaction up to 45%. We sought to suppress homocoupling by introducing nitrogen-based 
bidentate ligands. Fortunately, we were able to solve this problem with N-Ac-Leu ligand 
5.135, but the desired desulfitative coupling was obtained in a minute yield. Further, in our 
study with pre-formed palladacycle 5.131, where directed C-H activation had already been 
achieved, the desulfitative coupling was obtained in a moderate yield. Our time-based study 
allowed us to investigate the course of this reaction with analysis of possible intermediates.  
Our designed method involves two progressive steps: directed C-H activation and 
desulfination. It became clear that the last step of desulfitative coupling is a problematic step. 
We reasoned this owing to the slow SO2 expulsion from the intermediate 5.137 and reductive 
elimination thereafter. Based on our study, we surmised that extrusion of SO2 is a problematic 
step. In general, the kinetics of reductive elimination is difficult to predict but a detailed kinetic 
analysis will provide insight into the reaction mechanism. We also suggest that further 
optimisation can be performed in order to improve the reductive elimination step e.g. by 
varying transition metals, improving bidentate ligand design with the wide bite angle, and 
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The Synthesis of Pyridyl[2.2]paracyclophanes by 





6.0.  Introduction to Six-membered heteroarene sulfinates  
In heteroarene organometallic reagents, heteroarene boronates are a common choice of 
coupling partner.1,2 They are the main reagents for Suzuki-Miyaura,3,4 Chan-Evans-Lam,5,6 
Liebeskind-Srogl,7 and oxidative Heck coupling reactions.8 Apart from being nucleophilic 
coupling partners, they have also been utilised in much wider fields e.g. as radical precursors,9 
Lewis acid catalysts,10,11 traceless-directing groups,12 in materials science,13 and in drug 
design.14 However, reactions employing heteroarene boronates have several limitations due to 
their poor functional group tolerance and low reactivity.15 In particular, the coupling of 2-
substituted nitrogen-containing heteroarene boronates e.g. 2-pyridyl boronate is notoriously 
challenging.16,17  
The following discussion focuses on the limitations of 2-pyridyl boronates in cross-coupling 
reactions. In the ensuing discussion, the main emphasis will be given to the ‘pyridyl sulfinates’ 
– an emerging coupling partner to replace the pyridyl boronates.18,19 
 
6.1.  2-Pyridyl boronate as nucleophilic coupling partneri 
The 2-pyridyl motif is an important building block in many natural products,20,21 medicinal 
compounds,22-24 unnatural nucleotides,25,26 metal-complexing ligands,27,28 and materials.29,30 
Extensive efforts have been made to develop 2-pyridyl organometallic reagents that can be 
employed efficiently in cross-coupling reactions.31,32 However, they are not suitable substrates 
for coupling to aryl halides.16,17 
In comparison to 3- and 4-pyridyl boronates,33,34 2-pyridyl boronates readily undergo 
hydrolysis in Suzuki-Miyuara coupling reactions.35,36 This hydrolytic instability is attributed to 
two main factors.37 First, the transmetallation from boron to palladium of electron-deficient 2-
heteroarene boronates is a slow process, and second, 2-pyridyl boronates rapidly undergo 
protodeboronation.38,37 
  
Due to the ease of protodeboration of 2-pyridyl boronates, different techniques have been 
investigated to overcome this problem including the use of additives (Cu, Zn, and Ag salts),39-
41 high catalyst loading,42 improvement in ligand design,43 masked reagents,44 and slow-release 
 




from 2-pyridyl-N-methyl-iminodiacetic acid (MIDA) boronates 6.12.39,45,46 The most common 
approach is to increase the stability of the 2-pyridyl boronate 6.4 by modifying its structure 
(Figure 6.4).47  
 
Figure 6.4: 2-Pyridyl boronates exhibiting enhanced stability. 
Significant efforts have been carried out to improve the generality of the 2-pyridyl coupling 
partner in cross-coupling reactions. However, they are not as competent as other heteroarene 
coupling partners. There are still unsolved challenges associated with the coupling of 2-pyridyl 
derivatives in the Suzuki-Miyuara reactions. Due to the abundance of N-heterocycles and 
related pyridine-heteroaryl moieties in natural products and drug molecules, the chemistry 
community still needs new heteroaryl coupling partners.  In recent years, ‘heteroarene 
sulfinates’ have emerged as alternative coupling reagents.18,19  
 
6.2. Investigation of the role of pyridine sulfinates in cross-coupling reaction with bromo-           
substituted [2.2]paracyclophane derivatives 
 
[2.2]Paracyclophane-N-heterocycles are promising scaffolds for catalysis. They can co-
ordinate to transition metals through the lone pair on the sp2-nitrogen and form planar chiral 
catalysts.48,49 However, the synthesis of these derivatives is problematic. Most of the transition 
metal-mediated cross-coupling reactions reported in [2.2]paracyclophane chemistry involve 
aryl nucleophiles.50-52 The corresponding reactions with heteroarene coupling partners have not 
been thoroughly investigated. Inspired by the potential of hetero(arene)sulfinates as 
nucleophilic coupling partners, we sought to investigate their cross-coupling with 
bromo[2.2]paracyclophanes. If successful, this approach would provide a new avenue to access 
planar chiral heteroarenes based on the [2.2]paracyclophane framework. 
Our initial focus was on [2.2]paracyclophane-based pyridine derivatives since planar chiral 
pyridines are prospective ligands for catalysis,53,54 in the formation of supramolecular 




reported are based on the ferrocene moiety58-60 but the [2.2]paracyclophane skeleton also offers 
a potential platform. The reported procedures for the synthesis of [2.2]paracyclophane-pyridine 
derivatives are mainly based on cross-coupling reactions.61-66 However, these methodologies 
have several problems as discussed in the section below. 
 
6.2.1. [2.2]Paracyclophane-pyridine derivatives  
   
Hopf et al. reported the preparation of a pyridinyl[2.2]paracyclophane by a nitrone 
cycloaddition (Scheme 6.5).67 In this approach, 6.22 synthesised from 4-
acetyl[2.2]paracyclophane and N-methylhydroxylamine.hydrochloride undergoes Michael-
type addition with an activated double bond of the dipolarophile 6.23 to furnish the 
intermediate enolate 6.24. This intermediate 6.24 further proceeds for a sequence of steps to 
finally give [2.2]paracyclophane-6-phenyl pyridine 6.26. However, this approach has not 
proven versatile and does not work if there are other substituents on [2.2]paracyclophane. 
 
Scheme 6.5:  Hopf’s approach for [2.2]paracyclophane-pyridine derivative. 
Rowlands et al. developed a convenient regioselective cross-coupling method66 between 
bromo[2.2]paracyclophanes 6.27 and pyridine N-oxides 6.28 based on the direct arylation 
chemistry of Fagnou et al.(Scheme 6.6).68 The author proposed a SEAr mechanism of pyridine 
N-oxides arylation. Even though this two-steps strategy opened a new route to access 
pyridinyl[2.2]paracyclophanes, there are several limitations. Firstly, this protocol is limited to 
2-pyrdine substrates only. Moreover, all the products and by-products have limited solubility, 
making the purification tedious by chromatography technique. Lastly, the conversion of 
pyridine N-oxides to the corresponding pyridine derivatives involves reduction with the highly 
volatile and hazardous trichlorosilane, which limits the potential of the pyridine substrate for 





Scheme 6.6: Rowlands’s approach for the synthesis of [2.2]paracyclophane-mono- and bis(pyridine 
N-oxides). 
Over the last decade, Brӓse and co-workers have investigated the scope of various cross-
coupling reactions for the synthesis of (hetero)arene substituted [2.2]paracyclophanes. The 
scope of Suzuki, Stille, Kumada and Negishi cross-coupling reactions have been extended by 
utilising [2.2]paracyclophane derivatives as either the electrophilic or nucleophilic coupling 
partner.  
Their initial approach employed readily accessible [2.2]paracyclophane substrates (Br, I or, 
OTf) as the electrophilic coupling partners under Suzuki conditions (Scheme 6.7a) with pyridyl 
organometallic reagents as nucleophilic coupling partners.61 With pyridyl boronic acids, only 
4-pyridyl[2.2]paracyclophane 6.33 was obtained albeit in a moderate yield. Kumada cross-
coupling by in-situ magnesiation of 2-bromopyridine (Scheme 6.7b) and the Stille approach 
with stannylated 2-pyridine 6.41 (Scheme 6.7c) were not proven effective to provide the 






















Scheme 6.7: Brӓse’s approaches for (a) Suzuki coupling, (b) Kumada, and (c) Stille coupling. 
The alternative is to make [2.2]paracyclophane the nucleophilic coupling partner. As 
mentioned, boronic acids cannot be used51 so Brӓse investigated  4-
(tributylstannyl)[2.2]paracyclophane 6.43.62,63, The Stille coupling reaction with 
bromopyridines 6.44 proceeded with poor to average yields (Scheme 6.8). Moreover, the 
synthesis of bis-pyridyl[2.2]paracyclophane gave a low yield (27%). The problems appear to 
be the synthesis of precursor. It requires the lithiation approach (nBuLi), which limits the 
functional group tolerance of sensitive groups. Moreover, stannylated [2.2]paracyclophanes 
are unstable and difficult to purify, often leading to low yields.   
 
Scheme 6.8: Brӓse’s approach for Stille coupling. 
The authors circumvented the problem of instability of paracyclophane boronic acids and 
unreactivity of esters51 by using 4-trifluoroborate[2.2]paracyclophane 6.46.64,65 The potassium 
trifluoroborate BF3
-K+ salt was selected because [2.2]paracyclophane boronic acids are prone 




conditions.51 Pyridyl- and pyrimidyl-substituted [2.2]paracyclophanes were obtained in 
comparable yields compared to the previous methods (Scheme 6.9). The above strategy was 
extended to different aryl halides (Scheme 6.10).65 With modified conditions (replacing base 
K3PO4 with Na2CO3 and solvent system to toluene : H2O 1:1), improvement was observed in 
the synthesis of 2-pyridyl[2.2]paracyclophane 6.42 (73%). However, both these methods are 
limited to only the monosubstituted [2.2]paracyclophane derivative. Of note, these strategies 
were published when we had already started our study to synthesise 
pyridyl[2.2]paracyclophanes. 
 
Scheme 6.9: Brӓse’s approach for Suzuki coupling. 
 
 
Scheme 6.10: Brӓse’s modified approach for Suzuki coupling. 
The above examples clearly show that the synthesis of paracyclophane-substituted pyridines is 
an unsolved challenge. Most common cross-couplings have been studied and yet none have 
been proven general or high yielding. Furthermore, the synthesis of [2.2]paracyclophane-based 
organoboranes and stannanes requires a minimum of two-steps with low functional group 
tolerance. In addition, the modular synthesis with bis-substituted derivatives and diverse 





6.3. Results and discussion  
We were inspired by the recently reported nucleophilic characteristic of pyridylsulfinates in 
cross-coupling reactions.18,19 We sought to address the above challenges associated with the 
synthesis of pyridyl[2.2]paracyclophanes by employing pyridyl sulfinates. We thought this 
would give a more general route with a greater functional group tolerance than those previously 
reported.  
 
6.3.1. Role of pyridine sulfinates as a nucleophilic coupling partner in cross-coupling with 
bromo [2.2]paracyclophane derivatives 
 
The obvious starting point was the coupling of pyridinylsulfinates to (±)-4-
bromo[2.2]paracyclophane 6.40 using Willis’s methodology (Scheme 6.11, Table 6.1, entry 
1).19 The desired coupling was achieved in 27% isolated yield. However, this methodology 
suffered a problem of reproducibility (entry 2 & 3). It was, therefore, decided to evaluate the 
reaction parameters to achieve the optimal conversion.  
A number of different ligands, including, SPhos and Johnphos were screened (entry 4 to 9). 
None improved the yield compared to PCy3.  
 
Scheme 6.11: Optimisation study for synthesis of (±)-4-(2-pyridyl)[2.2]paracyclophane 6.42. 
              Table 6.1: Optimisation study for the synthesis of 6.42 
Entry Ligand [M] Yield 
1 PCy3 [0.1] 27%a 
2 PCy3 [0.1] SM:6.42b = 90:10 
3 PCy3 [0.1] SM:6.42b = 86:14 
4 SPhos [0.1] SM 
5 Johnphos [0.1] SM 
6 P(o-tolyl)3 [0.1] SM 




8 Xanthphos [0.2] 5%c 
9 PCy3 [0.2] 19%c 
               SM = Starting material recovered 
                        a = Isolated yield 
                        b = NMR yield 
     c = HPLC yield, conditions:- stationary phase : reverse phase C18 column, mobile phase : 5-100%                 
H2O : CH3CN over 20 min., flow rate = 0.3 ml/min., RT for 4-bromo[2.2]paracyclophane 6.40: 24.50 
min., Sodium pyridine-2-sulfinate 6.50 : 0.899 min., 4-(2-pyridyl)[2.2]paracyclophane 6.42: 10.103 
min., bipyridine: 2.790 min. 
 
Early results suggested that the best combination of reagents was Pd(OAc)2, PCy3, and K2CO3. 
As a result, we decided to optimise the ratio of these reagents and the solvents. We increased 
the Pd(OAc)2 loading from 5 mol% to 10 mol% in the hope to improve the catalytic turnover. 
We also thought that increasing ligand would minimise the dissociation of the 2-pyridine 
sulfinate 6.50. This may reduce the formation of thermodynamically stable chelated Pd(II)-
sulfinate complex through κ2N,O-chelation. The solvent concentration was also changed from 
[0.1 M] to [0.2 M]. Gratifyingly, the reaction conversion improved with increasing ratio of 
Pd(OAc)2 to PCy3 from 1:1 to 1:4 (Scheme 6.12, Table 6.2). 
 
Scheme 6.12: Optimisation study with increasing ligand loading and different solvents. 
                             Table 6.2: Effect of altering the catalyst: ligand ratio and solvents 
Entry Pd(OAc)2 : PCy3  Solvent Yield 
1 1:1 1,4-dioxane 16%a 
2 1:2 1,4-dioxane 26% a 
3 1:2 DMF 27%b 
4 1:4 1,4-dioxane 33% a 
5 1:4 DMF 38% a 
6 1:4 DMA 100% a (63%)b 
                                                   aHPLC yield 




At this stage, we also considered evaluating the solvent, particularly the use of more polar 
aprotic solvent in hope to increase the solubility of 2-pyridine sulfinate 6.50. A slightly 
increased conversion was detected with DMF solvent, both in Pd(OAc)2 : PCy3,1:2 and 1:4 
(entry 3 & 5, Table 1). To our delight, 100% conversion was observed under HPLC conditions 
using DMA. Further purification of this reaction mixture allowed us to isolate the coupled 
product 6.42 in 63% (entry 2). At this time, this was the highest yield for (±)-4-(2-
pyridyl)[2.2]paracyclophane 6.42 in our studies and in the literature.  
With the optimised reaction conditions in hand, we decided to expand the scope of desulfitative 
coupling to both substituted [2.2]paracyclophane derivatives and pyridine sulfinates. 
 
6.3.1.1. Scope of desulfitative coupling with bromo[2.2]paracyclophane  
Next, we looked at different sulfinates. Both 2- and 3-pyridine sulfinate 6.50 & 6.51 gave the 
desired product in good yields under the optimised reaction conditions (Scheme 6.13).  
 
Scheme 6.13: Desulfitative coupling between (±)-4-bromo[2.2]paracyclophane 6.40 and sodium 2- & 
3-pyridine sulfinates 6.50 & 6.51. 
 
The coupling with 4-pyridine sulfinate 6.53 was problematic and proceeded in only 50% 
isolated yield. The purification of the crude reaction mixture led to the isolation of the desired 
product 6.54, unreacted starting material 6.40, protodebrominated by-product 6.56, and 





Scheme 6.14: Desulfitative coupling between monosubstituted (±)-4-bromo[2.2]paracyclophane 6.40 
and 4-pyridine sulfinate 6.53. 
 
It is unclear how the thioether formed but a similar product was identified by Vogel et al. during 
their study of palladium-catalysed Stille cross-coupling of sulfonyl chlorides and 
organostannanes.69 They reasoned that the thioether was formed first by the reduction of the 
sulfonyl chloride to the sulfenyl chloride by the phosphine, then a palladium catalysed 
coupling. The reduction was confirmed by the synthesis of 1-naphthalenesulfenyl chloride 6.59 
from 1-naphthalenesulfonyl chloride 6.57 (Scheme 6.15).70 We assumed that the same process 
is occurring here. The 4-pyridine sulfinate 6.53 might be less reactive then the 2- and 3-pyridine 
sulfinate 6.50 & 6.51 due to delocalisation of the lone pair electrons on pyridine nitrogen. The 
slower coupling allows the phosphine time to reduce the sulfinate. 
 
Scheme 6.15: Vogel’s explanation of thioether formation. 
A separate reaction was carried out between (±)-4-bromo[2.2]paracyclophane 6.40 and 4-
pyridine thiol 6.61 under the standard reaction conditions. The thioether was formed in 46% 
yield with the rest of the material being unreacted 6.40. (Scheme 6.16). It was later observed 
that the competitive thioether formation could be suppressed by increasing the concentration 
of catalyst/ligand. Presumably, this increases the rate of the desired reaction so that reduction 
cannot compete. Based on our hypothesis, when we carried out the reaction with 4-pyridine 
sulfinate 6.53 as the reaction conditions shown in the scheme 6.17, the desired conversion was 





Scheme 6.16: Coupling between (±)-4-bromo[2.2]paracyclophane 6.40 and 4-pyridine thiol 6.61. 
 
Scheme 6.17: Desulfitative coupling between monosubstituted (±)-4-bromo[2.2]paracyclophane 6.40 
and 4-pyridine sulfinate 6.53 with double concentration of catalyst/ligand. 
 
6.3.1.2. Scope of bis-desulfitative coupling with dibromo[2.2]paracyclophane 
After successful results with mono desulfitative coupling, the scope of the reaction was further 
broadened to dibromo[2.2]paracyclophanes.  
We first decided to perform a bis-coupling with the pseudo-ortho-dibromo substrate 6.63. It 
was crucial that the number of equivalents of palladium and ligands were doubled. The results 
were not promising. The 2- and 3-pyridine sulfinates 6.50 & 6.51 gave a low yield of bis-
coupled product while the 4-pyridine sulfinate 6.53 did not react at all. (Scheme 6.18). For the 
reaction of 3-pyridine sulfinate 6.51, the thioether by-product 6.66 was the predominant 
product. This result suggests that the rate of oxidative addition is slower in this dibromo 





Scheme 6.18: Bis-desulfitative coupling with pseudo-ortho-dibromo[2.2]paracyclophane 6.63. 
Unsurprisingly, the pseudo-para-dibromo derivative is generally a good substrate in the bis-
coupling. In terms of the steric environment, it is identical to the 4-bromo substrate 6.40. 
Electronically, it is potentially activated. The desired products isolated in good yield for the 2- 
and 4-pyridine sulfinate 6.50 & 6.53. However, 3-pyridine sulfinate 6.51 only produced the 
thioether by-product 6.72 in 19% yield (Scheme 6.19). During 2-pyridine bis-coupling the 





Scheme 6.19: Bis-desulfitative coupling with pseudo-para-dibromo[2.2]paracyclophane 6.68. 
6.3.1.3. Scope of mono-desulfitative coupling with dibromo[2.2]paracyclophane 
We wondered if we could selectively add a single pyridine to a dibromo derivative as this 
would leave a bromide group suitable for further functionalisation. If we succeed in the desired 
transformation, it will open a new route to synthesise bulky N-heteroarene-[2.2]paracyclophane 
derivatives that could be of great potential in catalysis.  
Under the optimised conditions, the individual reaction was carried out between pseudo-ortho-
dibromo[2.2]paracyclophane and 2-, 3-, and 4-pyridine sulfinates 6.50, 6.51, & 6.53. These 
reactions were maintained by taking all reagents equivalent to mono-coupling. All three 
reactions were carefully monitored for consumption of the starting material, in an effort to 
avoid bis-coupling. The desired products were isolated albeit in moderate yield (34% to 45%) 





Scheme 6.20: Mono-desulfitative coupling of pseudo-ortho-dibromo[2.2]paracyclophane 6.63. 
Similarly, reactions were also performed with pseudo-para-dibromo[2.2]paracyclophane 6.68 
under the same conditions. In each case, the reaction conversion was slightly higher compared 
to the corresponding pseudo-ortho derivative presumably due to less steric hindrance. 
However, this time the unusual by-products, the monothioether product and bis-coupling 
product were isolated as shown in the Scheme 6.21. It is worth mentioning that all reactions 
were repeated three times and no consistency was found in the formation of by-products. It is 






Scheme 6.21: Mono-desulfitative coupling with pseudo-para-dibromo[2.2]paracyclophane 6.68. 
This inconsistency in desulfitative coupling with dibromo[2.2]paracyclophane suggests that a 
detailed mechanistic investigation is required. More understanding will allow us to reduce the 
by-product formation and subsequently to achieve better yields.  
The scope of the methodology was extended to evaluate the functional group tolerance at 
different positions on the [2.2]paracyclophane. The challenging pseudo-gem position was 
selected first for the study to assess the influence of steric hindrance on desulfitative coupling.  
 
6.3.1.4. Scope of pseudo-gem-[2.2]paracyclophane for desulfitative coupling  
First, we decided to check the compatibility of electron-withdrawing functionalities such as an 
ester and a nitro group. The synthesis of precursor, methyl (±)-4-bromo[2.2]paracyclophane-
13-caboxylate 6.81 was achieved in four steps from [2.2]paracyclophane 6.56 following the 
literature.71 Unfortunately, the coupling of 6.81 with 2-pyridine sulfinate 6.50 did not proceed 
under our standard reaction conditions. We then chose a non-nucleophilic solvent 1,4-dioxane 
as per Willis’s reaction conditions.19 The coupling product using 2-pyridine sulfinate 6.50 was 
isolated in 37% yield at the concentration [0.2 M] of 1,4-dioxane. We observed that the yield 




the more solubility of reagents. The coupling of 3-pyridine sulfinate 6.51 was, however, not 
promising as the reaction gave the coupled product 6.83 only in 20% yield with the 
protodebromination by-product 6.84 in 22%.  
 
Scheme 6.22: Desulfitative coupling with methyl (±)-4-bromo[2.2]paracyclophane-13-caboxylate 
6.81. 
 
We also checked the desulfitative coupling with the pseudo-gem nitro functionality (Scheme 
6.23). The precursor, (±)-4-bromo-13-nitro[2.2]paracyclophane 6.85 was synthesised by 
following Rowlands’s report.72 The precursor was found to be less reactive towards 
desulfitative coupling, furnishing the main starting material back 6.85 with minor 
protodebrominated by-product 6.90.  
We reduced the nitro group and investigated the reaction of (±)-4-bromo-13-
amino[2.2]paracyclophane 6.86. However, this bromide 6.86 was largely unreactive. Traces of 
the desulfitative coupling were observed with both 2- and 3-pyridine sulfinate 6.50 & 6.51 but 
mostly unreacted starting material was returned. Protecting the primary amino group as an 




Scheme 6.23: Desulfitative coupling with (±)-4-bromo-13-nitro/amino/N-acetyl 
amino[2.2]paracyclophane 6.85/6.86/6.87. 
 
6.3.1.5. Scope of pseudo-ortho-[2.2]paracyclophane for desulfitative coupling 
Next, we checked pseudo-ortho-[2.2]paracyclophane derivatives. The synthesis of pseudo-
ortho-substituted derivatives requires multistep sequences and can be low-yielding. The routes 
to ethyl (±)-4-bromo-[2.2]paracyclophane-12-carboxylate 6.100 and (±)-4-bromo-12-amino-
[2.2]paracyclophane 6.105 are given in Scheme 6.24. Ester 6.100 was synthesised from (±)-
4,12-dibromo[2.2]paracyclophane 6.63 by a lithium-halogen exchange followed by 
nucleophilic attack of the resulting organolithium intermediate on ethyl chloroformate. After 
hydrolysis, the resulting product 6.101 was first converted to an acyl chloride 6.102 and later 
to an acyl azide 6.103, which subsequently underwent a Curtius rearrangement to furnish the 





Scheme 6.24: Synthesis of ethyl (±)-4-bromo-[2.2]paracyclophane-12-carboxylate 6.100 and 4-
bromo-12-amino-[2.2]paracyclophane 6.105. 
 
First, we investigated the reactions of ethyl (±)-4-bromo-[2.2]paracyclophane-12-carboxylate 
6.100 with 2- and 3-pyridine sulfinates 6.50 & 6.51 under the optimised reaction conditions 
found for the pesudo-gem isomer (Scheme 6.25). However, this time, the results were not 
promising. The 2-pyridine sulfinate 6.50 failed to couple whereas only a trace of desulfitative 
coupling was observed with 3-pyridine sulfinate 6.51. 
 






The desulfitative coupling of 2-pyridine sulfinate 6.50 and (±)-4-bromo-12-amino-
[2.2]paracyclophane 6.105 gave the desulfitative product 6.109 in 61% yield along with the 
36% of protodebrominated amine 6.110. Based on our previous assumption about the pseudo-
gem substrate, it is evident that steric hindrance has a crucial role in deciding the course of the 
reaction.  
 
Scheme 6.26: Desulfitative coupling with (±)-4-bromo-12-amino-[2.2]paracyclophane 6.105. 
 
6.3.1.6. Scope of ortho-[2.2]paracyclophane for desulfitative coupling 
After evaluating the versatility of pyridine sulfinates to pseudo-gem and pseudo-ortho 
positions, we looked at the ortho-substituted-bromo[2.2]paracyclophane derivatives. Ortho-
substituted [2.2]paracyclophane derivatives are highly desirable but their synthesis is taxing as 
one cannot apply many standard aromatic transformations.  
The synthesis of (±)-4-bromo-5-formyl[2.2]paracyclophane 6.111 was achieved by Brӓse’s 
methodology,73 where Pd(II)-catalysed ortho-bromination was performed on oxime derivative 
of (±)-4-formyl[2.2]paracyclophane. Disappointingly, the protodebromination was the major 
product of the attempted coupling. Unexpectedly, only 4-pyridine sulfinate 6.53 gave the 
coupled product 6.115 (60% yield, Scheme 6.27). This is unusual as the 4-pyridyl derivative 
6.53 more frequently gave the thioether product. Increased steric congestion and the electron-
withdrawing effect resulting from the formyl substituent could be the possible reasons for the 





Scheme 6.27: Desulfitative coupling with (±)-4-bromo-5-formyl-[2.2]paracyclophane 6.111. 
Next, we considered performing coupling with (±)-4-bromo-5-amino[2.2]paracyclophane 
6.116. The desired precursor was obtained by treating 4-bromo-5-formyl[2.2]paracyclophane 
6.111 with Kosser’s reagent followed by Lossen-type rearrangement.71 Desulfitative coupling 
of 6.116 with 2- & 3-pyridine sulfinates 6.50 & 6.51 was accomplished in a moderate yield 
with the remainder of the reaction mixture containing unreacted starting material (Scheme 
6.28). We assumed that steric bulk arising from proximal ortho groups might have impeded 
further reaction. These results were exciting that the precursor 6.116 reacted at all as we have 









Over all, the goal of this project was to overcome the shortcomings in the synthesis of 
pyridyl[2.2]paracyclophanes. We have shown that pyridyl sulfinates can be employed as 
nucleophilic coupling partners successfully in desulfitative cross-coupling with the 
bromo[2.2]paracyclophane derivatives. Under the optimised reaction conditions, bromo- and 
dibromo[2.2]paracyclophane derivatives allow access to pyridines that can be problematic to 
synthesise via other routes. For example, the reported maximum isolated yield of 2-
pyridyl[2.2]paracyclophane 6.42 is 42%, while the same compound can be synthesised in a 
relatively higher yield of 62% with our optimised method.  In some cases, thioether by-products 
were observed, suggesting an in-depth study is required to improve the desired coupling 
reactions. A wide range of pyridyl[2.2]paracyclophane derivatives with diverse functionalities 
were also synthesised. One of the intriguing results was the desulfitaive coupling with the 
stubborn scaffold (±)-4-bromo-5-amino[2.2]paracyclophane 6.116, which, so far, has not 
reacted in any other reaction. Should these derivatives be synthesised in enantiomerically pure 
form, they should show great potential in asymmetric catalysis.  
The initial results of desulfitative couplings are promising. Nevertheless, some challenges still 




heteroarene[2.2]paracyclophanes. Further, there will be a great opportunity to create a modular 
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7.0. Future perspective  
 
7.1. Hydrazone and hydrazide-based directing groups for the remote C-H 
functionalisation of cyclic amines 
 
We have screened various directing groups in order to investigate the β-C(sp3)-H arylation of 
7-(benzo)azabicyclo[2.2.1]heptane (Chapter 3). Based on this study, we surmise that the 
thermodynamically favoured fused 5,5-metallacycle may facilitate the desired C-H 
functionalisation (Scheme 7.1). We also proposed hydrazone and hydrazide-based directing 
groups.1 The next strategy would be to study β-C(sp3)-H arylation on the piperidine system 7.3.  
 
Scheme 7.1: Hydrazone and hydrazide-based directing groups for the remote C-H functionalisation of 
cyclic and bicyclic amines. 
 
Once we have obtained ‘proof-of-concept’, this chemistry can be elaborated to investigate 
different heterocyclic derivatives. The ultimate goal will be to develop an asymmetric variant 
of this methodology. A number of directing groups can accommodate a stereogenic element, 
permitting diastereoselective functionalisation and the creation of a chiral auxiliary. Another 






7.2. Planar chiral dicarboxylic acids in Asymmetric catalysis 
In Chapter 3, we have shown that planar chiral [2.2]paracyclophane carboxylic acid derivatives 
can catalyse the γ-C(sp3)-H functionalisation of the N-cyclohexylpicolinamide 7.11. We did 
not have access to the enantiomerically enriched versions, however, once we obtain 
enantiopure planar chiral acids via the oxazoline coupling protocol (Chapter 4), it would be 
intriguing to investigate their potential in enantioselective C-H activation (Scheme 7.2). 
Further, taking inspiration from the success of chiral phosphoric acids in asymmetric 
catalysis,2-4 exploiting the scope of these planar chiral acids would be instrumental.  
 
Scheme 7.2: Exploiting planar chiral acids in asymmetric C-H functionalisation. 
 
7.3. Expanding the scope of bromo[2.2]paracyclophane derivatives for oxazoline coupling 
 
We have developed a protocol to couple chiral oxazolines with bromo[2.2]paracyclophane 
derivatives (Chapter 4). This methodology has provided exciting results. In some cases, the 
resolution of diastereomers was possible. It would be intriguing to elaborate the scope of 
bromo[2.2]paracyclophane derivatives. For example, we have synthesised two new 
bromo[2.2]paracyclophane precursors, (±)-4-(tert-butylamino)-7-bromo[2.2]paracyclophane 
carbamate 7.16 and (±)-4-(tert-butylamino)-8-bromo[2.2]paracyclophane carbamate 7.17 
(Scheme 7.3). With the oxazoline coupling, different amino[2.2]paracyclophane-oxazoline 





Scheme 7.3: Synthesis of 4-(tert-butylamino)-8-bromo[2.2]paracyclophane carbamate 7.16 & 4-(tert-
butylamino)-7-bromo[2.2]paracyclophane carbamate 7.17, and access to planar chiral amino acids. 
 
Planar chiral [2.2]paracyclophane amino acids (pseudo amino acids) provide a unique 
opportunity to prepare planar chiral pseudopeptides. They can be promising supramolecular 
organic frameworks. With these fascinating properties, planar chiral pseudopeptides can be 
applied in asymmetric catalysis, the biomedical field, and the development of new materials.  
 
7.4. Optimisation of imidazoline coupling with bromo[2.2]paracyclophanes  
Similar to oxazoline coupling, it would be interesting to broaden the scope of imidazolines 7.21 
in coupling reactions with bromo[2.2]paracyclophane derivatives 7.20 (Scheme 7.4). 
Imidazolines can be readily synthesised from basic precursors such as 1,2-diamines and β-
hydroxy amides.5 We have shown that (S)-1-(1-phenylethyl)-4,5-dihydro-1H-imidazole can be 
coupled with (±)-4-bromo[2.2]paracyclophane (Chapter 4). It would be interesting to optimise 
the coupling conditions of imidazolines. Introducing bulky substituents and polar/apolar 
functionalities at C4 and/or C5 position of the imidazoline framework may help in the 
resolution of [2.2]paracyclophane-imidazoline derivatives 7.22. These planar chiral 





Scheme 7.4: Optimisation of imidazoline coupling with bromo[2.2]paracyclophanes and expand the 
scope of imidazolines. 
 
7.5. Coupling of aromatic/nonaromatic heterocycles with [2.2]paracyclophane    
derivatives  
 
In [2.2]paracyclophane chemistry, the direct coupling of heteroarene derivatives via C-H 
functionalisation is uncommon. Most methodologies rely on traditional cross-coupling 
reactions, where heterocyclic compounds possess either halides (electrophilic partner) or 
organometallic intermediates (nucleophilic partner). These cross-coupling methodologies are 
not versatile and are limited due to poor functional group tolerance. Moreover, preparing 
appropriate [2.2]paracyclophane organometallic precursors requires multiple steps, and some 
of them are even unstable such as boronates. In Chapter 4, our initial study demonstrated the 
potential of the C-H functionalisation of both aromatic (benzimidazole and indole system) and 
non-aromatic (imidazoline system) heterocycles followed by coupling with (±)-4-
bromo[2.2]paracyclophane. It would be interesting to expand this study to various heterocyclic 
compounds 7.24 and bromo[2.2]paracyclophane derivatives 7.23 with diverse functionalities 
(Scheme 7.5). With this methodology, it will be a new paradigm in paracyclophane chemistry, 
allowing access to a wide range of planar chiral [2.2]paracyclophane-heterocyclic compounds 
7.25.  
 




7.6. [2.2]Paracyclophane sulfinate derivatives as potential nucleophilic coupling partners 
 
In Chapter 6, we explored pyridine sulfinates as nucleophilic coupling partners in the 
desulfitative cross-coupling reactions with the various bromo[2.2]paracyclophanes. This 
approach could be further extended to couple other heteroarene sulfinates 7.27 (Scheme 7.6). 
This will provide a new route to heteroarene[2.2]paracyclophane derivatives 7.28. These could 
be valuable moieties in the synthesis of bioactive molecules,6 materials,7 and ligands for 
catalysis.8 
 
Scheme 7.6: Scope of heteroarene sulfinates in desulfitative coupling with [2.2]paracyclophane 
halides/triflates. 
 
Recently, heterocyclic allyl sulfones 7.29 have emerged as latent heteroaryl nucleophiles. They 
are easy to synthesise and soluble in standard reaction solvents (Figure 7.1).9  
 
Figure 7.1:  Heterocyclic allyl sulfone as latent nucleophile. 
In the reverse approach, it would be intriguing to evaluate the potential of [2.2]paracyclophane 
sulfinate/allyl sulfone derivatives 7.30 & 7.31 as potential nucleophilic coupling partners with 
aryl- and heteroaryl halides 7.32 (Scheme 7.7). Since [2.2]paracyclophane boronic acids and 
derivatives are not stable or user friendly, finding an alternative nucleophilic coupling partner 
would be very useful. This reverse strategy will have more advantages since heterocyclic 
halides are commercially available and relatively easy to synthesis. Research work in this 
direction has already been initiated in our laboratory. We have synthesised both 
[2.2]paracyclophane sulfinate 7.30 and [2.2]paracyclophane allyl sulfone 7.31 derivatives. We 
are at the stage of investigating their potential in desulfitative reactions. If successful, this 




from simple precursors. Even more intriguing would be combining this with our original 
sulfoxide chemistry method to synthesise enantiomerically enriched compounds.10 
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8.0.  Experimental Section 
 
8.1. General Information 
 
All reactions were performed in oven- and/or flame-dried glassware under an atmosphere of 
dry argon or nitrogen unless otherwise noted. Schlenk tubes, pressure tubes, and scintillation 
vials were used as mentioned in the respective procedures. Moisture-sensitive reactions were 
carried out using standard syringe septum techniques and under an inert atmosphere of argon 
or nitrogen. All solvents and reagents were purified by standard techniques unless otherwise 
noted. Reaction solvent tetrahydrofuran (Fisher, HPLC grade) was dried by distillation from 
sodium-benzophenone radical ketyl. Dichloroethane (Fisher) was freshly dried by distillation 
over phosphorus pentoxide. Dichloromethane (Fisher) and acetonitrile (Fisher) were freshly 
dried by distillation over calcium hydride. DMA (Sigma-Aldrich) was stored under 
microwave-activated 4 Å molecular sieves. Toluene (Fisher, HPLC grade) was dried by 
percolation through two columns packed with neutral alumina under a positive pressure of 
argon. Solvents for filtration, transfers, and chromatography were certified ACS grade. NMR 
solvent, CDCl3 was stored under activated neutral alumina and dried over phosphorus 
pentoxide when applicable. Evaporation of solvents was carried out under reduced pressure on 
a rotary evaporator with the water bath below 42 °C. “Brine” refers to a saturated solution of 
sodium chloride in water. Palladium catalysts and phosphine ligands were purchased from 
Sigma-Aldrich, Sterm, and Apollo Scientific. Other reagents were purchased from Sigma-
Aldrich, Alfa Aesar or Acros.  
Purification of crude reaction mixtures was performed by column chromatography, Bruker 
Flash chromatography or preparative TLC. The stationary phase for column chromatography 
was silica gel 40-63 UM 60A, 230-400 mesh or neutral alumina Brockmann-I. Preparative TLC 
was performed on MERCK precoated silica gel 60- F254 (0.5-mm) aluminium plates. Solvents 
for purification were purchased from LabServe. TLC visualisation was carried out using 
ultraviolet light (254 nm) and different staining reagents such as potassium permanganate, 2,4-
dinitropyridine, ethanolic phosphomolybdic acid, or ninhydrin when applicable. The structures 





8.2. Analytical instruments  
Optical rotation was recorded on a Perkin Elmer 241 polarimeter using the sodium emitting at 
589 nm. All samples were measured in chloroform unless otherwise noted (c=1) in a 10 cm 
cell and an average taken of 3 readings.  
Infrared spectroscopy was carried out on ThermoScientific Nicolet iS5 iD7 ATR using solid, 
semisolid, or solution of the sample in CH2Cl2. 
NMR spectroscopy was carried out on a Bruker 400 MHz, Bruker 500 MHz or Bruker 700 
MHz. Chemical shifts are reported in parts per million (ppm) downfield from tetramethylsilane. 
All spectra were run in CDCl3 unless otherwise stated. Spin multiplicities are described as s 
(singlet), bs (broad singlet), d (doublet), dd (double of doublets), ddd (doublet of doublet of 
doublets), dddd  (doublet of doublet of doublet of doublets), t (triplet), td (triplet of doublets), 
q (quartet), m (multiplet), dt (doublet of triplet), ddt (doublet of doublet of doublets), dtd 
(doublet of triplet of doublets), dq (doublet of quartets). Coupling constants are reported in 
Hertz (Hz).  
HRMS data were recorded by David Lun using a ThermoScientific Q Exactive Focus Hybrid 
Quadrupole-orbitrap Mass Spectrometer. Sample(s) were injected via Dionex Ultimate 3000 
HPLC system running at 0.1 mL/min CH3OH. 
Gas chromatography was carried out on Shimadzu GC2010. The injector temperature was set 
to 200 °C and flame ionisation detector set to 300 °C with a temperature ramp 15 °C/min. 
HPLC was carried out on Dionex Ultimate 3000, both normal phase and reverse phase using 
optimised conditions, as described in Results and Discussion section. 
Single crystal X-ray analyses were performed by Prof. Paul Plieger and Prof. Martyn Coles of 
Victoria University of Wellington using a RigakuSpider X-ray diffractometer. 








8.3. Experimental for Chapter 2 
 
(RSp,SRP)-4-tert-butyl[2.2]paracyclophane phosphine oxide 2.47 
 
A solution of n-BuLi (1.2 M in hexanes; 18.3 ml, 21.9 mmol, 1.05 eq.) was added dropwise 
over 30 min. to a solution of (±)-4-bromo[2.2]paracyclophane 2.46 (6.0 g, 20.9 mmol, 1.0 eq.) 
in THF (60 ml), at -78 °C. The resulting yellow solution was stirred at -78 °C for 40 min. tert-
Butyldichlorophosphine (1M in Et2O; 21.9 ml, 21.9 mmol, 1.05 eq.) was added dropwise over 
20 min. The solution was warmed to room temperature overnight. H2O (75 ml) was added to 
the reaction mixture and the resulting organic phases were separated. The aqueous phase was 
extracted with EtOAc (3 × 50 ml), the combined organic fractions dried (MgSO4) and 
concentrated under reduced pressure to yield a yellow residue, which was purified by column 
chromatography on silica gel (EtOAc : Hexanes 6 :4) followed by recrystallisation (CH2Cl2 : 
pentane 2 : 8) to give white crystals of 2.47 (3.3 g, 1.05 mmol, 55 %). 
Rf  (4 : 6 Hex : EtOAc) 0.40. 
 
mp: 142 °C - 144 °C 
 
IR νmax (Solid) 2959, 2930, 2865, 1700, 1594, 1499, 1473, 1431, 1410, 1392, 1358, 1263, 1129, 
1094, 1069, 1022, 994, 925, 900 cm-1. 
 1H NMR (CDCl3, 500 MHz): δ 7.42 (d, JP-H = 398.1 Hz, 1H, P-H), 6.92 (d, J = 7.7 Hz, 1H, H-
5), 6.67 (d, J = 8.1 Hz, 1H, H-13), 6.61-6.58 (m, 2H, H-7, H-8), 6.53-6.52 (m, 2H, H-15, H-
16), 6.45 (d, J = 8.1 Hz, 1H, H-12), 3.94 (t, J = 11.5 Hz, 1H, H-2b), 3.45 (td, J = 12.0, 4.5 Hz, 
1H, H-2a), 3.22-3.18 (m, H-1a, 2H, H-10a), 3.13-2.99 (m, 4H, H-1b, H-10b, H-9a, H-9b), 1.00 




13C NMR (CDCl3, 125 MHz) δ 173.7, 145.3, 140.02, 139.6 (d, JP-C = 54.1 Hz), 135.5 (d, JP-C = 
71.3 Hz), 134.2 (d, JP-C = 133.8 Hz), 133.2 (d, JP-C = 105.2 Hz), 132.2, 126.3 (d, JP-C = 375.7 
Hz) 39.53, 36.2, 35.2, 32.6 (d, JP-C = 273.0 Hz), 23.5. 
31P NMR (CDCl3, 200 MHz) δ 57.81. 
 HRMS-EI: m/z found: [M], 312.1747. C25H25OP requires [M] 312.1643. 
 
(±)-4,13-ditert-butyl-[2.2]paracyclophane phosphine oxide 2.57 
 
tBuLi (1.6 M solution in hexane, 1.37 ml, 2.16 mmol) was added dropwise over 15 min. to a 
solution of (±)-4,12-dibromo-[2.2]paracyclophane 2.56 (200 mg, 0.54 mmol) in dry THF (7 
ml), at -78 °C under an inert argon atmosphere. The resulting yellow solution was stirred for 
40 min-. at -78 °C. After that tert-butyldichlorophosphine (tBuPCl2) (1 M solution in Et2O, 
1.15 ml, 1.15 mmol) was added dropwise over 10 min-., through a steady stream, via syringe. 
The solution was allowed to warm at room temperature overnight. H2O (75 ml) was then added 
to the reaction mixture. The resulting organic phase was separated and the aqueous phase was 
further extracted with EtOAc (3 × 10 ml), the combined organics dried (MgSO4) and 
concentrated under reduced pressure to yield a yellow residue, which was purified by column 
chromatography on silica gel using metahnol : DCM (1:9) give yellow solid. Analysis by 1H-
NMR spectroscopy indicated the compound isolated to be bis-phopshine oxide (±)-2.57 (10 
mg, 0.024 mmol, 5% yield). 
1H NMR (MeOD-d4, 500 MHz): δ 7.52 (d, JP-H = 116.6 Hz, 2H, H-19, H-19’), 7.10 (d, J = 18.1 
Hz, 2H, H-5, H-13), 6.72 (d, J = 7.9 Hz, 2H, H-7, H-8), 6.62 - 6.60 (m, 2H, H-15,H-16), 3.91 
(t, J = 11.0, 11.4 Hz, 2H, H-2a, H-2b), 3.48 - 3.45 (m, 2H, H-9a, H-9b), 3.09 (t, J = 10.0 Hz, 





(1R,2S)-(isopropylamino)-1-phenylpropan-1-ol 2.61  
 
To a solution of (1R,2S)-phenylpropanolamine (2.0 g, 13.2 mmol, 1.0 eq.) in CH3CN (20 ml) 
was added K2CO3 (9.14 g, 66 mmol, 5.0 Eq.) followed by isopropyl iodide (2.64 ml, 26.4 mmol, 
2.0 eq.). The reaction mixture was heated to reflux overnight. After cooling, the resulting slurry 
was filtered to remove salts. The filtrate was then concentrated under reduced pressure to yield 
a yellow residue. The residue was further purified by column chromatography [SiO2, EtOAC : 
hexane (4:6)] to give (1R,2S)-2-(isopropylamino)-1-phenylpropan-1-ol 2.61 (1.86 g, 9.73 
mmol, 93% yield ); 1H NMR (CDCl3, 500 MHz): δ  7.37 - 7.32 (m, 4H), 7.25 (m, 1H), 4.71 (d, 
J = 3.9 Hz, 1H), 3.09 - 3.05 (m, 1H), 2.99 (heptet, 1H), 1.12 (dd, J = 8.2, 6.3 Hz, 6H), 0.82 (d, 
J = 6.6 Hz, 3H).  
Data comparable to that reported in literature.1  
 
 (2S,4S,5R)-Borane-2-tert-butyl-oxazaphospholidine 2.63a 
 
Et3N (1.78 mL, 6.8 mmol) was added to a stirred solution of (1R,2S)-2-(isopropylamino)-1-
phenylpropan-1-ol (1.0 g, 6.7 mmol, 1.0 eq.) in THF (10 mL) at 0 °C under nitrogen. The 
reaction mixture was then allowed to stir for 30 min. tBuPCl2 (1 M solution in Et2O, 7.45 ml, 
8.04 mmol, 1.2 eq) was then added drop wise over 10 min.- and reaction mixture was allowed 
to stir overnight at room temperature. The reaction was again cooled to 0 °C and BH3.THF 
(0.67 mL, 7.0 mmol) was added dropwise. The reaction was allowed to reach room temperature 
and after 3 hrs the solvent was removed under vacuum. The residue was solved in CH2Cl2 and 
washed with distilled water. The organic phase was then washed with a brine solution, dried 
with MgSO4 and the solvent removed under vacuum. Purification by column chromatography 




crystalline solid. This solid was further separated by column chromatography [SiO2, EtOAC : 
hexane (2:8)] to provide pure diastereomer  2.63a and 2.63b respectively.  
 2.63a 
1H NMR (CDCl3, 500 MHz): δ 7.43 - 7.37 (m, 4H), 7.34 - 7.31 (m, 1H), 5.38 - 5.36 (m, 1H), 
3.88 (sept, 1H), 3.70 (quint, 1H), 1.34 (d, J = 16.3 Hz, 9H), 1.33 (d, J = 6.7 Hz, 3H), 0.90 (d, J 
= 6.5 Hz, 3H). 
(2R,4S,5R)-Borane-2-tert-butyl-oxazaphospholidine 2.63b 
 
1H NMR (CDCl3, 500 MHz): δ 7.40 - 7.37 (m, 2H), 7.33 - 7.29 (m, 3H), 5.63 (d, J = 5.9 Hz, 
1H), 3.91 (sept, 1H), 3.73 (quint, 1H), 1.40 (d, J = 5.2 Hz, 3H), 1.35 (d, J = 16.6 Hz, 9H), 1.27 
(d, J = 5.2 Hz, 3H), 0.76 (d, J = 6.7 Hz, 3H); 13C NMR (CDCl3, 125 MHz) δ 136.50 (d, JP-C  = 
43.7 Hz), 128.35, 127.84, 125.59, 80.38 (d, JP-C = 91.8 Hz), 53.54 (d, JP-C = 6.52 Hz), 47.80 (d, 
JP-C  = 124.7 Hz), 32.90 (d, JP-C  = 127.87), 26.36 (d, JP-C  = 44.6 Hz), 21.80 (d, JP-C  = 46.3 Hz), 




To an oven dried 100 ml RBF, pyridine (0.51 ml, 6.3 mmol) was added to a solution of menthol 
2.65 (1.0 g, 6.39 mmol, 1.0 eq.) in dry THF at 0 °C. The reaction mixture was stirred for 30 
min.- at 0 °C. tBuPCl2 (1 M solution in Et2O, 6.39 ml, 6.3 mmol, 1.0 eq.) was then added 
dropwise over 10 min. and reaction mixture was allowed to stir overnight at room temperature. 
The reaction was allowed to reach room temperature overnight and the solvent was removed 




organic phase was then washed with a brine solution, dried with MgSO4 and the solvent 
removed under vacuum. Purification was performed by column chromatography [SiO2, EtOAc 
: hexane (6:4)]. Analysis by 1H-NMR spectroscopy indicated the compound isolated to be 2.66 
(860 mg, 0.99 mmol, 86% yield) as oily product. 1H NMR (CDCl3, 500 MHz): δ 7.23 (d, JP-H 
= 491.8 Hz, 1H), 4.17-4.07 (m, 2H), 2.20-1.99 (m, 2H), 1.63 (d, J = 5.9 Hz, 2H), 1.42-1.32 (m, 
2H), 1.07 (dd, J = 17.8, 1.6 Hz, 9H), 0.86 (d, J = 4.9 Hz, 6H), 0.76 (d, J = 7.3 Hz, 3H).  
Data comparable to that reported in literature.2 
N-benzylaniline phosphine oxide 2.71 
 
N-Benzylaniline phosphine oxide 2.71 was prepared by the procedure mentioned for 2.47 (page 
no. 236) by taking N-benzylaniline 2.70 (1.1 g, 6.26 mmol, 1.0 eq.), n-BuLi (2.2M solution in 
hexane, 3.1 ml, 6.57 mmol, 1.05 eq.) and tBuPCl2 (1M solution in Et2O, 6.58 ml, 6.57 mmol). 
Residues were purified by column chromatography [SiO2, (EtOAc : hexane) (8:2)]. Analysis 
by 1H-NMR spectroscopy indicated the compound isolated to be white solid of 2.71 (113 mg, 
0.40 mmol, 18% yield, ); 1H NMR (CDCl3, 500 MHz): δ 7.41 (d, JP-H = 498.4 Hz, 1H), 7.31 
(d, J = 6.8 Hz, 2H), 7.27-7.26 (m, 1H), 7.26 - 7.24 (m, 5H), 7.21 - 7.19 (m, 1H), 7.08 (quintet, 
J = 8.6, 4.4 Hz, 1H), 4.90 (dd, 15.4, 9.2 Hz, 1H), 4.63 (dd, J = 15.4, 8.5 Hz, 1H), 1.14 (d, 13.6 




N-Benzyl-N-(tert-butylchlorophosphanyl)-4-methylbenzenesulfonamide 2.75 was obtained by 
the following procedure 2.47 (page no. 236) using N-benzyl-4-methylbenzenesulfonamide 2.74 




and tBuPCl2 (1M solution in Et2O, 4.01 ml, 4.01 mmol). Analysis by 
1H-NMR spectroscopy of 
crude product indicated the compound isolated to be 2.75 (980 mg, 2.55 mmol, 98% yield). 1H 
NMR (CDCl3, 500 MHz): δ 7.50 (d, J = 8.3 Hz, 2H), 7.27 (d, J = 3.4 Hz, 1H), 7.21 - 7.18 (m, 
3H), 7.15 (d, J = 15 Hz, 1H), 7.11 (d, J = 8.1 Hz, 1H), 4.73 (d, J = 16.1 Hz, 1H), 4.59 (d, J = 
15.9 Hz, 9H), 2.40 (s, 3H), 1.18 (d, J = 15.8 Hz, 9H). 
 HRMS calcd for C18H23ONNaO2PS 406.0773; found 406.0762. 
(RSp,RSP)-chloro(tert-butyl([2.2]paracyclophan-4-yl)phosphinous acid)gold (I) 2.95 
 
 
To a solution of secondary phosphine oxide 2.47 (30 mg, 0.01 mmol, 1.0 eq.) in CH2Cl2 (5 
mL) was added chloro(dimethyl sulfide)gold(I) (28 mg, 0.01 mmol, 1.0 eq.). The mixture was 
stirred at room temperature overnight in the absence of light. The crude mixture was 
concentrated under reduced pressure to give a greyish solid of 2.95.  
 
1H NMR (CDCl3, 500 MHz): δ 7.33 (dd, J = 20.1, 1H, 1.7 Hz, H-5), 6.96 (d, J = 7.7 Hz, 2H, 
H-8, H-7), 6.65 (d, J = 8.0 Hz, 2H, H-15, H-16), 6.55 (dd, J = 7.7, 3.2 Hz, 2H, H-12, H-13), 
6.52 (dd, J = 7.8, 1.7 Hz, 1H, H-5), 4.01 (t, 11.2 Hz, 1H, H-2a), 3.29-3.21 (m, H-9a, H-9b, 2H), 
3.22-3.16 (m, 2H, H-1a, H-1b), 3.15-3.11 (m, 1H, H-9b), 3.10-3.02 (m, 2H, H-10a, H-10b), 
1.00 (d, J = 17.3 Hz, 9H, tBu);  
 
31P NMR (CDCl3, 200 MHz) δ 125.63.  
 






To a solution of 2.95 (3 mg, 0.0074 mmol, 0.02 eq.) in CH2Cl2 (5 ml) was added AgSbF6 (4 
mg, 0.0074 mmol, 0.02 eq.) and suspension stirred for 10 min. During this time AgCl 
precipitates as a white solid. A solution of 1,6 enyne 2.100 (90 mg, 0.37 mmol, 1eq.) in CH2Cl2 
(5.5 ml) was to make a final concentration 0.05 M. The mixture was stirred at room temperature 
and was monitored by TLC. When reaction was completed (10 hrs), the mixture was filtered 
through a short pad of silica (CH2Cl2, 10 ml) and concentrated under reduced pressure. 
Subsequent purification by column chromatography on silica gel (EtOAc : hexanes 0.2 : 9.8) 
afforded product 2.101 as colourless oil (66 mg, 0.25 mmol, 76 %); 1H NMR (CDCl3, 500 
MHz): δ 5.75 (1H, s), 5.41 (1H, s), 3.76 (6H, s), 3.22 (2H, s), 3.07 (2H, s), 1.84 (3H s), 1.80 
(3H, s). 
Data comparable to that reported in literature.3 
 




To a solution of 2.95 (3 mg, 0.0074 mmol, 0.02 eq.) in CH3OH (2 ml) was added AgSbF6 (5 
mg, 0.0074 mmol, 0.02 eq.) and suspension stirred for 10 min.- During this time AgCl 
precipitates as a white solid. A solution of 1,6 enyne 2.100 (100 mg, 0.41 mmol, 1.0 eq.) in 
CH3OH (6.3 ml) was added to make a final concentration 0.05 M. The mixture was stirred at 
room temperature and was monitored by TLC. When reaction was completed (12 hrs), the 
mixture was filtered through a short pad of silica (CH2Cl2, 10 ml) and concentrated under 
reduced pressure. Subsequent purification by column chromatography on silica gel (EtOAc : 
hexanes 0.2 : 9.8) afforded product 2.95 as colorless oil (81 mg, 0.34 mmol, 92 %); 1H NMR 
(CDCl3, 500 MHz): δ 5.04 (1H, bs), 4.98 (1H, bs), 3.73 (3H, s), 3.72 (3H, s), 3.19 (3H, s), 2.94-
2.83 (3H, m), 2.55 (1H, ddd, J = 13.5, 9.4, 1.7 Hz), 2.00 (2H, dd, J = 13.5, 9.4 Hz), 1.18 (3H, 
s), 1.12 (3H, s). 








To a solution of 2.95 (3 mg, 0.0054 mmol, 0.02 eq.) in CH2Cl2 (2 ml) was added AgSbF6 (2 
mg, 0.0054 mmol, 0.02 eq.) and suspension stirred for 10 min. During this time AgCl 
precipitates as a white solid. A solution of 1,6 enyne 2.110 (75 mg, 0.27 mmol, 1.0 eq.) in 
CH3OH (3.4 ml) was added to make a final concentration: 0.05 M. The mixture was stirred at 
room temperature and was monitored by TLC. When reaction was completed (12 hrs), the 
mixture was filtered through a short pad of silica (CH2Cl2, 10 ml) and concentrated under 
reduced pressure. Subsequent purification by column chromatography on silica gel (EtOAC : 
hexanes 0.1 : 9.9) afforded product 2.111 as a white solid (67 mg, 0.21 mmol,  80% ); 1H NMR 
(CDCl3, 500 MHz): δ 7.74 (2H, d, J = 6.1 Hz), 7.35 (2H, d, J = 7.9 Hz), 5.04 (2H, m), 3.80 
(2H, m), 3.43 (1H, dd, J = 9.9, 4.2 Hz), 3.32-3.29 (1H, m), 2.74 (3H, s), 2.45 (3H, s), 1.14 (3H, 
s), 1.14 (3H, s), 1.03 (3H, s).  
Data comparable to that reported in literature.3 
General procedure for P-arylation of secondary phosphine oxide (SPO) 
To a flame-dried 25 ml RBF was added Pd(OAc)2 (2 mol%), dppf (2.2 mol%), and Cs2CO3 
(1.3 eq.). The reaction vessel was degassed and dioxane (2 ml) was added. The resulting 
suspension was stirred under a flow of argon for 10 min. SPO (RSp,SR)-2.47 (1.0 eq., 0.19 
mmol) and the respective electrophile (1.5 eq., 0.29 mmol) were dissolved separately in 
dioxane : DCE (9 : 1)  and resulting solution was added via syringe. The reaction mixture was 
heated at 100 °C until the starting material had been completely consumed as judged by TLC 
(24 h). The mixture was cooled to room temperature, passed through a celite pad, washed the 
celite pad with EtOAc, and purified by column chromatography on silica gel (EtOAc: hexanes 








(RSp,RSP)-tert-butyl([2.2]paracyclophan-4-yl)(p-tolyl)phosphine oxide 2.116 
 
Pd(OAc)2 (1 mg, 0.0038 mmol, 0.02 eq.), dppf (2 mg, 0.0042 mmol, 0.02 eq.), Cs2CO3 (81 mg, 
0.25 mmol, 1.3 eq.), SPO-2.47 (60 mg, 0.191 mmol, 1.0 eq.), 4-iodotoulene 2.114 (49.24 mg, 
0.287 mmol, 1.5 eq.), white solid of (RSp,RSP)-2.116 (52 mg, 0.086 mmol, 68 %).  
Rf  (7 : 3 Hex : EtOAc) 0.50. 
mp:  216 °C - 218 °C 
IR νmax (Solid) 2925, 2851, 1725, 1598, 1500, 1466, 1433, 1394, 1365, 1293, 1259, 1205, 1162, 
1150, 1111, 1066, 1013, 942, 919, 906, 906, 813, 799, 720 cm-1. 
1H NMR (CDCl3, 500 MHz): δ 8.05 (t, J = 8.5 Hz, 2H, H-22, H-20), 7.46 (d, J = 8.0 Hz, 2H, 
H-23, H-19), 6.68 (d, J = 5.7 Hz, 1H, H-5), 6.59 (m, 3H, H-7, H-8, H-13), 6.56 (dd, J = 7.8, 
1.7 Hz, 1H, H-15), 6.46 (dd, J = 7.7, 1.8 Hz, 1H, H-16), 5.79 (dd, J = 7.7, 1.8 Hz, 1H, H-12), 
4.48 ( t, J = 10.8 Hz, 1H, H-2a), 3.50 (td, J = 10.7, 5.4 Hz, 1H, H-9a), 3.12-3.07 (m, 2H, H-1a, 
H-1b), 3.01- 2.91 (m, 3H, H-2b, H-9b, H-10a), 2.85-2.78 (m, 1H, H-10b), 2.54 (s, 3H, Me), 
1.04 (d, J = 16.9 Hz, 9H, tBu). 
13C NMR (CDCl3, 125 MHz) δ 138.6 (d, JP-C = 47.9 Hz), 136.7 (d, JP-C = 47.5 Hz), 136.2 (d, 
JP-C = 48.8 Hz), 135.9 (d, JP-C = 12.7 Hz), 135.9, 134.0, 133.0 (d, JP-C = 29.4 Hz), 132.2 (t, JP-C 
= 37.60 Hz), 129.0 (d, JP-C = 42.05 Hz), 128.6, 127.5, 126.7, 36.8, 36.2, 35.2, 35.0, 25.1, 21.6. 
 31P NMR (CDCl3, 200 MHz) δ 42.19. 
HRMS-EI: m/z found: [M + H]+, 403.2178. C27H32OP requires 403.2191; [M + Na]
+ 425.2003. 






(RSp,RSP)-tert-butyl(4-methoxyphenyl)([2.2]paracyclophan-4-yl)phosphine oxide 2.119 
 
Pd(OAc)2 (1 mg, 0.0038 mmol, 0.02 eq.), dppf (2 mg, 0.0042 mmol, 0.022 eq.), Cs2CO3 (81 
mg, 0.25 mmol, 1.3 eq.), SPO-2.47 (60 mg, 0.19 mmol, 1.0 eq.), 4-iodoanisole 2.118 (67 mg, 
0.29 mmol, 1.5 eq.), yellow solid of (RSp,RSP)-2.119 (48 mg, 0.114, 60 %).
  
Rf  (7 : 3 Hex : EtOAc) 0.50. 
 
mp: 137 °C - 139 °C 
 
IR νmax (Solid) 2925, 2851, 1725, 1598, 1500, 1466, 1433, 1394, 1365, 1293, 1259, 1205, 1162, 
1150, 1111, 1066, 1013, 942, 919, 906, 906, 813, 799, 720 cm-1. 
1H NMR (CDCl3, 500 MHz): δ 8.09 (t, J = 8.7 Hz, 2H, H-22, H-20), 7.18 (d, J = 7.2 Hz, 2H, 
H-23, H-19), 6.66 (d, J = 13.2 Hz, 1H, H-5), 6.60-6.54 (m, 4H, H-7, H-8, H-15, H-16), 6.47 ( 
d, J = 7.5 Hz,1H, H-13), 5.81 (d, J = 7.4 Hz, 1H, H-12), 4.45 (d, J = 11.4 Hz, 1H, H-2a), 3.98 
(S, 3H, OCH3), 3.50 (dd, J = 11.8, 5.3 Hz, 1H, H-9a), 3.10 (t, J = 4.4 Hz, 2H, H-1a, H-1b), 
3.01-2.89 (m, 3H, H-9b, H-10a, H-10b), 2.84-2.78 (m, 1H, H-2b), 1.04 (d, J = 14.8 Hz, 9H, 
tBu). 
13C NMR (CDCl3, 125 MHz) δ 162.0 (d, JP-C = 10.3 Hz), 146.4 (d, JP-C = 28.8 Hz), 140.5, 138.7, 
138.6 (d, JP-C = 48.1 Hz), 136.7 (d, JP-C = 47.7 Hz), 136.3 (d, JP-C = 48.6 Hz), 135.9, 134.7 (d, 
JP-C = 32.9 Hz), 134.0, 132.2 (d, JP-C = 40.1 Hz), 132.1, 127.5, 126.8, 122.5, 121.7, 113.9 (d, 
JP-C = 44.9 Hz), 64.1, 55.3, 36.8, 36.2, 35.2 (d, JP-C = 27.5 Hz), 35.2, 35.0, 25.1. 
31P NMR (CDCl3, 200 MHz) δ 42.37. 
HRMS-EI: m/z found: [M + H]+, 419.2132. C27H31O2P requires 419.2140; [M + Na]
+ 441.1952 





(RSp,RSP)-tert-butyl(4-cyanophenyl)([2.2]paracyclophan-4-yl)phosphine oxide 2.121 
 
Pd(OAc)2 (1 mg, 0.0038 mmol, 0.02 eq.), dppf (2 mg, 0.0042 mmol, 0.022 eq.), Cs2CO3 (81 
mg, 0.25 mmol, 1.3 eq.), SPO-2.47  (60 mg, 0.19 mmol, 1.0 eq.), 4-iodobenzonitrile 2.120 (66 
mg, 0.29 mmol, 1.5 eq.), white solid of (RSp,RSP)-2.121 (50 mg, 0.12 mmol, 64 %). 
mp:  118 °C -120 °C 
 
IR νmax (Solid) 3430, 2960, 2926, 2855, 2230, 1669, 1500, 1476, 1465, 1394, 1367, 1263, 1200, 
1156, 1130, 1091, 1065, 1017, 942, 915 cm-1. 
1H NMR (CDCl3, 500 MHz): δ 8.31 (t, J = 5.7 Hz, 2H, H-22, H-20), 7.95 (d, J = 8.2 Hz, 2H, 
H-23, H-19), 6.62 (s, 2H, H-8, H-7), 6.56 (dd, J = 7.7, 1.6 Hz, 1H, H-5), 6.53-6.47 (m, 3H, H-
15, H-16, H-13), 5.74 (dd, J = 1.8, 7.8 Hz, 1H, H-12), 4.40 (t, J = 11.2 Hz, 1H, H-2a), 3.46 (td, 
J = 10.9, 5.4 Hz, 1H, H-9a), 3.13-3.05 (m, 2H, H-1a, H-1b), 3.00-2.96 (m, 1H, H-2b), 2.98-
2.90 (m, 2H, H-10a, H-10b), 2.81-2.75 (m, 1H, H-9b), 1.05 (d, J = 15.2 Hz, 9H, tBu). 
13C NMR (CDCl3, 125 MHz) δ 146.7 (d, JP-C = 26.7 Hz), 140.3, 139.0 (d, JP-C = 48.1 Hz), 138.6, 
137.1 (d, JP-C = 47.2 Hz), 136.5, 135.9 (d, JP-C = 47.9 Hz), 133.7, 133.6 (d, JP-C = 25.4 Hz), 
132.3 (d, JP-C = 58.1 Hz), 132.0, 131.7 (d, JP-C = 38.1 Hz), 118.1, 115.2, 36.7, 36.2,35.0, 25.0. 
31P NMR (CDCl3, 200 MHz) δ 41.75. 
HRMS-EI: m/z found: [M + H]+ 414.1979 C27H29NOP requires 414.1987; [M + Na]
+, 436.1800. 








 (RSp,SRP)-tert-butyl(pyridine-2-yl)([2.2]paracyclophan-4-yl)phosphine oxide 2.123  
 
Pd(OAc)2 (1 mg, 0.0038 mmol, 0.02 eq.), dppf (2 mg, 0.0042 mmol, 0.022 eq.), Cs2CO3 (81 
mg, 0.25 mmol, 1.3 eq.), SPO-2.47 (60 mg, 0.19 mmol, 1.0 eq.), 2-iodopyridine 117 (59 mg, 
0.29 mmol, 1.5 eq.), brownish solid of (RSp,SRP)-2.123 (43 mg, 0.11 mmol, 58 % ).  
 
mp:  136 °C - 137 °C 
 
IR νmax (Solid) 3042, 2953, 2928, 2852, 1726, 1573, 1564, 1500, 1473, 1450, 1431, 1420, 1391, 
1364, 1262, 1177, 1152, 1134, 1081, 1064, 1045, 1021, 991, 945, 918, 882 cm-1. 
1H NMR (CDCl3, 500 MHz): δ 8.93 (d, J = 3.9 Hz, H-20, 1H), 8.64 (t, J = 6.5 Hz, H-23, 1H), 
8.03 (tq, J = 7.7, 3.1, 1.7 Hz, 1H,  H-22), 7.53-7.50 (m, 1H, H-22), 7.34 (d, J = 12.4 Hz, 1H, 
H-5), 6.60-6.54 (m, 3H, H-8, H-7, H-15), 6.45 (d, J = 7.8 Hz, 1H, H-13), 6.37 (d, J = 7.8 Hz, 
1H, H-12), 4.52 (t, J = 10.8 Hz, 1H, H-2a), 3.44 (td, J = 10.5, 5.9 Hz, 1H, H-9a), 3.16-3.08 (m, 
2H, H-1a, H-1b), 2.96-2.85 (m, 4H, H-10a, H-10b, H-2b, H-9b), 1.06 (d, 9H, J = 15.1 Hz, tBu).   
13C NMR (CDCl3, 125 MHz) δ 149.0 (d, JP-C = 65.5 Hz), 146.4 (d, JP-C = 24.9 Hz), 140.5, 138.9, 
138.3 (d, JP-C = 47.2 Hz), 136.7 (d, JP-C = 41.8 Hz), 136.4 (d, JP-C = 47.2 Hz), 138.3 (d, JP-C = 
41.8 Hz), 136.2 (d, JP-C = 47.9 Hz), 135.8 (d, JP-C = 13.2 Hz), 133.4, 132.6, 132.3, 131.9, 130.0 
(d, JP-C = 65.8 Hz), 124.7 (d, JP-C = 12.1 Hz), 35.2 (d, JP-C = 48.1 Hz), 34.9, 34.4, 24.4.                    
31P NMR (CDCl3, 200 MHz) δ 36.12. 
HRMS-EI: m/z found: [M + H]+, 390.1978. C25H29NOP requires 390.1987; [M + Na]
+ 412.1798 







  (RSp,RSP)-tert-butyl(phenyl)([2.2]paracyclophan-4-yl)phosphine oxide 2.113 
 
Pd(OAc)2 (1 mg, 0.0038 mmol, 0.02 eq.), dppf (2 mg, 0.0042 mmol, 0.022 eq.), Cs2CO3 (81 
mg, 0.25 mmol, 1.3 eq.), SPO-47 (60 mg, 0.19 mmol, 1 eq.), Phenylbromide 2.112 (0.03 ml, 
47.53 mg, 0.30 mmol, 1.5 eq.); yellow solid of (RSp,Rs)-2.113 (45 mg, 61%).  
 
mp: 166 °C - 168 °C 
 
IR νmax (Soild) 2924, 2856, 1586, 1497, 1474, 1433, 1409, 1393, 1365, 1263, 1209, 1165, 1153, 
1129, 1100, 1074, 1066, 1020, 996, 941, 916, 902 cm-1. 
1H NMR (CDCl3, 500 MHz): δ 8.20-8.16 (m, 2H, H-22, H-20), 7.69-7.61 (m, 3H, H-23, H-
21,H-19), 6.68 (dd, J = 7.8, 1.7 Hz, 1H, H-5), 6.60-6.58 (m, 3H, H-7, H-8, H-15), 6.56 (dd, J 
= 7.8, 1.5 Hz, 1H, H-13), 6.47 (dd, J = 7.8, 1.8 Hz, 1H, H-16), 5.76 (dd, J = 7.8, 1.8 Hz, 1H, 
H-12), 4.49 (t,  J = 10.9 Hz, 1H, H-2b), 3.50 (td, J = 8.3, 5.6 Hz, 1H,  H-1a), 3.13-3.06 (m, 2H,  
H-9a, H-9b), 3.02-2.96 (m, 2H, H-10a, H-10b), 2.94- 2.90 (m, 1H, H-2a), 2.82-2.76 (m, 1H, 
H-1b), 1.07 (d, J = 16.1 Hz, 9H, tBu). 
13C NMR (CDCl3, 125 MHz) δ 146.6 (d, JP-C = 27.4 Hz), 140.4, 138.7, 138.6 (d, JP-C = 47.7 
Hz), 136.7 (d, JP-C = 47.8 Hz), 136.2 (d, JP-C = 47.7 Hz), 135.9 (d, JP-C = 11.5 Hz), 134.0, 133.0 
(d, JP-C = 27.9 Hz), 132.2 (d, JP-C = 40.5 Hz), 131.8, 131.3 (d, JP-C = 10.1 Hz), 131.1, 128.3, 
127.3, 126.6, 36.8, 36.2, 35.2 (d, JP-C = 25.5 Hz), 35.0, 34.6, 25.1. 
31P NMR (CDCl3, 200 MHz) δ 41.93. 
HRMS-EI: m/z found: [M + H]+, 389.2024. C26H30OP requires 389.2034; [M + Na]
+ 411.1846 





(RSp,SRP)-tert-butyl([2.2]paracyclophan-4-yl)(p-tolyl)phosphine 2.126  & (RSp,RSP)-tert-
butyl([2.2]paracyclophan-4-yl)(p-tolyl)phosphine 2.126   
 
Trichlorosilane (0.73 ml, 7.30 mmol, 28 eq.) was added to a stirred suspension of (RSp,RSP)-
tert-butyl([2.2]paracyclophan-4-yl)(p-tolyl)phosphine oxide 2.116 (105 mg, 0.261 mmol, 1.0 eq.) 
in p-xylene (2 mL) and slowly heated to 140 oC in a pressure tube for 20 h. The reaction mixture 
was cooled to 0 oC and quenched by the addition of 30% aqueous sodium hydroxide (10 mL) 
(Exothermic). The aqueous layer was extracted with ethyl acetate (3 x15 mL), dried (MgSO4) 
and the solvent was removed in vacuo. The crude product was obtained as a yellowish solid. 
(80 mg, 80% yield) 
1H NMR (CDCl3, 500 MHz): δ 7.76 (t,  J = 7.9 Hz, 2H,), 7.21 (d, J = 7.6 Hz, 2H), 7.10 (d, J = 
7.7 Hz, 1H), 7.03-6.99 (m, 3H), 6.93 (d, J = 7.8 Hz, 1H), 6.73 (d, J = 6.4 Hz, 1H), 6.51 (d, J = 
7.7 Hz, 1H), 6.46-6.43 (3H, m), 6.39-6.33 (m, 5H), 6.23-6.20 (m, 1H), 5.67 (d, J = 7.8 Hz, 1H), 
4.12-4.07 (m, 1H), 3.35-3.30 (m, 2H), 3.19-3.14 (m, 1H), 3.11-3.05 (m, 2H), 3.00-2.91 (m, 
3H), 2.90-2.84 (m, 3H), 2.82-2.77 (m, 2H), 2.76 (m, 2H), 2.39 (s, 3H, Me), 2.21 (s, 2H, Me), 
1.15 (d, J = 12.2 Hz, 6H, tBu), 0.90 (d, 9H J = 12.5 Hz, tBu). 












 To a flame dried two necked 25 ml RBF was added racemic tert-butyl([2.2]paracyclophan-4-
yl)(p-tolyl)phosphine 2.126  (80 mg, 0.20 mmol, 1.0 eq.) and 
Chloro(tetrahydrothiophene)gold(I) (66.3 mg, 0.20 mmol, 1.0 eq.) in dry CH3CN (5 ml). The 
mixture was refluxed under an argon atmosphere for 2 h. The crude mixture was concentrated 
under vacuum. The resulting yellow solid was dissolved in CH2Cl2 (1 mL) and pentane (10 
mL) was added to precipitate the desired complex as a yellow solid, which was isolated by 
decantation to obtain desired complex (20 mg, 0.032 mmol, 16 % yield). 
mp: 98 °C - 99 °C 
IR νmax (Soild) 2961, 2920, 1710, 1600, 1498, 1460, 1394, 1261, 1090, 805, 713 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 8.05-8.01 (m, 2H), 7.66 (d, J = 7.7 Hz, 1H), 7.44 (d, J = 6.4 
Hz, 2H), 7.38-7.34 (m, 1H), 7.16-7.15 (m, 1H), 7.10-7.09 (m, 1H), 7.04-6.98 (m, 2H), 6.65-
6.60 (m, 3H), 6.58-6.54 (m, 3H), 6.42-6.37 (m, 1H), 6.34 (d, J = 12.8 Hz, 1H), 5.91 (dd, J = 
7.8, 1.5 Hz, 1H), 4.81-4.76 (m, 1H), 4.28-4.17 (m,1H), 3.86-3.71 (m, 2H), 3.23-3.09 (m, 5H), 
3.14-3.03 (m, 6H), 2.98-2.95 (m, 3H), 2.89 (d, J = 7.2 Hz, 1H), 2.78-2.73 (m, 2H), 2.54 (s, 
3H), 2.38 (s, 2H), 1.36 (d, J = 16.4 Hz, 6H), 1.17 (d, J = 16.8 Hz, 9H).  
13C NMR (CDCl3, 125 MHz) δ 144.1 (d, JP-C = 48.2 Hz), 142.9, 139.2 (d, JP-C = 33.3 Hz), 139.0, 
136.9 (d, JP-C = 36.8 Hz), 136.7, 136.6, 136.4, 136.1, 135.6 (d, JP-C = 50.9 Hz), 133.0 (d, JP-C = 
35.1 Hz), 132.6, 132.3 (d, JP-C = 40.5 Hz), 132.0, 129.9 (d, JP-C = 46.4 Hz), 129.0 (d, JP-C = 47.3 
Hz), 42.1, 36.6, 36.5 (d, JP-C = 22.8 Hz), 36.2, 35.6, 35.1, 30.0, 34.9, 30.1, 28.3 (d, JP-C = 23.6 
Hz), 21.5 (d, JP-C = 79.7 Hz), 1.0. 
31P NMR (CDCl3, 200 MHz) δ 47.8, 46.7 





2.132 & (RSp,RSP)-tert-butyl([2.2]paracyclophan-4-yl)(p-tolyl)phosphinium 
tetrafluoroborate 2.132 
 
Racemic tert-butyl([2.2]paracyclophan-4-yl)(p-tolyl)phosphine 2.126 (80 mg, 0.214 mmol, 1.0 
eq.), HBF4.OEt2 (0.52 ml, 3.22 mmol, 15.0 eq., 54% solution in Et2O) and CH2Cl2 (7 ml) were 
combined at 0 oC. After 2 hrs, the reaction mixture was warmed to 22 oC and aqueous 
tetrafluoroboric acid (5 ml) was added. The reaction mixture was allowed to stir for more 2 
hrs. The aqueous phase was separated with EtOAc (3 x15 ml), dried (MgSO4) and the solvent 
was removed in vacuo. The crude product 2.132 was obtained as fluffy white powder (55 mg, 
0.12 mmol, 69 % yield). 
mp: 123 °C - 125 °C 
IR νmax (Soild) 2956, 2851, 1598, 1467, 1407, 1317, 1180, 1031, 919, 857, 809, 719 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 8.68 (s, 1H), 8.55 (s, 1H), 8.22-8.18 (m, 2H), 7.78-7.74 (m, 
1H), 7.68 (s, 2H), 7.45-7.44 (m, 1H), 7.40 (d, J = 14.8 Hz, 1H), 7.00 ( d, J = 12.8 Hz, 1H), 
6.87-6.79 (m, 3H), 6.68-6.65 (m, 1H), 6.62-6.60 (m, 2H), 6.55-6.47 (m, 2H), 5.96 (d, J = 7.6 
Hz, 1H), 5.78 (d, J = 7.3 Hz, 1H), 3.92 (t,  J = 11.4 Hz, 1H), 3.53-3.49 (m, 1H), 3.41-3.37 (m, 
1H), 3.30-3.25 (m, 3H), 3.22 (d, J = 10.2 Hz, 2H), 3.17 (d, J = 9.2 Hz, 2H), 3.06-3.00 (m, 4H), 
2.59 (s, 3H), 2.48 (s, 2H), 1.59 (d, J = 18.0 Hz, 6H), 1.31 (d, J = 16.1 Hz, 9H). 
13C NMR (CDCl3, 125 MHz) δ 146.7, 146.5 (d, J = 30.6 Hz), 146.2, 145.6, 141.9, 141.5 (d, J 
= 46.1 Hz), 140.0, 139.6, 139.5, 139.1 (d, J = 60.0 Hz), 138.8, 137.9 (d, J = 45.5 Hz), 137.3 
(d, J = 47.0 Hz), 136.0 (d, J = 32.5 Hz), 134.6 (d, J = 37.0 Hz), 134.4 (d, J = 41.2 Hz), 133.0 
(d, J = 34.1 Hz), 132.8, 132.6 (d, J = 42.7 Hz), 132.2, 131.9, 131.7 (d, J = 50.2 Hz), 131.05 (d, 
J = 51.1 Hz), 35.51, 35.2 (d, J = 21.2 Hz), 35.1, 34.6, 33.5, 33.1, 29.7, 26.1, 25.2, 22.01 (d, J 
= 65.5 Hz). 







To a solution of racemic tert-butyl([2.2]paracyclophan-4-yl)(p-tolyl)phosphine 2.126 (40 mg, 
0.10 mmol, 1.0 eq.) in dry CH2Cl2 (3 ml) was added chloro(dimethyl sulfide)gold(I) (31.57 
mg, 0.10 mmol, 1.0 eq.). The mixture was stirred at room temperature in the absence of light 
under an argon atmosphere. The crude mixture was concentrated after 2 hrs under vacuum. The 
resulting grey solid was dissolved in CH2Cl2 (1 ml) and pentane (10 ml) was added to 
precipitate the desired complex as a white solid, which was isolated by decantation. The solid 
was dissolved in CH2Cl2 (1 ml) and pentane was slowly added to get a biphasic solution. Slow 
crystallisation furnished crystals of the desired complex 2.137 (15 mg, 0.024 mmol, 23% 
yield). 
mp: 223 °C - 224 °C 
IR νmax (Solid) 2958, 2920, 1568, 1446, 1413, 1359, 1258, 1134, 1093, 805, 716 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 8.90 (d, J = 4.1 Hz, 1H,), 8.69-8.65 (m, 1H), 8.00-7.99 (m, 1H), 
7.57-7.53 (m, 1H), 6.82 (d, J = 7.8 Hz, 1H), 6.62 (dd, J = 7.8, 1.9 Hz, 1H), 6.59-6.58 (m, 1H), 
6.54 (dd, J = 7.8, 1.8 Hz, 1H), 6.49 (d, J = 12.1 Hz, 1H), 5.80 (dd, J = 7.8, 1.8 Hz, 1H), 4.89-
4.82 (m, 1H), 3.84-3.75 (m, 1H), 3.22-3.16 (m, 2H), 3.11-3.03 (m, 1H), 2.99-2.90 (m, 2H), 
2.76-2.71 (m, 1H), 1.21 (d, J = 17.4 Hz, 9H). 
13C NMR (CDCl3, 125 MHz) δ 150.3 (d, J = 50.6 Hz), 144.2 (d, J = 49.5 Hz), 139.8 (d, J = 
34.8 Hz), 139.3, 139.1, 137.2 (d, J = 11.3 Hz), 136.8, 136.7 (d, J = 16.7 Hz), 136.58, 136.51 
(d, J = 11.7 Hz), 134.8, 134.6, 133.0, 132.7, 132.4, 132.0, 125.4 (d, J = 8.9 Hz), 124.0, 36.6, 
36.5 (d, J = 31.2 Hz), 36.3, 35.7, 35.0 (d, J = 21.7 Hz), 34.1, 27.4 (d, J = 21.6 Hz), 22.3, 14.0. 
31P NMR (CDCl3, 200 MHz) δ 40.6. 
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8.4. Experimental for Chapter 3 
 
7-Azabicyclo[2.2.1]heptane.hydrochloride salt  3.1061 
 
Trans-4-(tosyloxyl)cyclohexylamine hydrobromide (7.78 g, 22.3 mmol,  1.0 eq.) was dissolved 
in EtOH-H2O (65:35,  277 ml : 71.15 ml) and treated with NaOH (2.40 g, 22.3 mmol, 1.0 eq.). 
The resulting solution was allowed to stir for 24 hours. To the solution, 32% aqueous HCl (15 
ml) was added and solvent was evaporated under reduced pressure. The solid residues were 
treated with 10% NaOH (125 ml) and extracted with Et2O (3 × 120 ml). The combined organic 
layers were dried over MgSO4 and HCl gas (generated from H2SO4 and NaCl) was bubbled 
through the solution. The solvent was evaporated under reduced pressure to get pale yellow 
solid of 7-azabicyclo[2.2.1]heptane.hydrochloride salt 3.106 (2.0 g, 15.0 mmol, 72%). 
1H NMR (DMSO, 500 MHz): δ 8.30 (bs, 1H, NH), 4.75 (t, J = 3.2 Hz, 1H, H-4), 3.11-3.06 (m, 
1H, H-1), 2.02-1.90 (m, 4H, H-6a, H-6b, H-5a, H-5b), 1.89-1.73 (m, 4H, H-3a, H-3b, H-2a, H-
2b). 
Data comparable to that reported in literature.1 
7-(2-Iodobenzyl)-7-azabicyclo[2.2.1]heptane 3.152. 
 
A 25ml RBF charged with 7-azabicyclo[2.2.1]heptane.hydrochloride salt (300 mg, 2.25 mmol, 
1eq.), K2CO3 (736 mg, 2.47 mmol, 1.1eq.), and magnetic stirrer in acetone. To the reaction 
mixture, 2-iodobenzyl bromide (778 mg, 5.6 mmol, 2.5 eq.) was added dropwise. The reaction 
mixture was allowed to stir under reflux for 16 h. The reaction mixture was cooled and filtered 




pressure. Purification of the residues was performed by column chromatography on silica gel 
(EtOAc : hexanes 10:90) to give a colourless oil of 3.186 (496 mg, 1.58 mmol, 47%). 
 
1H NMR (CDCl3, 500 MHz): δ 7.83-7.81 (d, J = 7.8 Hz, 1H, H-13), 7.63 (d, J = 7.6 Hz, 1H, 
H-11), 7.37 (t, J = 7.5 Hz, 2H, H-12), 6.97 (t, J = 7.6 Hz, 1H, H-11), 3.56 (s, 2H, H-8), 3.32 (s, 
2H, H-1, H-4), 1.87 (d, J = 6.9 Hz, 4H, H-6a, H-6b, H-5a, H-5b), 1.37 (d, J = 7.1 Hz, 4H, H-
2a, H-2b, H-3a, H-3b). 
7-((2',5'-Dimethyl-[1,1'-biphenyl]-2-yl)methyl)-7-azabicyclo[2.2.1]heptane 3.153 
 
In a 5 ml Schlenk tube, 7-(2-iodobenzyl)-7-azabicyclo[2.2.1]heptane (30 mg, 0.09 mmol, 1eq.), 
pivalic acid (0.5 mg, 0.019 mmol, 0.5 eq.), caesium carbonate (94 mg, 0.28 mmol, 3 eq.), 
tricyclohexyl phosphine (PCy3) (5.3 mg, 0.01 mmol, 0.2 eq.) and Pd(OAc)2 (2.1 mg, 0.009 
mmol, 0.1 eq.) were loaded accurately with a magnetic stirrer. The vial was purged and 
degassed with argon for three times. The solvent xylene (1 ml, 0.1 M) was transferred in a vial 
via syringe and the screw capped vial was heated at 140 oC for 24 h. The reaction mixture was 
allowed to cooled down at room temperature and diluted with CH2Cl2 and MeOH before 
passing through a pad of Celite. The resulting filtrate was removed under reduced pressure and 
crude product was purified by column chromatography on silica gel (EtOAc : hexanes 10:90) 
to give a pale yellow oil of 3.153 (18 mg, 0.06 mmol, 63%). 
1H NMR (CDCl3, 500 MHz): δ  7.74 (d, J = 7.1 Hz, 1H, H-20), 7.38 (td, J = 7.5, 1.4 Hz, 1H, 
H-11), 7.29-7.26 (m, 1H, H-14), 7.15 (d, J = 7.7 Hz, 1H, H-13), 7.11 (d, J = 7.5 Hz, 1H, H-
12), 7.08 (d, J = 7.7 Hz, 1H, H-18), 6.99 (s, 1H, H-17), 3.31 (dd, J = 14.3, 11.8 Hz, 2H, H-7, 
H-4), 3.16 (s, 2H, H-8a, H-8b), 2.34 (s, 3H, -Me), 2.02 (S, 3H, -Me), 1.65-1.55 (m, 4H, H-6a, 
H-6b, H-5a, H-5b), 1.23-1.17 (m, 4H, H-3a, H-3b, H-2a, H-2b). 
13C NMR (CDCl3, 125 MHz): δ 134.57 (C-19, C-9), 132.77 (C-15, C-10), 130.23 (C-17), 









To a solution of 7-azabicyclo[2.2.1]heptane.hydrochloride salt (800 mg, 6.6 mmol, 1eq.) and 
Et3N (1.69 ml, 13.22 mmol, 2.2 eq.)  in CH2Cl2 was picolinoyl chloride* (932.38 mg, 6.6 mmol, 
1.2 eq.) under argon at 0 °C. The mixture was allowed to reach at room temperature and stirred 
overnight. The crude mixture was concentrated under reduced pressure and purified with 
column chromatography on silica gel (EtOAc : hexanes 30:70) to give a brownish semisolid of 
3.162 (656 mg, 3.24 mmol, 54%). 
*Picolinoyl chloride was freshly prepared by adding a few drops of DMF in a solution of 2-
picolinic acid and oxalyl chloride in CH2Cl2.  
mp: 75 °C - 76 °C 
IR: νmax 3288, 2937, 1646, 1512, 1467, 1261, 1096 cm
-1  
 
1H NMR (CDCl3, 500 MHz): δ 8.58 (d, J = 4.5 Hz, 1H, H-13), 8.21 (d, J = 7.8 Hz, 1H, H-10), 
8.10 (bs, 1H, NH), 7.86 (td, J = 7.6,1.6 Hz, H-11), 7.45 - 7.42 (m, 1H, H-12), 4.59 - 4.57 (m, 
1H, H-4), 4.11- 4.04 (m, 1H, H-1), 2.18 - 2.14 (m, 2H, H-6a, H-6b), 2.06 - 2.00 (m, 2H, H-5a, 
H-5b), 1.95 -1.91 (m, 4H, H-3b, H-3a, H-2b, H-2a). 
13C NMR (CDCl3, 125 MHz): δ 163.4 (C-8), 149.9 (C-9), 148.0 (C-13), 137.3 (C-11), 126.1 









The compound 3.181 was synthesised from the starting materials, anthranilic acid, N-Boc 
pyrrole and isoamyl nitrile following a literature procedure. 
1H NMR (CDCl3, 400 MHz): δ 7.22 (d, J = 5.2, 3.0 Hz, 2H, H-11, H-8), 7.11 (dd, J = 5.2, 3.0 
Hz, 2H, H-10, H-9), 4.56-4.53 (m, 2H, H-4, H-1), 2.61 (bs, 1H, -NH), 2.07-2.04 (m, 2H, H-3a, 
H-3b), 1.29 (m, 2H, H-2a, H-2b). 




The compound 3.185 was synthesised from 2-bromo-2-methylpropanoyl chloride and 2-amino 
pyridine following a literature procedure of amide formation.3  
mp: 67 °C - 69 °C 
IR νmax (Solid) 3172, 2978, 1682, 1597, 1574, 1434, 1303, 1260, 1166, 1003 cm-1.  
1H NMR (CDCl3, 500 MHz): δ 8.9 (bs, 1H, NH), 8.32 (d, J = 6.1 Hz, 1H, ArH-1), 8.19 (d, J = 
9.5 Hz, 1H, ArH-1), 7.74 (td, J = 9.8, 2.2 Hz, 1H, ArH-3), 7.10 (dd, J = 6.1, 1.2 Hz, 1H, ArH-
4), 2.06 (S, 6H, -CH3). 
13C NMR (CDCl3, 125 MHz) δ 170.4 (C-6), 150.9 (C-5), 148.0 (C-7), 138.3 (C-1), 120.2 (C-
2), 113.6 (C-4), 61.1 (C-9), 32.1 (C-7, C-8). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C9H11Br
79N2NaO 243.0133; Found 243.1040; [M 
+ Na]+ Calcd for C9H11Br







In an oven dried pressure tube was charged with 7-benzoazabicyclo[2.2.1]heptane 3.181 (200 
mg, 1.37 mmol, 1.0 eq.), 2-bromo-2-methyl-N-(pyridin-2-yl)propenamide 3.185 (333 mg, 1.37 
mmol, 1.0 eq.), K2CO3 (381 mg, 2.74 mmol, 2.0 eq.), and NaI (103 mg, 0.68 mmol, 0.5 eq.). 
Anhydrous acetonitrile (7 ml, 0.2 M) was added. The tube was equipped with a stir bar, sealed 
with a Teflon-lined screw cap, and heated at 60 °C. The reaction was cooled after 18 h, diluted 
with EtOAc, and filtered through a pad of silica gel, washing with EtAOc. The filtrate was 
concentrated under reduced pressure. Purified of the residues by column chromatography on 
silica gel (AcOH : Et2O : toluene 10 : 20 :70) to give an orange powder of 3.186 (78 mg, 0.25 
mmol, 18%). 
1H NMR (CDCl3, 500 MHz): δ 10.1 (bs, 1H, -NH), 8.34 (d, J = 3.3 Hz, 1H, H-20), 8.28 (d, J 
= 8 Hz, 1H, H-17), 7.72 (t, J = 14.4, 7.1 Hz, 1H, H-18), 7.21 -7.11 (m, 4H, H-11, H-10, H-9, 
H-8), 7.05 (t, J = 11.9, 5.5 Hz, 1H, H-19), 4.47 (s, 2H, H-4, H-1), 2.30 (d, J = 6.2 Hz, 2H, H-
3a, H-3b), 1.31 (d, J = 6.6 Hz, 2H, H-2a, H-2b), 1.00 (S, 6H, CH3-23, CH3-22). 
13C NMR (CDCl3, 125 MHz) δ 176.2 (C-13), 151.6 (C-16), 147.9 (C-20), 145.8 (C-6), 138.21 
(C-5), 126.5 (C-19, C-18), 119.4 (C-11, C-10, C-9, C-8), 61.6 (C-4, C-1), 61.8 (C-12), 27.9 









General procedure for synthesis of 7-benzoazabicyclo[2.2.1]heptane-directing group 
To a solution of 7-benzoazabicyclo[2.2.1]heptane 3.181 and Et3N in CH2Cl2 was added 
acetyl/sulfinyl/phosphinic chloride under argon at 0 °C. The mixture was allowed to reach at 
room temperature and stirred overnight unless mentioned. The crude mixture was concentrated 
under reduced pressure and purified with column chromatography with a solvent system 
described in the respective compound section. 
(±)-7-(Tert-butylsulfinyl)-7-benzoazabicyclo[2.2.1]heptane 3.189 
 
General procedure was followed using 7-benzoazabicyclo[2.2.1]heptane 3.181 (800 mg, 5.51 
mmol, 1eq.), Et3N (0.85 ml, 6.06 mmol, 1.1 eq.), tert-butylsulfinyl chloride (140 mg, 6.06 
mmol, 1.1eq.). The crude mixture was obtained as a pure dark brown solid of 3.189 (870 mg, 
3.59 mmol, 67%).  
mp: 64 °C - 65 °C 
IR (Solid) νmax 2956, 1717, 1476, 1361, 1189, 1013 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.25 - 7.20 (m, 2H, H-11, H-10), 7.15 (dt, J = 8.4, 4.6 Hz, 2H, 
H-9, H-8), 4.83 (t, J = 9.6,4.8 Hz, 2H, H-4, H-1), 2.33 -2.28 (m, 1H, H-3a), 2.22 - 2.16 (m, 1H, 
H-3b), 1.44 - 1.39 (m, 1H, H-2a), 1.33 - 1.28 (m, 1H, H-2b), 1.19 (s, 9H, tBu). 
13C NMR (CDCl3, 125 MHz): δ 145.89 (C-6), 144.2 (C-5), 126.4 (C-10), 126.3 (C-9), 119.1 
(C-11), 118.9 (C-8), 64.3 (C-13), 64.0 (C-3), 57.6 (C-2), 27.7 (C-17), 26.4 (C-16), 22.5 (C-15). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C5H20NOS 250.1266; Found 250.1256; [M + Na]
+ 









General procedure was followed using 7-benzoazabicyclo[2.2.1]heptane 3.181 (200 mg, 1.37 
mmol, 1eq.), Et3N (0.21 ml, 1.50 mmol, 1.1 eq.) p-tolylsulfinyl chloride (287 mg, 1.64 mmol, 
1.2 eq.). The crude mixture was obtained as a pure brown solid of 3.192 (145 mg, 0.51 mmol, 
37%).  
1H NMR (CDCl3, 500 MHz): δ 7.57 (d, J = 8.1 Hz, 2H, H-19, H-15), 7.31 (d, J = 9.5 Hz, 2H, 
H-18, H-16), 7.25 (d, J = 6.7 Hz, 1H, H-8), 7.18 - 7.12 (m, 3H, H-11, H-10, H-9), 4.92 (d, J = 
3.8 Hz, 1H, H-4), 4.71 (d, J = 3.8 Hz, 1H, H-1), 2.44 (s, 3H, -CH3), 2.37 - 2.28 (m, 2H, H-3a, 
H-3b), 1.42 - 1.38 (m, 1H, H-2a), 1.30 - 1.27 (m, 1H, H-2b). 
13C NMR (CDCl3, 125 MHz) δ 145.57 (C-14), 144.84 (C-6), 141.61 (C-5), 141.02 (C-17), 
129.47 (C-19, C-15), 126.40 (d, J = 43.2 Hz, C-18, C-16), 126.08 (C-10, C-9), 118.74 (d, J = 
35.05 Hz, C-11, C-8), 63.60 (C-4), 63.00 (C-1), 28.06 (d, J = 19.25 Hz, C-3, C-2), 21.36 (C-
20). 
HRMS m/z: [M + H]+ Calcd for C17H18NOS 284.1109; Found 284.1099; [M + Na]
+ Calcd for 












General procedure was followed using 7-benzoazabicyclo[2.2.1]heptane 3.181 (500 mg, 3.44 
mmol, 1eq.), Et3N (0.53 ml, 3.79 mmol, 1.1 eq.), pivaloyl chloride (498 mg, 4.95 mmol, 1.2 
eq.). The crude mixture was obtained as a pure brown solid of 3.197 (678 mg, 2.95 mmol, 
87%).  
mp: 125 °C - 128 °C 
IR(Solid) νmax 2977, 2954, 1621, 1588, 1404, 1375, 1258, 1166 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.27 - 7.25 (m, 2H, H-11, H-8), 7.17 -7.16 (dd, J = 5.3, 3.0 Hz, 
2H, H-10, H-9), 5.55 (s, 2H, H-4, H-1), 2.16 (d, J = 7.3 Hz, 2H, H-3a, H-3b), 1.38 (d, J = 6.1 
Hz, 2H, H-2a, H-2b), 1.22 (s, 9H, tBu). 
13C NMR (CDCl3, 125 MHz) δ 174.29 (C-12), 144.81 (C-6), 126.51 (C-11, C-10, C-9, C-8), 
119.2 (C-5), 60.2 (C-13), 38.9 (C-4, C-3, C-2, C-1), 27.6 (C-17, C-16, C-15). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H20NO 230.1545; Found 230.1537; [M + Na]
+ 
Calcd for C15H19NNaO 252.1364; Found 252.1356. 
2,2-Dimethyl-1-(7-benzoazabicyclo[2.2.1]heptane)-1-propanethione 3.198 
 
In a 25ml RBF, 7-benzoazabicyclo[2.2.1]heptane 3.181 (200 mg, 0.87 mmol, 1eq.), 




in toluene. The reaction was set up under reflux overnight. The crude mixture was concentrated 
under reduced pressure and purified with flash chromatography [SiO2, EtOAc: hexanes (4:6)] 
to obtain the title compound 3.198 as greyish powder (190 mg, 0.77 mmol, 89%).  
mp: 122 °C - 124 °C 
IR(Solid) νmax 2960, 2924, 1723, 1593, 1458, 1396, 1260, 1111, 1020 cm
-1.  
1H NMR (CDCl3, 500 MHz): δ 7.36-7.34 (m, 1H, H-11), 7.27 (d, J = 2.1 Hz, 1H, H-8), 7.25-
7.22 (m, 2H, H-10, H-9), 6.52 (d, J = 3.5 Hz, 1H, H-4), 5.80 (d, J = 3.2 Hz, 1H, H-1), 2.30 (m, 
2H, H-3a, H-3b), 1.52 (d, J = 7.7 Hz, 1H, H-2a), 1.44 (d, J = 8.2 Hz, 1H, H-2b), 1.37 (s, 9H, 
tBu). 
13C NMR (CDCl3, 125 MHz) δ 203.4 (C-12), 143.2 (C-6), 142.3 (C-5), 127.3 (C-10), 126.9 
(C-8), 120.3 (C-11), 118.7 (C-9), 66.1 (C-4), 64.6 (C-1), 43.2 (C-13), 30.3 (C-17, C-16, C-15), 
27.9 (C-3), 23.8 (C-2). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H20NS 246.1316; Found 246.1309. 
7-(Diphenylphosphine oxide)-7-benzoazabicyclo[2.2.1]heptane 3.200 
 
General procedure was followed using 7-benzoazabicyclo[2.2.1]heptane 3.181 (400 mg, 2.75 
mmol, 1.0 eq.), Et3N (0.10 ml, 0.42 mmol, 1.1 eq.), diphenylphosphinic chloride (465 mg, 3.30 
mmol, 1.2 eq.). The reaction was allowed to stir for 60 h. The crude mixture was obtained as a 
pure brown solid of 3.200 (68 mg, 0.19 mmol, 59%).  
1H NMR (CDCl3, 500 MHz): δ 7.88-7.84 (m, 4H, H-25, H-21, H-19, H-15), 7.52 - 7.49 (m, 
2H, H-23, H-7), 7.45-7.42 (m, 4H, H-24, H-22, H-18, H-16), 7.19 -7.14 (m, 4H, H-11, H-10, 
H-9, H-8), 4.77 (bs, 2H, H-4, H-1), 2.37 (d, J = 7.6 Hz, 2H, H-3a, H-3b), 1.36 (d, J = 7.2 Hz, 




13C NMR (CDCl3, 125 MHz) δ 145.88 (d, J = 7.2 Hz, C-6, C-5), 132.35 (d, J = 36.7 Hz, C-25, 
C21, C-19, C-15), 131.71 (d, J = 9.7 Hz, C-23, C-17), 128.47 (d, J = 48.7 Hz, C-24, C-22, C-
18, C-16); 126.21 (C-11, C-8), 118.76 (C-10, C-9), 61.6 (C-4, C-1), 28.48 (C-3, C-2). 
31P NMR (CDCl3, 200 MHz) δ 20.07. 
7-(Diphenylphosphine sulfide)-7-benzoazabicyclo[2.2.1]heptane 3.201 
 
In a 25ml RBF, 7-benzoazabicyclo[2.2.1]heptane 3.181 (230 mg, 0.67 mmol, 1.0 eq.), 
Lawesson’s reagent (404 mg, 0.73 mmol, 1.1 eq.) were loaded accurately with a magnetic 
stirrer in toluene. The reaction was set up under reflux overnight. The crude mixture was 
concentrated under reduced pressure and purified with flash chromatography [SiO2, EtOAc: 
hexanes (4:6)] to obtain the title compound 3.201 as greyish powder (133 mg, 0.36 mmol, 
55%).  
1H NMR (CDCl3, 500 MHz): δ 7.99 - 7.95 (m, 4H, H-25, H-21, H-19, H-15), 7.50 -7.47 (m, 
2H, H-23, H-7), 7.44 - 7.40 (m, 4H, H-24, H-22, H-18, H-16), 7.13 (br, 4H, H-11, H-10, H-9, 
H-8), 4.73 (m, 2H, H-4, H-1), 2.47 (d, J = 5.15 Hz, 2H, H-3a, H-3b), 1.35 (m, 2H, H-2a, H-
2b). 
13C NMR (CDCl3, 125 MHz) δ 145.84 (d, J = 29.1 Hz, C-6, C-5), 134.91 (C-20), 133.32 (C-
14), 131.81 (d, J = 43.4 Hz, C-25, C-21, C-19, C-15), 131.52 (C-23, C-7), 128.37 (d, J = 51.2 
Hz, C-24, C-22, C-18, C-16), 126.18 (C-11, C-8), 118.81 (C-10, C-9), 62.83 (C-4, C-1), 27.89 
(d, J = 20.3 Hz, C-3, C-2). 








To a solution of 7-benzoazabicyclo[2.2.1]heptane 3.181 (250 mg, 1.72 mmol, 1.0 eq.) in THF 
(8.6 ml, 0.2 M) was added tert-butyl nitrile (0.37 ml, 2.58 mmol, 1.5 eq.) under argon. The 
reaction mixture was heated under reflux overnight. The excess of the tert-butyl nitrile and 
solvent were removed under reduced pressure. The title compound 7-(N-nitroso)-7-
benzoazabicyclo[2.2.1]heptane 3.215 was obtained as a residual yellowish oil. (200 mg, 1.15 
mmol, 67%) (The compound 3.215 is volatile under reduce pressure) 
1H NMR (CDCl3, 400 MHz): δ 7.37 (d, J = 6.2 Hz, 1H, H-11), 7.29-7.27 (m, 1H, H-10), 7.25-
7.22 (m, 2H, H-9, H-8), 5.94 (t, J = 6.3 Hz, 2H, H-4, H-1), 2.29-2.21 (m, 1H, H-3a), 2.09-2.01 
(m, 1H, H-3b), 1.61 (td, J = 9.2, 3.8 Hz, 1H, H-2a), 1.39-1.35 (m, 1H, H-2b). 
Data comparable to that reported in literature.2  
7-(Picolinoylhydrazine)-7-benzoazabicyclo[2.2.1]heptane 3.217 & 7-(Picolinoylhydrazine)-7-
benzoazabicyclo[2.2.1]heptane 3.211 
                   
General procedure was followed using a mixture of 7-benzoazabicyclo[2.2.1]heptane 3.198 
and 7-(amino)-7-benzoazabicyclo[2.2.1]heptane 3.216 (90 mg, 0.55 mmol, 1eq.)*, Et3N (0.093 
ml, 0.66 mmol, 1.2 eq.), and picolinoyl chloride** (75.65 mg, 0.60 mmol, 1.1 eq.). The crude 




the brownish semisolid of 3.217 (23 mg, 0.08 mmol, 16%) and yellow semisolid of 3.211 (16 
mg, 0.06 mmol, 10%). 
* Calculated according to 1.0 eq. of 7-(amino)-7-benzoazabicyclo[2.2.1]heptane 3.216 
** Picolinoyl chloride was freshly prepared by adding a few drops of DMF in a solution of 2-   
picolinic acid and oxalyl chloride in CH2Cl2.  
3.217 
1H NMR (CDCl3, 400 MHz): δ 8.30 (d, J = 4.4 Hz, 1H, H-16) 8.16 (d, J = 7.8 Hz, 1H, H-8), 
7.78 (td, J = 7.6, 1.5 Hz, 1H, H-17), 7.39-7.36 (m, 2H, H-11, H-8), 7.32-7.28 (m, 3H, H-10, H-
9, NH), 4.51 (s, 2H, H-4, H-1), 2.50-2.38 (m, 2H, H-3a, H-3b), 1.28 (q, J = 4.1 Hz, 2H, H-1a, 
H-1b). 
3.211 
1H NMR (CDCl3, 400 MHz): δ 7.37 (d, J = 4.1 Hz, 1H, H-18), 7.90 (d, J = 7.8 Hz, 1H, H-15), 
7.80 (td, J = 7.6, 1.7 Hz, 1H, H-17), 7.40 (m, 1H, H-16), 7.34 (d, J = 7.2 Hz, 1H, H-11), 7.23-
7.15 (m, 3H, H-10, H-9, H-8), 6.17 (d, J = 3.9 Hz, 1H, H-4), 5.79 (d, J = 4.0 Hz, 1H, H-1), 
2.35-2.19 (m, 2H, H-3a, H-3b), 1.45 (d, J = 10.7 Hz, 2H, H-2a, H-2b).  
4-(2-Picolinoylhydrazineylidene)cyclohexyl acetate 3.223 
 
A 25 ml RBF was charged with 4-oxocyclohexyl acetate 3.221 (1000 mg, 6.40 mmol, 1.0 eq.), 
picolinohydrazide 3.222 (878 mg, 6.40 mmol, 1.0 eq.), CeCl3.7H2O (238 mg, 0.64 mmol, 0.1 
eq.) and ethanol (12.81 ml, 0.5 M) and a stir bar. The reaction mixture was stirred overnight. 
The reaction mixture was filtered through a pad of silica gel, washing with EtAOc. The filtrate 
was concentrated under reduced pressure. Purification of the residue was performed by flash 
chromatography on neutral alumina (MeOH:CH2Cl2 10:90) to give a greyish powder of 4-(2-




1H NMR (CDCl3, 400 MHz): δ 8.54 (d, J = 4.6 Hz, 1H, H-17), 8.28 (d, J = 7.8 Hz, 1H, H-14), 
7.89 (td, J = 7.6, 2.0 Hz, 1H, H-16), 7.47 (dd, J = 7.51, 6.7 Hz, 1H, H-15), 5.09 - 5.04 (m, 1H, 
H-3), 2.75 (ddt, J = 14.0, 8.3, 5.2 Hz, 2H, H-5a, H-5b), 2.56 (ddt, J = 13.2, 8.0, 5.1 Hz, 2H, H-
1a, H-1b), 2.07 (s, 3H, -CH3), 2.03-1.84 (m, 4H, H-4a, H-4b, H-2a, H-2b). 
4-(2-Picolinoylhydrazineyl)cyclohexyl acetate 3.224 
  
A 50 ml RBF was charged with 4-(2-picolinoylhydrazineylidene)cyclohexyl acetate 3.223 (458 
mg, 1.66 mmol, 1.0 eq.), sodium cynoborohydride (878 mg, 1.12 mmol, 0.68 eq.) and a stir bar 
under argon. Methanolic HCl (5M, pH = 3) (27.5, 0.06M) was added dropwise over 15 min.- 
The reaction mixture carefully quenched with saturated solution of NaHCO3 at 0 °C. Methanol 
evaporated under reduced pressure. The aqueous was extracted with EtOAc (3 × 20 ml), 
washed with brine and dried over MgSO4. The filtrate was concentrated under reduced 
pressure. Purification of the residue was performed by flash chromatography on silica gel 
(EtOAc : hexanes 50:50, Et3N few drops) to give a brownish powder of 4-(2-
picolinoylhydrazineyl)cyclohexyl acetate 3.224 (241 mg, 0.87 mmol, 52%). 
1H NMR (CDCl3, 500 MHz): δ 9.22 (bs, 1H, -NH-9), 8.57 (d, J = 3.7 Hz, 1H, H-17), 8.18 (d, 
J = 7.7 Hz, 1H, H-14), 7.89 (t, J = 7.7 Hz, 1H, H-16), 7.47 (t, J = 6.0 Hz, 1H, H-15), 4.9 (bs, 
1H, -NH8), 4.75 - 4.74 (m, 1H, H-3), 3.06-2.97 (m, 1H, H-6), 2.07 (s, 3H, -CH3), 1.97 - 1.77 







*Repetition of the same numbers in the below 13C NMR is indicating cis and trans isomers of 
3.224 
13C NMR (CDCl3, 125 MHz)* δ 170.60 (C-18), 163.58 (C-10), 163.52 (C-10), 149.16 (C-12), 
149.11 (C-12), 148.33 (C-17), 148.32 (C-17), 137.37 (C-14, C-14), 126.46 (C-16), 126.43 (C-
16), 122.24 (C-15, C-15), 72.40 (C-3), 69.64 (C-3), 57.83 (C-6), 57.26 (C-6), 29.30 (C-4,C-4), 
28.69 (C-2, C-2), 27.83 (C-5, C-5), 26.09 (C-1, C-1), 24.40 (-CH3), 21.63 (-CH3). 
N-3-(4-Methoxyphenyl)cyclohexyl)picolinamide 3.240 
 
A Schlenk tube was charged with N-picolinoycyclohexylamine 3.234  (40 mg, 0.2 mmol, 1.0 
eq.), 4-iodoanisole 3.187 (94 mg, 0.4 mmol, 1.0 eq.), Ag2CO3 (83 mg, 0.3 mmol, 1.5 eq.), and 
Pd(OAc)2 (9 mg, 0.04 mmol, 0.2 eq.). The tube was covered with aluminium foil, then purged, 
and degassed with argon for three times. The solvent tert-amyl-OH (1 ml, 0.2M) was 
transferred in a tube via syringe and the screw capped tube was heated at 110 oC for 48 h under 
dark. The reaction mixture was diluted with CH2Cl2 and filtered through a pad of silica gel, 
washing with CH2Cl2 and MeOH. The filtrate was concentrated under reduced pressure. 
Purification of the residue was performed by flash chromatography on silica gel (EtOAc : 
hexanes 30 : 70) to give a pale brown solid of N-3-(4-methoxyphenyl)cyclohexyl)picolinamide 
3.240 (37 mg, 0.12 mmol, 60%). 
1H NMR (CDCl3, 400 MHz): δ 8.54 (d, J = 4.6 Hz, 1H, H-14), 8.22 (d, J = 7.8 Hz, 1H, H-11), 
7.98 (bs, 1H, -NH), 7.86 (td, J = 7.6, 1.5 Hz, 1H, H-13), 7.43 (dd, J = 7.5, 4.7 Hz, 1H, H-12), 
7.15 (d, J = 8.7 Hz, 2H, H-21, H-17), 6.85 (d, J = 10.8 Hz, 2H, H-20, H-18), 4.17 (dtt, J = 19.6, 
6.8, 3.9 Hz, 1H, H-1ax), 3.79 (s, 3H, -OMe), 2.74 (ddt, J = 15.4, 4.0 Hz, 1H, H-1ax), 2.28 (d, 
J = 12.2 Hz, 1H, H-2eq), 2.17 (d, J = 12.3 Hz, 1H, H-5eq), 1.98-1.89 (m, 2H, H-5eq, H-4eq), 
1.65 (qt, J = 16.6, 3.4 Hz, 1H, H-5ax), 1.48-1.26 (m, 3H, H-2ax, H-4ax, H-6ax). 
13C NMR (CDCl3, 125 MHz) δ 163.28 (C-8), 157.89 (C-19), 150.11 (C-9), 147.89 (C-14), 




20, C-18), 55.25 (C-22 -OMe), 48.79 (C-1), 42.30 (C-2), 41.50 (C-3), 33.50 (C-4), 32.82 (C-
6), 25.21 (C-5). 
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8.5. Experimental for Chapter 4 
 
General procedures for the synthesis of oxazoline 
Method I 
A solution of amino alcohol (1.0 eq.), triethyl orthoformate (1.5 eq.), and catalytic glacial acetic 
acid (10 mol%) in dry. DCE (dried over P2O5) was heated to reflux overnight under argon. The 
solution was allowed to cool down and volatiles were removed under reduced pressure. The 
residues were purified either Kugelrohr distillation or flash chromatography as specified in the 
respective compound procedure. 
Method II 
A solution of amino alcohol (1.0 eq.), DMF-DMA (1.0 eq.), in dry. CH2Cl2 (dried over CaH) 
was heated to reflux for 6 hrs under argon. The residues were purified either Kugelrohr 
distillation or flash chromatography as specified in the respective compound procedure. 
(4S)-4-benzyl-oxazoline 4.101  
 
General method A was used to synthesise (4S)-4.10 by taking (S)-phenylalaninol (3.0 g, 29.09 
mmol, 1.0 eq.), triethyl orthoformate (6.4 g, 43.64 mmol, 1.0 eq.), and glacial acetic acid (0.17 
ml, 2.90 mmol, 0.1 eq.). 
Purification: Kugelrohr distillation at 55 °C, 5 mTorr to obtain a colourless liquid of 4.10 (1.8 
g, 11.18 mmol, 56% yield). 
1H NMR (CDCl3, 400 MHz): δ 7.33-7.21 (5H, m), 6.83 (1H, d, J = 1.8 Hz), 4.43 (1H, ddd, J = 
15.5, 7.8, 1.8 Hz), 4.19 (1H, t, J = 9.2, 8.5 Hz), 3.95 (1H, dd, J = 8.3, 7.5 Hz), 3.12 (1H, dd, J 
= 13.8, 5.8 Hz), 2.71 (1H, dd, J = 13.9, 8.3 Hz). 







General procedure A: Coupling of (4S)-4-benzyl-oxazoline with 
bromo[2.2]paracyclophane  
 
A 4 ml scintillation vial was charged with bromo[2.2]paracyclophane (1.0 eq.), (4S)-4-benzyl-
oxazoline 4.10 (1.1 eq.), LiOtBu (2.5 eq.), di-tert-butyl SPO [(tBu)2P(O)H] 4.15 (0.1 eq.), and 
Pd(OAc)2 (0.05 eq.). The vial was purged and degassed with argon three times. The degassed 
DMA (0.25 M) was transferred by syringe and the screw-capped vial was heated at 100 oC 
until the time indicated in the respective compound section. The reaction mixture was cooled 
down at room temperature and diluted with CH2Cl2 and MeOH before passing through a pad 
of Celite©. The resulting filtrate was removed under reduced pressure and the crude product 
was purified by flash chromatography with a solvent system described in respective compound 
section. 
 
General procedure B: Bis-coupling of (4S)-4-benzyl-oxazoline with 
dibromo[2.2]paracyclophane 
 
A 4 ml scintillation vial was charged with dibromo[2.2]paracyclophane (1.0 eq.), (4S)-4-
benzyl-oxazoline 4.10 (2.2 eq.), LiOtBu (5 eq.), di-tert-butyl SPO [(tBu)2P(O)H] 4.15 (0.2 eq.), 
and Pd(OAc)2 (0.1 eq.). The vial was purged and degassed with argon three times. The 
degassed DMA (0.25 M) was transferred by syringe and the screw-capped vial was heated at 
100 oC until the time indicated in the respective compound section. The reaction mixture was 




a pad of Celite©. The resulting filtrate was removed under reduced pressure and the crude 
product was purified by flash chromatography with a solvent system described in the respective 
compound section. 
General procedure C: Mono-coupling of (4S)-4-benzyl-oxazoline with 
dibromo[2.2]paracyclophane 
 
A 4 ml scintillation vial was charged with dibromo[2.2]paracyclophane (1.0 eq.), (4S)-4-
benzyl-oxazoline 4.10 (1.1 eq.), LiOtBu (2.5 eq.), di-tert-butyl SPO [(tBu)2P(O)H] 4.15 (0.1 
eq.), and Pd(OAc)2 (0.05 eq.). The vial was purged and degassed with argon three times. The 
degassed DMA (0.25 M) was transferred by syringe and the screw-capped vial was heated at 
100 oC until the time indicated in the respective compound section. The reaction mixture was 
cooled down at room temperature and diluted with CH2Cl2 and MeOH before passing through 
a pad of Celite©. The resulting filtrate was removed under reduced pressure and the crude 
product was purified by flash chromatography with a solvent system described in the respective 
compound section. 
Repetitions of the same numbers in the section below is assigning 1H/13C NMR peaks of a 















General procedure A was followed using 4-bromo[2.2]paracyclophane 4.9 (70 mg, 0.24 mmol, 
1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (43 mg, 0.27 mmol, 1.1 eq.), LiOtBu (49 mg, 0.61 mmol, 
2.5 eq.), (tBu)2P(O)H (4 mg, 0.025 mmol, 0.1 eq.), Pd(OAc)2 (4 mg, 0.012 mmol, 0.05 eq.), 
DMA (0.98 ml) for 28 h.  
Purification: Flash chromatography [SiO2, EtOAc : hexanes (30:70)] to obtain the title 
compound 4.11 as pinkish semisolid (74 mg, 0.20 mmol, 82% yield). 
 
Rf : 0.6 
IR: νmax 2925, 2852, 2121, 1896, 1712, 1634, 1497 cm
-1.  
1H NMR (MeOD4, 500 MHz): δ 7.35-7.34 (m, 8H, H-28, H-28, H-27, H-27, H-25, H-25, H-
24, H-24), 7.27-7.24 (m, 2H, H-26, H-26), 7.01 (d, J = 19.4 Hz, 2H, H-5, H-5), 6.65-6.63 (m, 
1H, H-8, H-8), 6.57-6.50 (m, 3H, H-7, H-7, H-13, H-13, H-12, H-12), 6.48-6.46 (m, 1H, H-16, 
H-16), 6.42 (s, 1H, H-15, H-15), 4.66-4.58 (m, 1H, H-20, H-20), 4.45 (q, J = 17.7, 8.7 Hz, 2H, 
H-19a, H-19a), 4.28-4.22 (m, 2H, H-19b, H-19b), 4.04-3.89 (m, 2H- H-22a, H-22a), 3.19-2.82 
(m, 18H, H-22b, H-22b, H-2a, H-2a, H-2b,  H-2b, H-9a, H-9a, H-9b, H-9b, H-1a, H-1a, H-1b, 
H-1b, H-10a, H-10a, H-10b, H-10b).   
13C NMR (MeOD4, 125 MHz): δ 165.93 (C-17), 165.51  (C-17), 140.87 (C-14), 140.68 (C-14), 
139.75 (C-11, C-11), 139.48 (C-3, C-3), 139.27 (C-23, C-23), 137.99 (C-4), 137.59 (C-4), 
135.81 (C-6, C-6), 135.23 (C-7, C-7), 133.91 (C-15, C-15), 132.73 (C-16, C-16), 132.50 (C-
13, C-13), 132.06 (C-5, C-5), 131.18 (C-27, C-27), 129.34 (C-25, C-25), 129.19 (C-28, C-28), 
128.20 (C-8, C-8, C-7, C-7), 127.80 (C-24, C-24), 126.24 (C-26, C-26), 71.2 (C-20, C-20), 
61.17 (C-19), 66.85 (C-19), 41.30 (C-22), 40.84 (C-22), 35.27 (C-2, C-2), 35.12 (C-9, C-9), 
34.80 (C-1, C-1), 34.57 (C-10, C-10).   






General procedure B was followed using 4,16-dibromo[2.2]paracyclophane 4.18  (50 mg, 0.13 
mmol, 1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (49 mg, 0.30 mmol, 2.2 eq.), LiOtBu (55 mg, 
0.68 mmol, 5 eq.), (tBu)2P(O)H (4 mg, 0.027 mmol, 0.2 eq.), Pd(OAc)2 (4 mg, 0.013 mmol, 
0.1 eq.), DMA (0.55 ml) for 48 h. 
Purification: Flash chromatography [SiO2, EtOAc: hexanes (30:70)] to obtain the title 
compound 4.19 as a pale yellowish semisolid (58 mg, 0.11 mmol, 81% yield). 
 
Rf : 0.6 
IR: νmax 3018, 2988, 2900, 1393 cm
-1. 
 
1H NMR (CDCl3, 500 MHz): δ 7.40-7.27 (m, 8H, H-40, H-39, H-36, H-37, H-28, H-27, H-24, 
H-25), 7.30-7.27 (m, 2H, H-38, H-26), 7.11 (d, J = 11.6 Hz, 2H, H-15, H-5), 6.66-6.63 (m, 2H, 
H-12, H-8), 6.56 (t, J = 7.6 Hz, 2H, H-13, H-7), 4.72-4.63 (m, 2H, H-32, H-20), 4.44 (dt, J = 
22.7, 8.7 Hz, 2H, H-10a, H-2a), 4.26-4.09 (m, 4H, H-31a, H-31b, H-19a, H-19b), 3.35 (quint,  
J = 13.5, 5.5 Hz, 2H, H-34a, H-22a), 3.13-3.03 (m, 4H, H-9a, H-9b, H-1a, H-1b), 2.96-2.90 
(m, 2H, H-10b, H-2b), 2.87 (m, 2H, H-34b, H-22b). 
13C NMR (CDCl3, 125 MHz): δ 164.40 (C-20), 164.12 (C-16), 140.92 (C-11), 140.66 (C-3), 
139.81 (C-35), 139.68 (C-23), 138.18 (C-16), 138.14 (C-4), 135.14 (C-14), 135.06 (C-6), 
134.21 (C-8), 134.14 (C-5), 135.14 (C-14), 135.06 (C-6), 134.21 (C-8), 134.14 (C-5), 133.37 
(C-12), 133.25 (C-15), 129.40 (C-37, C-25), 129.36 (C-39, C-27), 128.63 (C-36, C-24), 128.58 
(C-40, C-28), 128.50 (C-13), 128.31 (C-7), 126.55 (C-38, C-26), 71.85 (C-32), 70.92 (C-20), 
68.20 (C-31), 66.16 (C-19), 42.05 (C-34), 41.92 (C-22), 34.94 (C-9, C-1), 34.42 (C-2), 34.32 
(C-10). 







General procedure C was followed using (±)-4,12-dibromo-[2.2]paracyclophane 4.21 (50 mg, 
0.14 mmol, 1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (24 mg, 0.15 mmol, 1.1 eq.), LiOtBu (27 
mg, 0.34 mmol, 2.5 eq.), (tBu)2P(O)H (2 mg, 0.013 mmol, 0.1 eq.), Pd(OAc)2 (2 mg, 0.006 
mmol, 0.05 eq.), DMA (0.55 ml) for 24 h. Purification: Flash chromatography [SiO2, EtOAc : 
hexanes (30:70)] to obtain the title compound 4.22 as a white semisolid (19 mg, 0.042 mmol, 
31% yield). Rf : 0.5, IR: νmax 3675, 2989, 2900, 1405, 1393 cm
-1. 
 
1H NMR (CDCl3, 500 MHz): δ 7.70 (d, J = 8.5 Hz, 2H, H-13, H-13), 7.40-7.35 (m, 8H, H-28, 
H-28, H-24, H-24, H-27, H-27, H-25, H-25), 7.31-7.26 (m, 2H, H-26, H-26), 6.66-6.58 (m, 
8H, H-16, H-16, H-15, H-15, H-8, H-8, H-7, H-7), 6.52 (d, J = 7.7 Hz, 2H, H-5, H-5), 4.70-
4.60 (m, 2H, H-20, H-20), 4.40 (t, J = 8.6 Hz, 1H, H-22a), 4.34 (t, J = 8.6 Hz, 1H, H-22b), 
4.28-4.12 (m, 4H, H-19a, H-19a, H-19b, H-19b), 3.51 (t, J = 10.2 Hz, 2H, H-22a, H-22b), 3.37 
(dd, J = 13.8, 5.6 Hz, 1H, H-10a), 3.30 (dd, J = 13.7, 5.4 Hz, 1H, H-10b), 3.24-3.19 (m, 2H, 
H-10a, H-10b), 3.12-2.78 (m, 12H, 9a, 9b, 1a, 1b, 2a, 2b).       
13C NMR (CDCl3, 125 MHz): δ 163.92 (C-17), 163.63 (C-17), 142.16 (C-6), 142.03 (C-6), 
140.73 (C-11), 140.57 (C-11), 139.25 (C-23), 139.20 (C-23),138.86 (C-3), 138.82 (C-3), 
138.39 (C-12), 138.32 (C-12), 135.67 (C-16, C-16, C-15, C-15), 135.16 (C-14), 135.11 (C-14), 
134.97 (C-5), 134.90 (C-5), 131.36 (C-27), 131.25 (C-25), 130.44 (C-25), 130.19 (C-25), 
129.40 (C-28, C-28), 129.30 (C-24, C-24), 128.61 (C-8, C-8), 128.54 (C-7, C-7), 128.06 (C-
26), 127.97 (C-26), 126.68 (C-13), 126.63 (C-13), 126.49 (C-4), 126.45 (C-4), 71.05 (C-20), 
70.90 (C-20), 65.51 (C-19), 68.29 (C-19), 42.22 (C-22), 42.03 (C-22), 36.06 (C-10), 35.85 (C-
10), 35.79 (C-9), 35.69 (C-9), 33.93 (C-1), 33.68 (C-1), 32.66 (C-2), 32.60 (C-2). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C26H25Br
79NO 446.1114; Found 446.1111; 
C26H25Br






General procedure B was followed using (±)-4,16-dibromo-[2.2]paracyclophane 4.21 (60 mg, 
0.16 mmol, 1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (58 mg, 0.36 mmol, 2.2 eq.), LiOtBu (66 
mg, 0.82 mmol, 5 eq.), (tBu)2P(O)H (5 mg, 0.032 mmol, 0.2 eq.), Pd(OAc)2 (4 mg, 0.016 mmol, 
0.1 eq.), DMA (0.66 ml) for 12 hrs. Purification: Flash chromatography [SiO2, EtOAc:hexanes 
(0-5 to 5:20, gradient elution)] to obtain the title compound 4.23 (70% yield) as separate 
diastereomer, (Sp,S)-4.23, pale yellowish semisolid (30 mg, 0.057 mmol, 34% yield) and 
(Rp,S)-4.23, pale yellowish semisolid (31 mg, 0.068 mmol, 36% yield). 
Rf : 0.6  
[α]D
22 : -61.70 (c=0.47, CHCl3) 
IR: νmax 3627, 2955, 2919, 1639, 1601, 1590, 1452 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.36-7.30 (m, 8H, H-24, H-25, H-28, H-27, H-36, H-37, H-40, 
H-39), 7.28-7.25 (m, 2H, H-26, H-38), 7.17 (s, 2H, H-5, H-13), 6.69 (d, J = 7.6 Hz, 2H, H-8, 
H-15), 6.60 (d, J = 7.7 Hz, 2H, H-7, H-16), 4.71-4.65 (m, 2H, H-20, H-32), 4.33-4.26 (m, 4H, 
H-19a, H-19b, H-31a, H-31b), 4.08-4.05 (t, J = 7.5 Hz, 2H, H-2a, H-9a), 3.29 (dd, J = 13.7, 
4.8 Hz, 2H, H-1a, H-10a), 3.18-3.15 (m, 4H, H-22a, H-22b, H-34a, H-34b), 2.88-2.82 (m, 2H, 
H-2b, H-9b), 2.73-2.68 (dd, J = 13.4, 9.4 Hz, 2H, H-1b, H-10b).      
13C NMR (CDCl3, 125 MHz): δ 163.69 (C-29, C-17), 141.02 (C-35, C-23), 140.10 (C-11, C-
3), 138.44 (C-12, C-4), 135.75 (C-14, C-6), 134.87 (C-27, C-25), 132.57 (C-39, C-37), 129.25 
(C-40, C-36, C-28, C-24), 128.55 (C-16, C-13, C-8, C-5), 127.98 (C-15, C-7), 126.43 (C-38, 
C-26), 70.73 (C-32, C-20), 68.43 (C-31, C-19), 41.97 (C-34, C-22), 36.04 (C-9, C-1), 34.02 
(C-11, C-2). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd C36H34N2O2 527.2693 for; Found 527.2690. 






Rf : 0.5  
[α]D
24 : +23.61 (c=0.72, CHCl3)  
IR: νmax 3674, 2925, 1634, 1590, 1495, 1352 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.39-7.38 (m, 8H, H-24, H-25, H-28, H-27, H-36, H-37, H-40, 
H-39), 7.32-7.29 (m, 2H, H-26, H-38), 7.20 (s, 2H, H-5, H-13), 6.68 (d, J = 7.7 Hz, 2H, H-8, 
H-15), 6.59 (d, J = 7.8 Hz, 2H, H-7, H-16), 4.67-4.61 (m, 2H, H-20, H-32), 4.35-4.30 (m, 4H, 
H-19a, H-19b, H-31a, H-31b), 4.11 (t, J = 7.7 Hz, 2H, H-2a, H-9a), 3.41 (dd, J = 13.8, 5.9 Hz, 
2H, H-1a, H-10a), 3.26-3.20 (m, 2H, H-22a, H-34a), 3.16 (t, J = 10.5 Hz, 2H, H-2b, H-9b), 
2.93 (dd, J = 13.8, 8.5 Hz, 2H, H-1b, H-10b), 2.87-2.83 (m, 2H, H-22b, H-34b) 
 13C NMR (CDCl3, 125 MHz): δ 163.51 (C-29, C-17), 141.10 (C-35, C-23), 140.14 (C-11, C-
3), 138.64 (C-12, C-4), 135.95 (C-14, C-6), 135.00 (C-27, C-25), 132.11 (C-39, C-37), 129.28 
(C-40, C-36, C-28, C-24), 128.65 (C-16, C-13, C-8, C-5), 128.00 (C-15, C-7), 126.50 (C-38, 
C-26), 70.71 (C-32, C-20), 68.74 (C-31, C-19), 42.27 (C-34, C-22), 35.66 (C-9, C-1), 33.72 
(C-11, C-2). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd C36H34N2O2 527.2693 for; Found 527.2690. 












General procedure A was followed using (±)-4-bromo-13-amino[2.2]paracyclophane 4.25 (58 
mg, 0.19 mmol, 1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (34 mg, 0.21 mmol, 1.1 eq.), LiOtBu 
(39 mg, 0.48 mmol, 2.5 eq.), (tBu)2P(O)H (3 mg, 0.019 mmol, 0.1 eq.), Pd(OAc)2 (2 mg, 0.009 
mmol, 0.05 eq.), DMA (0.77 ml) for 24 h. 
Purification: Flash chromatography [SiO2, Et3N:EtOAc:hexanes (2:14:86)] to obtain the title 
compound 4.26 (74% yield) as a separate diastereomer, 4.26dia1, brownish semisolid (13 mg, 
0.033 mmol, 18% yield), mixture of diastereomers (28 mg, 0.073 mmol, 38% yield), and a  
separate diastereomer 4.23dia2, brownish semisolid (13 mg, 0.033 mmol, 18% yield). 
 
Rf : 0.4 (dia.1) 
1H NMR (CDCl3, 500 MHz): δ 7.37-7.34 (m, 2H, H-28, H-27), 7.31-7.26 (m, 3H, H-26, H-25, 
H-24), 7.16 (s, 1H, H-5), 6.64-6.62 (d, J = 10.0 Hz, 1H, H-8), 6.44 (d, J = 7.7 Hz, 1H, H-7), 
6.38 (d, J = 7.6 Hz, 1H, H-16), 6.20 (d, J = 8.1 Hz, 1H, H-15), 5.49 (s, 1H, H-16), 4.63-4.57 
(m, 1H, H-20), 4.33-4.27 (m, 2H, H-22a, H-22b), 4.13 (t, J = 8.1 Hz, 1H, H-19a), 3.34 (dd,  J 
= 13.7, 4.4 Hz, 1H, H-19b), 3.21-3.09 (m, 2H, H-9a, H-9b), 3.07-3.00 (m, 2H, H-10a, H-10b), 
2.94-2.91 (m, 2H, H-2a, H-2b), 2.79-2.72 (m, 2H, H-1a, H-1b). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd C26H26N2O 383.2118 for; Found 383.2114. 
 










General procedure A was followed using (±)-4-bromo-(piperidin-1-yl)-[2.2]paracyclophane 
4.29 (36 mg, 0.097 mmol, 1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (17 mg, 0.017 mmol, 1.1 eq.), 
LiOtBu (20 mg, 0.24 mmol, 2.5 eq.), (tBu)2P(O)H (2 mg, 0.009 mmol, 0.1 eq.), Pd(OAc)2 (1 
mg, 0.004 mmol, 0.05 eq.), DMA (0.39 ml) for 24 h. 
Purification: Preparative TLC [SiO2, Et3N:EtOAc:hexanes (2:09:89)] to obtain the title 
compound 4.29 (83% yield) as a separate diastereomer, 4.29dia1, brownish semisolid (17 mg, 
0.037 mmol, 29% yield), mixture of diastereomers (14 mg, 0.031 mmol, 31% yield), and a 
separate diastereomer 4.23dia2, brownish semisolid (11 mg, 0.024 mmol, 24% yield). 
Rf : 0.3 (dia.2)  
[α]D
20 : -77.78 (c=0.90, CHCl3)  
IR: νmax 3745, 3020, 2938, 2400, 1312 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.41-7.28 (m, 5H, H-28, H-27, H-26, H-25, H-24), 7.10 (s, 1H, 
H-5), 6.62 (d, J = 7.7 Hz, 1H, H-8), 6.42 (d, J = 7.7 Hz, 1H, H-7), 6.35 (d, J = 7.6 Hz, 1H, H-
16), 6.17 (d, J = 7.7 Hz, 1H, H-15), 5.42 (s, 1H, H-12), 4.67 (m, 1H, H-20a), 4.40 (t, J = 8.6 
Hz, 1H, H-22a), 4.34-4.29 (m, 1H, H-20b), 4.20 (t, J = 7.8 Hz, 1H, H-22b), 3.18 (dd, J = 13.8, 
4.5 Hz, 1H, H-20), 3.11-2.88 (m, 6H, H-9a, H-9b, H-10a, H-10b, H-2a, H-2b), 3.04-2.96 (bs, 
2H, -NH2), 2.75-2.69 (m, 2H, H-1a, H-1b).  
13C NMR (CDCl3, 125 MHz): δ 165.22 (C-17), 146.36 (C-13), 140.55 (C-3), 140.13 (C-23), 
138.33 (C-11), 137.90 (C-4), 136.00 (C-6), 134.84 (C-26), 134.28 (C-7), 132.17 (C-8), 129.95 
(C-25), 128.62 (C-27), 126.66 (C-24), 125.09 (C-28), 123.99 (C-14), 122.15 (C-16), 121.15 
(C-12), 70.25 (C-20), 67.64 (C-19), 40.84 (C-22), 34.80 (C-10), 32.34 (CC-2), 30.72 (C-1). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd C26H26N2O 383.2118 for; Found 383.2114. 







General procedure A was followed using (±)-4-bromo-(piperidin-1-yl)-[2.2]paracyclophane 
4.28 (36 mg, 0.097 mmol, 1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (17 mg, 0.017 mmol, 1.1 eq.), 
LiOtBu (20 mg, 0.24 mmol, 2.5 eq.), (tBu)2P(O)H (2 mg, 0.009 mmol, 0.1 eq.), Pd(OAc)2 (1 
mg, 0.004 mmol, 0.05 eq.), DMA (0.39 ml) for 24 h. 
Purification: Preparative TLC [SiO2, Et3N:EtOAc:hexanes (2:09:89)] to obtain the title 
compound 4.29 (83% yield) as a separate diastereomer, 4.29dia1, brownish semisolid (17 mg, 
0.037 mmol, 29% yield), mixture of diastereomers (14 mg, 0.031 mmol, 31% yield), and a 
separate diastereomer 4.23dia2, brownish semisolid (11 mg, 0.024 mmol, 24% yield). 
Rf : 0.5 (dia.1) 
[α]D
20 : +50.91 (c=1.1, CHCl3)  
IR: νmax 3681, 3019, 2931, 2400, 2183, 1517 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.36-7.31 (m, 2H, H-31, H-33), 7.29-7.25 (m, 3H, H-30, H-34, 
H-32), 7.04 (s, 1H, H-5), 6.66 (d, J = 7.6 Hz, 1H, H-8), 6.61 (d,  J = 5.6 Hz, 1H, H-7), 6.56 (d,  
J = 7.5 Hz, 1H, H-15), 6.33 (d, J = 7.5 Hz, 1H, H-16), 5.75 (s, 1H, H-12), 4.68 (m, 1H, H-26), 
4.48 (tt, J = 13.6, 5.3 Hz, 1H, H-25a), 4.31 (t, J = 8.8 Hz, 1H, H-28a), 3.95 (t, J = 8.6 Hz, 1H, 
H-28b), 3.55 (tt, J = 13.5, 4.5 Hz, 1H, H-25b), 3.42 (dd, J = 13.7, 4.5 Hz, 1H, H-22a), 3.13-
3.08 (m, 1H, H-18a), 3.07-3.02 (m, 1H, H-18b), 3.01-2.92 (m, 3H, H-2a, H-2b, H-9a), 2.85-
2.74 (m, 5H, H-9b, H-1a, H-10a, H-10b), 2.66 (dd, J = 13.5, 9.8 Hz, 1H, H-22b), 1.74-1.72 (m, 
2H, H-21a, H-21b), 1.58-1.56 (m, 2H, H-19a, H-19b), 1.51-1.48 (m, 2H, H-2a, H-20b)    
13C NMR (CDCl3, 125 MHz): δ 152.60 (C-23), 142.03 (C-13), 140.05 (C-3), 138.51 (C-29), 
137.99 (C-11), 135.81 (C-5), 135.74 (C-7, C-8), 134.75 (C-4), 132.29 (C-6), 131.58 (C-14), 
129.14 (C-15, C-31, C-33), 128.59 (C-30, C-34), 126.43 (C-16), 126.30 (C-12), 119.01 (C-32), 




(C-2), 34.19 (C-1), 26.60 (C-21, C-19), 24.53 (C-20).  HRMS (ESI-TOF) m/z: [M + H]+ Calcd 
for; Found  
HRMS (ESI-TOF) m/z: [M + H]+ Calcd C31H34N2O 451.2744 for; Found 454.2741. 
*The exact configuration of the diastereomer is not determined yet. 
4-((4S)-Benzyl-oxazoline-2-yl)-13-(piperidin-1-yl)-[2.2]paracyclophane 4.29dia2* 
 
Rf : 0.4 (dia.1) 
IR: νmax 3680, 3019, 2929, 2165, 2087 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.36-7.33 (m, 2H, H-31, H-33), 7.29-7.25 (m, 3H, H-30, H-34, 
H-32), 7.19 (s, 1H, H-5), 6.69 (d, J = 7.5 Hz, 1H, H-8), 6.59 (d, J = 7.7 Hz, 1H, H-8), 6.54 (d,  
J = 9.0 Hz, 1H, H-15), 6.31 (d, J = 7.4 Hz, 1H, H-16), 5.86 (s, 1H, H-12), 4.54 (m, 1H, H-26), 
4.34 (t, J = 8.7 Hz, 1H, H-25a), 4.22-4.19 (m, 2H, H-28a, H-28b), 3.53-3.48 (m, 1H, H-25b), 
3.30 (dd, J = 13.6, 4.9 Hz, 1H, H-22a), 3.17-3.11 (m, 1H, H-18a), 3.08-3.02 (m, 1H, H-18b), 
2.97-2.82 (m, 8H, H-2a, H-2b, H-9a, H-9b, H-1a, H-1b, H-10a, H-10b), 2.74 (dd,  J = 13.6, 9.4 
Hz, 1H, H-22b), 1.78-1.72 (m, 2H, H-21a, H-21b), 1.63-1.57 (m, 2H, H-19a, H-19b), 1.54-
1.51 (m, 2H, H-20a, H-20b) 
13C NMR (CDCl3, 125 MHz): δ 152.76 (C-23), 141.47 (C-13), 140.06 (C-3), 138.45 (C-29), 
138.38 (C-11), 135.85 (C-5), 135.38 (C-7, C-8), 134.65 (C-4), 132.49 (C-6), 131.87 (C-14), 
129.22 (C-15, C-31, C-33), 128.59 (C-30, C-34), 126.63 (C-16), 126.45 (C-12), 118.84 (C-32), 
71.24 (C-26), 67.74 (C-25), 53.31 (C-22, C-18), 41.91 (C-28), 35.28 (C-9), 35.07 (C-10), 34.76 
(C-2), 33.40 (C-1), 26.46 (C-21, C-19), 24.46 (C-20). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd C31H34N2O 451.2744 for; Found 454.2741 









1H NMR (CDCl3, 500 MHz): δ 6.74 (d, J = 7.6 Hz, 1H, H-8), 6.55 (d, J = 7.7 Hz, 1H, H-15), 
6.47 (d, J = 7.7 Hz, 1H, H-16), 6.42-6.41 (m, 2H, H-12, H-13), 6.27 (d, J = 7.5 Hz, 1H, H-7), 
5.73 (s, 1H, H-5), 3.44-3.39 (m, 1H, H-2a), 3.31-3.25 (m, 1H, H-18a), 3.07-3.01 (m, 3H, H-
12b, H-9a, H-9b), 3.01-2.97 (m, 1H, H-22), 2.96-2.89 (m, 4H, H-1a, H-1b, H-10a, H-10b), 
2.73-2.67 (m, 1H, H-18b), 1.88-1.73 (m, 4H, H-19a, H-19b, H-21a, H-21b), 1.62-1.59 (m, 3H, 



















(4-((4S)-Benzyl-oxazoline-2-yl)-[2.2]paracyclophane-13-methyl ester 4.35dia1* 
 
General procedure A was followed using (±)-4-bromo[2.2]paracyclophane-13-methyl ester 
4.34 (75 mg, 0.22 mmol, 1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (39 mg, 0.24 mmol, 1.1 eq.), 
LiOtBu (44 mg, 0.54 mmol, 2.5 eq.), (tBu)2P(O)H (4 mg, 0.022 mmol, 0.1 eq.), Pd(OAc)2 (2 
mg, 0.010 mmol, 0.05 eq.), DMA (0.87 ml) for 24 h. 
Purification: Flash chromatography [SiO2, EtOAc : hexanes (0-10 to 30:70, gradient elution)] 
to obtain the title compound 4.35 (21% yield) as a separate diastereomer, 4.35dia1, white 
semisolid (6 mg, 0.037 mmol, 6% yield), mixture of diastereomers (11 mg, 0.031 mmol, 12% 
yield), and a separate diastereomer 4.23dia2, brownish semisolid (5 mg, 0.024 mmol, 5% 
yield). 
Rf : 0.7 (dia.1)  
IR: νmax 3676, 3019, 2970, 2399, 1523, 1394 cm
-1.  
1H NMR (CDCl3, 500 MHz): δ 7.35-7.32 (m, 2H, H-24, H-28), 7.29-7.24 (m, 3H, H-24, H-25, 
H-26), 7.19 (s, 1H, H-12), 7.02 (s, 1H, H-5), 6.71-6.61 (m, 4H, H-8, H-7, H-16, H-15), 4.63-
4.57 (m, 1H, H-20), 4.42 (td,  J = 14.1, 3.9 Hz, 1H, H-19a), 4.31 (t,  J = 8.7 Hz, 1H, H-22a), 
4.20 (td,  J = 10.6, 3.4 Hz, 1H, H-19b), 4.02 (t,  J = 8.05 Hz, 1H, H-22b), 3.80 (s, 3H, -OMe), 
3.31 (dd,  J = 13.7, 4.9 Hz, 1H, H-2a), 3.18-3.00 (m, 6H, H-1a, H-1b, H-9a, H-9b, H-10a, H-
10b), 2.70 (dd,  J = 14.0, 9.4 Hz, 1H, H-2b). 
13C NMR (CDCl3, 125 MHz): δ 167.28 (C-29), 163.30 (C-17), 142.76 (C-14), 141.31 (C-3), 
139.35 (C-23), 139.08 (C-4), 138.48 (C-6), 136.40 (C-11), 135.99 (C-13), 135.63 (C-25), 
134.89 (C-27), 134.01 (C-16), 132.84 (C-12), 129.78 (C-5), 129.18 (C-28, C-24), 128.56 (C-
8, C-15), 128.03 (C-7), 126.42 (C-25), 70.98 (C-20), 68.66 (C-19), 51.47 (C-31, -OMe), 41.86 
(C-22), 34.70 (C-9, C-10), 34.57 (C-2), 34.48 (C-1). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd C28H27NO3 426.2064 for; Found 426.2060. 




4-((4S)-Benzyl-oxazoline-2-yl)-[2.2]paracyclophane-13-methyl ester 4.35dia2* 
 
Rf : 0.6 (dia.2) 
IR: νmax 3680, 2971, 2325, 2167, 1707, 1522 1410 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.36-7.30 (m, 4H, H-28, H-27, H-25, H-24), 7.27-7.24 (m, 1H, 
H-26), 7.13 (s, 1H, H-12), 6.71-6.67 (m, 1H, H-5), 6.67-6.60 (m, 4H, H-15, H-16, H-8, H-7), 
4.55-4.49 (m, 1H, H-20), 4.35 (t,  J = 8.6 Hz, 1H, H-19a), 4.28 (tt,  J = 22.9, 10.6, 4.1 Hz, 2H, 
H-2a, H-2b), 4.14 (t,  J = 7.3 Hz, 1H, H-19b), 3.87 (s, 3H, -OMe), 3.33 (dd,  J = 13.7, 5.1 Hz, 
1H, H-22a), 3.20-2.97 (m, 6H, H-9a, H-9b, H-10a, H-10b, H-1a, H-1b), 2.83 (dd,  J = 13.6, 9.3 
Hz, 1H, H-22b). 
13C NMR (CDCl3, 125 MHz): δ 166.94 (C-29), 164.26 (C-17), 143.19 (C-14), 141.14 (C-3), 
139.53 (C-23), 139.06 (C-4), 138.45 (C-6), 136.37 (C-11), 135.99 (C-13), 135.68 (C-25), 
135.21 (C-27), 134.14 (C-16), 132.91 (C-12), 129.34 (C-5), 129.24 (C-28, C-24), 128.59 (C-
8, C-15), 128.09 (C-7), 126.42 (C-25), 71.47 (C-20), 67.95 (C-19), 51.53 (C-31, -OMe), 41.39 
(C-22), 34.85 (C-2), 34.70 (C-9, C-10), 34.16 (C-1).  
HRMS (ESI-TOF) m/z: [M + H]+ Calcd C28H27NO3 426.2064 for; Found 426.2060. 











4-((4S)-Benzyl-oxazoline-2-yl)-[2.2]paracyclophane-13-carboxylic acid 4.38 
 
General procedure A was followed using (±)-4-bromo[2.2]paracyclophane-13-carboxylic acid 
4.37 (50 mg, 0.15 mmol, 1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (27 mg, 0.16 mmol, 1.1 eq.), 
LiOtBu (30 mg, 0.38 mmol, 2.5 eq.), (tBu)2P(O)H (2 mg, 0.015 mmol, 0.1 eq.), Pd(OAc)2 (2 
mg, 0.0075 mmol, 0.05 eq.), DMA (0.6 ml) for 24 h.  
Purification: Flash chromatography [SiO2, EtOAc : hexanes 40:60] to obtain the title compound 
as a mixture of diastereomers 4.38, white semisolid (27 mg, 0.065 mmol, 44% yield). 
 
Rf : 0.3 
IR: νmax 3650, 2973, 2196, 2007, 1683, 1419 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.50 (s, 1H, H-12), 7.30 (s, 1H, H-12), 7.23 (d, J = 6.8 Hz, 2H, 
H-5, H-5), 7.19-7.15 (m, 4H, H-24, H-24, H-28, H-28), 7.10-1.05 (m, 6H, H-27, H-27, H-26, 
H-26, H-25, H-25), 6.79 (dd,  J = 15.6, 6.2 Hz, 2H, H-15, H-15), 6.71-6.65 (m, 6H, H-16, H-
16, H-7, H-7, H-8, H-8), 4.69-4.55 (m, 2H, H-20, H-20), 4.38-4.34 (m, 2H, H-19a, H-19a) 
4.28-4.21 (m, 3H, H-2a, H-2a, H-22a), 4.17-4.12 (m, 2H, H-19b, H-19b), 3.90 (t,  J = 8.3 Hz, 
1H, H-22a), 3.34-3.27 (m, 2H, H-2b, H-2b), 3.20-3.08 (m, 12H, H-9a, H-9ad2, H-9b, H-9b, H-
10a, H-10b, H-10b), 3.00-2.95 (m,1H, H-22b), 2.63-2.56 (m, 2H, H-1b, H-1b). 
13C NMR (CDCl3, 125 MHz): δ 172.07 (C-29), 170.72 (C-29), 165.77 (C-17), 163.36 (C-17), 
143.92 (C-14), 143.11 (C-14), 141.53 (C-3), 141.29 (C-3), 139.75 (C-23), 139.51 (C-23), 
139.32 (C-4), 139.18 (C-4), 138.21 (C-6), 137.25 (C-6), 136.33 (C-11), 136.22 (C-11), 129.26 
(C-28, C-28), 128.89 (C-24, C-24), 128.43 (C-27, C-27), 128.35 (C-25, C-25), 129.81 (C-8), 
128.78 (C-8), 126.29 (C-7), 126.13 (C-7), 71.81 (C-19), 71.07 (C-19), 68.12 (C-20), 66.45 (C-
20), 41.54 (C-22), 41.18 (C-22), 34.94 (C-2), 34.61 (C-2),  34.74 (C-9, C-9), 34.68 (C-1), 34.61 
(C-1), 34.49 (C-10), 34.11 (C-10). 




4-((4S)-Benzyl-oxazoline-2-yl)-[2.2]paracyclophane-12-carboxylic acid 4.45 
 
General procedure A was followed using (±)-4-bromo[2.2]paracyclophane-12-carboxylic acid 
4.44 (50 mg, 0.15 mmol, 1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (27 mg, 0.16 mmol, 1.1 eq.), 
LiOtBu (30 mg, 0.38 mmol, 2.5 eq.), (tBu)2P(O)H (2 mg, 0.015 mmol, 10 mol%), Pd(OAc)2 (2 
mg, 0.0075 mmol, 5 mol%), DMA (0.6 ml) for 22 h.  
Purification: Flash chromatography [SiO2, EtOAc:hexanes 40:60] to obtain the title compound 
as a mixture of diastereomers 4.45, white semisolid (41 mg, 0.093 mmol, 61% yield). Rf : 0.3 
IR: νmax 3647, 2980, 2906, 2240, 2043, 1713, 1523 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ  7.41-7.25 (m, 10H, H-28, H-28, H-24, H-24, H-27, H-27, H-
25, H-25, H-26, H-26), 7.16 (s, 2H, H-13, H-13), 6.94 (d, J = 9.0 Hz, 2H, H-5, H-5), 6.81 (d,  
J = 7.7 Hz, 2H, H-16, H-16), 6.65-6.59 (m, 6H, H-15, H-15, H-8, H-8, H-7, H-7), 4.83-4.70 
(m, 2H, H-20, H-20), 4.54-4.49 (m, 2H, H-19a, H-19a), 4.37 (t, J = 17.0 Hz, 2H, H-10a, H-
10a), 4.02-3.95 (m, 2H, H-10b, H-10b), 3.74-3.66 (m, 2H, H-22a, H-22a), 3.59 (dd, J = 13.8, 
4.3 Hz, 1H, H-19b), 3.31 (dd, J = 13.7, 4.4 Hz, 1H, H-19b), 3.21-2.84 (m, 14H, H-10b, H-10b,  
H-2ad1, H-2a, H-2b, H-2b, H-1a, H-1a, H-1b, H-1b, H-9a, H-9a, H-9b, H-9b), 2.83-2.73 (m, 
2H, H-22b, H-22b).  
13C NMR (CDCl3, 125 MHz): δ 169.48 (C-29), 169.30 (C-29), 168.81 (C-17), 168.58 (C-17), 
140.93 (C-23), 140.83 (C-23), 140.02 (C-11), 139.73 (C-11), 139.02 (C-3), 138.93 (C-3), 
136.84 (C-5), 136.57 (C-5), 135.97 (C-6, C-14), 135.92 (C-6, C-14), 135.56 (C-8, C-7), 135.51 
(C-8, C-7), 134.99 (C-12), 134.97 (C-12), 129.49 (C-27, C-27), 129.26 (C-25, C-25), 129.06 
(C-16), 129.03 (C-16), 128.94 (C-28, C-28), 128.71 (C-24, C-24), 127.87 (C-4), 127.85 (C-4), 
127.04 (C-26), 126.90 (C-26), 73.91 (C-20), 72.64 (C-20), 66.48 (C-19), 65.67 (C-19), 41.06 
(C-22, C-22), 34.76 (C-10), 34.72 (C-10), 34.48 (C-9), 34.44 (C-9), 34.29 (C-1, C1), 33.95 (C-
2), 33.93 (C-2).  




4-((4S)-Benzyl-oxazoline-2-yl)-5-amino[2.2]paracyclophane 4.47dia1* & 4-((4S)-benzyl-
oxazoline-2-yl)-5-amino[2.2]paracyclophane 4.47dia2* 
 
General procedure was followed using (±)-4-Bromo-5-amino[2.2]paracyclophane 4.48 (48 mg, 
0.16 mmol,  1.0 eq.), (4S)-4-benzyl-oxazoline 4.10 (28 mg, 0.17 mmol, 1.1 eq.), LiOtBu (32 
mg, 0.39 mmol, 2.5 eq.), (tBu)2P(O)H  (3 mg, 0.015 mmol, 10 mol%), Pd(OAc)2 (2 mg, 0.0079 
mmol, 5 mol%), DMA (0.64 ml) for 24 h. 
Purification: Preparative TLC [SiO2, EtOAc:hexanes 15:85] to obtain the separate 
diastereomers of 4.47, yellowish semisolid (21 mg, 0.054 mmol, 34% yield). 
Rf : 0.6 & 0.5 
Dia 1 
1H NMR (CDCl3, 500 MHz): δ 7.34-7.31 (m, 4H, H-28, H-27, H-24, H-23), 7.25-7.24 (m, 1H, 
H-26), 7.08 (d, J = 9.6 Hz, 1H, H-16), 6.63 (d, J = 9.7 Hz, 1H, 1H, H-15), 6.43 (d, J = 9.7 Hz, 
1H, H-8), 6.38-6.35 (m, 2H, H-13, H-12), 6.14 (d, J = 9.4 Hz, 1H, H-7), 4.65-4.58 (m, 1H, H-
20), 4.27-4.18 (m, 2H, H-19a, H-19b), 4.04 (t, J = 7.9 Hz, 1H, H-10a), 3.85-3.76 (m, 1H, H-
10b), 3.11-3.03 (m, 4H, H-22a, H-22b, H-9a, H-9b), 2.75-2.65 (m, 4H, H-2a, H-2b, H-9a, H-
9b). 
Dia 2 
1H NMR (CDCl3, 500 MHz): δ 7.40-7.37 (m, 4H, H-28, H-27, H-24, H-23), 7.30-7.28 (m, 1H, 
H-26), 7.10 (d, J = 9.6 Hz, 1H, H-16), 6.63 (d, J = 9.8 Hz, 1H, H-15), 6.43 (d, J = 9.7 Hz, 1H, 
H-8), 6.38 (d, J = 9.5 Hz, 2H, H-13, H-12), 6.12 (d, J = 9.4 Hz, 1H, H-7), 4.62-4.54 (m, 1H, 
H-20), 4.27 (t, J = 10.5 Hz, 1H, H-19a), 4.05 (t, J = 10.1 Hz, 1H, H-19b), 3.82-3.75 (m, 1H, 
H-10a), 3.25 (dd, J = 17.04, 7.4 Hz, 1H, H-22a), 3.13-3.05 (m, 4H, H-9a, H-9b, H-2a, H-2b), 
2.96 (dd, J = 17.0, 9.5 Hz, 1H, H-22b), 2.75-2.64 (m, 3H, H-10b, H-1a, H-1b). 






General method I was followed to synthesise (4R)-4.49 by taking (R)-(-)2-phenyl glycinol (2.5 
g, 18.22 mmol, 1.0 eq.), triethyl orthoformate (4.54 ml, 27.33 mmol, 1.0 eq.), and glacial acetic 
acid (0.10 ml, 1.82 mmol, 0.1 eq.). 
Purification: Kugelrohr distillation at 45 °C, 60 mTorr to obtain a colourless liquid of 4.49 (1.4 
g, 9.51 mmol, 52% yield). 
IR: νmax 3020, 2973, 2399, 2166, 2009, 1917, 1684, 1517, 1215 cm
-1.  
1H NMR (CDCl3, 400 MHz): δ 7.38-7.24 (5H, m), 7.05 (1H, d, J = 1.8 Hz), 5.23 (1H, ddd, J = 
10.2, 8.5, 1.9 Hz), 4.62 (1H, ddd, J = 10.5, 8.6 Hz), 4.09 (1H, d, J = 8.3 Hz).  
13C NMR (CDCl3, 125 MHz): δ 161.68, 138.34, 128.92, 128.02, 126.66, 66.02, 54.75. 

















General procedure A was followed using (±)-4-bromo[2.2]paracyclophane 4.9 (40 mg, 0.27 
mmol, 1.0 eq.), (R)-4-Phenyl-oxazoline 4.49 (86 mg, 0.29 mmol, 1.1 eq.), LiOtBu (54 mg, 0.68 
mmol, 2.5 eq.), (tBu)2P(O)H (4 mg, 0.027 mmol, 0.1 eq.), Pd(OAc)2 (3 mg, 0.013 mmol, 0.05 
eq.), DMA (1.09 ml) for 24 h.  
Purification: Flash chromatography [SiO2, EtOAc:hexanes 05:95] gave the by-product 4.50, 
white semisolid (27 mg, 0.076 mmol, 28% yield). 
Rf : 0.7 
IR: νmax 3019, 2972, 2401, 2254, 2008, 1968, 1394, 1215 cm
-1.  
1H NMR (CDCl3, 400 MHz): δ 7.73-7.62 (2H, m), 7.53-7.42 (1H, m), 7.34-7.29 (1H, m), 7.26-
7.18 (1H, m), 6.94 (1H, d, J = 7.9 Hz), 6.79 (1H, d, J = 1.3 Hz), 6.76 (1H, d, J = 7.9 Hz), 6.62 
(1H, d, J = 7.9 Hz), 6.55 (2H, s), 6.53 (1H, d, J = 7.9 Hz), 3.57 (1H, ddd, J = 13.4, 10.5, 2.3 
Hz), 3.35 (1H, ddd, J = 13.2, 10.8, 4.6 Hz), 3.20-3.04 (6H, m).  
13C NMR (CDCl3, 125 MHz): δ 144.26, 140.94, 139.54, 139.19, 137.13, 136.80, 134.53, 
133.52, 132.90, 132.71, 130.98, 129.93, 129.58, 129.03, 128.96, 128.29, 128.09, 127.30, 











(S)-4-(Tert-hydroxyl diphenyl)-oxazoline 4.57 
 
General method I was used to synthesise (4S)-4.57 by taking (R)-2-amino-1,1-
diphenylpropane-1,3-diol 4.55 (350 mg, 1.43 mmol, 1.0 eq.), triethyl orthoformate (320 mg, 
2.15 mmol, 1.0 eq.), and glacial acetic acid (8 mg, 0.14 mmol, 0.1 eq.). 
Purification: Kugelrohr distillation at 45 °C, 60 mTorr to obtain a colourless liquid of 4.57 (462 
mg, 1.83 mmol, 60% yield). 
[α]D
20 : -70.00 (c=1.7, CHCl3) 
IR: νmax 2989, 2158, 2013, 1652, 1449, 1394 cm
-1.  
1H NMR (CD3OD, 700 MHz): δ 7.60 (2H, d, J = 8.4, 1.5 Hz), 7.52 (2H, dd, J = 8.4, 1.7 Hz), 
7.32-7.29 (4H, m), 7.21 (2H, t, J = 7.3 Hz), 7.05 (1H, d, J = 1.6 Hz), 5.44 (1H, td, J = 10.0, 1.5 
Hz), 4.22 (2H, dd, J = 9.9, 1.7 Hz). 
13C NMR (CD3OD, 176 MHz): δ 159.59, 147.23, 147.05, 129.53, 129.21, 128.19, 128.06 
128.00, 127.52, 79.51, 73.17, 69.56.  
HRMS (ESI-TOF) m/z: [M+H]+ Calcd C16H16NO2 254.1176 for; Found 254.1170. 
 





General method I was used to synthesise (4S)-4.65 and (4S)-4.66 by taking dibenzyl tertiary 
aminoalcohol 4.64 (150 mg, 0.55 mmol, 1.0 eq.), triethyl orthoformate (123 mg, 0.82 mmol, 
1.5 eq.), and glacial acetic acid (3 mg, 0.05 mmol, 0.1 eq.). 
Purification: Flash chromatography [SiO2, EtOAc:hexanes 30:70] to obtain the title 
compounds, (4S)-4.65 and (4S)-4.66 yellowish liquid (15 mg, 0.05 mmol, 10% yield). 
1H NMR (CDCl3, 500 MHz): δ 7.36-7.24 (m, 10H, H-20, H-16, H-15, H-11, H-19, H-17, H-
14, H-12, H-18, H-13), 6.93 (s, 1H, H-2), 4.23-4.19 (t, J = 9.6 Hz, 1H, H-5a), 4.12-4.09 (m, 
1H, H-4), 4.06 (t, J = 10.2 Hz, 1H, H-5b), 2.96 (d, J = 17.3 Hz, 1H, H-9a), 2.87 (q, J = 12.5 
Hz, 2H, H-7a, H-7b), 2.68 (d, J = 17.3 Hz, 1H, H-9b). 
13C NMR (CDCl3, 125 MHz): δ 156.62 (C-2), 136.62 (C-10), 136.51 (C-8), 130.89 (C-20, C-
16), 130.84 (C-15, C-11), 128.32 (C-19, C-17, C-14, C-12), 126.69 (C-18, C-13), 75.19 (C-6), 
70.60 (C-4), 67.28 (C-5), 42.18 (C-9), 41.84 (C-7). 




1H NMR (CDCl3, 500 MHz): δ 7.37-7.33 (m, 5H, H-19, H-15, H-12, H-8, H-18), 7.23-7.19 
(m, 3H, H-16, H-11, H-9), 7.12-7.10 (m, 2H, H-17, H-10), 6.72 (s, 1H, H-1), 5.23 (s, 1H, -
OH), 4.16 (td,  J = 10.1, 2.7 Hz, 1H, H-3), 3.88 (dd,  J = 12.9, 6.5 Hz, 1H, H-20a), 3.78 (d, J = 
10.9 Hz, 1H, H-20b), 3.27 (d, J = 17.7 Hz, 1H, H-9a), 3.06 (q, J = 17.7 Hz, 2H, H-13a, H-13b), 









General method II was used to synthesise (4S,5S)-4.70 by taking (1S,2S)-(+)-2-amino-1-
phenyl-1,3-propanediol 4.68  (700 mg, 4.18 mmol, 1.0 eq.), DMF-DMA (499 mg, 4.18 mmol, 
1.0 eq.). Purification: Kugelrohr distillation at 135 °C, 30 mTorr to obtain a white liquid of 
4.10 (482 mg, 2.72 mmol, 65% yield). 
 
[α]D
20 : -66.30 (c=0.92, MeOH) 
IR: νmax 3390, 3266, 2994, 2900, 1679, 1637, 1559, 1394, 1280 1084 cm
-1.  
1H NMR (CDCl3, 500 MHz): δ 7.47-7.31 (m, 5H, H-13, H-12, H-11, H-10, H-11, H-9), 7.08 
(s, 1H, H-2), 5.33 (d, J = 7.8 Hz, 1H, H-5), 4.10-4.07 (m, 1H, H-4), 3.99-3.95 (m, 1H, H-7a), 
3.74 (dd, J = 11.7, 3.6 Hz, 1H, H-7b), 3.37 (bs, 1H, -OH. 
13C NMR (CDCl3, 125 MHz): δ 155.76 (C-2), 1339.87 (C-6), 128.31 (C-12, C-10), 128.54 (C-
13, C-9), 128.54 (C-11), 82.22 (C-5), 74.75 (C-4), 62.23 (C-7).  
HRMS (ESI-TOF) m/z: [M+H]+ Calcd C10H12NO2 178.0863 for; Found 178.0861. 















General method I was used to synthesise (4S,5S)-4.71 by taking (1S,2S)-(+)-2-amino-1-phenyl-
1,3-propanediol 4.68 (350 mg, 0.86 mmol, 1.0 eq.), triethyl orthoformate (192 mg, 0.21 mmol, 
1.5 eq.), and glacial acetic acid (5 mg, 0.05 mmol, 0.1 eq.). 
Purification: Flash chromatography [SiO2, EtOAc:hexanes 20:80] to obtain the title compound, 
(4S,5S)-4.68  as a white solid (378 mg, 0.91 mmol, 35% yield). 
Rf : 0.7 
[α]D
20 : +33.68 (c=0.95, CHCl3) 
IR: νmax 3308, 3070, 2930, 2865, 1699, 1659, 1427, 1114, 1039 cm
-1.  
1H NMR (CDCl3, 500 MHz): δ 7.72 (t, J = 7.5 Hz, 4H, H-18, H-13, H-22, H-17), 7.48-7.28 
(m, 11H, H-27, H-26, H-25, H-24, H-23, H-21, H-20, H-19, H-16, H-15, H-14), 7.06 (s, 1H, 
H-2), 5.46 (d, J = 6.7 Hz, 1H, H-5), 4.15-4.12 (m, 1H, H-4), 3.96 (dd, J = 10.7, 3.7 Hz, 1H, H-
7a), 3.86 (dd, J = 9.4, 6.0 Hz, 1H, H-7b), 1.1 (s, 9H, tBu). 
13C NMR (CDCl3, 125 MHz): δ 154.90, 140.64, 136.25, 135.70, 135.63, 133.28, 133.12, 
133.03, 129.84, 129.81, 128.75, 128.58, 128.46, 128.34, 128.21, 127.80, 125.81, 81.25, 75.36, 
65.17, 26.87, 19.06. 











General procedure A was followed using (±)-4-bromo[2.2]paracyclophane 4.9 (70 mg, 0.24 
mmol, 1.0 eq.), (4S,5S)-4-(methylalcohol)-5-phenyloxazoline 4.70 (45 mg, 0.26 mmol, 1.05 
eq.), LiOtBu (49 mg, 0.61 mmol, 2.5 eq.), (tBu)2P(O)H  (4 mg, 0.024 mmol, 0.1 eq.), Pd(OAc)2 
(3 mg, 0.012 mmol, 0.05 eq.), DMA (0.98 ml) for 12h. Purification: Flash chromatography 
[SiO2, EtOAc:hexanes 50:50] to obtain the title compound as a mixture of diastereomers 4.72, 
white semisolid (14 mg, 0.039 mmol, 15% yield). Rf : 0.4 
IR: νmax 3020, 2996, 2908, 2398, 2170, 1521cm
-1.  
1H NMR (CDCl3, 500 MHz): δ 7.48-7.44 (m, 8H, H-30, H-30, H-26, H-26, H-29, H-29, H-27, 
H-27), 7.41-7.37 (m, 2H, H-28, H-28), 7.20-7.16 (d, J = 17.8 Hz, 2H, H-5, H-5), 6.6.6-6.63 
(m, 4H, H-8, H-8, H-7, H-7), 6.60-6.50 (m, 8H, H-16, H-16d, H-15, H-15, H-13, H-13, H-12, 
H-12), 5.51 (d, J = 7.7 Hz, 2H, H-19, H-19), 4.40 (s, 2H, OH-24, OH-24), 4.27-4.21 (q, J = 
11.5 Hz, 2H, H-22a, H-22a), 4.12 (dd, J = 11.4, 3.9 Hz, 2H, H-22a, H-22b), 3.91 (dd, J = 11.2, 
4.4 Hz, 1H, H-20), 3.85 (dd, J = 9.7, 4.0 Hz, 1H, H-20), 3.22-2.76 (m, 16H, H-1a, H-1a, H-1b, 
H-1b, H-9a, H-9a, H-9b, H-9b, H-10a, H-10a, H-10b, H-10b, H-2a, H-2a, H-2b, H-2b).  
13C NMR (CDCl3, 125 MHz): δ 165.21 (C-17, C-17), 141.39 (C-14), 141.27 (C-14), 140.77 
(C-11), 140.64 (C-14), 139.87 (C-25), 139.78 (C-25), 139.47 (C-3), 139.42 (C-3), 136.11 (C-
4), 136.05 (C-4), 134.66 (C-16), 134.51 (C-16), 133.09 (C-15), 133.05 (C-15), 132.89 (C-13), 
132.80 (C-13), 132.42 (C-12), 132.22 (C-12), 131.42 (C-5), 131.33 (C-5), 128.97 (C-29, C-
27), 128.95 (C-29, C-27), 128.48 (C-8), 128.41 (C-8), 125.99 (C-30, C-26, C-30, C-26), 125.78 
(C-7, C-28, C-7, C-28), 82.42 (C-19), 82.19 (C-19), 76.94 (C-20), 76.55 (C-20), 64.43 (C-22), 
64.03 (C-22), 35.97 (C-1, C-1), 35.32 (C-9, C-9), 35.08 (C-10, C-10), 34.98 (C-2, C-2).  







General method I was used to synthesise (4S,5S)-4.71 by taking (1S,2S)-2-amino-3-
(benzyloxy)-1-phenylpropan-1-ol (400 mg, 1.5 mmol, 1.0 eq.), triethyl orthoformate (346 mg, 
1.5 mmol, 1.5 eq.), and glacial acetic acid (9 mg, 0.15 mmol, 0.1 eq.). 
Purification: Flash chromatography [SiO2, EtOAc:hexanes 20:80] to obtain the title compound, 
(4S,5S)-4.73  as a yellow semisolid (170 mg, 0.63 mmol, 41% yield). 
Rf : 0.4 
[α]D
20 : +20.19 (c=5.10, CHCl3) 
IR: νmax 3019, 2986, 2897, 2400, 2044, 1685 cm
-1.  
1H NMR (CDCl3, 500 MHz): δ 7.40-7.28 (m, 10H, H-20, H-19, H-18, H-17, H-16, H-13, H-
12, H-11, H-10, H-9), 7.05 (s, 1H, H-2), 5.36 (d, J = 7.0 Hz, 2H, 1H, H-5), 4.67 (q, J = 12.1 
Hz, 2H, H-14a, H-14b), 4.20-4.18 (m, 1H, H-4), 3.80 (dd, J = 9.7, 4.0 Hz, 1H, H-7a), 3.66 (dd, 
J = 9.6, 6.4 Hz, 1H, H-7b). 
13C NMR (CDCl3, 125 MHz): δ 155.04 (C-2), 140.35 (C-6), 137.98 (C-5), 128.77 (C-19, C-
17), 128.44 (C-12, C-10), 128.26 (C-18), 127.75 (C-11), 127.69 (C-13, C-9), 125.58 (C-20, C-
16), 82.58 (C-5), 74.01 (C-4), 73.40 (C-14), 71.34 (C-7). 












General procedure was followed using (±)-4-bromo[2.2]paracyclophane 4.9 (70 mg, 0.24 
mmol, 1.0 eq.), (4S,5S)-4-((benzyloxy)(methyl))-5-phenyloxazoline 4.73 (69 mg, 0.25 mmol, 
1.05 eq.), LiOtBu (49 mg, 0.61 mmol, 2.5 eq.), (tBu)2P(O)H (4 mg, 0.024 mmol, 0.1 eq.), 
Pd(OAc)2 (3 mg, 0.012 mmol, 0.05 eq.), DMA (0.98 ml) for 14 h. 
Purification: Flash chromatography [SiO2, EtOAc:hexanes 20:80] to obtain the title compound 
as a mixture of diastereomers 4.74, white semisolid (62 mg, 0.13 mmol, 53% yield). 
Rf : 0.6 
IR: νmax 2997, 2880, 2398, 2209, 2171, 1989, 1635, 1516 cm
-1.  
1H NMR (CDCl3, 500 MHz): δ 7.47-7.30 (m, 20H, H-30, H-30, H-26, H-26, H-29, H-29, H-
27, H-27, H-28, H-28, H-36, H-36, H-32, H-32, H-35, H-35, H-33, H-33, H-34, H-34), 7.21 
(d, J = 7.1 Hz, 2H, H-5, H-5), 6.73-6.72 (d, J = 6.7 Hz, 1H, H-8), 6.67-6.64 (m, 3H, H-8, H-7, 
H-7), 6.60-6.52 (m, 8H, H-16, H-16, H-15, H-15, H-13, H-13, H-12, H-12), 5.59 (d, J = 6.3 
Hz, 2H, H-19, H-19), 4.77 (dt,  J = 21.6, 9.8 Hz, 4H, H-24a, H-24a, H-24b, H-24b), 4.48 (dddd,  
J = 13.4, 10.4, 6.5, 4.1 Hz, 2H, H-20, H-20), 4.39-4.31 (m, 1H, H-10a), 4.25 (t, J = 9.4 Hz, 1H, 
H-10a), 3.95 (tt, J = 5.8, 4.0 Hz, 2H, H-22a, H-22a), 3.88 (dd, J = 9.5, 6.1 Hz, 1H, H-22b), 
3.82 (dd, J = 9.6, 6.4 Hz, 1H, H-22b), 3.22-3.02 (m, 12H, H-10b, H-10b, H-9a, H-9a, H-9b, H-
9b, H-1a, H-1a, H-1b, H-1b, H-2a, H-2a), 2.92-2.85 (m, 2H, H-2b, H-2b). 
13C NMR (CDCl3, 125 MHz): δ 164.61 (C-17), 164.05 (C-17d), 141.55 (C-14d), 141.44 (C-
14d), 141.36 (C-11), 141.33 (C-11), 140.10 (C-3), 140.01 (C-3), 139.68  (C-31), 139.62 (C-
31), 139.37 (C-25), 139.31 (C-25), 138.15 (C-4, C-4), 135.99 (C-5), 135.95 (C-5), 135.11 (C-
6, C-6), 134.61 (C-16), 134.53 (C-16), 133.03 (C-15), 132.92 (C-15), 132.85 (C-8, C-8), 132.42 
(C-13), 132.24 (C-13), 131.51 (C-12), 131.32 (C-12), 128.80 (C-29, C-29, C-27, C-27, C-35, 




127.87 (C-33, C-33), 127.77 (C-8, C-8), 127.75 (C-7, C-7), 125.76 (C-34, C-34), 125.58 (C-
28, C-28), 82.96 (C-19), 82.52 (C-19), 75.28 (C-20, C-20), 73.50 (C-24), 73.48 (C-24), 72.00 
(C-22), 71.97 (C-22), 36.08 (C-10), 35.97 (C-10), 35.35 (C-9, C-9), 35.10(C-1, C-1), 34.87 (C-
2), 34.52 (C-2).  




A 4 ml scintillation vial was charged with, (±)-4-bromo[2.2]paracyclophane 4.9 (50 mg, 0.28 
mmol,  1.0 eq.), (S)-1-(1-phenylethyl)-4,5-dihydro-1H-imidazole 4.78 (82 mg, 0.28 mmol, 1.0 
eq.), DBU (44 mg, 0.28 mmol, 1.0 eq.), CuI (55 mg, 0.28 mmol, 1.0 eq.), PPh3 (8 mg, 0.028 
mmol, 10 mol%), Pd(OAc)2 (3 mg, 0.014 mmol, 5 mol%). The vial was purged and degassed 
with argon for three times. The degassed DMF (0.82 ml, 0.35 M) was transferred in a vial via 
syringe and the screw capped vial was heated at 110 oC for 16 hrs. The reaction mixture was 
allowed to cooled down at room temperature and diluted with CH2Cl2 and MeOH before 
passing through a pad of Celite©. The resulting filtrate was removed under reduced pressure 
and crude product was purified. 
Purification: Flash chromatography [Neutral Alumina, CH2Cl2 : hexanes 40:60] to obtain the 
title compound as a mixture of diastereomers 4.79, brownish semisolid (36 mg, 0.094 mmol, 
33% yield). 
Rf : 0.5 
1H NMR (CDCl3, 500 MHz): δ 7.37-7.26 (m, 5H, H-29, H-29, H-28, H-28, H-27d1), 7.19-7.13 
(m, 3H, H-27, H-26, H-26), 7.05 (dd, J = 18.9, 7.8 Hz, 2H, H-8, H-8), 6.88-6.81 (m, 4H, H-5, 




H-12), 4.71 (q, J = 7.0 Hz, 1H, H-22), 4.57 (q, J = 5.8 Hz, 1H, H-22), 4.07 (qd, J =8.1, 5.3 Hz, 
1H, H-20a), 3.98-3.86 (dddd, J = 20.6, 11.3, 3.0 Hz, 3H, H-20a, H-20b), 3.55-3.40 (m, 3H, H-
19a, H-19a, H-19b), 3.31-3.28 (m, 1H, H-19b), 3.24-3.12 (m, 7H, H-10a, H-10a, H-10b, H-
10b, H-9a, H-9a, H-9b), 3.08-2.96 (m, 9H, H-9b, H-2a, H-2a, H-2b, H-2b, H-1a, H-1a, H-1b, 
H-1b), 1.55 (d, J = 7.0 Hz, 3H, -CH3), 1.55 (d, J = 6.8 Hz, 3H, -CH3).      
 13C NMR (CDCl3, 125 MHz): δ 166.86 (C-17), 166.22 (C-17), 141.68 (C-24, C-24), 140.40 
(C-14), 140.24 (C-14), 140.06 (C-11, C-11), 139.37 (C-6), 139.28 (C-6), 139.25 (C-3), 139.07 
(C-3), 138.44 (C-4), 138.35 (C-4), 135.04 (C-16), 134.96 (C-16), 134.51 (C-15), 134.41 (C-
15), 133.52 (C-13), 133.41 (C-15), 133.52 (C-13, 133.43 (C-13), 132.84 (C-12, C-12), 132.39 
(C-29, C-1), 132.39 (C29), 132.35 (C-29), 132.30 (C-25), 132.24 (C-25), 131.71 (C-5, C-5), 
128.37 (C-28, C-28), 128.15 (C-26, C-26), 127.10 (C-27, C-27), 127.03 (C-8), 126.99 (C-8), 
126.78 (C-7, (C-7), 53.37 (C-22), 52.73 (C-22), 44.08 (C-20, C-20), 43.44 (C-19, C-19), 35.38 
(C-10, C-10), 35.32 (C-9, C-9), 35.22 (C-2), 35.18 (C-2), 33.80 (C-1), 33.60 (C-1), 18.08 (C-
23,-CH3), 14.91 (C-23,-CH3). 




The compound 4.81 was synthesised following the same procedure (Page no. 296) as the 
synthesise of 4.79 by taking reagents, (±)-4-bromo[2.2]paracyclophane (87 mg, 0.30 mmol, 
1.0 eq.), 1-methyl-benzimidazole 4.80 (40 mg, 0.30 mmol, 1.0 eq.), K2CO3 (105 mg, 0.75 
mmol, 2.5 eq.), CuI (58 mg, 0.30 mmol, 1.0 eq.), PCy3 (9 mg, 0.030 mmol, 0.1 eq.), Pd(OAc)2 
(3 mg, 0.015 mmol, 0.05 eq.), DMA (1.21 ml, 0.25 M), for 48 h. 
Purification: Flash chromatography [SiO2, EtOAc : hexanes 30:70] to obtain the title compound 





Rf : 0.5 
1H NMR (CDCl3, 400 MHz): δ 8.01 (m, 1H, H-20), 7.42-7.35 (m, 3H, H-23, H-22, H-21), 7.00 
(s, 1H, H-5), 7.00 (d, J = 9.8 Hz, 1H, H-8), 6.78 (d, J = 9.8 Hz, 1H, H-7), 6.67-6.59 (m, 4H, H-
16, H-15, H-13, H-12), 3.62 (s, 3H, -CH3), 3.32-3.05 (m, 5H, H-10a, H-10b, H-9a, H9b, H-2a), 
2.97-2.89 (m, 3H, H-2b, H-1a, H-1b). 
13C NMR (CDCl3, 125 MHz): δ 140.69 (C-17), 139.49 (C-24), 139.35 (C14, C-11), 138.98 (C-
19), 135.10 (C-6, C-4), 134.17 (C-23, C-20), 133.77 (C-3), 132.59 (C-22, C-21), 132.18 (C-
16, C-15), 131.70 (C-13, C-12), 122.68 (C-8), 119.89 (C-5), 109.67 (C-7), 35.34 (C-10), 35.24 
(C-9), 35.15 (C-1), 34.02 (-CH3), 30.81 (C-2). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd C24H23N2 339.1856 for; Found 339.1852. 
 




The compound 4.83 & 4.84 were synthesised following the same procedure (Page no. 296) as 
the synthesise of 4.79 by taking reagents, 1-methyl-indole 4.82 (20 mg, 0.30 mmol, 1.0 eq.), 
(±)-4-bromo[2.2]paracyclophane 4.9 (87 mg, 0.30 mmol, 2.0 eq.), K2CO3 (53 mg, 0.75 mmol, 
2.5 eq.),  PivOH (8 mg, 0.076 mmol, 0.5 eq.)  PCy3 (4 mg, 0.015 mmol, 0.1 eq.), Pd(OAc)2 (2 
mg, 0.0076 mmol, 0.05 eq.), DMA (0.61 ml, 0.25 M) for 24 h. 
Purification: Flash chromatography [SiO2, EtOAc:hexanes 5:95] to obtain the title compounds 
(±)-4.83, brownish semisolid (31 mg, 0.09 mmol, 61% yield) and (±)-4.84, brownish semisolid 
(12 mg, 0.038 mmol, 24% yield). 





1H NMR (CDCl3, 500 MHz): δ 7.78 (d, J = 7.8 Hz, 1H, H-24), 7.43 (d, J = 8.1 Hz, 1H, H-23), 
7.30 (d, J = 7.0 Hz, 1H, H-21), 7.23 (t, J = 9.8 Hz, 1H, H-22), 6.88 (d, J = 7.8 Hz, 1H, H-8), 
6.77 (s, 1H, H-5), 6.70 (d, J = 7.8 Hz, 1H, H-8), 6.77 (s, 1H, H-5), 6.70-6.68 (m, 2H, H-16, H-
15), 6.62-6.65 (m, 3H, H-7, H-13, H-12), 6.60 (s, 1H, H-18), 3.55 (s, 3H, -CH3), 3.21-2.79 (m, 
8H, H-10a, H-10b, H-9a, H-9b, H-2a, H-2b, H-1a, H-1b). 
Data comparable to that reported in literature.4 
(±)-4.84 
1H NMR (CDCl3, 500 MHz): δ 7.65 (d, J = 7.9 Hz, 1H, H-23), 7.41 (d, J = 8.2 Hz, 1H, H-22), 
7.31 (d, J = 7.4 Hz, 1H, H-20), 7.25 (s, 1H, H-5), 7.18 (t, J = 7.7 Hz, 1H, H-21), 6.77 (d, J = 
8.0 Hz, 1H, H-8), 6.68 (d, J = 6.3 Hz, 1H, H-7), 6.62-6.50 (m, 4H, H-16, H-15, H-13, H-12), 
6.60 (s, 1H, H-25), 3.95 (s, 3H, -CH3), 3.41 (td, J = 13.4 Hz, 1H, H-10a), 3.21-2.65 (m, 7H, H-
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8.6. Experimental for Chapter 5 and Chapter 6 
 
Preparation of Palladacycle 5.1311,2 
 
Ortho-toluic acid (2.0 g, 14.68 mmol, 1.0 eq.) was treated with KOH (0.659 g, 11.74 mmol, 
0.8 eq.) in water (15 ml) at room temperature. Water was removed in a rotary evaporator, the 
white solid was washed with CH2Cl2 (20 ml × 3) to remove excess of ortho-toluic acid and 
dried under vacuum at 100 °C to give potassium ortho-toluate (1.8 g, 10.3 mmol, 73% yield). 
Pd(OAc)2 (516 mg, 2.29 mmol, 1.0 eq.) was added to a suspension of potassium ortho-toluate 
(400 mg, 2.29 mmol, 1.0 eq.) in 1,4-dioxane (9 ml) and heated to 100 oC for overnight. The 
reaction mixture was filtered and washed with CH2Cl2 (5 ml) and dried under vacuum to get 
the palladacycle 5.131 (880 mg, 1.19 mmol, 55% yield). 
Data comparable to that reported in the literature.1,2 
2-(m-tolyl)pyridine 5.1363 
 
A flame dried Schlenk tube was charged with palladacycle (100 mg, 0.13 mmol, 1.0 eq.), 
pyridine-2-sulfinate (44.83 mg, 0.27 mmol, 2.0 eq.), potassium carbonate (75 mg, 0.54 mmol, 
4.0 eq.). The Schlenk tube was degassed and back filled with argon three time. The dry 1,4-
dioxane (1.3 ml, 0.1 M) was transferred into tube under constant argon flow. The Hi-Vac valve 
was closed and the reaction allowed to stir at 150 °C. After 24 h, the reaction mixture was 




solvent fractions were removed in a rotary evaporator. The resulting crude was purified by 
column chromatography [SiO2, Et2O : Pentane (3:7)] to obtain title compound as pale brownish 
powder (7 mg, 0.088 mmol, 15% yield). 
 
Rf : 0.7  
 
1H NMR (CDCl3, 500 MHz): δ 8.73 (d, J = 4.7 Hz, 1H, H-12), 7.86 (s, 1H, H-5), 7.80-7.44 (m, 
3H, H-11, H-10, H-9), 7.41 (t, J = 7.62 Hz, 1H, H-2), 7.27-7.24 (m, 2H, H-3, H-1), 2.47 (s, 3H, 
-CH3). 
13C NMR (CDCl3, 125 MHz): δ 149.47 (C-8), 139.18 (C-12), 136.89 (C-6), 129.82 (C-4), 
128.67 (C-10, C-5), 127.67 (C-2, C-1), 124.04 (C-3), 122.06 (C-11), 120.73 (C-9), 21.52 (C-
7, -Me). 
MS (ESI-TOF) m/z: [M + H]+ Calcd for C12H12N 170.09; Found 170.03. 
 





N-Methoxy-2-methylbenzamide (100 mg, 0.60 mmol, 1.0 eq.), and Pd(OAc)2 (135 mg, 0.60 
mmol, 1.0 eq.),  were suspended in 15 ml pressure tube. accurately. Then glacial AcOH (6.0 
ml) was added via cannula and the tube was evacuated and back filled with argon gas three 
times. The septum was removed under an optimal flow of argon and the tube was closed with 
a screw cap. The reaction was allowed to stir at 120 oC for 15 min. the reaction was cooled 
down to room temperature and diluted with CH2Cl2 (5 ml) and MeOH (5 ml), filtered through 
a pad of Celite©, and filtrate was concentrated under vacuum. The crude residue (107 mg, 0.397 





1H NMR (CD3CN, 500 MHz): δ 7.03 (d, J = 7.2 Hz, 1H, H-2), 6.84 - 6.78 (m, 2H, H-1, H-3), 
3.58 (s, 3H, -OMe), 2.52 (s, 3H, -Me). 
13C NMR (CDCl3, 125 MHz): δ 177.5 (C-8), 144.04 (C-6), 137.9 (C-5), 133.5 (C-2), 129.9 
(C-1), 128.4 (C-13), 126.6 (C-7). 
Data comparable to that reported in the literature.4 
 
2-methyl-6-(pyridin-2-yl)benzoic acid 5.1265 
 
The compound 5.126 was synthesised by following the same procedure as mentioned in for 
5.136 (page no. 237) by taking palladacycle 5.140 (65 mg, 0.24 mmol, 1.0 eq.), pyridine-2-
sulfinate (79.74 mg, 0.48 mmol, 2.0 eq.), potassium carbonate (133.56 mg, 0.96 mmol, 4.0 
eq.), solvent CH3CN ( [0.1M], 2.4 ml ), The crude was purified using a preparative TLC [SiO2, 
EtOAc : hexanes (7:3)] to obtain the title compound 5.126 as while powder (4 mg, 0.018 mmol, 
8% yield). 
Rf : 0.3  
1H NMR (CDCl3, 500 MHz): δ 8.57 - 8.52 (m, 1H, H-13), 7.84 - 7.74 (m, 3H, H-16, H-15), 
7.63 - 7.62 (m, 1H, H-14), 7.39 - 7.36 (m, 2H, H-3, H-2), 7.29 - 7.27 (m, 1H, H-1), 2.47 (s, 3H, 
-CH3). 
 
MS (ESI-TOF) m/z: [M + H]+ Calcd for C13H10NNaO2 235.06; Found 235.21. 
 










Time-based study with stoichiometric quantity of Pd(OAc)2 

























Procedure for pyridine thiol oxidation:  
 
Pyridine thiol (1 g, 9 mmol, 1.0 eq.) was dissolved in a mixture of 40 ml of water containing 
sodium hydroxide (468 mg, 11.7 mmol, 1.3 eq.) and 40 ml of ethanol. An aqueous solution of 
hydrogen peroxide (1 ml, 9.9 mmol, 1.1 eq., 30% (w/w) in H2O) was added dropwise at room 
temperature. The reaction was stirred until completion (TLC monitoring). The solvent was 
removed under vacuum and the remaining residue was washed with ethyl acetate (40 ml × 3). 
The aqueous phase was evaporated to obtain wet sulfinate salt which was dried under freeze 
dryer overnight to afford dry sulfinate salts. 
Sodium pyridine-2-sulfinate 5.123 & 6.516 
 
The above procedure was followed using pyridine-2-thiol (1000 mg, 9 mmol, 1.0 eq.). The 
product was obtained as a white solid (985 mg, 6.00 mmol, 58 %).  
Data comparable to that reported in literature.6 
1H NMR (CD3OD, 400 MHz): δ 8.54 (1H, dt, J = 5.0, 1.0 Hz), 7.99 (1H, td, J = 7.6, 1.8 Hz), 
7.91(1H, dt, J = 7.8, 2.0 Hz), 7.44 (1H, ddd, J = 7.3, 4.8, 1.2 Hz).  
Sodium pyridine-4-sulfinate6.536  
 
The above procedure was followed using pyridine-2-thiol (1000 mg, 9 mmol, 1.0 eq.). The 
product was obtained as a white solid (710 mg, 4.32 mmol, 42 %).  
1H NMR (CD3OD, 400 MHz): δ 8.78 (2H, d, J = 6.2 Hz), 7.69 (2H, d, J = 6.2 Hz). 






Sodium pyridine-3-sulfinate 6.527  
 
 
Phosphorus pentachloride (16.25 g, 78.0 mmol, 1.2 eq.) and phosphorus oxychloride (20.0 ml, 
213.9 mmol, 3.2 eq.) were added to 3-pyridinesulfonic acid (10.40 g, 65.0 mmol, 1 eq.) at 0 
oC. The reaction mixture was brought to reflux and stirred overnight at 120 0 °C. Next morning, 
the reaction mixture was cooled to room temperature and diluted with dry CH2Cl2 (30 ml). The 
reaction mixture was further cooled to 5 °C and saturated with HCl gas. The white precipitate 
was collected by filtration, washed with dry CH2Cl2 (50 ml) and dried under reduced pressure. 
3-Pyridinesulfonyl chloride was obtained as a white powder and used immediately for the next 
reaction (11.73 g, 55.3 mmol, 84%). 
3-Pyridinesulfonyl chloride (11.73 g, 55.08 mmol, 1eq.) was added to a solution of NaHCO3 ( 
13.88 g, 165.24 mmol, 3 eq.) and Na2SO3.7H2O (110.16 g, 27.76 mmol, 2 eq.) and H2O (75 
ml). Th reaction mixture was heated at 80 °C for 3 hrs. The resulting crude was filtered and 
filtrate was concentrated under reduced pressure to give 3-pyridylsulfinic acid sodium salt was 
pale yellow solid. (4.32 g, 26.3 mmol, 48%) (ASC 2004 925, PCT. INT.Appl. 2008014199 31 
Jan 2008) 
1H NMR (CD3OD, 400 MHz): δ 8.78 (1H, d, J = 1.4 Hz), 8.57 (1H, dd, J = 5.0, 1.7 Hz), 8.09 
(1H, dt, J = 7.8, 2.0 Hz), 7.54 (1H, dd, J = 7.2, 4.4 Hz).   













General procedure A: Desulfitative coupling with bromo[2.2]paracyclophane  
 
A 4 ml scintillation vial was charged with bromo[2.2]paracyclophane (1.0 eq.), pyridine 
sulfinate (2.0 eq.), K2CO3 (1.5 eq.), PCy3 (0.4 eq.), and Pd(OAc)2 (0.1 eq.). The vial was purged 
and degassed with argon for three times. Degassed DMA or 1,4-dioxane (0.2 M) was 
transferred by syringe and the screw-capped vial was heated at 150 °C until completion. The 
reaction mixture was cooled to room temperature and diluted with CH2Cl2 and MeOH before 
passing through a pad of Celite©. The resulting filtrate was removed under reduced pressure 
and the crude product was purified by flash chromatography. 
General procedure B: Bis-desulfitative coupling with dibromo[2.2]paracyclophane 
 
A 4 ml scintillation vial was charged with dibromo[2.2]paracyclophane (1.0 eq.), pyridine 
sulfinate (4.0 eq.), K2CO3 (3 eq.), PCy3 (0.8 eq.), and Pd(OAc)2 (0.2 eq.). The vial was purged 
and degassed with argon for three times. Degassed DMA (0.2 M) was transferred by syringe 
and the screw-capped vial was heated at 150 °C until completion. The reaction mixture was 
cooled to room temperature and diluted with CH2Cl2 and MeOH before passing through a pad 
of Celite©. The resulting filtrate was removed under reduced pressure and the crude product 







General procedure C: Mono-desulfitative coupling with dibromo[2.2]paracyclophane 
 
A 4 ml scintillation vial was charged with dibromo[2.2]paracyclophane (1.0 eq.), pyridine 
sulfinate (2.0 eq.), K2CO3 (1.5 eq.), PCy3 (0.4 eq.), and Pd(OAc)2 (0.1 eq.). The vial was purged 
and degassed with argon for three times. Degassed DMA (0.2 M) was transferred by syringe 
and the screw-capped vial was heated at 150 °C until completion. The reaction mixture was 
cooled to room temperature and diluted with CH2Cl2 and MeOH before passing through a pad 
of Celite©. The resulting filtrate was removed under reduced pressure and the crude product 

























General procedure A was followed using (±)-4-bromo[2.2]paracyclophane 6.40 (50 mg, 0.17 
mmol,  1.0 eq.), pyridine-2-sulfinate 6.50 (58 mg, 0.35 mmol, 2 eq.), K2CO3 (36 mg, 0.26 
mmol, 1.5 eq.), PCy3 (20 mg, 0.069 mmol, 40 mol%), Pd(OAc)2 (4 mg, 0.017 mmol, 10 mol%), 
DMA (0.87 ml) for 24 hrs.  
Purification: Flash chromatography [SiO2, EtOAc: hexanes (30 : 70)] to obtain the title 
compound 6.42 as pinkish white powder (31mg, 0.10 mmol, 63% yield). 
Rf : 0.5 
IR: νmax 3418, 2927, 2849, 1892, 1651, 1584, 1511, 1446, 1261, 1178, 1035 cm
-1  
1H NMR (CDCl3, 500 MHz): δ  8.79 (d,  J = 4.7 Hz, 1H, H-21), 7.82 (t,  J = 7.7, 1.4 Hz, H-
19), 7.55 (d,  J = 7.8 Hz, 1H, H-18), 7.28-7.25 (m, 1H, H-20), 6.88 (S, 1H, H-5), 6.65-6.57 (m, 
6H, H-7, H-8, H-12, H-13, H-15, H-16), 3.74-3.68 (m, 1H, H-2a), 3.25-3.17 (m, 2H, H-1a, H-
1b), 3.14-3.05 (m, 2H, H-9a, H-9b), 3.01-2.94 (m, 2H, H-10a, H-10b), 2.72-2.65 (m, 1H, H-
2b). 
13C NMR (CDCl3, 125 MHz): δ 159.21 (C-17), 149.64 (C-21), 140.62 (C-14), 139.79 (C-11), 
139.61 (C-6), 139.39 (C-4), 138.17 (C-3), 136.25 (C-12), 136.18 (C-13), 133.16 (C-19), 132.88 
(C-5), 132.65 (C-15), 132.57 (C-16), 132.38 (C-7), 130.67 (C-20), 124.17 (C-18), 35.49 (C-2), 
35.26 (C-9), 35.12 (C-10), 34.50 (C-1). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H20N 286.1590; Found 286.1588. 
 











General procedure A was followed using (±)-4-bromo[2.2]paracyclophane 6.40 (50 mg, 0.17 
mmol,  1.0 eq.), pyridine-3-sulfinate 6.51 (58 mg, 0.35 mmol, 2 eq.), K2CO3 (36 mg, 0.26 
mmol, 1.5 eq.), PCy3 (20 mg, 0.069 mmol, 40 mol%), Pd(OAc)2 (4 mg, 0.017 mmol, 10 mol%), 
DMA (0.87 ml) for 24 hrs. 
Purification: Flash chromatography [SiO2, EtOAc: hexanes (30 : 70)] to obtain the title 
compound 6.52 as a white powder (41mg, 0.14 mmol, 84% yield). 
Rf : 0.5 
IR: νmax 3850, 3742, 3673, 2975, 2252, 2199, 2155, 2029, 1975, 1469, 1384, 1089 cm
-1  
 
1H NMR (CDCl3, 500 MHz): δ 8.78 (s, 1H, H-22), 8.64 (d,  J = 4.1 Hz, 1H, H-20), 7.82 (dt,  J 
= 6.3, 1.4 Hz, 1H, H-18), 7.44 (dd,  J = 7.8, 4.8 Hz, 1H, H-19), 6.68-6.65 (m, 2H, H-5, H-7), 
6.60-6.58 (m, 5H, H-8, H-13, H-12, H-15, H-16), 3.41 (td,  J = 10.4, 3.3 Hz, 1H, H-2a), 3.23-
3.06 (m, 4H, H-1a, H-1b, H-9a, H-9b), 3.03-2.89 (m, 2H, H-10a, H-10b), 2.69-2.64 (m, 1H, H-
2b). 
13C NMR (CDCl3, 125 MHz): δ 150.57 (C-22), 148.00 (C-21), 140.16 (C-14), 139.58 (C-11), 
139.52 (C-17), 138.19 (C-6), 137.18 (C-4), 136.86 (C-13), 136.57 (C-3), 136.09 (C-12), 133.27 
(C-15), 133.04 (C-16), 132.76 (C-18), 132.10 (C-5), 131.99 (C-7), 129.59 (C-19), 123.42 (C-
8), 35.50 (C-2), 35.22 (C-9), 34.87 (C-10), 33.91 (C-1). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H20N 286.1590; Found 286.1587. 









General procedure A was followed using (±)-4-bromo[2.2]paracyclophane 6.40 (50 mg, 0.17 
mmol, 1.0 eq.), pyridine-4-sulfinate 6.53 (57 mg, 0.35 mmol, 2 eq.), K2CO3 (72 mg, 0.26 mmol, 
3 eq.), PCy3 (39 mg, 0.14 mmol, 80 mol%), Pd(OAc)2 (8 mg, 0.035 mmol, 20 mol%), DMA 
(0.87 ml) for 72 hrs. 
Purification: Flash chromatography [SiO2, Et3N:CH2Cl2:hexanes (2:19:79)] to obtain the title 
compound 6.54 as a white powder (50 mg, 0.17 mmol, 100% yield). 
Rf : 0.5 
IR: νmax 3070, 3022, 2953, 2925, 2897, 2853, 1922, 1896, 1617, 1595, 1496, 1399, 1259, 1091 
cm-1 
1H NMR (CDCl3, 500 MHz): δ 8.73 (d,  J = 3.7 Hz, 2H, H-22, H-21), 7.45 (d,  J = 5.6 Hz, 2H, 
H-18, H-19), 6.67-6.64 (m, 2H, H-5, H-7), 6.61-6.54 (m, 5H, H-8, H-12, H-13, H-15, H-16), 
3.44 (td,  J = 10.6 Hz, 1H, H-2a), 3.22-3.05 (m, 4H, H-1a, H-1b, H-9a, H-9b), 3.03-2.90 (m, 
2H, H-10a, H-10b), 2.71-2.65 9m, 1H, H-2b). 
13C NMR (CDCl3, 125 MHz): δ 150.06 (C-21, C-19, C-22, C-18), 148.59 (C-17), 140.19 (C-
6), 139.54 (C-11, C-14), 139.18 (C-4), 137.24 (C-3), 136.20 (C-12, C-13), 133.51 (C-5), 133.03 
(C-15, C-16), 132.73 (C-5), 132.02 (C-7), 131.99 (C-8), 129.76 (C-18), 124.47 (C-22), 35.49 
(C-1), 35.21 (C-10), 34.92 (C-9), 33.91 (C-2). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H20N 286.1590; Found 286.1588. 











A 4 ml scintillation vial was charged with 4-bromo[2.2]paracyclophane 6.40 (40 mg, 0.14 
mmol, 1.0 eq.), pyridine-4-thiol 6.61 (57 mg, 0.35 mmol, 2 eq.), K2CO3 (29 mg, 0.21 mmol, 
1.5 eq.), PCy3 (16 mg, 0.055 mmol, 0.4 eq.), and Pd(OAc)2 (3 mg, 0.014 mmol, 0.1 eq.). The 
vial was purged and degassed with argon for three times. Degassed DMA (0.7 ml, 0.2 M) was 
transferred by syringe and the screw-capped vial was heated at 150 °C for 52 hrs. The reaction 
mixture was cooled to room temperature and diluted with CH2Cl2 and MeOH before passing 
through a pad of Celite©. The resulting filtrate was removed under reduced pressure and the 
crude product was purified by flash chromatography.  
Purification: Flash chromatography [SiO2, EtOAc: Hexane (30:70)] to obtain the title 
compound 6.55 as a white powder (20 mg, 0.15 mmol, 46%). 
Rf : 0.6 
IR: νmax 3850, 3742, 3673, 2975, 2292, 2199, 2155, 2029, 1975, 1469, 1384, 1089 cm
-1  
1H NMR (CDCl3, 500 MHz): δ 8.30 (d,  J = 5.05 Hz, 2H, H-20, H-22), 6.92 (d,  J = 5.25 Hz, 
2H, H-19, H-23), 6.88 (d,  J = 4.1 Hz, 1H, H-5), 6.70-6.65 (m, 3H, H-12, H-13, H-15), 6.58 (q,  
J = 13.7, 7.8 Hz, 2H, H-7, H-8), 6.49 (d,  J = 7.8 Hz, 1H, H-16), 3.40-3.35 (m, 1H, H-2a), 3.25 
(td,  J = 13.1, 5.7 Hz, 1H, H-2b), 3.18-3.10 (m, 4H, H-1a, H-1b, H-10a, H-10b), 3.07-3.00 (m, 
1H, H-9a), 2.86-2.80 (m, 1H, H-9b). 
13C NMR (CDCl3, 125 MHz): δ 150.34 (C-18), 148.98 (C-22,C-20), 144.20 (C-14), 141.47 (C-
11), 140.10 (C-6), 139.57 (C-4), 139.38 (C-3), 135.54 (C-15), 134.85 (C-13), 133.37 (C-12), 
133.31 (C-16), 132.30 (C-8), 129.96 (C-5), 129.80 (C-7), 120.35 (C-23, C-19), 35.32 (C-10), 
34.84 (C-9), 34.71 (C-1), 34.35 (C-2). 









General procedure B was followed using 4,12-dibromo-[2.2]paracyclophane 6.63 (60 mg, 0.16 
mmol,  1.0 eq.), pyridine-2-sulfinate 6.50 (109 mg, 0.66 mmol, 4 eq.), K2CO3 (68 mg, 0.49 
mmol, 3.0 eq.), PCy3 (37 mg, 0.131 mmol, 80 mol%), Pd(OAc)2 (7 mg, 0.017 mmol, 20 mol%), 
DMA (0.82 ml) for 22 hrs. 
Purification: Flash chromatography [SiO2, Et3N:CH2Cl2:hexanes (2:39:59)] to obtain the title 
compound 6.64 as yellowish semisolid (12 mg, 0.05 mmol, 20% yield). 
Rf : 0.3 
IR: νmax 37.86, 3693, 3532, 2252, 2197, 2183, 2166, 2002, 1957 cm
-1  
1H NMR (CDCl3, 500 MHz): δ  8.97 (bs, 2H, H-25, H-21), 7.97 (d,  J = 7.8 Hz, 2H, H-28, H-
18), 7.87-7.85 (m, 2H, H-27, H-20), 7.38-7.27 (m, 2H, H-26, H-21), 6.90 (s, 2H, H-4, H-12), 
6.79 (d,  J = 7.7 Hz, H-18, H-15), 6.70 (d,  J = 7.3 Hz, H-7, H-16), 3.87 (m, 2H, H-9a, H-2a), 
3.07-3.03 (m, 2H, H-9b, H-2b), 2.94-2.87 (m, 2H, H-1a, H-10a), 2.50-2.42 (m, 2H, H-1b, H-
10b) 
13C NMR (CDCl3, 125 MHz): δ 148.96 (C-17, C-23, C-21, C-25), 139.98 (C-11, C-3), 138.10 
(C-27, C-19, C-6, C-5), 136.22 (C-13, C-14, C-12, C-4), 133.02 (C-16, C-8, C-26, C-20), 
130.78 (C-7, C-15, C-28, C-18), 35.67 (C-2), 35.13 (C-10), 34.24 (C-10, C-9). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C26H23N2 363.1856; Found 363.1849. 









4,12-Bis(pyridin-3,3ʹ-yl)[2.2]paracyclophane 6.65 and 4-(Pyridin-3-ylthio)-12-(pyridin-3-
yl)[2.2]paracyclophane 6.66  
 
General procedure B was followed using 4,12-dibromo[2.2]paracyclophane 6.63 (60 mg, 0.16 
mmol, 1.0 eq.), pyridine-3-sulfinate 6.51 (109 mg, 0.66 mmol, 4 eq.), K2CO3 (68 mg, 0.49 
mmol, 3.0 eq.), PCy3 (37 mg, 0.131 mmol, 0.8 eq.), Pd(OAc)2 (7 mg, 0.017 mmol, 0.2 eq.), 
DMA (0.82 ml) for 21 hrs. 
Purification: Flash chromatography [SiO2, Et3N:CH2Cl2:hexanes (2:39:59)] gave the title 
compound 6.65 as yellowish semisolid (7 mg, 0.01 mmol, 13%) and by-product 6.66 yellowish 
semisolid (14 mg, 0.03 mmol, 22%). 
Rf : 0.3 
1H NMR (CDCl3, 500 MHz): δ 8.61(2H, dd, J = 5.1, 1.8 Hz), 8.59 (2H, d, J = 1.5 Hz), 7.62 
(2H, ddd, J = 7.9, 3.8, 1.8 Hz), 7.36 (2H, dd, J = 7.9, 5.2 Hz), 6.80 (2H, d, J = 7.7 Hz), 6.73 
(2H, dd, J = 7.9, 1.8 Hz), 6.62 (2H, d, J = 1.5 Hz), 3.51 (2H, ddd, J = 13.2, 10.1, 1.8 Hz), 3.21 
(2H, ddd, J = 12.3, 10.1, 2.0 Hz), 3.05 (2H, ddd, J = 13.7, 10.4, 6.6 Hz), 2.79 (2H, ddd, J = 
13.3, 10.2, 6.6 Hz). 











4-(Pyridin-3-ylthio)-12-(pyridin-3-yl)[2.2]paracyclophane 28  
 
Rf : 0.5 
1H NMR (CDCl3, 500 MHz): δ 8.83 (1H, d, J = 1.6 Hz), 8.62 (1H, dd, J = 4.8, 1.5 Hz), 8.47 
(1H, d, J = 1.8 Hz), 8.37 (1H, dd, J = 4.7, 1.4 Hz), 8.00 (1H, ddd, J = 7.9, 4.2, 2.1 Hz), 7.45 
(1H, dd, J = 7.2, 4.2 Hz), 7.42 (1H, ddd, J = 8.0, 3.9, 1.6 Hz), 7.13 (1H, ddd, J = 7.9, 4.7, 0.4 
Hz), 6.95 (1H, d, J = 1.7 Hz), 6.74-6.68 (3H, m), 6.62 (2H, dd, J = 7.3, 1.7 Hz), 3.51-3.43 (2H, 
m), 3.29-3.20 (2H, m), 2.93-2.82 (3H, m), 2.46-2.36 (1H, m).  


















yl)[2.2]paracyclophane 6.71, and 4-(Pyridin-2-ylthio)-16-(pyridin-2-yl) 
[2.2]paracyclophane 6.70 
 
General procedure B was followed using 4,16-dibromo-[2.2]paracyclophane 6.63 (60 mg, 0.16 
mmol, 1.0 eq.), pyridine-2-sulfinate 6.50 (109 mg, 0.66 mmol, 4 eq.), K2CO3 (68 mg, 0.49 
mmol, 3.0 eq.), PCy3 (37 mg, 0.131 mmol, 0.8 eq.), Pd(OAc)2 (7 mg, 0.017 mmol, 0.2 eq.), 
DMA (0.82 ml) for 18 hrs. 
Purification: Flash chromatography [SiO2, Et3N:CH2Cl2:hexanes (2:39:59)] gave the title 
compound 6.69 as a yellowish semisolid (38 mg, 0.10 mmol, 66%), by-product 6.71 as 
yellowish semisolid (7 mg, 0.01 mmol, 12%), and by-product 6.70 as white semisolid (6 mg, 
0.01 mmol, 9%). 
Rf : 0.3 
IR: νmax 3743, 3674, 2988, 2899, 2253, 2143, 2106, 1998, 1393, 1240, 1240, 1062, 1057 cm
-1  
 
1H NMR (CDCl3, 500 MHz): δ  8.80 (d,  J = 5.2 Hz, 2H, H-21, H-25), 7.82 (td,  J = 2.1, 9.6 
Hz, 2H, H-19, H-26), 7.56 (d,  J = 9.8 Hz, H-18, H-28), 7.28-7.26 (m, 2H, H-20, H-27), 6.96 
(S, 2H, H-5, H-15), 6.74 (d,  J = 9.7 Hz, 2H, H-8 H-7), 6.63 (d,  J = 9.6 Hz, H-13, H-12), 3.67 
(td,  J = 12.6, 4.9 Hz, H-2a, H-2b), 3.15 (td,  J = 12.7, 6.0 Hz, H-10a, H-10b), 2.99 (td,  J = 
12.7, 4.9 Hz, H-1a, H-b), 2.86 (td,  J = 12.5, 5.9 Hz, H-9a, H-9b). 
13C NMR (CDCl3, 125 MHz): δ 159.21 (C-17, C-23), 149.68 (C-21, C-25), 140.82 (C-14, C-
3), 139.78 (C-11, C-6), 137.82 (C-4, C-16), 136.26 (C-12, C-13), 135.47 (C-19, C-27), 132.55 
(C-5, C-15), 131.19 (C-20, C-26), 124.44 (C-7, C-8), 121.41 (C-18, C-28), 34.95 (C-2, C-10), 
33.87 (C-1), 29.70 (C-9). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C26H23N2 363.1856; Found 363.1852. 




4-(Pyridin-2-ylthio)-16-(pyridin-2-yl) [2.2]paracyclophane 6.70 
 
Rf : 0.4 
IR: νmax 3675, 2989, 2900, 2253, 1393, 1241, 1066 cm
-1. 
 
1H NMR (CDCl3, 500 MHz): δ 8.81 (1H, d, J = 4.2 Hz), 8.44 (1H, d, J = 4.6 Hz), 7.81 (1H, td, 
J = 7.6, 1.6 Hz), 7.51 (1H, d, J = 7.8 Hz), 7.39 (1H, td, J = 7.8, 1.7 Hz), 7.28-7.26 (1H, m), 
6.99-6.95 (2H, m),  6.92 (1H, d, J = 1.4 Hz), 6.84 (1H, d, J = 1.0 Hz), 6.79 (1H, d, J = 8.1 Hz), 
6.76-6.74 (1H, m), 6.71 (1H, d, J = 7.8 Hz), 6.62 (1H, d, J = 7.9 Hz), 3.70 (1H, ddd, J = 13.5, 
10.1, 3.5 Hz), 3.57 (1H, ddd, J = 13.1, 10.4, 2.7 Hz), 3.36 (1H, ddd, J = 13.0, 10.5, 4.9 Hz), 
3.13-3.00 (2H, m), 2.95 (2H, ddd, J = 13.1, 10.5, 5.6 Hz), 2.80 (1H, ddd, J = 14.5, 10.0, 4.8 
Hz). 
Due to small quantity, a satisfactory 13C NMR was not obtained. 
















Rf : 0.5 
IR: νmax 3674, 2988, 2899, 2253, 2154, 2000, 1967, 1471, 1393, 1204 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ  8.82 (1H, d, J = 4.2 Hz), 7.84 (1H, t, J = 7.2 Hz), 7.52 (1H, d, 
J = 7.8 Hz), 7.32 (1H, t, J = 6.1 Hz), 7.22 (1H, d, J = 7.7 Hz), 6.94 (1H, s), 6.65-6.61 (3H, m), 
6.54 (1H, d, J = 7.7 Hz), 3.66 (1H, ddd, J = 13.8, 10.1, 4.0 Hz), 3.56 (1H, ddd, J = 12.8, 10.2, 
2.2 Hz), 3.30-3.25 (1H, ddd, J = 13.0, 10.3, 5.2 Hz), 3.13-2.95 (3H, m), 2.87 (1H, ddd, J = 
13.8, 10.2, 3.9 Hz), 2.78 (1H, ddd, J = 14.4, 10.2, 4.8 Hz).  
13C NMR (CDCl3, 125 MHz): δ 158.96, 149.67, 141.79, 139.37, 138.76, 137.62, 136.22, 
137.01, 135.29, 134.51, 132.87, 129.92, 129.38, 129.08, 126.46, 124.43, 121.46, 35.38, 34.54, 
33.93, 33.34. 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C21H19Br
79N 364.0695; Found 364.0693; 
C21H29Br








General procedure B was followed using (±)-4,16-dibromo-[2.2]paracyclophane 6.68 (70 mg, 
0.19 mmol, 1.0 eq.), pyridine-3-sulfinate 6.51 (127 mg, 0.77 mmol, 4 eq.), K2CO3 (80 mg, 0.57 
mmol, 3.0 eq.), PCy3 (43 mg, 0.15 mmol, 80 mol%), Pd(OAc)2 (9mg, 0.039 mmol, 20 mol%), 
DMA (0.96 ml) for 24 hrs.  
Purification: Flash chromatography [SiO2, EtOAc: hexanes (40:60)] to obtain the by-product 
compound 6.72 as yellowish semisolid (13 mg, 0.03 mmol, 16% yield). 
Rf : 0.3 
IR: νmax 3683, 3674, 3666, 2988, 2971, 2899, 2245, 2155, 2029, 1406, 1393, 1249, 1075 cm
-1  
1H NMR (CDCl3, 500 MHz): δ 8.47 (s, 2H, H-19, H-26), 8.39 (d,  J = 4.2 Hz, 2H, H-21, H-
28), 7.40 (d,  J = 8.05 Hz, 1H, H-23, H-30), 7.15 (dd,  J = 8.05, 4.75 Hz, 1H, H-22, H-29), 7.08 
(d,  J = 7.7 Hz, 2H, H-5, H-15), 6.52-6.49 (m, 4H, H-7, H-8, H-12, H-13), 3.44-3.39 (m, 2H, 
H-2a, H-2b), 3.27 (ddd,  J = 13.1, 10.5, 5.0 Hz, 1H, H-9a, H-9b), 3.03-2.98 (m, 2H, H-10a, H-
10b), 2.83 (ddd,  J = 13.3, 10.8, 5.1 Hz, 2H, H-1a, H-1b). 
13C NMR (CDCl3, 125 MHz): δ 148.99 (C-25,C-18), 147.01 (C-26, C-190, 142.05 (C-28,C-
21), 140.89 (C-14, C-6), 138.59 (C-29, C-22, C-23,C-30), 135.78 (C-8,C-12), 134.54 (C-5, C-
15), 133.36 (C-4, C-16), 130.26 (C-7, C-15), 123.82 (C-3,C-11), 34.03 (C-1,C-9), 33.33 (C-2, 
C-10).  











General procedure B was followed using 4,16-dibromo[2.2]paracyclophane 6.68 (50 mg, 0.14 
mmol, 1.0 eq.), pyridine-4-sulfinate 6.53 (91 mg, 0.55 mmol, 4 eq.), K2CO3 (57 mg, 0.41 mmol, 
3.0 eq.), PCy3 (34 mg, 0.11 mmol, 0.8 eq.), Pd(OAc)2 (6 mg, 0.013 mmol, 0.2 eq.), DMA (0.69 
ml) for 20 hrs. 
Purification: Flash chromatography [EtOAc:hexanes (0 – 100 to 100:0, gradient elution)] to 
obtain the title compound 6.73 as a white solid powder (33 mg, 0.10 mmol, 66%). 
Rf : 0.2 [EtOAc:hexanes (80:20)] 
IR: νmax 3683, 3675, 2989, 2900, 2197, 1405, 1393, 1241, 1076, 1057 cm
-1.  
1H NMR (CDCl3, 500 MHz): δ 8.76 (4H, bs), 7.48 (4H, d, J = 5.3 Hz), 6.70-6.71 (4H, m), 6.63 
(2H, dd, J = 8.0, 1.7 Hz), 3.49 (2H, ddd, J = 13.9, 9.8, 4.0 Hz), 3.14 (2H, ddd, J = 14.3, 10.2, 
4.5 Hz), 2.97 (2H, ddd, J = 13.4, 10.3, 4.0 Hz), 2.85 (2H, ddd, J = 14.2, 10.1, 4.4 Hz).  
13C NMR (CDCl3, 175 MHz): δ 150.02, 148.56, 140.16, 139.56, 137.17, 135.10, 132.28, 
130.41, 124.51, 34.69, 33.56. 
HRMS (ESI-TOF) m/z: [M+H]+ C26H23N2 363.1856; Found 363.1854.  













4-Bromo-12-(pyridin-2-yl)[2.2]paracyclophane 6.74  
 
General procedure C was followed using (±)-4,12-dibromo-[2.2]paracyclophane 6.63 (50 mg, 
0.14 mmol, 1.0 eq.), pyridine-2-sulfinate 6.50 (45 mg, 0.27 mmol, 2 eq.), K2CO3 (28 mg, 0.26 
mmol, 1.5 eq.), PCy3 (15 mg, 0.069 mmol, 40 mol%), Pd(OAc)2 (3 mg, 0.017 mmol, 10 mol%), 
DMA (0.69 ml) for 26 hrs.  
Purification: Flash chromatography [SiO2, EtOAc: hexanes (30:70)] to obtain the title 
compound 6.74 as yellowish semisolid (17 mg, 0.046 mmol, 34% yield). 
Rf : 0.6 
IR: νmax 3616.06, 2973.20, 2252.56, 2189.84, 2007.88, 1793.65, 1587.10 cm
-1  
1H NMR (CDCl3, 500 MHz): δ  8.74 (d,  J = 4.7 Hz, 1H, H-21), 7.90-7.86 (m, 2H, H-18, H-
19), 7.27 (d,  J = 3.4 Hz, 1H, H-20), 7.25 (s, 1H, H-13), 6.74 (d,  J = 7.7 Hz, 1H, H-16), 6.69 
(s, 1H, H-5), 6.62 (s, 2H, H-8, H-7), 6.61 (dd,  J = 7.8, 1.7 Hz, 1H, H-15), 3.97 (dd,  J = 12.4, 
10.3 Hz, 1H, H-9a), 3.57 (ddd,  J = 1.8, 9.3, 13.2 Hz, 1H, H-10a), 3.25-3.18 (m, 2H, H-9a, H-
10b), 2.98-2.93 (m, 1H, H-2a), 2.92-2.85 (m, 2H, H-1a, H-1b), 2.42-2.36 (m, 1H, H-2b). 
13C NMR (CDCl3, 125 MHz): δ 159.40 (C-17), 149.40 (C-21), 142.12 (C-6), 140.28 (C-14), 
139.15 (C-3), 138.85 (C-5), 138.42 (C-12), 136.81 (C-11), 136.38 (C-8), 135.07 (C-13), 133.62 
(C-7), 133.04 (C-15), 131.61 (C-16), 129.00 (C-20), 125.97 (C-19), 122.91 (C-4), 121.52 (C- 
18), 36.06 (C-9), 34.92 (C-2), 33.92 (C-10), 32.54 (C-1). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H18Br
79N 364.0701; Found 364.0690; 
C21H29Br









General procedure C was followed using 4,12-dibromo[2.2]paracyclophane 6.63 (60 mg, 0.14 
mmol, 1.0 eq.), pyridine-3-sulfinate 6.51 (54 mg, 0.27 mmol, 2 eq.), K2CO3 (34 mg, 0.26 mmol, 
1.5 eq.), PCy3 (20 mg, 0.065 mmol, 0.4 eq.), Pd(OAc)2 (4 mg, 0.017 mmol, 0.1 eq.), DMA 
(0.82 ml) for 23 hrs. 
Purification: Flash chromatography [SiO2, Et3N:CH2Cl2:hexanes (2:39:59)] to obtain the title 
compound 6.75 as brownish semisolid (27 mg, 0.074 mmol, 45%). 
Rf : 0.4 
IR: νmax 3673, 2925, 2888, 2850, 1906, 1584, 1537, 1274, 1186, 1036 cm
-1.   
1H NMR (CDCl3, 500 MHz): δ 8.44 (2H, d, J = 10.1 Hz), 7.65 (1H, d, J = 8.0 Hz), 7.30-7.28 
(1H, m), 7.14 (1H, d, J = 1.6 Hz), 7.01 (1H, s), 6.68 (1H, d, J = 7.8 Hz), 6.66-6.58 (1H, m), 
6.57-6.54 (2H, m), 3.49 (1H, ddd, J = 12.0, 9.8, 2.0 Hz), 3.36 (1H, ddd, J = 12.2, 9.6, 2.4 Hz), 
3.16-3.02 (4H, m), 2.87-2.79 (2H, m). 
13C NMR (CDCl3, 125 MHz): δ 141.73, 141.39, 141.23, 138.87, 137.95, 135.58, 135.08, 
133.93, 133.70, 133.60, 131.69, 126.63, 124.30, 35.61, 34.45, 33.14, 32.48. 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C21H18Br
79N 364.0695; Found 364.0691; 
C21H29Br












General procedure C was followed using (±)-4,12-dibromo-[2.2]paracyclophane 6.63 (50 mg, 
0.14 mmol, 1.0 eq.), pyridine-4-sulfinate 6.53 (45 mg, 0.27 mmol, 2 eq.), K2CO3 (28 mg, 0.21 
mmol, 1.5 eq.), PCy3 (15 mg, 0.069 mmol, 40 mol%), Pd(OAc)2 (3 mg, 0.017 mmol, 10 mol%), 
DMA (0.69 ml) for 22 hrs. 
Purification: Flash chromatography [SiO2, EtOAc : hexanes (20:80)] to obtain the title 
compound 6.76 as yellowish semisolid (18 mg, 0.049 mmol, 36%). 
Rf : 0.6 
IR: νmax 3742, 3682, 3673, 3649, 3626, 2977, 2966, 2904, 2225, 2166, 1990, 1574, 1399, 1248, 
1065 cm-1 
1H NMR (CDCl3, 500 MHz): δ 8.74 (d, J = 5.7 Hz, 2H, H-21, H-19), 7.60 (d,  J = 4.5 Hz, 2H, 
H-22, H-18), 7.15 (s, 1H, H-4), 6.75 (d,  J = 7.4 Hz, 1H, H-12), 6.66-6.59 (m, 4H, H-8, H-7, 
H-15, H-16), 3.59-3.52 (m, 2H, H-9a, H-9b), 3.24-3.18 (m, 2H, H-1a, H-1b), 2.95-2.83 (m, 
3H, H-2a, H-10a, H-10b), 2.41-2.36 (m, 1H, H-2b)  
13C NMR (CDCl3, 125 MHz): δ 149.22 (C-21, C-19), 141.42 (C-17), 139.95 (C-11), 139.06 
(C-14), 138.51 (C-3), 136.89 (C-5), 136.33 (C-12), 135.04 (C-15), 133.71 (C-6), 133.45 (C-4, 
C-8), 131.71 (C-16, C-7), 128.75 (C-18), 125.98 (C-13), 124.50 (C-22), 36.01 (C-2), 34.35 (C-
10), 33.69 (C-9), 32.42 (C-1). 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C21H19Br
79N 364.0695; Found 364.0693; 
C21H19Br









General procedure C was followed using (±)-4,16-dibromo-[2.2]paracyclophane 6.68 (50 mg, 
0.14 mmol, 1.0 eq.), pyridine-2-sulfinate 6.50 (45 mg, 0.27 mmol, 2 eq.), K2CO3 (28 mg, 0.21 
mmol, 1.5 eq.), PCy3 (15 mg, 0.069 mmol, 40 mol%), Pd(OAc)2 (3 mg, 0.014 mmol, 10 mol%), 
DMA (0.69 ml). 
Purification: Flash chromatography [SiO2, EtOAc : hexanes (30:70)] to obtain the title 
compound 6.71 as yellowish semisolid (18 mg, 0.04 mmol, 36% yield). 
Rf : 0.5 
IR: νmax 3674, 2988, 2899, 2253, 2154, 2000, 1967, 1471, 1393, 1204 cm
-1  
1H NMR (CDCl3, 500 MHz): δ  8.82 (d, J = 4.2 Hz, 1H, H-19), 7.84 (d,  J = 7.3 Hz, 1H, H-
22), 7.52 (d,  J = 7.8 Hz, 1H, H-21), 7.32 (t, J = 6.1 Hz, H-20), 7.22 (d,  J = 7.7 Hz, 1H,  H-
12), 6.94 (s, 1H, H-15), 6.65-6.61 (m, 3H, H-13, H-8, H-7), 3.66 (td,  J = 10.2, 4.0 Hz, 1H, H-
10a), 3.56 (td,  J = 12.8, 2.2 Hz, 1H, H-10b), 3.30-3.25 (m, 1H, H-9a) 3.13-2.95 (m, 3H, H-9a, 
H-2a, H-2b), 2.87 (m, 1H, H-1a), 2.78 (m, 1H, H-1b).  
13C NMR (CDCl3, 125 MHz): δ 158.96 (C-17), 149.67 (C-19), 141.79 (C-6), 139.37 (C-14), 
138.76 (C-3), 137.62 (C-5), 136.22 (C-11), 137.01 (C-16), 135.29 (C-8), 134.51 (C-15), 132.87 
(C-7), 129.92 (C-13), 129.38 (C-20), 129.08 (C-12), 126.46 (C-4), 124.43 (C-22), 121.46 (C-
21), 35.38 (C-1), 34.54 (C-9), 33.93 (C-10), 33.34 (C-2) 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C21H19Br
79N 364.0695; Found 364.0693; 
C21H29Br










General procedure C was followed using (±)-4,16-dibromo-[2.2]paracyclophane 6.63 (60 mg, 
0.16 mmol, 1.0 eq.), pyridine-3-sulfinate 6.51 (54 mg, 0.33 mmol, 2 eq.), K2CO3 (34 mg, 0.25 
mmol, 1.5 eq.), PCy3 (18 mg, 0.066 mmol, 40 mol%), Pd(OAc)2 (4 mg, 0.016 mmol, 10 mol%), 
DMA (0.82 ml) for 21 hrs. 
Purification: Flash chromatography [SiO2, Et3N:CH2Cl2:hexanes (2:39:59)] to obtain the title 
compound 6.78 as yellowish semisolid (29 mg, 0.07 mmol, 48% yield). 
Rf : 0.4 
IR: νmax 3852, 3743, 3674, 2976, 2252, 2177, 20004, 1975, 1472, 1380, 1078.01 cm
-1  
1H NMR (CDCl3, 500 MHz): δ 8.77 (d,  J = 1.7 Hz, 1H, H-18), 8.65 (d,  J = 4.7 Hz, 1H, H-
20), 7.80 (dt,  J = 6.1, 1.7 Hz, 1H, H-22), 7.44 (dd,  J = 7.8, 4.9 Hz, 1H, H-15), 7.25 (dd,  J = 
7.7, 1.6 Hz, 1H, H-21), 6.65-6.61 (m, 3H, H-5, H-7, H-8), 6.57-6.54 (m, 2H, H-12, H-13), 3.60-
3.55 (m, 1H, H-10a), 3.37 (ddt,  J = 29.0, 10.4, 5.9 Hz, 2H, H-9a, H-9b), 3.12-3.02 (m, 2H, H-
2a, H-2b), 2.97-2.91 (m, 1H, H-10b), 2.83-2.77 (m, 1H, H-1a), 2.75-2.68 (m, 1H, H-1b). 
13C NMR (CDCl3, 125 MHz): δ 150.47 (C-18), 148.10 (C-20), 141.59 (C-9), 139.91 (C-6), 
138.98 (C-17), 138.63 (C-3), 137.48 (C-14), 136.96 (C-5), 136.74 (C-16), 136.52 (C-11), 
135.29 (C-22), 133.93 (C-8), 132.13 (C-15), 129.20 (C-13), 128.70 (C-7), 126.65 (C-21), 
123.46 (C-4), 35.63 (C-9), 34.34 (C-1), 33.87 (C-10), 33.20 (C-2).  
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C21H19Br
79N 364.0695; Found 364.0693; 
C21H19Br








4-Bromo-16-(pyridin-4-yl)[2.2]paracyclophane 6.79 and 4-Bromo-16-(pyridin-4-
ylthio)[2.2]paracyclophane 6.80 
 
General procedure C was followed using (±)-4,16-dibromo-[2.2]paracyclophane 6.68 (60 mg, 
0.16 mmol, 1.0 eq.), pyridine-4-sulfinate 6.53 (54 mg, 0.33 mmol, 2 eq.), K2CO3 (34 mg, 0.25 
mmol, 1.5 eq.), PCy3 (18 mg, 0.066 mmol, 40 mol%), Pd(OAc)2 (4 mg, 0.016 mmol, 10 mol%), 
DMA (0.82 ml) for 19 hrs.  
Purification: Flash chromatography [SiO2, Et3N:CH2Cl2:hexanes (2:39:59)] gave the title 
compound 6.79 as yellowish semisolid (15 mg, 0.04 mmol, 30%) and the by-product 6.80 as 
yellowish semisolid (10 mg, 0.04 mmol, 20%). 
Rf : 0.5 
IR: νmax 3674, 2980, 2968, 2905, 2252, 2023, 1966, 1596, 1472, 1383 cm
-1 
1H NMR (CDCl3, 500 MHz): δ 8.73 (d,  J = 5.3 Hz, 2H, H-19, H-21), 7.41 (d,  J = 5.9 Hz, 2H, 
H-18, H-22), 7.26 (dd,  J = 7.7, 1.6 Hz, 1H, H-15), 6.65-6.63 (m, 3H, H-13, H-12, H-5), 6.56-
6.51 (m, 2H, H-8, H-7), 3.61 (td,  J = 12.8, 2.1 Hz, 1H, H-10a), 3.41 (td,  J = 14.1, 4.6 Hz, 1H, 
H-10b), 3.33 (dq,  J = 7.5, 5.6 Hz, 1H, H-2a), 3.12-3.02 (m, 2H, H-9a, H-9b), 2.97 (dq,  J = 
7.8, 5.5 Hz, 1H, H-2b), 2.83 (dddd,  J = 28.1, 17.9, 10.2, 4.5 Hz, 2H, H-1a, H-1b). 
13C NMR (CDCl3, 125 MHz): δ 150.02 (C-21, C-19), 148.56 (C-17), 141.55 (C-6), 139.95 (C-
14), 139.63 (C-3), 139.00 (C-16), 137.51 (C-11, C-5), 136.80 (C-8), 135.41 (C-15), 133.91 (C-
13), 132.09 (C-7), 129.64 (C-22), 128.84 (C-18), 126.65 (C-12), 124.54 (C-4), 35.62 (C-1), 
34.37 (C-9), 33.39 (C-10), 33.18 (C-2) 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H18Br
79N 364.0701; Found 364.0691; 
C21H29Br








Rf : 0.6 
IR: νmax 2971, 2935, 2252, 2160, 2017, 2010, 1992, 1575, 1478, 1393, 1066 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 8.46 (s, 1H, H-18), 8.38 (d,  J = 3.5 Hz, 1H, H-20), 7.40-7.37 
(m, 1H, H-22), 7.13-7.11 (m, 1H, H-21), 7.01 (d,  J = 7.7 Hz, 1H, H-15), 6.61-6.51 (m, 4H, H-
13, H-12, H-8, H-7), 6.46-6.43 (m, 1H, H-5), 3.44-3.37 (m, 1H, H-1a), 3.30-2.92 (m, 6H, H-
1b, H-10a, H-10b, H-9a, H-9b, H-2a), 2.84-2.77 (m, 1H, H-2b). 
13C NMR (CDCl3, 125 MHz): δ 142.39 (C-17), 141.14 (C-20), 139.31 (C-18), 139.31 (C-6), 
138.69 (C-3), 138.31 (C-21), 137.41 (C-14), 135.68 (C-4), 135.48 (C-22), 134.62 (C-11), 
134.07 (C-5), 133.45 (C-16), 133.04 (C-8), 132.19 (C-12), 129.92 (C-17), 129.45 (C-15), 
128.64 (C-13), 35.23 (C-1), 34.86 (C-9), 34.61 (C-2), 34.08 (C-10) 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C21H19Br
79NS 396.0416; Found 396.0415; 
C21H19Br












Methyl 13-(pyridin-3-yl)[2.2]paracyclophane-4-carboxylate 6.82 
 
General procedure was followed using 4-bromo[2.2]paracyclophane-13-carboxylate 6.81 (60 
mg, 0.17 mmol,  1.0 eq.), pyridine-2-sulfinate 6.50 (58 mg, 0.35 mmol, 2 eq.), K2CO3 (36 mg, 
0.21 mmol, 1.5 eq.), PCy3 (20 mg, 0.069 mmol, 40 mol%), Pd(OAc)2 (4 mg, 0.017 mmol, 10 
mol%), 1,4-dioxane (0.87 ml) for 36 hrs. 
Purification: Flash chromatography [SiO2, EtOAc: hexanes (30:70)] to obtain the title 
compound 6.82 as a white solid (41 mg, 0.12 mmol, 68% yield).* 
Rf : 0.4 
IR: νmax 3866, 3813, 3746, 3673, 2988, 2927, 1712, 1582.83, 1556.83, 1457, 1449, 1266 cm
-1  
1H NMR (CDCl3, 500 MHz): δ  8.73 (d,  J = 4.7 Hz, 1H, H-21), 7.73 (td,  J = 7.7, 1.7 Hz, 1H, 
H-19), 7.44 (d,  J = 7.9 Hz, 1H, H-18), 7.22 (m, 1H, H-20), 7.07 (s, 1H, H-5), 6.82 (d,  J = 7.7 
Hz, 1H, H-8), 6.77 (d,  J = 7.7 Hz, H-7), 6.70 (d,  J = 7.7 Hz, H-5), 6.59 (d,  J = 6.2 Hz, 1H, 
H-16), 6.53 (s, 1H, H-12), 3.98 (t,  J = 10.3 Hz, H-1a), 3.79 (ddd,  J = 13.5, 9.45, 7.05 Hz, 2H, 
H-1a, H-2a), 3.51(s, 3H, OMe), 3.29-3.13 (m, 4H, H-1b, H-2b, H-9a, H-9b), 2.90-2.84 (m, 2H, 
H-10a, H-10b). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C23H22NO2 344.1645; Found 344.1637. 









Methyl 13-(pyridin-3-yl)[2.2]paracyclophane-4-carboxylate 6.82 
 
General procedure was followed using 4-bromo[2.2]paracyclophane-13-carboxylate 6.81 (60 
mg, 0.17 mmol,  1.0 eq.), pyridine-3-sulfinate 6.51 (58 mg, 0.35 mmol, 2 eq.), K2CO3 (36 mg, 
0.21 mmol, 1.5 eq.), PCy3 (20 mg, 0.069 mmol, 40 mol%), Pd(OAc)2 (4 mg, 0.017 mmol, 10 
mol%), 1,4-dioxane (0.87 ml).  
Purification: Flash chromatography [SiO2, EtOAc: hexanes (30:70)] to obtain the title 
compound 6.82 as a white solid (12 mg, 0.034 mmol, 20% yield). 
Rf : 0.5 
IR: νmax 3793, 3682, 3674, 3491, 2988, 2970, 2899, 2252, 2202, 2157, 1711.57, 1449, 1406, 
1393, 1382, 1075, 1065, 1057 cm-1  
 
1H NMR (CDCl3, 500 MHz): δ  8.63 (d,  J = 1.85 Hz, 1H, H-18), 8.57 (d,  J = 4.7 Hz, 1H, H-
20), 7.73 (dt,  J = 7.8, 1.7 Hz, 1H, H-22), 7.37-7.33 (m, 2H, H-5, H-12), 6.86 (d,  J = 7.7, 1.65 
Hz, 1H, H-21), 6.80 (d,  J = 7.7 Hz, 1H, H-8), 6.72-6.70 (m, 2H, H-15, H-16), 6.60 (dd,  J = 
7.7, 1.5 Hz, 1H, H-7), 4.01 (dd,  J = 12.5, 8.9 Hz, 1H, H-1a), 3.55 (s, 3H, -OMe), 3.46-3.40 
(m, 1H, H-1b), 3.33-3.20 (m, 3H, H-2a, H-2b, H-9a), 3.13-3.06 (m, 2H, H-10a, H-10b), 2.87-
2.81 (m, 1H, H-9b). 
13C NMR (CDCl3, 125 MHz): δ 166.30 (-C=O), 150.34 (C-18), 147.88 (C-19), 143.38 (C-14), 
139.75 (C-17), 139.45 (C-6), 138.74 (C-3), 137.77 (C-11), 136.69 (C-4), 136.51 (C-2), 136.29 
(C-13), 135.65 (C-7), 134.58 (C-15), 133.54 (C-16), 130.24 (C-12), 128.12 (C-21), 123.07 (C-
8), 51.47 (-Me, C-24), 37.25 (C-1), 35.03 (C-2), 34.96 (C-9), 32.68 (C-10). 






Ethyl 4-bromo[2.2]paracyclophane-12-carboxylate 6.101 
 
A solution of n-BuLi (1.2 M in hexanes; 0.80 ml, 1.60 mmol, 1.17 eq.) was added dropwise 
over 15 min. to a solution of 4,12-dibromo[2.2]paracyclophane 6.63 (500 mg, 1.37 mmol, 1.0 
eq.) in THF (11 ml, 0.1M), at -78 0 °C. The resulting yellow solution was stirred at -78 0 °C 
for 40 min. Ethyl chloroformate (0.16 ml in 1 ml dry THF, 1.64 mmol, 1.2 eq.) was added 
dropwise over 10 min. The solution was warmed to room temperature overnight. Saturated 
NH4Cl (10 ml) was added to the reaction mixture at 0 °C and the resulting organic phases were 
separated. The aqueous phase was extracted with EtOAc (3 × 15 ml), the combined organics 
dried (MgSO4) and concentrated under reduced pressure to give a yellow residue.  
Purification: Flash chromatography [SiO2, EtOAc:hexanes (3:97)] to obtain the title compound 
6.101 as a white semisolid (357 mg, 0.99 mmol, 73%). 
Rf : 0.7 
IR: νmax 3683, 3675, 2989, 2900, 2304, 1976, 1696, 1407, 1265, 1076 cm
-1. 
1H NMR (CDCl3, 400 MHz): δ 7.79 (1H, d, J = 1.6 Hz), 6.69 (1H, d, J = 7.8, 1.6 Hz), 6.65 
(1H, d, J = 1.7 Hz), 6.61-6.59 (2H, m), 6.51 (1H, d, J = 7.5 Hz), 4.51 (1H, dq, J = 10.7, 7.1 
Hz), 4.38 (1H, dq, J = 10.7, 7.1 Hz), 4.13 (1H, dd, J = 12.2, 10.6 Hz), 3.52 (1H, ddd, J = 11.9, 
10.0, 1.5 Hz), 3.28 (1H, ddd, J = 13.1, 10.1, 1.6 Hz), 3.16 (2H, q, J = 11.4 Hz), 3.07 (1H, ddd, 
J = 13.1, 10.1, 7.5 Hz), 2.88-2.79 (2H, m), 1.49 (3H, t, J = 7.1 Hz).  
13C NMR (CDCl3, 125 MHz): δ 166.93, 142.01, 142.05, 139.50, 138.87, 136.61, 135.90, 
135.46, 135.01, 131.25, 131.04, 130.74, 126.68, 60.56, 36.01, 35.68, 34.04, 32.60, 14.53.  
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C19H20Br
79O2 359.0641; Found 359.0647;  
C19H20Br
81O2 361.0621; Found 361.0625.              
 
 




4-Bromo[2.2]paracyclophane-12-carboxylic acid 6.102 
 
A solution of ethyl 4-bromo[2.2]paracyclophane-12-carboxylate 6.101 (357 mg, 0.99 mmol, 
1.0 eq.) in 25% methanolic KOH (10 ml) was heated to reflux overnight. The reaction mixture 
cooled to room temperature and diluted with 10 ml H2O. The reaction mixture was acidified 
cautiously with concentrated HCl till pH 3 and extracted with CH2Cl2 (3 × 10 ml). The 
combined organics dried (MgSO4) and concentrated under reduced pressure to yield a white 
residue of 4-bromo[2.2]paracyclophane-12-carboxylic acid 6.101 (300 mg, 0.91 mmol, 91% 
yield). The crude was used in the next reaction without purification. 
Rf : 0.3 [EtOAc: hexanes (30:70)] 
IR: νmax 3046, 2930, 2852, 1679, 1587, 1479, 1319, 1268, 1197, 1035 cm
-1. 
1H NMR (CDCl3, 400 MHz): δ 7.96 (1H, s), 6.74 (1H, dd, J = 7.8, 1.4 Hz), 6.69-6.67 (2H, m), 
6.64 (1H, dd, J = 8.1, 1.6 Hz), 6.53 (1H, d, J = 7.7 Hz), 4.24 (1H, dd, J = 12.1, 10.4 Hz), 3.55 
(1H, d, J = 12.2, 10.2 Hz), 3.32-3.23 (1H, m), 3.22-3.02 (3H, m), 2.96-2.79 (2H, m).  
13C NMR (CDCl3, 125 MHz): δ 171.77, 143.09, 142.09, 139.72, 138.98, 137.71, 136.19, 
135.81, 135.00, 131.87, 131.17, 129.31, 126.80, 36.24, 35.78, 34.09. 32.51.  
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C16H14Br
79O2 329.0172; Found 329.0175; 
C17H14Br
81O2 331.0151; Found 331.0155.                                                                                                    












To 4-bromo[2.2]paracyclophane-12-carboxylic acid 6.101 (300 mg, 0.91 mmol, 1.0 eq.) in an 
anhydrous CH2Cl2 (9 ml, 0.1 M) was added oxalyl chloride (0.39 ml, 4.54 mmol, 5 eq.) and 
DMF (3 drops) under argon at 0 °C. The reaction mixture was stirred for 3 hrs at room 
temperature and concentrated under reduced pressure to afford the crude 4-
bromo[2.2]paracyclophane-12-carbonyl chloride 6.102 (300 mg, 0.90 mmol). The crude was 
used in the next reaction without purification. 
To a suspension of the crude 4-bromo[2.2]paracyclophane-12-carbonyl chloride 6.102 (300 
mg, 0.86 mmol, 1.0 eq.) in acetone (20 ml) was added dropwise an aqueous solution of NaN3 
(65 mg, 0.90 mmol, 10.0 eq.) in water (10 ml) at 0 °C. The reaction mixture was stirred for 2 
hrs. An ice-cold water (30 ml) was added and the precipitate was filtered off. The precipitates 
were further washed three times with an ice-cold water and dried to obtain the an off white 
powder of 4-bromo[2.2]paracyclophane-12-carbonyl azide 6.103 (229 mg, 0.64 mmol). The 
crude was used further without purification. 
The crude 4-bromo[2.2]paracyclophane-12-carbonyl azide 6.103 (229 mg, 0.64 mmol, 1.0 eq.) 
was refluxed in dry toluene (10 ml) under argon for 3 hrs. The solvent was evaporated under 
reduced pressure to afford a white solid of 4-bromo-12-(isocyanato)[2.2]paracyclophane 6.104 
(209 mg, 0.63 mmol). The crude was used in the next reaction without purification. 
The crude 4-bromo-12-(isocyanato)[2.2]paracyclophane 6.104 (209 mg, 0.63 mmol, 1.0 eq) 
was dissolved in ethanol (20 ml) and refluxed for 2 hrs. After cooling down, 20% aqueous 
KOH solution (10 ml) was added, and the resulting reaction mixture was refluxed for 45 hrs. 
To the cooled reaction mixture was added 20% aqueous KOH (20 ml), and mixture was stirred 
for 5 minutes. The precipitates were removed by filtration and purified. 
Purification: Flash chromatography [SiO2, EtOAc:Hexane (30:70)] to obtain the title 





Rf : 0.4 
IR: νmax 3472, 3381, 2998, 2925, 2855, 1615, 1497, 1288, 1034 cm
-1. 
1H NMR (CDCl3, 500 MHz): δ 7.30 (1H, d, J = 1.6 Hz), 6.60 (1H, d, J = 7.7 Hz), 6.45 (1H, d, 
J = 7.7 Hz), 6.38 (1H, d, J = 7.6 Hz), 6.16 (1H, d, J = 7.7 Hz), 6.11 (1H, s), 3.52 (2H, bs), 3.42 
(1H, ddd, J = 12.1, 9.9, 1.7 Hz), 3.15 (1H, d, J = 10.8, 7.4, 3.4 Hz), 3.06-3.03 (2H, m), 3.01-
2.91 (2H, m), 2.84-2.79 (1H, m), 2.71-2.65 (1H, m). 
13C NMR (CDCl3, 125 MHz): δ 144.92, 141.25, 141.51, 138.28, 135.32, 134.41, 131.92, 
130.96, 125.93, 124.33, 122.71, 117.59, 35.55, 32.91, 32.31, 32.11. 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C16H17Br
79N 302.0539; Found 302.0536; 
C16H17Br
81N 304.0518; Found 304.0514.                                                                                                    




















General procedure A was followed using (±)-4-bromo-12-amino[2.2]paracyclophane 6.105 (40 
mg, 0.11 mmol, 1.0 eq.), pyridine-2-sulfinate 6.50 (36 mg, 0.22 mmol, 2 eq.), K2CO3 (23 mg, 
0.21 mmol, 1.5 eq.), PCy3 (12 mg, 0.043 mmol, 40 mol%), Pd(OAc)2 (2 mg, 0.011 mmol, 10 
mol%), DMA (0.55 ml) for 22 hrs. 
Purification: Flash chromatography [SiO2, CH2Cl2:hexanes (40:60)] to obtain the title 
compound 6.109 as a brownish semisolid (20 mg, 0.06 mmol, 61% yield). 
Rf : 0.4 
IR: νmax 3912, 3845, 3769, 3741, 3683, 3658, 3612, 3403, 2988, 2968, 2929, 2849, 2251, 2197, 
2189, 1586, 1462, 1425, 1065 cm-1  
1H NMR (CDCl3, 500 MHz): δ 8.80 (d,  J = 4.7 Hz, 1H, H-19), 7.75 (td,  J = 7.6, 1.7 Hz, 1H, 
H-21), 7.52 (d,  J = 1.7 Hz, 1H, H-22), 7.44 (d,  J = 7.8 Hz, 1H, H-20), 7.27 (tdd,  J = 7.2, 4.8 
0.9, Hz, 1H, H-4), 6.70 (d,  J = 7.7 Hz, 1H, H-7), 6.45 (dd,  J = 7.7, 1.5 Hz, 1H, H-8), 6.41 (d,  
J = 7.6 Hz, 1H, H-15), 6.23 (dd,  J = 7.7, 1.5 Hz, 1H, H-16), 5.57 (d,  J = 1.2 Hz, 1H, H-9a), 
4.14 (bs, 2H, -NH2), 3.43 (td,  J = 13.8, 3.8 Hz, 1H, H-9a), 3.27-3.22 (m, 1H, H-9b), 3.20-3.14 
(m, 2H, H-2a, H-2b), 3.00 (td,  J = 14.6 Hz, 1H, H-1a), 2.80-2.73 (m, 2H, H-10a, H-10b), 2.58 
(d,  J = 14.7, 4.6 Hz, 1H, H-1b). 
13C NMR (CDCl3, 125 MHz): δ 159.18 (C-17), 149.95 (C-19), 146.42 (C-13), 140.96 (C-21), 
140.30 (C-3), 138.77 (C-11), 137.01 (C-6), 135.95 (C-5), 134.47 (C-4), 133.76 (C-15), 127.55 
(C-8), 125.12 (C-20), 124.64 (C-16), 123.17 (C-8), 121.42 (C-16), 120.15 (C-12), 34.48 (C-2), 
33.37 (C-10), 32.60 (C-9), 31.84 (C-1). 







General procedure was followed using (±)-4-bromo-5-formyl[2.2]paracyclophane 6.111 (50 
mg, 0.16 mmol, 1.0 eq.), pyridine-4-sulfinate 6.53 (53 mg, 0.32 mmol, 2 eq.), K2CO3 (33 mg, 
0.24 mmol, 1.5 eq.), PCy3 (18 mg, 0.064 mmol, 40 mol%), Pd(OAc)2 (4 mg, 0.016 mmol, 10 
mol%), DMA (0.8 ml) for 36 hrs. 
Purification: Flash chromatography [SiO2, EtOAc: hexanes (3:7) + Et3N] to obtain the title 
compound 6.115 as white solid (30 mg, 0.09 mmol, 60% yield). 
Rf : 0.4 
IR: νmax 3835, 3746, 3685, 2951, 2923, 2850, 2749, 1907, 1759, 1673, 1589, 1553, 1497, 1446, 
1409, 1158 cm-1 
1H NMR (CDCl3, 500 MHz): δ 9.50 (s, 1H, -CHO), 8.76 (d,  J = 5.3 Hz, 2H, H-19, H-22), 7.39 
(bs,1H, H-22), 7.14 (  ,1H, H-18), 6.84  (d,  J = 9.75 Hz, 1H, H-8), 6.76  (dd,  J = 9.7, 2.1 Hz, 
2H, H-7), 6.66-6.62 (m, 2H, H-12, H-13), 6.55 (dd,  J = 9.9, 2.2 Hz, 1H, H-15), 3.97-3.87 (m, 
1H, H-20), 3.35-3.26 (m, 2H, H-9a, H-9b), 3.06-2.99 (m, 1H, H-2b), 2.97-2.80 (m, 4H, H-1a, 
H-1b, H-10a, H-10b) 
13C NMR (CDCl3, 125 MHz): δ 192.17 (C-23), 149.65 (C-21), 144.41 (C-19), 142.63 (C-17), 
142.09 (C-4), 140.57 (C-6), 139.15 (C-3), 138.95 (C-11, C-14), 138.36 (C-5), 135.93 (C-12, 
C-13), 133.37 (C-15, C-16), 132.15 (C-8), 131.24 (C-7), 129.61 (C-18), 126.65 (C-22), 35.39 
(C-1), 35.20 (C-10), 34.91 (C-2), 32.40 (C-9). 









General procedure A was followed using (±)-4-bromo-5-amino[2.2]paracyclophane 6.116 (50 
mg, 0.16 mmol, 1.0 eq.), pyridine-2-sulfinate 6.50 (55 mg, 0.33 mmol, 2 eq.), K2CO3 (34 mg, 
0.25 mmol, 1.5 eq.), PCy3 (19 mg, 0.066 mmol, 40 mol%), Pd(OAc)2 (4 mg, 0.017 mmol, 10 
mol%), DMA (0.83 ml) for 48 hrs.  
Purification: Flash chromatography [SiO2, CH2Cl2:hexanes (40:60)] to obtain the title 
compound 6.117 as a brownish semisolid (19 mg, 0.06 mmol, 38% yield). 
Rf : 0.3 
IR: νmax 3799, 3743, 3674, 3156, 2988, 2899, 2252, 2199, 2148, 2031, 1793, 1647, 1467, 
1393, 1066 cm-1  
 
1H NMR (CDCl3, 500 MHz): δ 8.76 (d,  J = 4.8 Hz, 1H, H-20), 7.71 (td,  J = 7.7, 1.7 Hz, 1H, 
H-18), 7.27 (d,  J = 7.8 Hz, 2H, H-19, H-17), 7.20 (t,  J = 5.2 Hz, 1H, H-7), 6.68 (d,  J = 7.8 
Hz, 1H, H-8), 6.63 (d,  J = 7.7 Hz, 1H, H-11), 6.58 (d,  J = 7.7 Hz, 1H, H-12), 6.36 (d,  J = 7.6 
Hz, 1H, H-15), 6.27 (d,  J = 7.6 Hz, 1H, H-16), 5.14 (bs, 2H, -NH2), 3.25-3.08 (m, 4H, H-9a, 
H-9b, H-10a, H-10b), 2.80 (m, 2H, H-2a, H-2b), 2.76-2.70 (m, 1H, H-1a), 2.59-2.53 (m, 1H, 
H-1b). 
13C NMR (CDCl3, 125 MHz): δ 158.23 (C-16), 148.44 (C-20), 139.43 (C-14), 138.93 (C-11), 
138.75 (C-18), 135.98 (C-6), 135.51 (C-12), 132.57 (C-13), 132.15 (C-15), 131.08 (C-16), 
128.02 (C-3), 127.23 (C-19), 125.89 (C-5), 125.30 (C-7), 124.93 (C-4), 120.74 (C-8), 34.96 
(C-9), 34.50 (C-2), 33.33 (C-10), 32.07 (C-1). 








General procedure A was followed using (±)-4-bromo-5-amino[2.2]paracyclophane 6.116 (50 
mg, 0.16 mmol, 1.0 eq.), pyridine-3-sulfinate 6.51 (55 mg, 0.33 mmol, 2 eq.), K2CO3 (34 mg, 
0.25 mmol, 1.5 eq.), PCy3 (19 mg, 0.066 mmol, 40 mol%), Pd(OAc)2 (4 mg, 0.017 mmol, 10 
mol%), DMA (0.83 ml) for 48 hrs. 
Purification: Flash chromatography [SiO2, CH2Cl2 : hexanes (40:60)] to obtain the title 
compound 6.118 as a brownish semisolid (16 mg, 0.05 mmol, 32% yield). 
Rf : 0.3 
IR: νmax 3912, 3877, 3742, 3520, 2977, 2252, 2058, 2016, 1644, 1467, 1382, 1102 cm
-1 
 
1H NMR (CDCl3, 500 MHz): δ 8.34 (s, 1H, H-21), 8.28 (d,  J = 4.5 Hz, 1H, H-19), 7.18 (d,  J 
= 8.3 Hz, 1H, H-7), 7.06-7.03 (m, 2H, H-17, H-18), 6.64-6.62 (m, 2H, H-13, H-12), 6.47-6.45 
(m, 2H, H-15, H-16), 6.31 (d,  J = 7.6 Hz, 1H, H-8), 4.32 (bs, 2H, -NH2), 3.44-3.39 (m, 1H, H-
9a), 3.17-3.04 (m, 6H, H-2a, H-2b, H-1a, H-1b, H-10a, H-10b), 2.80-2.73 (m, 1H, H-9b).  
13C NMR (CDCl3, 125 MHz): δ 147.94 (C-21), 147.23 (C-19), 145.83 (C-4), 138.76 (C-14), 
138.41 (C-11), 136.48 (C-17), 134.97 (C-3), 133.72 (C-16), 133.52 (C-15), 132.40 (C-13), 
128.94 (C-12), 126.48 (C-8), 125.41 (C-6), 123.92 (C-18), 123.60 (C-5), 115.00 (C-7), 34.57 
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Bond distance and angle of crystal structures 
 
Figure 2.4. Crystal structure of (RSp,SRP)-4-tert-butyl[2.2]paracyclophane phosphine oxide 2.47.  
(Ellipsoids are drawn at a 50% probability level.) 
 
bond_distance 
P1 O1 1.504(4)    
P1 C4 1.817(5)    
P1 C17 1.819(5)    
P1 H1 1.52(4)    
C3 C4 1.397(6)    
C3 C8 1.391(6)    
C3 C2 1.519(7)    
S51 
 
C11 C12 1.385(7)    
C11 C16 1.383(7)    
C11 C10 1.520(7)    
C4 C5 1.396(6)    
C8 H8 0.9300    
C8 C7 1.397(6)    
C17 C18 1.529(6)    
C17 C19 1.532(6)    
C17 C20 1.531(6)    
C18 H18A 0.9600    
C18 H18B 0.9600    
C18 H18C 0.9600    
C7 H7 0.9300    
C7 C6 1.388(6)    
C14 C15 1.391(7)    
C14 C13 1.393(7)    
C14 C1 1.504(7)    
C19 H19A 0.9600    
C19 H19B 0.9600    
C19 H19C 0.9600    
S52 
 
C5 H5 0.9300    
C5 C6 1.377(6)    
C15 H15 0.9300    
C15 C16 1.386(7)    
C6 C9 1.518(6)    
C20 H20A 0.9600    
C20 H20B 0.9600    
C20 H20C 0.9600    
C12 H12 0.9300    
C12 C13 1.384(7)    
C13 H13 0.9300    
C2 H2A 0.9700    
C2 H2B 0.9700    
C2 C1 1.590(6)    
C1 H1A 0.9700    
C1 H1B 0.9700    
C16 H16 0.9300    
C10 H10A 0.9700    
C10 H10B 0.9700    
C10 C9 1.574(6)    
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C9 H9A 0.9700    
C9 H9B 0.9700    
 
angle 
O1 P1 C4 115.7(2) .    
O1 P1 C17 113.5(2) .    
O1 P1 H1 110.7(15) .    
C4 P1 C17 107.9(2) .    
C4 P1 H1 104.3(15) .    
C17 P1 H1 103.8(15) .    
C4 C3 C2 123.7(5) .    
C8 C3 C4 116.4(5) .    
C8 C3 C2 118.6(5) .    
C12 C11 C10 120.9(6) .    
C16 C11 C12 116.3(6) .    
C16 C11 C10 121.0(6) .    
C3 C4 P1 122.0(4) .    
C5 C4 P1 117.8(4) .    
C5 C4 C3 119.9(5) .    
C3 C8 H8 119.4 .    
S54 
 
C3 C8 C7 121.2(5) .    
C7 C8 H8 119.4 .    
C18 C17 P1 109.6(4) .    
C18 C17 C19 110.1(5) .    
C18 C17 C20 110.6(5) .    
C19 C17 P1 107.3(4) .    
C20 C17 P1 109.4(4) .    
C20 C17 C19 109.8(5) .    
C17 C18 H18A 109.5 .    
C17 C18 H18B 109.5 .    
C17 C18 H18C 109.5 .    
H18A C18 H18B 109.5 .    
H18A C18 H18C 109.5 .    
H18B C18 H18C 109.5 .    
C8 C7 H7 119.7 .    
C6 C7 C8 120.6(5) .    
C6 C7 H7 119.7 .    
C15 C14 C13 116.6(6) .    
C15 C14 C1 121.8(6) .    
C13 C14 C1 120.2(5) .    
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C17 C19 H19A 109.5 .    
C17 C19 H19B 109.5 .    
C17 C19 H19C 109.5 .    
H19A C19 H19B 109.5 .    
H19A C19 H19C 109.5 .    
H19B C19 H19C 109.5 .    
C4 C5 H5 118.9 .    
C6 C5 C4 122.1(6) .    
C6 C5 H5 118.9 .    
C14 C15 H15 119.4 .    
C16 C15 C14 121.2(6) .    
C16 C15 H15 119.4 .    
C7 C6 C9 120.8(5) .    
C5 C6 C7 116.5(5) .    
C5 C6 C9 121.4(5) .    
C17 C20 H20A 109.5 .    
C17 C20 H20B 109.5 .    
C17 C20 H20C 109.5 .    
H20A C20 H20B 109.5 .    
H20A C20 H20C 109.5 .    
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H20B C20 H20C 109.5 .    
C11 C12 H12 118.9 .    
C13 C12 C11 122.3(6) .    
C13 C12 H12 118.9 .    
C14 C13 H13 120.0 .    
C12 C13 C14 120.0(6) .    
C12 C13 H13 120.0 .    
C3 C2 H2A 109.1 .    
C3 C2 H2B 109.1 .    
C3 C2 C1 112.4(4) .    
H2A C2 H2B 107.9 .    
C1 C2 H2A 109.1 .    
C1 C2 H2B 109.1 .    
C14 C1 C2 113.5(4) .    
C14 C1 H1A 108.9 .    
C14 C1 H1B 108.9 .    
C2 C1 H1A 108.9 .    
C2 C1 H1B 108.9 .    
H1A C1 H1B 107.7 .    
C11 C16 C15 121.0(6) .    
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C11 C16 H16 119.5 .    
C15 C16 H16 119.5 .    
C11 C10 H10A 108.9 .    
C11 C10 H10B 108.9 .    
C11 C10 C9 113.4(4) .    
H10A C10 H10B 107.7 .    
C9 C10 H10A 108.9 .    
C9 C10 H10B 108.9 .    
C6 C9 C10 113.4(4) .    
C6 C9 H9A 108.9 .    
C6 C9 H9B 108.9 .    
C10 C9 H9A 108.9 .    
C10 C9 H9B 108.9 .    















P1 C4 C5 C6 -176.3(4) . . .    
O1 P1 C4 C3 -44.4(5) . . .    
O1 P1 C4 C5 129.9(4) . . .    
O1 P1 C17 C18 61.4(4) . . .    
O1 P1 C17 C19 -58.1(4) . . .    
O1 P1 C17 C20 -177.1(4) . . .    
C3 C4 C5 C6 -1.8(7) . . .    
C3 C8 C7 C6 -0.7(8) . . .    
C3 C2 C1 C14 10.1(7) . . .    
C11 C12 C13 C14 1.2(8) . . .    
C11 C10 C9 C6 -3.1(7) . . .    
C4 P1 C17 C18 -68.2(5) . . .    
C4 P1 C17 C19 172.3(4) . . .    
C4 P1 C17 C20 53.3(5) . . .    
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C4 C3 C8 C7 -14.4(7) . . .    
C4 C3 C2 C1 74.5(6) . . .    
C4 C5 C6 C7 -13.4(8) . . .    
C4 C5 C6 C9 153.8(5) . . .    
C8 C3 C4 P1 -170.1(4) . . .    
C8 C3 C4 C5 15.6(7) . . .    
C8 C3 C2 C1 -91.9(6) . . .    
C8 C7 C6 C5 14.6(8) . . .    
C8 C7 C6 C9 -152.7(5) . . .    
C17 P1 C4 C3 83.9(5) . . .    
C17 P1 C4 C5 -101.7(4) . . .    
C7 C6 C9 C10 87.3(7) . . .    
C14 C15 C16 C11 -0.4(8) . . .    
C5 C6 C9 C10 -79.3(7) . . .    
C15 C14 C13 C12 -14.0(8) . . .    
C15 C14 C1 C2 74.2(7) . . .    
C12 C11 C16 C15 -12.3(8) . . .    
C12 C11 C10 C9 85.8(7) . . .    
C13 C14 C15 C16 13.6(8) . . .    
C13 C14 C1 C2 -91.6(6) . . .    
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C2 C3 C4 P1 23.2(7) . . .    
C2 C3 C4 C5 -151.0(5) . . .    
C2 C3 C8 C7 152.9(5) . . .    
C1 C14 C15 C16 -152.7(5) . . .    
C1 C14 C13 C12 152.6(5) . . .    
C16 C11 C12 C13 12.0(8) . . .    
C16 C11 C10 C9 -78.3(7) . . .    
C10 C11 C12 C13 -152.9(5) . . .    











Figure 2.6: X-ray structure of tertiary phosphine oxide (RSp,SRP)-2.116. 
(Ellipsoids are drawn at a 50% probability level.) 
bond_distance 
P O 1.4902(13)    
P C17 1.8153(19)    
P C4 1.8246(18)    
P C24 1.845(2)    
C1 C14 1.513(3)    
C1 C2 1.579(3)    
C1 H1A 0.99    
C1 H1B 0.99    
S62 
 
C2 C3 1.515(3)    
C2 H2A 0.99    
C2 H2B 0.99    
C3 C8 1.398(3)    
C3 C4 1.412(2)    
C4 C5 1.403(2)    
C5 C6 1.394(3)    
C5 H5 0.95    
C6 C7 1.392(3)    
C6 C9 1.515(3)    
C7 C8 1.383(3)    
C7 H7 0.95    
C8 H8 0.95    
C9 C10 1.571(3)    
C9 H9A 0.99    
C9 H9B 0.99    
C10 C11 1.512(3)    
C10 H10A 0.99    
C10 H10B 0.99    
C11 C16 1.392(3)    
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C11 C12 1.397(3)    
C12 C13 1.388(3)    
C12 H12 0.95    
C13 C14 1.393(3)    
C13 H13 0.95    
C14 C15 1.396(3)    
C15 C16 1.387(3)    
C15 H15 0.95    
C16 H16 0.95    
C17 C22 1.402(3)    
C17 C18 1.404(3)    
C18 C19 1.386(3)    
C18 H18 0.95    
C19 C20 1.393(3)    
C19 H19 0.95    
C20 C21 1.394(3)    
C20 C23 1.505(3)    
C21 C22 1.388(2)    
C21 H21 0.95    
C22 H22 0.95    
S64 
 
C23 H23A 0.98    
C23 H23B 0.98    
C23 H23C 0.98    
C24 C27 1.530(3)    
C24 C25 1.534(3)    
C24 C26 1.535(3)    
C25 H25A 0.98    
C25 H25B 0.98    
C25 H25C 0.98    
C26 H26A 0.98    
C26 H26B 0.98    
C26 H26C 0.98    
C27 H27A 0.98    
C27 H27B 0.98    





O P C17 109.44(8) .    
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O P C4 113.44(8) .    
C17 P C4 107.21(8) .    
O P C24 110.53(8) .    
C17 P C24 109.72(8) .    
C4 P C24 106.38(8) .    
C14 C1 C2 112.28(17) .    
C14 C1 H1A 109.1 .    
C2 C1 H1A 109.1 .    
C14 C1 H1B 109.1 .    
C2 C1 H1B 109.1 .    
H1A C1 H1B 107.9 .    
C3 C2 C1 112.58(16) .    
C3 C2 H2A 109.1 .    
C1 C2 H2A 109.1 .    
C3 C2 H2B 109.1 .    
C1 C2 H2B 109.1 .    
H2A C2 H2B 107.8 .    
C8 C3 C4 116.84(18) .    
C8 C3 C2 116.87(17) .    
C4 C3 C2 124.80(16) .    
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C5 C4 C3 118.32(16) .    
C5 C4 P 119.88(13) .    
C3 C4 P 121.53(14) .    
C6 C5 C4 122.41(17) .    
C6 C5 H5 118.8 .    
C4 C5 H5 118.8 .    
C7 C6 C5 116.73(18) .    
C7 C6 C9 121.29(18) .    
C5 C6 C9 120.54(18) .    
C8 C7 C6 119.99(17) .    
C8 C7 H7 120 .    
C6 C7 H7 120 .    
C7 C8 C3 122.03(17) .    
C7 C8 H8 119 .    
C3 C8 H8 119 .    
C6 C9 C10 112.09(17) .    
C6 C9 H9A 109.2 .    
C10 C9 H9A 109.2 .    
C6 C9 H9B 109.2 .    
C10 C9 H9B 109.2 .    
S67 
 
H9A C9 H9B 107.9 .    
C11 C10 C9 111.97(17) .    
C11 C10 H10A 109.2 .    
C9 C10 H10A 109.2 .    
C11 C10 H10B 109.2 .    
C9 C10 H10B 109.2 .    
H10A C10 H10B 107.9 .    
C16 C11 C12 117.0(2) .    
C16 C11 C10 119.9(2) .    
C12 C11 C10 121.1(2) .    
C13 C12 C11 120.5(2) .    
C13 C12 H12 119.7 .    
C11 C12 H12 119.7 .    
C12 C13 C14 120.83(19) .    
C12 C13 H13 119.6 .    
C14 C13 H13 119.6 .    
C13 C14 C15 117.2(2) .    
C13 C14 C1 120.1(2) .    
C15 C14 C1 121.2(2) .    
C16 C15 C14 120.5(2) .    
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C16 C15 H15 119.8 .    
C14 C15 H15 119.8 .    
C15 C16 C11 121.0(2) .    
C15 C16 H16 119.5 .    
C11 C16 H16 119.5 .    
C22 C17 C18 117.94(17) .    
C22 C17 P 126.64(14) .    
C18 C17 P 115.41(14) .    
C19 C18 C17 121.06(18) .    
C19 C18 H18 119.5 .    
C17 C18 H18 119.5 .    
C18 C19 C20 121.10(18) .    
C18 C19 H19 119.4 .    
C20 C19 H19 119.4 .    
C19 C20 C21 117.84(18) .    
C19 C20 C23 121.4(2) .    
C21 C20 C23 120.7(2) .    
C22 C21 C20 121.77(18) .    
C22 C21 H21 119.1 .    
C20 C21 H21 119.1 .    
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C21 C22 C17 120.28(18) .    
C21 C22 H22 119.9 .    
C17 C22 H22 119.9 .    
C20 C23 H23A 109.5 .    
C20 C23 H23B 109.5 .    
H23A C23 H23B 109.5 .    
C20 C23 H23C 109.5 .    
H23A C23 H23C 109.5 .    
H23B C23 H23C 109.5 .    
C27 C24 C25 109.27(16) .    
C27 C24 C26 109.57(16) .    
C25 C24 C26 109.37(17) .    
C27 C24 P 114.18(13) .    
C25 C24 P 106.61(13) .    
C26 C24 P 107.73(13) .    
C24 C25 H25A 109.5 .    
C24 C25 H25B 109.5 .    
H25A C25 H25B 109.5 .    
C24 C25 H25C 109.5 .    
H25A C25 H25C 109.5 .    
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H25B C25 H25C 109.5 .    
C24 C26 H26A 109.5 .    
C24 C26 H26B 109.5 .    
H26A C26 H26B 109.5 .    
C24 C26 H26C 109.5 .    
H26A C26 H26C 109.5 .    
H26B C26 H26C 109.5 .    
C24 C27 H27A 109.5 .    
C24 C27 H27B 109.5 .    
H27A C27 H27B 109.5 .    
C24 C27 H27C 109.5 .    
H27A C27 H27C 109.5 .    










Figure 2.7: X-ray structure of gold complex of phosphine 2.137.AuCl. 




P O 1.4902(13)    
P C17 1.8153(19)    
P C4 1.8246(18)    
P C24 1.845(2)    
C1 C14 1.513(3)    
C1 C2 1.579(3)    
C1 H1A 0.99    
C1 H1B 0.99    
C2 C3 1.515(3)    
C2 H2A 0.99    
C2 H2B 0.99    
C3 C8 1.398(3)    
C3 C4 1.412(2)    
C4 C5 1.403(2)    
C5 C6 1.394(3)    
C5 H5 0.95    
C6 C7 1.392(3)    
C6 C9 1.515(3)    
C7 C8 1.383(3)    
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C7 H7 0.95    
C8 H8 0.95    
C9 C10 1.571(3)    
C9 H9A 0.99    
C9 H9B 0.99    
C10 C11 1.512(3)    
C10 H10A 0.99    
C10 H10B 0.99    
C11 C16 1.392(3)    
C11 C12 1.397(3)    
C12 C13 1.388(3)    
C12 H12 0.95    
C13 C14 1.393(3)    
C13 H13 0.95    
C14 C15 1.396(3)    
C15 C16 1.387(3)    
C15 H15 0.95    
C16 H16 0.95    
C17 C22 1.402(3)    
C17 C18 1.404(3)    
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C18 C19 1.386(3)    
C18 H18 0.95    
C19 C20 1.393(3)    
C19 H19 0.95    
C20 C21 1.394(3)    
C20 C23 1.505(3)    
C21 C22 1.388(2)    
C21 H21 0.95    
C22 H22 0.95    
C23 H23A 0.98    
C23 H23B 0.98    
C23 H23C 0.98    
C24 C27 1.530(3)    
C24 C25 1.534(3)    
C24 C26 1.535(3)    
C25 H25A 0.98    
C25 H25B 0.98    
C25 H25C 0.98    
C26 H26A 0.98    
C26 H26B 0.98    
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C26 H26C 0.98    
C27 H27A 0.98    
C27 H27B 0.98    





O P C17 109.44(8) .    
O P C4 113.44(8) .    
C17 P C4 107.21(8) .    
O P C24 110.53(8) .    
C17 P C24 109.72(8) .    
C4 P C24 106.38(8) .    
C14 C1 C2 112.28(17) .    
C14 C1 H1A 109.1 .    
C2 C1 H1A 109.1 .    
C14 C1 H1B 109.1 .    
C2 C1 H1B 109.1 .    
H1A C1 H1B 107.9 .    
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C3 C2 C1 112.58(16) .    
C3 C2 H2A 109.1 .    
C1 C2 H2A 109.1 .    
C3 C2 H2B 109.1 .    
C1 C2 H2B 109.1 .    
H2A C2 H2B 107.8 .    
C8 C3 C4 116.84(18) .    
C8 C3 C2 116.87(17) .    
C4 C3 C2 124.80(16) .    
C5 C4 C3 118.32(16) .    
C5 C4 P 119.88(13) .    
C3 C4 P 121.53(14) .    
C6 C5 C4 122.41(17) .    
C6 C5 H5 118.8 .    
C4 C5 H5 118.8 .    
C7 C6 C5 116.73(18) .    
C7 C6 C9 121.29(18) .    
C5 C6 C9 120.54(18) .    
C8 C7 C6 119.99(17) .    
C8 C7 H7 120 .    
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C6 C7 H7 120 .    
C7 C8 C3 122.03(17) .    
C7 C8 H8 119 .    
C3 C8 H8 119 .    
C6 C9 C10 112.09(17) .    
C6 C9 H9A 109.2 .    
C10 C9 H9A 109.2 .    
C6 C9 H9B 109.2 .    
C10 C9 H9B 109.2 .    
H9A C9 H9B 107.9 .    
C11 C10 C9 111.97(17) .    
C11 C10 H10A 109.2 .    
C9 C10 H10A 109.2 .    
C11 C10 H10B 109.2 .    
C9 C10 H10B 109.2 .    
H10A C10 H10B 107.9 .    
C16 C11 C12 117.0(2) .    
C16 C11 C10 119.9(2) .    
C12 C11 C10 121.1(2) .    
C13 C12 C11 120.5(2) .    
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C13 C12 H12 119.7 .    
C11 C12 H12 119.7 .    
C12 C13 C14 120.83(19) .    
C12 C13 H13 119.6 .    
C14 C13 H13 119.6 .    
C13 C14 C15 117.2(2) .    
C13 C14 C1 120.1(2) .    
C15 C14 C1 121.2(2) .    
C16 C15 C14 120.5(2) .    
C16 C15 H15 119.8 .    
C14 C15 H15 119.8 .    
C15 C16 C11 121.0(2) .    
C15 C16 H16 119.5 .    
C11 C16 H16 119.5 .    
C22 C17 C18 117.94(17) .    
C22 C17 P 126.64(14) .    
C18 C17 P 115.41(14) .    
C19 C18 C17 121.06(18) .    
C19 C18 H18 119.5 .    
C17 C18 H18 119.5 .    
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C18 C19 C20 121.10(18) .    
C18 C19 H19 119.4 .    
C20 C19 H19 119.4 .    
C19 C20 C21 117.84(18) .    
C19 C20 C23 121.4(2) .    
C21 C20 C23 120.7(2) .    
C22 C21 C20 121.77(18) .    
C22 C21 H21 119.1 .    
C20 C21 H21 119.1 .    
C21 C22 C17 120.28(18) .    
C21 C22 H22 119.9 .    
C17 C22 H22 119.9 .    
C20 C23 H23A 109.5 .    
C20 C23 H23B 109.5 .    
H23A C23 H23B 109.5 .    
C20 C23 H23C 109.5 .    
H23A C23 H23C 109.5 .    
H23B C23 H23C 109.5 .    
C27 C24 C25 109.27(16) .    
C27 C24 C26 109.57(16) .    
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C25 C24 C26 109.37(17) .    
C27 C24 P 114.18(13) .    
C25 C24 P 106.61(13) .    
C26 C24 P 107.73(13) .    
C24 C25 H25A 109.5 .    
C24 C25 H25B 109.5 .    
H25A C25 H25B 109.5 .    
C24 C25 H25C 109.5 .    
H25A C25 H25C 109.5 .    
H25B C25 H25C 109.5 .    
C24 C26 H26A 109.5 .    
C24 C26 H26B 109.5 .    
H26A C26 H26B 109.5 .    
C24 C26 H26C 109.5 .    
H26A C26 H26C 109.5 .    
H26B C26 H26C 109.5 .    
C24 C27 H27A 109.5 .    
C24 C27 H27B 109.5 .    
H27A C27 H27B 109.5 .    
C24 C27 H27C 109.5 .    
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